0001493152-21-000499.txt : 20210108 0001493152-21-000499.hdr.sgml : 20210108 20210107203101 ACCESSION NUMBER: 0001493152-21-000499 CONFORMED SUBMISSION TYPE: 10-Q PUBLIC DOCUMENT COUNT: 73 CONFORMED PERIOD OF REPORT: 20200930 FILED AS OF DATE: 20210108 DATE AS OF CHANGE: 20210107 FILER: COMPANY DATA: COMPANY CONFORMED NAME: BIOPLUS LIFE CORP. CENTRAL INDEX KEY: 0001746214 STANDARD INDUSTRIAL CLASSIFICATION: RETAIL-DRUG STORES AND PROPRIETARY STORES [5912] IRS NUMBER: 300987011 STATE OF INCORPORATION: NV FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 10-Q SEC ACT: 1934 Act SEC FILE NUMBER: 333-226885 FILM NUMBER: 21515318 BUSINESS ADDRESS: STREET 1: NO.9 & 10, JALAN P4/8B STREET 2: BANDAR TEKNOLOGI KAJANG CITY: SEMENYIH, SELANGOR STATE: N8 ZIP: 43500 BUSINESS PHONE: 60387032020 MAIL ADDRESS: STREET 1: NO.9 & 10, JALAN P4/8B STREET 2: BANDAR TEKNOLOGI KAJANG CITY: SEMENYIH, SELANGOR STATE: N8 ZIP: 43500 10-Q 1 form10-q.htm

 

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM 10-Q

 

[X] QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d)
OF THE SECURITIES EXCHANGE ACT OF 1934

 

For The Quarterly Period Ended September 30, 2020

 

or

 

[  ] TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d)
OF THE SECURITIES EXCHANGE ACT OF 1934

 

For the transition period from to

 

Commission File Number 333-226885

 

BIOPLUS LIFE CORPORATION

(Exact name of registrant issuer as specified in its charter)

 

Nevada   30-0987011

(State or other jurisdiction of

incorporation or organization)

  

(I.R.S. Employer

Identification No.)

 

No 9 & 10, Jalan P4/8B, Bandar Teknologi Kajang,

Semenyih, Selangor D.E., Malaysia 43500

(Address of principal executive offices)(zip code)

 

Issuer’s telephone number: +60 3 8703 2020

(Registrant’s telephone number, including area codes)

 

Securities registered pursuant to Section 12(b) of the Act: None

 

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.

YES [  ] NO [X]

 

Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (section 232.405 of this chapter) during the preceding twelve months (or shorter period that the registrant was required to submit and post such files).

YES [  ] NO [X]

 

Large accelerated filer [  ]   Accelerated filer [  ]
Non-accelerated filer [X]   Smaller reporting company [X]
    Emerging growth company [X]

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. [  ]

 

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).

 

Yes [  ] No [X]

 

APPLICABLE ONLY TO ISSUERS INVOLVED IN BANKRUPTCY

PROCEEDINGS DURING THE PRECEDING FIVE YEARS:

 

Indicate by check mark whether the registrant has filed all documents and reports required to be filed by Sections 12, 13 or 15(d) of the Securities Exchange Act of 1934 subsequent to the distribution of securities under a plan confirmed by a court.

 

Yes [  ] No [  ]

APPLICABLE ONLY TO CORPORATE ISSUERS:

 

Indicate the number of shares outstanding of each of the issuer’s classes of common stock, as of the latest practicable date.

 

Class   Outstanding at October 12, 2020
Common Stock, $.0001 par value   362,905,561

 

 

 

 
 

 

TABLE OF CONTENTS

 

    Page
PART I FINANCIAL INFORMATION  
ITEM 1. FINANCIAL STATEMENTS: F-1
  Condensed Consolidated Balance Sheets as of September 30, 2020 (unaudited) and December 31, 2019 (audited) F-2
  Condensed Consolidated Statements of Operations and Comprehensive Income (Loss) for the Nine Months Ended September 30, 2020 and 2019 (unaudited) F-3
  Consolidated Statement of Changes in Stockholders’ Equity for the Nine Months Ended September 30, 2020 F-4
  Condensed Consolidated Statements of Cash Flows for the Nine Months Ended September 30, 2020 and 2019 (unaudited) F-5
  Notes to the Condensed Consolidated Financial Statements F-6 - F-14
ITEM 2. MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS 3
ITEM 3. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK 9
ITEM 4. CONTROLS AND PROCEDURES 9
PART II OTHER INFORMATION  
ITEM 1 LEGAL PROCEEDINGS 10
ITEM 2 UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS 10
ITEM 3 DEFAULTS UPON SENIOR SECURITIES 10
ITEM 4 MINE SAFETY DISCLOSURES 10
ITEM 5 OTHER INFORMATION 10
ITEM 6 EXHIBITS 10
  SIGNATURES 11

 

2
 

 

PART I FINANCIAL INFORMATION

 

ITEM 1. FINANCIAL STATEMENTS:

 

BIOPLUS LIFE CORP.

CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

 

  Page
Condensed Consolidated Financial Statements  
   
Condensed Consolidated Balance Sheet for the Nine Months Ended September 30, 2020 and December 31, 2019 (audited) F-2
Condensed Consolidated Statements of Operations and Comprehensive Income (Loss) for the Nine Months Ended September 30, 2020 and 2019 (unaudited) F-3
Consolidated Statement of Changes in Stockholders’ Equity for the Nine Months Ended September 30, 2020 F-4
Condensed Consolidated Statements of Cash Flows for the Nine Months Ended September 30, 2020 and 2019 (unaudited) F-5
Notes to the Condensed Consolidated Financial Statements F-6 - F-14

 

F-1
 

 

BIOPLUS LIFE CORP.

CONSOLIDATED BALANCE SHEETS

(Amount expressed in United States Dollars (“US$”), except for number of shares)

 

      As of 
   Note  September 30,  2020   December 31, 2019 
      (Unaudited)   (Audited) 
ASSETS           
Current assets:             
Cash and bank balances     $334,162   $210,740 
Account receivables      553,917    308,688 
Income tax receivables      55,446    7,675 
Amount due from related parties  3   30,282    19,771 
Amount due from directors      -    5,821 
Inventories  4   357,526    303,954 
Other receivables, deposits and prepayments  5   39,174    133,060 
Total current assets      1,370,507    989,709 
              
Non-current assets:             
Property, plant and equipment, net  6   2,222,182    2,217,247 
Total non-current assets      2,222,182    2,217,247 
TOTAL ASSETS     $3,592,689   $3,206,956 
              
LIABILITIES AND STOCKHOLDERS’ EQUITY             
Current liabilities:             
Account payables     $210,968   $48,298 
Obligation under finance lease  7   31,632    33,343 
Bank borrowings  8   39,129    195,027 
Other payables and accrued liabilities  9   510,723    494,045 
Provision for taxation      3,604    3,604 
Bank overdraft      72,173    - 
Amount due to directors      4,569    8,489 
Total current liabilities      872,798    782,806 
              
Non-current liabilities:             
Obligation under finance lease  7   82,739    92,133 
Bank borrowings  8   550,660    553,144 
Deferred taxation  10   41,954    42,631 
Total non-current liabilities      675,353    687,908 
TOTAL LIABILITIES     $1,548,151   $1,470,714 
              
Stockholders’ equity:             
Common stock, par value $0.0001: 362,905,561 and 359,305,561 shares issued and outstanding as of September 30, 2020 and December 31 2019, respectively.  11  $36,291   $35,931 
Additional paid up share capital  11   1,998,870    1,998,870 
Accumulated profit/(loss)      99,379    (216,550)
Other comprehensive loss      (90,002)   (82,009)
Total stockholders’ equity      2,044,538    1,736,242 
TOTAL LIABILITIES AND STOCKHOLDERS EQUITY     $3,592,689   $3,206,956 

 

The accompanying notes are an integral part of these financial statements.

 

F-2
 

 

BIOPLUS LIFE CORP.

CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE INCOME/ (LOSS)

(Amount expressed in United States Dollars (“US$”), except for number of shares)

(Unaudited)

 

      Nine months ended September 30,   Three months ended September 30, 
   Note  2020   2019   2020   2019 
                        
Revenues, net     $2,449,661   $1,201,326   $989,461   $446,437 
                        
Cost of revenues      (1,422,514)   (614,299)   (588,637)   (210,313)
                        
Gross profit      1,027,147    587,027    400,824    236,124 
                        
Other income  13   2,192    3,400    592    285 
                        
Operating expenses:                       
General and operating expenses      (721,176)   (559,247)   (281,687)   (188,020)
Finance cost      (9,738)   (24,913)   -    (8,137)
                        
Total expenses      (730,914)   (584,160)   (281,687)   (196,157)
                        
Profit from operations      298,425    6,267    119,729    40,252 
Gain on disposal of subsidiary  13   17,505    1,099    17,505    - 
                        
Income tax expense  10   -    -    -    - 
                        
NET PROFIT     $315,930   $7,366   $137,234   $40,252 
Other comprehensive income/(loss):                       
- Foreign currency translation gain/(loss)      (7,993)   (17,100)   60,146    (15,699)
                        
TOTAL COMPREHENSIVE INCOME/(LOSS)     $307,937   $(9,734)  $197,380   $24,553 
                        
Earnings per share     $0.00   $0.00   $0.00   $0.00 
                        
Weighted average number of common shares outstanding -Basic and diluted      362,905,561    358,787,945    362,905,561    358,787,945 

 

The accompanying notes are an integral part of these financial statements.

 

F-3
 

 

BIOPLUS LIFE CORP.

CONSOLIDATED STATEMENT OF CHANGES IN STOCKHOLDERS’ EQUITY

FOR THE NINE MONTHS ENDED SEPTEMBER 30, 2020

(Amount expressed in United States Dollars (“US$))

 

   Common stock   Additional
  
   Accumulated
other		    
   Number of shares   Amount  paid up share capital  

Accumulated

profit/(loss)

   comprehensive
loss		   Total equity 
Balance as of January 1, 2019   359,305,561    35,931         1,998,870    (123,358)   (114,711)   1,796,732 
Net loss for the year   -    -    -    (93,192)   -    (93,192)
Foreign currency translation gain   -    -    -    -    32,702    32,702 
Balance as of December 31, 2019   359,305,561    35,931    1,998,870    (216,550)   (82,009)   1,736,242 
Common stock issued   3,600,000    360    -    -    -    360 
Net profit for the period   -    -    -    8,219    -    8,219 
Foreign currency translation loss   -    -    -    -    (87,070)   (87,070)
Balance as of March 31, 2020   362,905,561    36,291    1,998,870    (208,331)   (169,079)   1,657,751 
Net profit for the period   -    -    -    170,476    -    170,476 
Foreign currency translation gain   -    -    -    -    18,931    18,931 
Balance as of June 30, 2020   362,905,561    36,291    1,998,870    (37,855)   (150,148)   1,847,158 
Net profit for the period   -    -    -    137,234    -    137,234 
Foreign currency translation gain   -    -    -    -    60,146    60,146 
Balance as of September 30, 2020   362,905,561    36,291    1,998,870    99,379    (90,002)   2,044,538 

 

The accompanying notes are an integral part of these financial statements.

 

F-4
 

 

BIOPLUS LIFE CORP.

CONSOLIDATED STATEMENTS OF CASH FLOWS

(Amount expressed in United States Dollars (“US$))

(Unaudited)

 

   Nine months ended September 30, 
   2020   2019 
Cash flows from operating activities:          
Net profit  $315,928   $7,366 
Adjustments to reconcile net profit/(loss) to net cash used in operating activities:          
Depreciation of property, plant and equipment   93,429    82,857 
Interest expenses   9,738    24,912 
Bad debt written off   23,092    - 
Operating profit before working capital changes   442,187    115,135 
Changes in operating assets and liabilities:          
Inventories   (57,768)   141,160 
Account receivables   (253,739)   204,680 
Other receivables, deposits and prepayments   74,029    (12,290)
Amount due from related parties   (10,708)   (69,699)
Amount due from directors   2,063    (2,725)
Account payable   161,677    (212,063)
Other payables and accrued liabilities   22,477    (187,355)
Cash generated from/ (used in) operating activities   380,218    (23,157)
Tax refunded   -    1,942 
Tax paid   (47,378)   (34,845)
Net cash generated from/(used in) operating activities   332,840    (56,060)
Cash flows from investing activities:          
Purchase of property, plant and equipment   (133,810)   (33,692)
Net cash used in investing activities   (133,810)   (33,692)

 

Cash flows from financing activities:

          
Proceed from issued shares   360    - 
Interest expenses   (9,738)   (24,912)
Repayment of term loan borrowing   (7,155)   (28,574)
Repayment of hire purchase borrowing   (9,015)   (18,108)
Net cash used in financing activities   (25,548)   (71,594)
Foreign currency translation adjustment   19,287    6,522 
NET CHANGE IN CASH AND CASH EQUIVALENTS   173,842    (154,824)
           
CASH AND CASH EQUIVALENTS, BEGINNING OF FINANCIAL PERIOD   69,220    255,554 
CASH AND CASH EQUIVALENTS, END OF FINANCIAL PERIOD  $261,989   $100,730 
CASH AND CASH EQUIVALENTS INFORMATION          
Cash and bank balance  $334,162   $100,730 
Bank overdraft   (72,173)   - 
Cash and cash equivalents, end of financial period  $261,989   $100,730 

 

The accompanying notes are an integral part of these financial statements.

 

F-5
 

 

BIOPLUS LIFE CORP.

NOTES TO CONSOLIDATED FINANCIAL STATEMENT

SEPTEMBER 30, 2020

 

NOTE 1- ORGANIZATION AND BUSINESS BACKGROUND

 

Bioplus Life Corp., a Nevada corporation (“the Company”) was incorporated under the laws of the State of Nevada on April 13, 2017. For purposes of financial statements presentation, Bioplus Life Corp. and its subsidiaries are herein referred to as “the Company” or “We”.

 

We have historically conducted our business through Bio Life Neutraceuticals Sdn Bhd, a private limited liability company, incorporated in Malaysia. Bioplus Life Corp. (US), incorporated in United State of Nevada, is an investment holding company with 100% equity interest in Bioplus Life Corp. (Labuan), a company incorporated in Labuan, which subsequent hold 100% equity interest in Bioplus Life International Holdings Limited, a company incorporated in Hong Kong, which subsequent hold 99.8% equity interest in Bio Life Holdings Berhad, a company incorporated in Malaysia, which subsequent hold 100% equity interest in Bio Life Neutraceuticals Sdn Bhd. On December 31, 2017, Bioplus Life Corp was organized to be holding company parent to, and succeed to the operations of, Bioplus Life Corp. (Labuan), Bioplus Life International Holdings Ltd, Bio Life Holdings Berhad and Bio Life Neutraceuticals Sdn Bhd. This transaction was accounted for as a transaction among entities under common control and the assets, liabilities, revenues, and expenses, and as if the transfer occurred at the beginning of the period. Prior periods have been retrospectively adjusted to furnish comparative information.

 

The Company, through its subsidiaries, supplies high quality health products. Details of the Company’s subsidiaries:

 

No   Company Name   Place/Date of Incorporation   Particulars of Issued Capital   Principal Activities
1   Bioplus Life Corp. (Labuan)  

Malaysia, Labuan

May 19, 2017

   100 shares of
ordinary shares of US$1 each		   Investment Holding
                 
2   Bioplus Life International Holdings Ltd. (A)  

Hong Kong

June 20, 2017

   1 shares of ordinary shares
of HK$1 each		   Investment Holding
                 
3   Bio Life Holdings Berhad  

Malaysia

May 19, 2016

   107,992 shares of ordinary shares of RM1 each   Investment Holding
                 

4

 

  

Bio Life Neutraceuticals Sdn Bhd

  

Malaysia, Selangor

August 27, 2009

  

5,456,207 shares of ordinary shares of RM1 each

  

Trading of Consumer Products

                 
5   Bio Life Neutraceuticals (Shenzhen) Pty Ltd. (B)  

Shenzhen

October 27, 2017

   500,000 shares of ordinary shares of RMB1 each   Trading of Healthy Supplement and Cosmetics

 

(A) Bioplus Life International Holdings Ltd. was officially disposed off by the Group on August 5, 2020 at a consideration of RMB 5,000. The transfer results in gain on disposal of subsidiary of USD 17,505 as disclosed in Note 13 in Consolidated Statements of Operations and Comprehensive Income/(Loss).

 

(B) Bio Life Neutraceuticals (Shenzhen) Pty Ltd. was being officially de-registered in Shenzhen on September 4, 2020.

 

F-6
 

 

2. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

 

● Basis of presentation

 

These accompanying financial statements have been prepared in accordance with generally accepted accounting principles in the United States of America (“US GAAP”).

 

● Basis of consolidation

 

In this Quarterly Report, “the Company,” “us” or “we” refer to the consolidated entity, including its subsidiaries and affiliates. The terms refer only to the publicly held holding company, The Bioplus Life Corporation, excluding its subsidiaries and affiliates. Furthermore, in which the Company has a variable interest have been consolidated where the Company is the primary beneficiary. All intercompany transactions and balances have been eliminated in consolidation.

 

● Use of estimates

 

In preparing these financial statements, management makes estimates and assumptions that affect the reported amounts of assets and liabilities in the balance sheets and revenues and expenses during the periods reported. Actual results may differ from these estimates.

 

● Cash and cash equivalents

 

Cash and cash equivalents represent cash on hand, demand deposits placed with banks or other financial institutions and all highly liquid investments with an original maturity of three months or less as of the purchase date of such investments.

 

● Property, plant and equipment

 

Property and plant and equipment are stated at cost less accumulated depreciation and accumulated impairment losses, if any. Depreciation is calculated on the straight-line basis to write off the cost over the following expected useful lives of the assets concerned. The principal annual rates used are as follows:

 

Categories  Principal Annual Rates/Expected Useful Life 
Computer hardware   20%
Furniture & fittings   10%
Handphone   20%
Landscape   20%
Leasehold land and building   99 years 
Machinery   10%
Motor vehicle   20%
Office equipment   10%
Renovation   20%
Signboard   10%
Tools and equipment   10%

Kitchen utensils 10%

 

Fully depreciated plant and equipment are retained in the financial statements until they are no longer in use.

 

● Inventories

 

Inventories consisting of products available for sell, are stated at the lower of cost or market value. Cost of inventory is determined using the first-in, first-out (FIFO) method. Inventory reserve is recorded to write down the cost of inventory to the estimated market value due to slow-moving merchandise and damaged goods, which is dependent upon factors such as historical and forecasted consumer demand, and promotional environment. The Company takes ownership, risks and rewards of the products purchased. Write downs are recorded in cost of revenues in the Consolidated Statements of Operations and Comprehensive Income.

 

F-7
 

 

● Revenue recognition

 

Revenues are recognized when control of the promised goods or services are transferred to a customer, in an amount that reflects the consideration that the Company expects to receive in exchange for those goods or services. The Company applies the following five steps in order to determine the appropriate amount of revenue to be recognized as it fulfills its obligations under each of its agreements:

 

  ● identify the contract with a customer;
  ● identify the performance obligations in the contract;
  ● determine the transaction price;
  ● allocate the transaction price to performance obligations in the contract; and
  ● recognize revenue as the performance obligation is satisfied.

 

● Cost of revenues

 

Cost of revenue includes the purchase cost of retail goods for re-sale to customers and packing materials (such as boxes). It excludes purchasing and receiving costs, inspection costs, warehousing costs, internal transfer costs and other costs of distribution network in cost of revenues.

 

● Shipping and handling fees

 

Shipping and handling fees, if billed to customers, are included in revenue. Shipping and handling fees associated with inbound and outbound freight are expensed as incurred and included in selling and distribution expenses.

 

● Comprehensive income

 

ASC Topic 220, “Comprehensive Income” establishes standards for reporting and display of comprehensive income, its components and accumulated balances. Comprehensive income as defined includes all changes in equity during a period from non-owner sources. Accumulated other comprehensive income, as presented in the accompanying statements of stockholders’ equity consists of changes in unrealized gains and losses on foreign currency translation and cumulative net change in the fair value of available-for-sale investments held at the balance sheet date. This comprehensive income is not included in the computation of income tax expense or benefit.

 

● Income tax expense

 

Income taxes are determined in accordance with the provisions of ASC Topic 740, “Income Taxes” (“ASC Topic 740”). Under this method, deferred tax assets and liabilities are recognized for the future tax consequences attributable to differences between the financial statement carrying amounts of existing assets and liabilities and their respective tax basis. Deferred tax assets and liabilities are measured using enacted income tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. Any effect on deferred tax assets and liabilities of a change in tax rates is recognized in income in the period that includes the enactment date.

 

ASC 740 prescribes a comprehensive model for how companies should recognize, measure, present, and disclosed in their financial statements uncertain tax positions taken or expected to be taken on a tax return. Under ASC 740, tax positions must initially be recognized in the financial statements when it is more likely than not the position will be sustained upon examination by the tax authorities. Such tax positions must initially and subsequently be measured as the largest amount of tax benefit that has a greater than 50% likelihood of being realized upon ultimate settlement with the tax authority assuming full knowledge of the position and relevant facts.

 

The Company conducts major businesses in Malaysia and is subject to tax in their own jurisdictions. As a result of its business activities, the Company will file separate tax returns that are subject to examination by the foreign tax authorities.

 

● Foreign currencies translation

 

Transactions denominated in currencies other than the functional currency are translated into the functional currency at the exchange rates prevailing at the dates of the transaction. Monetary assets and liabilities denominated in currencies other than the functional currency are translated into the functional currency using the applicable exchange rates at the balance sheet dates. The resulting exchange differences are recorded in the statement of operations.

 

The functional currency of the Company is the United States Dollars (“US$”) and the accompanying financial statements have been expressed in US$. In addition, the Company maintains its books and record in a local currency, Malaysian Ringgit (“MYR” or “RM”), which is functional currency as being the primary currency of the economic environment in which the entity operates.

 

F-8
 

 

● Foreign currencies translation (continued)

 

In general, for consolidation purposes, assets and liabilities of its subsidiaries whose functional currency is not US$ are translated into US$, in accordance with ASC Topic 830-30, “Translation of Financial Statement”, using the exchange rate on the balance sheet date. Revenues and expenses are translated at average rates prevailing during the period. The gains and losses resulting from translation of financial statements of foreign subsidiary are recorded as a separate component of accumulated other comprehensive income.

 

Translation of amounts from the local currency of the Company into US$1 has been made at the following exchange rates for the respective period:

 

   As of and for the nine months ended September 30, 
   2020   2019 
Period-end MYR: US$1 exchange rate   4.1585    4.1349 
Period average MYR: US$1 exchange rate   4.2038    4.1870 
Period-end US$1: RMB exchange rate   0.1473    0.1454 
Period average US$1: RMB exchange rate   0.1446    0.1471 

 

● Related parties

 

Parties, which can be a corporation or individual, are considered to be related if the Company has the ability, directly or indirectly, to control the other party or exercise significant influence over the other party in making financial and operating decisions. Companies are also considered to be related if they are subject to common control or common significant influence.

 

● Fair value of financial instruments

 

The carrying value of the Company’s financial instruments: cash and cash equivalents, trade receivable, deposits and other receivables, amount due to related parties and other payables approximate at their fair values because of the short-term nature of these financial instruments.

 

The Company also follows the guidance of the ASC Topic 820-10, “Fair Value Measurements and Disclosures” (“ASC 820-10”), with respect to financial assets and liabilities that are measured at fair value. ASC 820-10 establishes a three-tier fair value hierarchy that prioritizes the inputs used in measuring fair value as follows:

 

● Level 1: Observable inputs such as quoted prices in active markets;
● Level 2: Inputs, other than the quoted prices in active markets, that are observable either directly or indirectly; and
● Level 3: Unobservable inputs in which there is little or no market data, which require the reporting entity to develop its own assumptions

 

As of September 30, 2020, and December 31, 2019, the Company did not have any nonfinancial assets and liabilities that are recognized or disclosed at fair value in the financial statements, at least annually, on a recurring basis, nor did the Company have any assets or liabilities measured at fair value on a non-recurring basis.

 

● Recent accounting pronouncements

 

Management has considered all recent accounting pronouncements issued since the last audit of our financial statements. The Company’s management believes that these recent pronouncements will not have a material effect on the Company’s financial statements.

 

3. AMOUNT DUE FROM RELATED PARTIES

 

The amounts are unsecured, bear no interest and are payable on demand.

 

4. INVENTORIES

 

   As of 
   September 30, 2020   December 31, 2019 
Raw material  $302,918   $245,877 
Packing Material   27,294    23,858 
Finished goods   27,314    34,219 
Total inventories  $357,526   $303,954 

 

F-9
 

 

5. OTHER RECEIVABLES, DEPOSITS AND PREPAYMENTS

 

   As of 
   September 30, 2020   December 31, 2019 
Other receivables  $12,970   $9,981 
Deposits  5.119,394    63,308 
Prepayments  5.26,810    59,771 
   $39,174   $133,060 

 

5.1 The deposits of $ 19,394 (2019: $ 63,308) representing deposits paid for rental of hostels and various utilities.

 

5.2 The prepayments of $ 6,810 (2019: $ 59,771) representing advanced payments made to suppliers for purchase of manufacturing materials.

 

6. PROPERTY, PLANT AND EQUIPMENT, NET

 

Property, plant and equipment consisted of the following:

 

   As of 
   September 30, 2020   December 31, 2019 
         
Computer hardware  $40,430   $32,814 
Furniture & fittings   112,198    106,945 
Handphone   3,724    3,514 
Landscape   3,691    3,475 
Leasehold land and building   1,875,962    1,872,476 
Machinery   175,677    119,413 
Motor vehicle   243,630    243,630 
Office equipment   59,123    52,725 
Renovation   142,099    92,646 
Signboard   5,470    4,648 
Tools and equipment   6,930    4,348 
Kitchen utensils   1,740    - 
   $2,670,674   $2,536,634 
(Less): Accumulated depreciation   (412,814)   (315,762)
Add/(Less): Foreign translation difference   (35,678)   (3,625)
Property, plant and equipment, net  $2,222,182   $2,217,247 

 

Depreciation expense for the period ended September 30, 2020 and September 30, 2019 were $93, 429 and $82,857, respectively.

 

As of September 30, 2020, and December 31, 2019 the Company acquired motor vehicles under finance leases with carrying value of $101,385 and $129,925 respectively.

 

The leasehold land and building with carrying amount of $1,786,756 and $1,797,002 as of September 30, 2020 and December 31, 2019, respectively have been charged to licensed bank to secure banking facilities granted to the Company.

 

7. OBLIGATION UNDER FINANCE LEASE

 

The Company purchased motor vehicles under finance lease agreements with the effective interest rate of 2.48% - 4.31% per annum (2019: 5.22% per annum), with principal and interest payable monthly. The obligation under the finance leases are as follows:

 

   As of 
   September 30, 2020   December 31, 2019 
Present value of hire purchase liabilities:  $    $  
Not later than one year   31,632    33,343 
Later than one year but not later than two years   32,097    32,496 
Later than two years but not later than five years   50,642    59,637 
    114,371    125,476 

 

   As Of 
   September 30, 2020   December 31, 2019 
Analyzed as:  $    $  
Current portion   31,632    33,343 
Non-current portion   82,739    92,133 
    114,371    125,476 

 

F-10
 

 

8. BANK BORROWINGS

 

   As of 
   September 30, 2020   December 31, 2019 
Secured: -  $   $ 
Bank overdraft   72,173    141,520 
Term loan   589,789    606,651 
   661,962   748,171 

 

   As of 
   September 30, 2020   December 31, 2019 
Analyzed as:  $   $ 
Current portion   111,302    195,027 
Non-current portion   550,660    553,144 
   $661,962   $748,171 

 

The bank overdraft of the Company is secured by way of the following:

 

  a. A Facilities Agreement for US$377,277 (MYR579,171);

 

  b. Master Facility Agreement.

 

  c. Joint and Several Guarantee to be executed by the subsidiary directors of Bio Life Neutraceuticals Sdn Bhd.

 

Interested charged on the bank overdraft is 4% (2019: 4%) above the bank base lending rate per annum.

 

The term loan of the Company is secured by way of the following:

 

  a. A Facilities Agreement for US$1,705,086 (MYR2,842,719);

 

  b. Master Facility Agreement.

 

  c. Joint and Several Guarantee to be executed by the subsidiary directors of Bio Life Neutraceuticals Sdn Bhd.

 

The term loan is payable by 240 monthly installments of US$4,492 (MYR18,248) each including interest, commencing from Oct 10, 2016 and subject to interest at 4% per annum flat.

 

F-11
 

 

9. OTHER PAYABLES AND ACCRUED LIABILITIES

 

   As of 
   September 30, 2020   December 31, 2019 
Other payables generated from:   $     $  
Local   5,262    41,645 
Foreign, representing:          
Malaysia   -    - 
Common outstanding from non-trade payable   36,562    37,110 
Common outstanding from third parties   827    1,004 
China   -    - 
Common outstanding from third parties   147    861 
   $42,798   $80,620 
           
Accrued other expenses          
Local          
Foreign, representing:          
Malaysia          
Payroll   23,640    18,550 
Payroll deduction   8,961    7,873 
Professional Fee   1,619    11,499 
Commission   37,255    43,563 
Expenses   787    1,157 
   $72,262   $82,642 
Hong Kong   -    - 
           
Deposit received from customers   285,663    226,783 
           
Share subscription receipts in advance   110,000    104,000 
   $510,723   $494,045 

 

10. INCOME TAXES

 

   Nine months ended 
   2020   2019 
Tax jurisdictions from:          
Local  $(58,232)  $(36,326)
Foreign, representing:          
Malaysia   392,990    47,020 
Hong Kong   (17,775)   (1,859)
China   (1,054)   (1,469)
Profit/(Loss) before income tax  $315,929   $7,366 

 

The provision for income taxes consisted of the following:

 

   Nine months ended 
   2020   2019 
Tax expense - Current                  
Local  $-   $- 
Foreign, representing:          
Malaysia   -    - 
Hong Kong   -    - 
           
Tax expense – Prior year          
Foreign, representing:          
Malaysia   -    - 
           
Deferred          
Local   -    - 
Foreign, representing:          
Malaysia   -    - 
Hong Kong   -    - 
   $-   $- 

 

The effective tax rate in the periods presented is the result of the mix of income earned in various tax jurisdictions that apply a broad range of income tax rates. The Company has subsidiaries that operate in various countries: United States, Hong Kong and Malaysia that are subject to taxes in the jurisdictions in which they operate, as follows:

 

United States of America

 

The Company is registered in the State of Nevada and is subject to the tax laws of the United States of America. As of September 30, 2020, the operations in the United States of America incurred $461,206 of cumulative net operating losses which can be carried forward to offset future taxable income. The net operating loss carry forwards begin to expire in 2039, if unutilized. The Company has provided for a full valuation allowance of $4,896 against the deferred tax assets on the expected future tax benefits from the net operating loss carry forwards as the management believes it is more likely than not that these assets will not be realized in the future.

 

F-12
 

 

Malaysia

 

Bio Life Holdings Berhad (“BLHB”) and Bio Life Neutraceuticals Sdn Bhd (“BLNSB”) are subject to the Malaysia Corporate Tax Laws at a tax rate of 24% on the assessable income for its tax year.

 

Hong Kong

 

Bioplus Life International Holdings Ltd is subject to Hong Kong Profits Tax, which is charged at the statutory income tax rate of 16.5% on its assessable income.

 

China

 

Bio Life Neutraceuticals (Shenzhen) Pty Ltd. is registered in the Shen Zhen and is subject to the China Corporate Tax, which is charged at the statutory income tax rate of 25% on its assessable income.

 

11. STOCKHOLDERS’ EQUITY

 

During the year, the Company has issued the following common stock:

 

   As of 
   September 30, 2020   December 31, 2019 
Issued and fully paid:  $     $   
           
At the beginning of the period   2,034,801    2,034,801 
Issued during the period   360    - 
           
At the end of the period  $2,035,161   $2,034,801 

 

As of September 30, 2020, and December 31, 2019, Bioplus Life Corp has an issued and outstanding common share of 362,905,561 and 359,305,561 respectively.

 

12. CONCENTRATION OF RISK

 

(a) Major Customers

 

For the three months ended September 30, 2020 and 2019, the customers who accounted for 10% or more of the Company’s revenues and its accounts receivable at period-end are presented as follows:

 

   Revenues   Percentage of revenues 
   2020   2019   2020   2019 
                 
Customer A  $-   $55,257    -    12%
Customer B   152,423    53,979    15%   12%
Customer C   369,623    -    37%   - 
                     
   $522,046   $109,236    52%   24%

 

For the nine months ended September 30, 2020 and 2019, the customers who accounted for 10% or more of the Company’s revenues and its accounts receivable at period-end are presented as follows:

 

   Revenues   Percentage of revenues 
   2020   2019   2020   2019 
                 
Customer A  $138,771   $153,195    5%   12%
Customer B   964,146    49,515    39%   4%
                     
   $1,102,917   $202,710    44%   16%

 

F-13
 

 

(b) Major Suppliers

 

For the three months ended September 30, 2020 and 2019, there was no supplier who accounted for 10% or more of the Company’s purchases nor with significant outstanding payables.

 

   Revenues   Percentage of revenues 
   2020   2019   2020   2019 
                 
Supplier A  $352,297   $93,455    64%   88%
Supplier B   99,328    -    18%   - 
Supplier C   65,418    -    12%   - 
                     
   $517,043   $93,455    94%   88%

 

For the nine months ended September 30, 2020 and 2019, there was no supplier who accounted for 10% or more of the Company’s purchases nor with significant outstanding payables.

 

   Revenues   Percentage of revenues 
   2020   2019   2020   2019 
                 
Supplier A  $633,555   $267,081    58%   88%
Supplier B   250,203    16,308    23%   5%
                     
   $883,758   $283,389    81%   93%

 

13. OTHER INCOME

 

   Nine months ended 
   2020   2019 
Other income  $192   $77 
Realized gain on foreign exchange   1,999    3,323 
   $2,191   $3,400 
           
Gain on disposal of subsidiary  $17,505   $1,099 

 

14. FOREIGN CURRENCY EXCHANGE RATE

 

The Company cannot guarantee that the current exchange rate will remain stable, therefore there is a possibility that the Company could post the same amount of income for two comparable periods and because of the fluctuating exchange rate post higher or lower income depending on exchange rate converted into US$ at the end of the financial period. The exchange rate could fluctuate depending on changes in political and economic environments without notice.

 

15. SUBSEQUENT EVENTS

 

In accordance with ASC Topic 855, “Subsequent Events”, which establishes general standards of accounting for and disclosure of events that occur after the balance sheet date but before financial statements are issued, the Company has evaluated all events or transactions that occurred after September 30, 2020 up through the date November 18, 2020 was the Company presented these audited consolidated financial statements.

 

16. SIGNIFICANT EVENTS

 

During the fiscal year, the World Health Organization (WHO) declared the Coronavirus (COVID-19) outbreak to be a pandemic, which has caused severe global social and economic disruptions and uncertainties, including markets where the Company operates.

 

The Company considers this outbreak as non-adjusting-events. The consequences brought about by Covid-19 continue to evolve and whilst the Company actively monitoring and managing its operations to respond to these changes, the Company does not consider it practicable to provide any quantitative estimate on the potential impact it may have on the Company.

 

F-14
 

 

ITEM 2. MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS

 

The information contained in this quarterly report on Form 10-Q is intended to update the information contained in our Form 10-K dated March 27, 2020, for the year ended December 31, 2019 and presumes that readers have access to, and will have read, the “Management’s Discussion and Analysis of Financial Condition and Results of Operations” and other information contained in such Form 10-K. The following discussion and analysis also should be read together with our consolidated financial statements and the notes to the consolidated financial statements included elsewhere in this Form 10-Q.

 

The following discussion contains certain statements that may be deemed “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995. Such statements appear in a number of places in this Report, including, without limitation, “Management’s Discussion and Analysis of Financial Condition and Results of Operations.” These statements are not guaranteeing of future performance and involve risks, uncertainties and requirements that are difficult to predict or are beyond our control. Forward-looking statements speak only as of the date of this quarterly report. You should not put undue reliance on any forward-looking statements. We strongly encourage investors to carefully read the factors described in our Form 10-K dated March 27, 2020 in the section entitled “Risk Factors” for a description of certain risks that could, among other things, cause actual results to differ from these forward-looking statements. We assume no responsibility to update the forward-looking statements contained in this transition report on Form 10-Q. The following should also be read in conjunction with the unaudited Condensed Consolidated Financial Statements and notes thereto that appear elsewhere in this report.

 

Company Overview

 

Bioplus Life Corp., a Nevada corporation (“Company”), was incorporated under the laws of the State of Nevada on April 13, 2017. For purposes of financial statements presentation, Bioplus Life Corp. and its subsidiaries are herein referred to as “the Company” or “We”.

 

On July 10, 2017, the Company acquired 100% of the equity interests of Bioplus Life Corp., a Malaysian company. On July 19, 2017, the Company, through its Malaysian subsidiary, Bioplus Life Corp., acquired 100% of the equity interests of Bioplus Life International Holdings Ltd, a Hong Kong company. On October 27, 2017, the Company through its Hong Kong subsidiary, Bioplus Life International Holdings Ltd, acquired 100% equity interest of Bioplus Life Corp. (ShenZhen), a company incorporated in China.

 

On June 11, 2018, the Company through its subsidiary in Hong Kong, Bioplus Life International Holdings Ltd, acquired 99.8% equity interest of Bio Life Holdings Berhad, a company incorporated in Malaysia. Bio Life Holdings Berhad owns 100% of the equity interests of Bio Life Neutraceuticals Sdn. Bhd., a company incorporated in Malaysia, which is the sole operating subsidiary.

 

Our corporate structure is depicted below (see special note below):

 

 

Special Note.

 

(1) Bioplus Life International Holdings Ltd. was officially disposed of on August 5, 2020.

 

(2) Bio Life Neutraceuticals (Shenzhen) Pty Ltd. was being officially de-registered in Shenzhen on September 4, 2020.

 

3
 

 

Bioplus Life Corp., through its wholly owned subsidiaries, is a company specialized in providing health and beauty care products to our customers. The Company mission is to create awareness for good health and personal care to improve our customers’ quality of life. We seek to achieve this by offering an affordable solution to existing health food businesses through the production, information, advisory and services pertaining to our product line. Our website, http://www.biolife2u.com/, can be utilized to inquire about our product offerings. While we sell products through our website and we primarily sell our products to wholesalers and exporters

 

The product series, or line, of our company includes, but is not strictly limited to, products that fall into the following categories: bone, fiber, bee-propolis, cardiovascular health, herbal, health beverages, apple stem cell, beauty care, feminine health, UT care, anti-oxidant and eye health series. These health and beauty supplies are designed to help improve the consumers’ metabolism rate, burn excessive fats, provide anti-aging effects and improve the overall health and physical appearance of our customers. At our current, and reasonable future operating level, our supplier has indicated that they will have ample supply to fulfil our orders for raw materials while also fulfilling any and all orders they may receive from other customers.

 

Our financial statements are prepared in US Dollars and in accordance with accounting principles generally accepted in the United States. See information immediately below for information concerning the exchange rates at the Malaysian Ringett (MYR) and Chinese Renminbi (RMB) translated into US Dollars (“USD”) at various pertinent dates and for pertinent periods.

 

Translation of amounts from the local currency of the Company into US$1 has been made at the following exchange rates for the respective years:

 

   As of and for the nine months ended June 30, 
   2020   2019 
Period-end MYR: US$1 exchange rate   4.1585    4.1349 
Period average MYR: US$1 exchange rate   4.2038    4.1870 
Period-end US$1: RMB exchange rate   0.1473    0.1454 
Period average US$1: RMB exchange rate   0.1446    0.1471 

 

Results of Operation

 

For the three months ended September 30, 2020 and 2019

 

Revenues. For three months ended September 30, 2020, the Company realized revenues of $989,461 as compared to $446,437 for the three months period ended September 30, 2019. The increase in revenues of approximately 121.6% was a result of broader distribution of our products through our existing distributors and the addition of new distributors to our network.

 

Cost of Revenues. For the three months ended September 30, 2020, we had cost of revenues of $588,637 compared with cost of revenues of $210,313 for the same period last year. The increase of 179.8% corresponds to the increase in product sales for the current quarter. Cost of revenue includes raw materials, packaging materials and lab tests.

 

Gross Profit. For the three months ended September 30, 2020, we had a gross profit of $400,824 compared with gross profit of $236,124 for the same period last year. The 69.7% increase in gross profit is due to the reasons discussed above.

 

Other Income. For the three months ended September 30, 2020, we had other income of $592, as compared $285 for the three months ended September 30, 2019, a gain from the same period last year. The difference primarily is due to fluctuation of foreign exchange rate between these periods.

 

Operating Expenses. For the three months ended September 30, 2020, we had operating expenses of $281,687, as compared to operating expenses of $188,020 for the quarterly period ended September 30, 2019, a increase of approximately 49.8% from the prior period due to higher revenues during the current three month period. Operating expenses consists of general and administrative expenses which includes depreciation of fixed assets, employee compensation and benefits, professional fees and marketing and travel expenses.

 

Net Profit. For the three months ended September 30, 2020, we had a net profit of $137,234 compared with a net profit of $40,252 for the same period last year. The increase in net profit is due to the reasons discussed above.

 

Foreign currency translation gain/loss. For the three months ended September 30, 2020, we had foreign currency translation gain of $60,146 compared with foreign currency translation loss of $15,699 for the same three months period last year. Foreign currency translation gain represents the movement of the US Dollar against the Malaysian Ringgit.

 

4
 

 

For the nine months ended September 30, 2020 and 2019

 

Revenues. For nine months ended September 30, 2020, the Company realised revenues of $2,449,661 as compared to $1,201,326 for the nine months period ended September 30, 2019. The increase is revenues of approximately 103.9% is due to the fulfilment of pre-existing orders from prior quarters.

 

Cost of Revenues. For the nine months ended September 30, 2020, we had cost of revenues of $1,422,514 compared with cost of revenues of $614,299 for the same period last year. The increase of 131.5% corresponds to the increase in product sales for the current period. Cost of revenue includes raw materials, packaging materials and lab tests.

 

Gross Profit. For the nine months ended September 30, 2020, we had a gross profit of $1,027,147 compared with gross profit of $587,027 for the same period last year. The 74.9% increase in gross profit is due to the reasons discussed above.

 

Other Income. For the nine months ended September 30, 2020, we had other income of $2,192, as compared $3,400 for the nine months period ended September 30, 2019, a substantial loss from the same period last year. The difference primarily is due to fluctuation of foreign exchange rate between these periods.

 

Operating Expenses. For the nine months ended September 30, 2020, we had operating expenses of $721,176, as compared to operating expenses of $559,247 for the nine months ended September 30, 2019, an increase of approximately 28.9% from the prior period due to higher revenues during the current nine month period. Operating expenses consists of general and administrative expenses which includes depreciation of fixed assets, employee compensation and benefits, professional fees and marketing and travel expenses.

 

Income Tax Expense. For the nine months ended September 30, 2020, we had no income tax expense which same with the nine months ended September 30, 2019. During the current period, we had losses carry forward from 2019, income taxes was not payable for the quarter.

 

Net Profit. For the nine months ended September 30, 2020, we had a net profit of $315,930 compared with a net profit of $7,366 for the same period last year. The increase in net profit is due to the reasons discussed above.

 

Foreign currency translation gain/loss. For the nine months ended September 30, 2020, we had foreign currency translation loss of $7,993 compared with foreign currency translation loss of $17,100 for the same nine months period last year. Foreign currency translation loss represents the movement of the US Dollar against the Malaysian Ringgit.

 

Liquidity and Capital Resources

 

As of September 30, 2020, and 2019, we had cash and bank balances of $334,162 and $210,740 respectively.

 

Our primary uses of cash have been for operations. The main sources of cash have been from operational revenues and the private placement of our common stock. The following trends are reasonably likely to result in a material increase in our liquidity over the near to long term:

 

● Addition of administrative and marketing personnel as the business grows,
● Increases in advertising and marketing in order to attempt to generate more revenues, and
● The cost of being a public company.

 

Our financial statements reflect the fact that we have sufficient revenue to cover our operating expenses for the next 12 months, although at present time, we are under-capitalized. The Company intends to continue with capital investment or other financing to fund its marketing and promotional campaigns and the expansion of production capacity for 2020 and beyond to achieve a 20% to 30% increase in revenues in Malaysia, China, Taiwan, Indonesia, India and African markets. If continued funding and capital resources are unavailable at reasonable terms, the Company may not be able to implement its expansion plan.

 

Summary of Cash Flows

 

The following is a summary of the Company’s cash flows generated from (used in) operating, investing, and financing activities for the nine months ended September 30, 2020 and 2019:

 

   Nine months ended September 30 
   2020   2019 
         
Net cash generated from / (used in) operating activities   332,840    (56,060)
           
Net cash used in investing activities   (133,810)   (33,692)
           
Net cash used in financing activities   (25,548)   (71,594)
           
Foreign currency translation adjustment   19,287    6,522 
           
NET CHANGE IN CASH AND CASH EQUIVALENTS   173,842    (154,824)

 

5
 

 

Operating Activities

 

During the nine months ended September 30, 2020, the Company had a net profit $315,928 which, after adjusting for depreciation, interest expense and bad debt written off, and changes in operating assets and liabilities, resulted in net cash of $332,840 generated from operating activities during the period. By comparison, during the nine months ended September 30, 2019, the Company incurred a net profit of $7,366 which, after adjusting for depreciation and interest expense, and changes in operating assets and liabilities, resulted in net loss of $56,060 in operating activities during the period.

 

Investing Activities

 

During the nine months ended September 30, 2020, cash flow from investing activities consisted of purchase of the property, plant and equipment of $133,810 compared with purchases of $33,692 for the prior nine month period.

 

Financing Activities

 

For the nine months ended September 30, 2020, the cash provided by financing activities primarily consisted of the proceeds from stock issuances of $360, offset by $9,738 in interest expense, $7,155 in repayment of loans and $9,015 in repayment of hire purchase borrowing. For the nine months ended September 30, 2019, the cash used in financing activities primarily consisted of $24,912 in interest expense, $28,574 in repayment of loans and $18,108 in repayment of hire purchase borrowing.

 

Summary of Significant Accounting Policies

 

● Basis of presentation

 

These accompanying financial statements have been prepared in accordance with generally accepted accounting principles in the United States of America (“US GAAP”).

 

● Basis of consolidation

 

In this Quarterly Report, “the Company,” “us” or “we” refer to the consolidated entity, including its subsidiaries and affiliates. The terms refer only to the publicly held holding company, The Bioplus Life Corporation, excluding its subsidiaries and affiliates. Furthermore, in which the Company has a variable interest have been consolidated where the Company is the primary beneficiary. All intercompany transactions and balances have been eliminated in consolidation.

 

● Use of estimates

 

In preparing these financial statements, management makes estimates and assumptions that affect the reported amounts of assets and liabilities in the balance sheets and revenues and expenses during the periods reported. Actual results may differ from these estimates.

 

● Cash and cash equivalents

 

Cash and cash equivalents represent cash on hand, demand deposits placed with banks or other financial institutions and all highly liquid investments with an original maturity of three months or less as of the purchase date of such investments.

 

● Property, Plant and equipment

 

Property, plant and equipment are stated at cost less accumulated depreciation and accumulated impairment losses, if any. Depreciation is calculated on the straight-line basis to write off the cost over the following expected useful lives of the assets concerned. The principal annual rates used are as follows:

 

Categories  Principal Annual Rates/Expected Useful Life 
Computer hardware   20%
Furniture & fittings   10%
Handphone   20%
Landscape   20%
Leasehold land and building   99 years 
Machinery   10%
Motor vehicle   20%
Office equipment   10%
Renovation   20%
Signboard   10%
Tools and equipment   10%
Kitchen utensils   10%

 

Fully depreciated plant and equipment are retained in the financial statements until they are no longer in use.

 

6
 

 

● Inventories

 

Inventories consisting of products available for sell, are stated at the lower of cost or market value. Cost of inventory is determined using the first-in, first-out (FIFO) method. Inventory reserve is recorded to write down the cost of inventory to the estimated market value due to slow-moving merchandise and damaged goods, which is dependent upon factors such as historical and forecasted consumer demand, and promotional environment. The Company takes ownership, risks and rewards of the products purchased. Write downs are recorded in cost of revenues in the Condensed Statements of Operations and Comprehensive Income.

 

● Revenue recognition

 

Revenues are recognized when control of the promised goods or services are transferred to a customer, in an amount that reflects the consideration that the Company expects to receive in exchange for those goods or services. The Company applies the following five steps in order to determine the appropriate amount of revenue to be recognized as it fulfills its obligations under each of its agreements:

 

  ● identify the contract with a customer;
  ● identify the performance obligations in the contract;
  ● determine the transaction price;
  ● allocate the transaction price to performance obligations in the contract; and
  ● recognize revenue as the performance obligation is satisfied.

 

● Cost of revenues

 

Cost of revenue includes the purchase cost of retail goods for re-sale to customers and packing materials (such as boxes). It excludes purchasing and receiving costs, inspection costs, warehousing costs, internal transfer costs and other costs of distribution network in cost of revenues.

 

● Shipping and handling fees

 

Shipping and handling fees, if billed to customers, are included in revenue. Shipping ang handling fees associated with inbound and outbound freight are expensed as incurred and included in selling and distribution expenses.

 

● Comprehensive income

 

ASC Topic 220, “Comprehensive Income” establishes standards for reporting and display of comprehensive income, its components and accumulated balances. Comprehensive income as defined includes all changes in equity during a period from non-owner sources. Accumulated other comprehensive income, as presented in the accompanying statements of stockholders’ equity consists of changes in unrealized gains and losses on foreign currency translation and cumulative net change in the fair value of available-for-sale investments held at the balance sheet date. This comprehensive income is not included in the computation of income tax expense or benefit.

 

● Income tax expense

 

Income taxes are determined in accordance with the provisions of ASC Topic 740, “Income Taxes” (“ASC Topic 740”). Under this method, deferred tax assets and liabilities are recognized for the future tax consequences attributable to differences between the financial statement carrying amounts of existing assets and liabilities and their respective tax basis. Deferred tax assets and liabilities are measured using enacted income tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. Any effect on deferred tax assets and liabilities of a change in tax rates is recognized in income in the period that includes the enactment date.

 

ASC 740 prescribes a comprehensive model for how companies should recognize, measure, present, and disclosed in their financial statements uncertain tax positions taken or expected to be taken on a tax return. Under ASC 740, tax positions must initially be recognized in the financial statements when it is more likely than not the position will be sustained upon examination by the tax authorities. Such tax positions must initially and subsequently be measured as the largest amount of tax benefit that has a greater than 50% likelihood of being realized upon ultimate settlement with the tax authority assuming full knowledge of the position and relevant facts.

 

7
 

 

The Company conducts major businesses in Malaysia and is subject to tax in their own jurisdictions. As a result of its business activities, the Company will file separate tax returns that are subject to examination by the foreign tax authorities.

 

● Foreign currencies translation

 

Transactions denominated in currencies other than the functional currency are translated into the functional currency at the exchange rates prevailing at the dates of the transaction. Monetary assets and liabilities denominated in currencies other than the functional currency are translated into the functional currency using the applicable exchange rates at the balance sheet dates. The resulting exchange differences are recorded in the statement of operations.

 

The functional currency of the Company is the United States Dollars (“US$”) and the accompanying financial statements have been expressed in US$. In addition, the Company maintains its books and record in a local currency, Malaysian Ringgit (“MYR” or “RM”), which is functional currency as being the primary currency of the economic environment in which the entity operates.

 

In general, for consolidation purposes, assets and liabilities of its subsidiaries whose functional currency is not US$ are translated into US$, in accordance with ASC Topic 830-30, “Translation of Financial Statement”, using the exchange rate on the balance sheet date. Revenues and expenses are translated at average rates prevailing during the period. The gains and losses resulting from translation of financial statements of foreign subsidiary are recorded as a separate component of accumulated other comprehensive income.

 

Translation of amounts from the local currency of the Company into US$1 has been made at the following exchange rates for the respective periods:

 

   As of and for the nine months ended
September 30,		 
   2020   2019 
Period-end MYR: US$1 exchange rate   4.1585    4.1349 
Period average MYR: US$1 exchange rate   4.2038    4.1870 
Period-end US$1: RMB exchange rate   0.1473    0.1454 
Period average US$1: RMB exchange rate   0.1446    0.1471 

 

● Related parties

 

Parties, which can be a corporation or individual, are considered to be related if the Company has the ability, directly or indirectly, to control the other party or exercise significant influence over the other party in making financial and operating decisions. Companies are also considered to be related if they are subject to common control or common significant influence.

 

● Fair value of financial instruments

 

The carrying value of the Company’s financial instruments: cash and cash equivalents, trade receivable, deposits and other receivables, amount due to related parties and other payables approximate at their fair values because of the short-term nature of these financial instruments.

 

The Company also follows the guidance of the ASC Topic 820-10, “Fair Value Measurements and Disclosures” (“ASC 820-10”), with respect to financial assets and liabilities that are measured at fair value. ASC 820-10 establishes a three-tier fair value hierarchy that prioritizes the inputs used in measuring fair value as follows:

 

● Level 1: Observable inputs such as quoted prices in active markets;

 

● Level 2: Inputs, other than the quoted prices in active markets, that are observable either directly or indirectly; and

 

● Level 3: Unobservable inputs in which there is little or no market data, which require the reporting entity to develop its own assumptions

 

As of September 30, 2020, and December 31, 2019, the Company did not have any nonfinancial assets and liabilities that are recognized or disclosed at fair value in the financial statements, at least annually, on a recurring basis, nor did the Company have any assets or liabilities measured at fair value on a non-recurring basis.

 

● Recent accounting pronouncements

 

Management has considered all recent accounting pronouncements issued since the last audit of our financial statements. The Company’s management believes that these recent pronouncements will not have a material effect on the Company’s financial statements.

 

8
 

 

ITEM 3. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK

 

As a “smaller reporting company” as defined by Item 10 of Regulation S-K, the Company is not required to provide information required by this Item.

 

ITEM 4. CONTROLS AND PROCEDURES

 

Evaluation of Disclosure Controls and Procedures

 

In connection with the preparation of this quarterly report, an evaluation was carried out by the Company’s management, with the participation of the principal executive officer and the principal financial officer, of the effectiveness of the Company’s disclosure controls and procedures (as defined in Rules 13a-15(e) and 15d-15(e) under the Exchange Act (“Exchange Act”) as of September 30, 2020. Disclosure controls and procedures are designed to ensure that information required to be disclosed in reports filed or submitted under the Exchange Act is recorded, processed, summarized, and reported within the time periods specified in the Commission’s rules and forms, and that such information is accumulated and communicated to management, including the principal executive officer and the principal financial officer, to allow timely decisions regarding required disclosures.

 

Based on that evaluation, the Company’s management concluded, as of the end of the period covered by this report, that the Company’s disclosure controls and procedures were not effective in recording, processing, summarizing, and reporting information required to be disclosed, within the time periods specified in the Commission’s rules and forms, and that such information was not accumulated and communicated to management, including the principal executive officer and the principal financial officer, to allow timely decisions regarding required disclosures.

 

Management’s Report on Internal Control over Financial Reporting

 

The management of the Company is responsible for establishing and maintaining adequate internal control over financial reporting. The Company’s internal control over financial reporting is a process, under the supervision of the principal executive officer and the principal financial officer, designed to provide reasonable assurance regarding the reliability of financial reporting and the preparation of the Company’s financial statements for external purposes in accordance with United States generally accepted accounting principles (GAAP). Internal control over financial reporting includes those policies and procedures that:

 

  i)

Pertain to the maintenance of records that is in reasonable detail accurately and fairly reflect the transactions and dispositions of the Company’s assets;

 

  ii)

Provide reasonable assurance that transactions are recorded as necessary to permit preparation of the financial statements in accordance with generally accepted accounting principles, and that receipts and expenditures are being made only in accordance with the authorizations of management and the board of directors; and

 

  iii)

Provide reasonable assurance regarding prevention or timely detection of unauthorized acquisition, use, or disposition of the Company’s assets that could have a material effect on the financial statements.

 

Because of its inherent limitations, internal control over financial reporting may not prevent or detect misstatements. Also, projections of any evaluation of effectiveness to future periods are subject to the risk that controls may become inadequate because of changes in conditions or that the degree of compliance with the policies or procedures may deteriorate.

 

The Company’s management conducted an assessment of the effectiveness of our internal control over financial reporting as of September 30, 2020, based on criteria established in Internal Control – Integrated Framework issued by the Committee of Sponsoring Organizations of the Treadway Commission, which assessment identified material weaknesses in internal control over financial reporting. A material weakness is a control deficiency, or a combination of deficiencies in internal control over financial reporting that creates a reasonable possibility that a material misstatement in annual or interim financial statements will not be prevented or detected on a timely basis. Since the assessment of the effectiveness of our internal control over financial reporting did identify a material weakness, management considers its internal control over financial reporting to be ineffective.

 

Management has concluded that our internal control over financial reporting had the following material deficiencies:

 

  i)

We were unable to maintain segregation of duties within our business operations due to our reliance on a single individual fulfilling the role of sole officer and director.

 

  ii)

Lack of a functioning audit committee due to a lack of a majority of independent members and a lack of a majority of outside directors on our Board of Directors, resulting in ineffective oversight in the establishment and monitoring of required internal controls and procedures.

 

While these control deficiencies did not result in any audit adjustments to our 2020 or 2019 interim or annual financial statements, it could have resulted in a material misstatement that might have been prevented or detected by a segregation of duties. Accordingly, we have determined that this control deficiency constitutes a material weakness.

 

9
 

 

To the extent reasonably possible, given our limited resources, our goal is, upon consummation of a merger with a private operating company, to separate the responsibilities of principal executive officer and principal financial officer, intending to rely on two or more individuals. We will also seek to expand our current board of directors to include additional individuals willing to perform directorial functions. Since the recited remedial actions will require that we hire or engage additional personnel, this material weakness may not be overcome in the near term due to our limited financial resources. Until such remedial actions can be realized, we will continue to rely on the advice of outside professionals and consultants.

 

This quarterly report does not include an attestation report of our registered public accounting firm regarding our internal controls over financial reporting. Management’s report was not subject to attestation by our registered public accounting firm pursuant to Section 404(c) of the Sarbanes-Oxley Act that permit us to provide only management’s report in this annual report.

 

Changes in Internal Controls over Financial Reporting

 

During the nine months ended September 30, 2020, there has been no change in internal control over financial reporting that has materially affected or is reasonably likely to materially affect our internal control over financial reporting.

 

PART II

 

OTHER INFORMATION

 

Item 1. Legal Proceedings

 

There are presently no material pending legal proceedings to which the Company, any executive officer, any owner of record or beneficially of more than five percent of any class of voting securities is a party or as to which any of its property is subject, and no such proceedings are known to the Company to be threatened or contemplated against it.

 

Item 1A. Risk Factors

 

As a “smaller reporting company” as defined by Item 10 of Regulation S-K, the Company is not required to provide information required by this Item.

 

Item 2. Unregistered Sale of Equity Securities and Use of Proceeds

 

None.

 

Item 3. Defaults Upon Senior Securities

 

None.

 

Item 4. Mine Safety Disclosures

 

Not applicable to our Company.

 

Item 5. Other Information

 

None

 

Item 6. Exhibits

 

Exhibit   Description
31.1   Certification of the Company’s Principal Executive Officer and Principal Financial Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002*
     
32.1   Certification of the Company’s Principal Executive Officer and Principal Financial pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002+
     
101.INS   XBRL INSTANCE DOCUMENT*
     
101.SCH   XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT*
     
101.CAL   XBRL TAXONOMY CALCULATION LINKBASE DOCUMENT*
     
101.DEF   XBRL TAXONOMY DEFINITION LINKBASE DOCUMENT*
     
101.LAB   XBRL TAXONOMY LABEL LINKBASE DOCUMENT*
     
101.PRE   XBRL TAXONOMY PRESENTATION LINKBASE DOCUMENT*

 

+ In accordance with SEC Release 33-8238, Exhibit 32.1 is being furnished and not filed.

 

* Filed herewith.

 

10
 

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

 

  BIOPLUS LIFE CORP.
  (Name of Registrant)
     
Date: January 7, 2021    
  By: /s/ Chong Khooi You
    Chong Khooi You
    CEO, President, Secretary, Treasurer, Director

 

11

 

 GRAPHIC 2 image_001.jpg begin 644 image_001.jpg M_]C_X 02D9)1@ ! 0$ 8 !@ #_VP!# @&!@<&!0@'!P<)"0@*#!0-# L+ M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#7J#A(6&AXB)BI*3E)66EYB9FJ*CI*6FIZBIJK*SM+6VM[BYNL+#Q,7& MQ\C)RM+3U-76U]C9VN'BX^3EYN?HZ>KQ\O/T]?;W^/GZ_\0 'P$ P$! 0$! M 0$! 0 $" P0%!@<("0H+_\0 M1$ @$"! 0#! <%! 0 0)W $" M Q$$!2$Q!A)!40=A<1,B,H$(%$*1H;'!"2,S4O 58G+1"A8D-.$E\1<8&1HF M)R@I*C4V-S@Y.D-$149'2$E*4U155E=865IC9&5F9VAI:G-T=79W>'EZ@H.$ MA8:'B(F*DI.4E9:7F)F:HJ.DI::GJ*FJLK.TM;:WN+FZPL/$Q<;'R,G*TM/4 MU=;7V-G:XN/DY>;GZ.GJ\O/T]?;W^/GZ_]H # ,! (1 Q$ /P#W^BBB@ HH MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH * M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH MHH **** "BBB@#+N[N__ +5%E9"V_P!1YI,P;^]CM^%'_$^_ZAO_ (_1_P S M5_VY?^SUJ5S0@YN3>#1['^\_O_P" '+YLM?\ $^_ZAO\ X_1_Q/O^H;_X_3M/U[3=5>-+ M.X+NZ/($:)T8!'V,&# %6#<%3@@]J7^W=,^R6MV;I5M[J0QQ2,K %@&)SD<< M(W)P.*/8_P!Y_?\ \ .7S8S_ (GW_4-_\?H_XGW_ %#?_'Z73-?T_5[26YM) M)O*C 9O.MI(3M(R&"NH)4CHP!!P<'BG_ -MZ=]GLY_M'[J]C,MNVQOG4)O)Z MYAM4G(!''6M&[UJQL=,BU"Y>6.&79Y:FWD\UBWW5$6 MW?N_V=N1SQP:/8_WG]__ Y?-D?_$^_ZAO_ (_1_P 3[_J&_P#C]59?&6B1 M0Q2>==2-(K,(8;&>29%4[6+Q*A= #Q\P'-++XQT*&Y@A-X[^?#%.DL-O+)"( MY6*QLTJJ40,5;!8CI1['^\_O_P" '+YLL_\ $^_ZAO\ X_1_Q/O^H;_X_3+7 MQ/I-YJSZ9#--]I5Y(QOM94C=T.'59&4(Y'/"DG@^AK7H]C_>?W_\ .7S9E_\ M3[_J&_\ C]'_ !/O^H;_ ./UJ44>Q_O/[_\ @!R^;,O_ (GW_4-_\?H_XGW_ M %#?_'ZU**/8_P!Y_?\ \ .7S9E_\3[_ *AO_C]'_$^_ZAO_ (_6I11['^\_ MO_X "T*3[^80V1M&>_X5K5EWW_(>TG_M MM_Z"*BI!P2:D]UU\_0EJVMS4HHHKI- HHHH **** "BBB@ HHHH **** "BB MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** M "BBB@ HHHH **** "BBB@ HHHH **** ,O_ )FK_MR_]GK4K+_YFK_MR_\ M9ZU*QH_:]7^A,>OJ%%%%;%!1110 5PWQ%O-/LY="EU"9EB2YDTW2&$EI"@;5+)IU2.1G>4X=X\#?@#YCPW M'(KURB@#R^+Q/X9\.:]:2V6L6>J6[6TJ3W"ZM9[_ #9)1(SOOE3J=Q^48'0 M# JK;^)](:'3-(EU+0_*TVZFN'NI=8M?(N%VRA%4!R^6\Q<[D &&Y; W>M44 M >9>&_%NAP6NIV[^(+"STWRD2QL[_6;::6)MK;P'65\QG*;0S$C#=%VBJ%GX MLTB[TO0K:;4--LWTZU>"4SZM9D.QMR@*[)FXW8'..M>N44 >.W=_X6L]$\-Q MPZZEZ;699+R&W\3J)D/V:1/D=[A=H#,,A& QV(K?U;QEX<>#0M3M-9TJ:73Y MO->QDU>V\\JT3QD!VD*%UWYY?!PWS6 M6'UT4 >9:3K'A>SN[O5;WQ=87$D-[=W-G8+J=H$4NS M89<$$LRL1\[X&\].WI%KTG_MM_Z"*U*R[[_D/:3_ -MO_016-?X5ZK\T3/;[ MC4HHHK8H**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH M**** "BBB@#+_P"9J_[JGC-@/#3Q,-T-Q=6MM.N, MYAEN(XY ?;8S9]JQH_:]7^A,>OJ;]%(+C3;#5)=/2YU&[:66&*-W^ M2.$KC>K ME45YE;^(=2O/+M],\5-J$$[62R7R00,;>261EDC7:@0': 0K!F4X+9! J#4? M$&L/XCU+1K77;C M[F$1>= ;I'CA#"01+ "FXC@EVR&R%'&T ]4HKRS_ (2? M5!?Z1:V7B?3FM3:P21W.H7T,7V]VD82*"(&$A7:%PC(P)^8DD8NZ)JDFI^-- M->?6#=72K>K<6'EH!8D, J_*H9<@=)"Q;&5P <@'HU%>>27FJSZS/I]CJ9TV M-I-1E=[>VA+,8S!L^\A&@G\3:U;SW%G/.9)K>UDU622P17\RU^S\)$67!/GD[2020G M/4T >A45Y3I?BZ_N(&@U#Q3!;V2WYA?5[>>WG 'D+(L8E,*1'+$C_5]BN2>: MJZ;XGU#3V\,64&H"%76T26TGDCB\\2S%&:.%HC(<#.3YBA2!P<$$ ]@HKF_% MMQ#<>%TO()4FMH;^SN))8CO58XKN)Y&R.RJC$^FTUS\^JR:EXEEN- U95M+Z MYM+(WUJ$F5ML=P[JC$%21E.>0#USR* /1**\HO=4U.YT^>:35I;2>VC1)K^" M.&.1DBOWB9G8H0%V+N(&%!SQ@D&Y_P )/K9\3W$%KJ^FRQP K;V-Q>1K->H( M ZR)$L(9RS'(9) G!&T8- 'I=%<#X+OUU'Q-=7*:X=8#Z7;%I]D8$;EY"T8, M:A>,]#EAGDGBN8CEM-/L)X-'UF&"&&YLI;O6M-*1R,C7 5EO ZL!* S,S'!; M!W* "I /9:*\GU/Q+JUUK6L:;8ZY,(S:7:QQ)/ UQ&T:!ED"+ "@8@[27;9GU9=3OK+5[(QRV\D,EN@EG\LI$T:JP/E,X97RRYSD@Y/I5 ! M67??\A[2?^VW_H(K4K+OO^0]I/\ VV_]!%8U_A7JOS1,]ON-2BBBMB@HHHH M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** ,O_ M )FK_MR_]GJ[>V<&H64UG=(7@F0HZABIP?0@@@^A!!'455N].N)M0%Y;7OV= MQ%Y1_=!\C.>YIGV'5?\ H,_^2JUS1S\[[/'L\Z5II.2IY^ ME4OL.J_]!G_R56C[#JO_ $&?_)5:/:R_D?X?YAS/L:E%9?V'5?\ H,_^2JT? M8=5_Z#/_ )*K1[67\C_#_,.9]C4HK+^PZK_T&?\ R56C[#JO_09_\E5H]K+^ M1_A_F',^QJ45E_8=5_Z#/_DJM'V'5?\ H,_^2JT>UE_(_P /\PYGV-2BLO[# MJO\ T&?_ "56HY[;4[>WDF?6"5C0N0+5,X SZTG5DE=P?X?YBYGV-BD(R"/7 MTK(@MM3N+>.9-8(61 X!M4S@C/K4GV'5?^@S_P"2JT*K)JZ@_P /\PYGV+MG M:06%G#:6L8C@A0(B DX ]SR?J:GK+^PZK_T&?_)5:/L.J_\ 09_\E5I^UE_( M_P /\Q\S[&I167]AU7_H,_\ DJM'V'5?^@S_ .2JT>UE_(_P_P PYGV-2BLO M[#JO_09_\E5H^PZK_P!!G_R56CVLOY'^'^8UE_(_P_S#F?8NW%G;W;V[SQ[S;R^='DG ?! .._#'KWP>H!J> MLO[#JO\ T&?_ "56C[#JO_09_P#)5:/:R_D?X?YAS/L:E9=]_P A[2?^VW_H M(H^PZK_T&?\ R56B+3+O[?;W5UJ'G^1NVKY(7[PP>0:BE MC4HHHKI- HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "JNI_\@J\_P"N#_\ MH)JU574_^05>?]<'_P#0345/@EZ/\F*6S#3/^059_P#7!/\ T$5:JKIG_(*L M_P#K@G_H(JU13^"/HOR01V044458RMJ&H6NE6$M[>S"&WB +,02L1WD MND745A%!+=21E$2>4Q)SP26"L1@$GH#LVGN: -L^,M"$EPGVJ8M "2%M)CYN'$9\K"_O<.RJ=F[ M!8#O6E9:I9:B1]DF\T&*.;(4XV.,KSCJ1SCK@CCD5R2>$-3FC2VOA9O;V-O- M#9/'=2I),SRQR([E55HBOE+]QFR3G(Q5OPUX4O?#NN3LEV7TLP[44W,C%WVQ M#)B(V+@I)@J>D@7 "+0!UU%%% !1110 4444 %%%% !1110 4444 %%%% !1 M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%% M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 9=W=W_]JBRLA;?Z MCS29@W][';\*/^)]_P!0W_Q^C_F:O^W+_P!GK4KFA!S?W_ / #E\V9?_$^_P"H;_X_4<\.N7%O)"YT MX+(A0D;\X(Q6Q12="ZLY/[_^ +D\V8\$.N6]O'"ATXK&@0$[\X Q4G_$^_ZA MO_C]:E%"H65E)_?_ , .3S9E_P#$^_ZAO_C]'_$^_P"H;_X_6I13]C_>?W_\ M ?+YLR_^)]_U#?\ Q^C_ (GW_4-_\?K4HH]C_>?W_P# #E\V9?\ Q/O^H;_X M_1_Q/O\ J&_^/UJ44>Q_O/[_ /@!R^;,O_B??]0W_P ?H_XGW_4-_P#'ZU** M/8_WG]__ Y?-F7_P 3[_J&_P#C]'_$^_ZAO_C]:E%'L?[S^_\ X M2LO_ )FK_MR_]GK4K&C] MKU?Z$QZ^H4445L4%%%% !1110!X7&+.*#6WM9])GNI;'68[J&QA"7$*[F8/< ML&;>,J%7(3&_C-=#JXT!VU]=:,)\297^R1)C[4!Y2>1]DS\W^LWQT^\4J]XCW!*26;]1*<*05#%@4^Z& M#5VNK:MIND^/-/DU+4+2R2739TC:YF6,.WFQ< L1D^U6O^$-TO\ Y^M<_P#! M[>__ !ZC_A#=+_Y^M<_\'M[_ /'J .,T[11K.JZ,IATJ006UU(1J%A]J _TO M^#YUV-_M<_2K_P /4TE=7U1X[KP^^IM=7H>&WMT6_5?M3Y\U]Y9E^[_"O\/M M72?\(;I?_/UKG_@]O?\ X]1_PANE_P#/UKG_ (/;W_X]0!Q\ITLZ?K90QGQX MK7WE;/\ C^SB3RMH'S>7Y>S;_!]WO5'75\,'1=5/@YK,A=!OO[1:R(P4\D[/ M/Q_RUW]-_P W^L_VJ[[_ (0W2_\ GZUS_P 'M[_\>H_X0W2_^?K7/_![>_\ MQZ@#A+C2T6X;2O[ T>*4ZQ;N=$WXLBIMI,2!O*Y#%6Y\L?-%C'&X^@^&K1=' MTFVT::YMVO((S(T$3<1(SL550>?+7[BD@9"=!T$/_"&Z7_S]:Y_X/;W_ ./5 M;4G=D*$76I7%PN,@\+([ 'CKC/7U- &I1110 4444 %%%% ! M67??\A[2?^VW_H(K4K+OO^0]I/\ VV_]!%8U_A7JOS1,]ON-2BBBMB@HHHH M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** ,O_ M )FK_MR_]GK4K+_YFK_MR_\ 9ZU*QH_:]7^A,>OJ%%%%;%!1110 45QTVO:@ MFJ6TBS_Z+)K4UIY(5?\ 516[A(L[E1YC;/D*]3@/QTR>* .UHKE+OQ5J=B\WG:/;,EBL3:@T=\3Y>]C MCR@8QYF%PQW;.N!FHD\7:K.8/L^AVS?:]0FL;3S+\KN,7G;W?$1V#]SQC<3G MMCD ["BN*7QW1H[EYK>/RHA'N=#+"KL^TU+&46L%Y$J7'G;HI=X4-\ MHVN"AR!N'(PQH Z"BO-++Q;K3>%[BUFNP^N3NALY_+0$0R!F+[0-I*"*? Q@ M^6N?O&KD7CRY$EE8/;QS-/;*IO(C(2DYMC-AQY(B4X&=HD+8*G;@\ '?T5PM MMXYO!>:;IWV&*]EN((U,R22J1.UOYH5_W/E)G X\S=A@=N*FG\>NUFEW8:8D MML4MS).ATG49KG6-4M)7+I&(9X,J 5CD3[IQ MUPR.<^X]* -FBBB@ HHHH *R[[_D/:3_ -MO_016I67??\A[2?\ MM_Z"*QK M_"O5?FB9[?<:E%%%;%!1110 4444 %%%% !1110 4444 %%%% !1110 4444 M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 M4444 %%%% !1110 4444 9?_ #-7_;E_[/6I6==Z=<3:@+RVO?L[B+RC^Z#Y M&<]S3/L.J_\ 09_\E5KFBYPUE_(_P_ MS#F?8BB\.6BW<\TP$J->->P)RODR-"8GY!^;(9SR."Y]!A9_"NC7%M';R6A\ MN."*",K,ZLB1MNCVL&R&4@$,#N]ZD^PZK_T&?_)5:/L.J_\ 09_\E5H]K+^1 M_A_F',^Q6/A#16GAF>&YDDB" F2]G?S0C%D\T%SYNTDD;]V.U,U#PC87R:=" MK2V]M9WDMX4BED1V>19 V)%8,AW2EL@^W2KGV'5?^@S_ .2JT?8=5_Z#/_DJ MM'M9?R/\/\PYGV*Q\&Z#OMV%DZ""..,*EQ(JR*A)02J&Q+@DGYPW)/J:EN?# M&DW=BMG)!*D2W$MRIAN98G621G:0AT8,-QD?(SCG&,5)]AU7_H,_^2JT?8=5 M_P"@S_Y*K1[67\C_ _S#F?8KGPAH9A6#[&PA6R2P\M9Y IA3[@(#8)7)VL? MF&>"*'\(Z1+!#%,M[,(79D>;4;B1\, &0NSEBAVC*$E3CD58^PZK_P!!G_R5 M6HKFWU6WM9I_[7W>6C/M^S*,X&:3K22NX/\ #_,7,^Q.WA_2VL;&R-KFWL4\ MNV3S&^1?+,6,YR?D9ASGKGKS4UMI=G:7/VB"'9+]GCMMVXG]VA8JO)[;VYZ\ MU2MK?5;BUAG_ +7V^8BOM^S*<9&:E^PZK_T&?_)5:%6DU=0?X?YAS/L-C\,: M-%+;RI8IYEM;26L+EF)2)R"RY)[X'/4170M)1)$/D474OE@^ M7Y6[9NVEO+^7=C..]6_L.J_]!G_R56C[#JO_ $&?_)5:?M9?R/\ #_,?,^Q7 MC\(:)%J-O?1VLJS6[*\0%S+Y8=8_*5S'NV%PGR[B"<<9JO:^"]/CTB?3[B2X M9+B[FNY3:W,MKN:1B=I\MP2H4A<$D84<5H?8=5_Z#/\ Y*K1]AU7_H,_^2JT M>UE_(_P_S#F?8JWW@O0-0A>*>R=4?S P@N98=RN%5T.QAE&")E/NG:.*NZ?I M2V%Y?W(D+M=.F!C'EHB!50<\]&.?5C3/L.J_]!G_ ,E5H^PZK_T&?_)5:/:R M_D?X?YAS/L:E%9?V'5?^@S_Y*K1]AU7_ *#/_DJM'M9?R/\ #_,.9]C4HK+^ MPZK_ -!G_P E5H^PZK_T&?\ R56CVLOY'^'^8TG_MM_Z"*/ ML.J_]!G_ ,E5HBTR[^WV]U=:AY_D;MJ^2%^\,'D&HG*C_)BELPTS_D%6?\ UP3_ -!%6JJZ9_R"K/\ MZX)_Z"*M44_@CZ+\D$=D%%%%6,IZK>36&EW%U;VANIHDW+") @8^I8]%'4D MG . QP#@WOB^X@*/;Z8DT$5I!>7S-<[6ACE8@;%V'S&&QR02G '//&_J=DVH MZ;/9K=SVAF7:9H A=1WQO5EY&1R#UXP>:PQX)MRMNLFK:E(J0QV]P&,(%W%& MY9%DQ&.%W$93:2#R30!0N?'D]K#]IFTRVBM)XVDLIY;[:C*LT<1,QV8B'[U6 MR-_R@YP1BM;P[XLL_$4EM\ MOE1 K&I*_+NY$,8Y)'R\ $G(!M4444 %%%% !1110 4444 %%%% !1110 44 M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111 M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110!DO=ZG-J5U; M68M D&SF8-D[AGM^-._XGW_4-_\ 'ZR]4UC^P!X@U/RXI/(%N=LLWE)SA87C?:N\8RO08((YQ7-3@ MYIMR>[Z^?H9I7UN;O_$^_P"H;_X_1_Q/O^H;_P"/UAW?C'4M*LC=ZKH4=O%- M:37-J([WS&+1Q&7RI1L 1BJM]TN,JW/3,UIXMNCJ<&FW^FP0WDEW' PM[LS1 MJCPR2JVXQJ=W[H@K@8R#DYQ5^Q_O/[_^ 5R^;-;_ (GW_4-_\?H_XGW_ %#? M_'ZJ77B;[-8^([G[)N_L:7RMOF8\[]Q%+G./E_UN._W<]\ T3Q#/K.K:C;"S M@BM[.:2 N+K=,KH^T>9%M&P.,LIW-E<'C(H]C_>?W_\ #E\V6_^)]_U#?\ MQ^C_ (GW_4-_\?JI+XE\K2[F]^R9\G4EL-GF?>S.L6_./]K./;&>]8>>#V/]Y_?_ , .7S9M M?\3[_J&_^/T?\3[_ *AO_C]<_<^+M6RW3 QUH]C_>?W M_P# #E\V;W_$^_ZAO_C]1SQ:Y<6\D+_V=MD4H<;\X(Q6*OC^)KV2$Z=(D1TQ M;^WEDDQYC&,R>21CY6V@GO\ =;TYT/\ A*E_MW3]-%I\MU KO/YG$4CJ[I&1 MCG(CDYXQ\O!W4G0NK.3^_P#X N3S9:@BURWMXX4_L[;&H09WYP!BI/\ B??] M0W_Q^L)?%FMQ/J9OM$T^.+3IXK>5H-2>1F=Q&PV@P+QB4D(^AP7;6LMT;K$WRR>6\BQ;,% X/.\$A20#P"*A964G]__ #D\V:W_$^_ MZAO_ (_1_P 3[_J&_P#C]8FG>.EOFN(GT\PSQ:F+(1F;.^)I6B68<="T;C'J MI&>]/N/&R01>))5L2\>D6DMS _G8%WY6]9%''RE9(RIZ]0?:G['^\_O_ . / ME\V;'_$^_P"H;_X_1_Q/O^H;_P"/T_7=630]%N=3D56CMP&8,^P8R 23V SF ML)_'VGW%Y=VVC&VU9XDMEA>UNU9))IGE4(S#(0*(MQ/)P?NG !/8_P!Y_?\ M\ .7S9M?\3[_ *AO_C]'_$^_ZAO_ (_69%XJNXM372]2TN*WOS/"A6&Y,L1C ME$A616**3S$ZE2HQCKR*9J?BR^TZ[U:0:3#-I6DE/M.5L]2 ML[>73S]GFO9[6:X$W^H$;J@^==*Z MW%T8HHXX9WA#%PC'.:X22^ D 8E285VXE12!ELJ<$<9XK1.J MSR:MJ6FVUK&\]I:PSQF28HLC2&0!20I*@>7UP?O=..3V/]Y_?_P Y?-A_P 3 M[_J&_P#C]07MWK5C:/+=>EM%E.@Z:KR:@^GQ*-4D( M,B.ZL6/V?A?W9Q@$G(X%6IM7DU3P[JD=S:?9+VRN!;W,(D\Q0WR."K8&Y2KJ M02 ><$ @UG6IN%.4E)W2?7_@$R5HMW9U-%%%=1H%%%% !1110 4444 %%%% M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 % M%%% !1110 4444 %%%% !1110 4444 %%%% !1110!QWB&&[NH];MK&TN+F> M62VV^0L3%"HWAB))8P5RH& V>:PAI6K7=Q<7.J^'-8N)KMY#="W2RA1E:W$& M%!NV(.T9R2V3Z# '=6/_ "'M6_[8_P#H)K4K&A\+]7^;)AM]YYC=V7B;5;%[ M35M(U:X2.TFMK5HK>RC*M)&8_-DS>'>P4M]W8/F;CIBU=VM_#8Z=!X?\&7ND MO8W?VI0MO8M$[>6\9RB7:PKT2BMBCS2YM?$ET;V)M$U1;35#&^I1K! M9[I'5$C8Q,;P^6K+&@PP M>(]3\.W.FZEX;U-[B<%?/MH[.- ,@CY&O&.>/[U9FJZ3J.IQ28\-Z]#<'4A? M),IL3M4[-\1'VKD,$]N=IQ\HKTRB@#@-135KZWUV-/#.MQ/J@3:S?8F$150O M(^U#=TSU%5;^QU7Q"ULWB;PE?7_D).BK#;V<0'F! &7=>.5==IPP/\7&,<^D MT4 >87^E:QJ>DW]O>:%KK7MU;P(MXJV(,;&^5,$D(29;%="U@:'-=M=26IBLC,= MTAE:,2_:\!"Y/&PG:2 1P1Z310!YC+I&IL=,EA\.Z[% M4P^U=F*X.?X3TW&J<_A:];2A;0:%XH6ZDL+FRN;B>[MYEE$\9#LL;7FV/,FR M0A0 =N/0CUJB@#A)[OQ-J6@W.GZIX=U*2>5P5FM8;2)54%3@HUZY)R#SN'4< M<#@'!!.1Z%10!Y MG/;>*+F7^T)=$U(ZP)X76;[-:>0J1APJ"+[;NZR.2=_4^@ IEQ:>*;UM2AN] M&U(V6JA!?QP6UHDC@1JC*CF^8(K!<$%6."<'."/3Z* /.Q8WDEV\EWX2UJXM MY#>>;;N;+#K<%25)^U=@N/?/:LRWT/7+/28+:/0]5NKD?:$NI-1M[&XBO(Y9 MFFQ)$+M?F#-PP8#ELCD;?5Z* /+8=*UU+'2--?P_J3:=I\L-P(UMK%9%EC?= MF)Q>?NU/W2-K':6&[GC6DNO$T?BF75K/P[J4=O<0P0W%O-#:2.RQM(?D<7JA M21(1RK=!]*[RB@#SJ:'7ETZ.&R\/:M%21]A47BDX\S&=P MZ9QVJ]:17L?A[69-1T^^M[VZG2XGFN1 JRL=B8C6*63:JJBC#'/N3FNWK+\1 M?\@&Y_X#_P"A"L<1_!GZ,F?PLU****V*"BBB@ HHHH **** "BBB@ HHHH * M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH MHH **** "BBB@ HHHH **** "BBB@ HHHH R['_D/:M_VQ_]!-:E9=C_ ,A[ M5O\ MC_Z":U*QH?"_5_FR8;?>%%%%;%!4=Q/%:VTMQ.XCAB0O([=%4#))_"I M*Q/&,4LW@[5TAC\US:N?+ SO &2OXC(H T;/4K6_>9+>1F>$J)%9&4J64. 0 M0/X6!]OK5JN&O?#CZWKL=Q-9Q7>D3ZM'=MN=622$6#Q@E<_,/,*C&.>N,53T MWPW>66HV/]H>'?M\<%O'!82Y@D&F,DTI#8=@0-AA(*;FQ'C' R >BT5Y7;^# M;^6PC@7P_P#86$-K#J.9HC_:,JW,3O,65B6VJDIW/ASYG3.:G&@K+XNU*'2] M"CB>TU6S:#48Q$J64200-)&%R& = 4PJD'=S@"@#TVBO*K;P;J,MBD/]@_8I MEM8H-2D\Z+_B:3?:(7:;*MEL+',=TFUOWN .M7;KPA.?'EM-!H4$>F13+$&@ MM[1(#:?9RC(_'G,V\D;!\FS'<4 >B03PW5O'<6\LA!'!%1W M-];VDMK%/)L>ZE\F$;2=S[6?''3Y48\^E>5'P1>_V)HME+H=]%;V=JT,L&G" MPW_:?ES<#SLJ-P!PX*R#'(&:VX/#=\OBVSNY-%+SP:I)R6 M)KB38)95A3@G+L< <>]<=>>%)=3\42R:AIT=SIDFJ?:'24JR/&+)8P60GD>8 MN,$=0#C'-3-X=O;CP5H>DSQ3"2VGM_.$=R4=(T;G$BL#PH'0YH ZJWOK>ZN+ MJ"&3=+:2"*9=I&UBBN!SU^5E/'K5BO.;CPE/9ZE=&31;C6M';4/.-G<72W#S M VT:+(?M$F&VNKC#MD9! X%10>"+X6_GW5BDNH6UO8+9RM,':!DE9G",3D$+ MM!;C]9F-P$>%OM$SQ8<'(C=).@Y1F)QEFP >D45YS#X/^VZC:G_A&H].T,ZD MDTNER>2$ 6UG1I&2-F3#.\2[023MR1C-S@$0SZAS$%A[-6[0 4444 %9?B+_D W/\ P'_T M(5J5E^(O^0#<_P# ?_0A6.(_@S]&3/X6:E%%%;%!1110 4444 %%%% !1110 M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% ! M1110 4444 %%%% !1110 4444 %%%% !1110 4444 9=C_R'M6_[8_\ H)K4 MK+ETR[^WW%U:ZAY'G[=R^2&^Z,#DFC[#JO\ T&?_ "56N:$IP37*]WV[^IFF MUI8U**R_L.J_]!G_ ,E5H^PZK_T&?_)5:OVLOY'^'^97,^QJ45E_8=5_Z#/_ M )*K1]AU7_H,_P#DJM'M9?R/\/\ ,.9]C4HK+^PZK_T&?_)5:/L.J_\ 09_\ ME5H]K+^1_A_F',^QJ45E_8=5_P"@S_Y*K1]AU7_H,_\ DJM'M9?R/\/\PYGV M-2BLO[#JO_09_P#)5:/L.J_]!G_R56CVLOY'^'^8/N GYNHZ9ZBHO$,1FT&[C73FU&0J#';)Y>6<$%6'F,J@J< M-DD8V\3_OTM:E%+V$//[W_F'(C+_LV_/75Y?PB44?V9>_\ 07G_ .^% MK4HH]A#S^]_YAR(R_P"S+W_H+S_]\+1_9E[_ -!>?_OA:U**/80\_O?^8_]!>?_OA:U**/80\_O?\ F'(C+_LN[_Z"US^0H_LN M[_Z"US^0K4HH]A#S^]_YAR(R_P"R[O\ Z"US^0H_LN[_ .@M<_D*U**/80\_ MO?\ F'(C+_LN[_Z"US^0I&TBXD1D?5;EE88(XYK5HH^KT_Z;_P PY$9,>C2Q M1K''J=TJ*, C@4[^R;C_H*W?YBM2BCZO373\7_F')$R_P"R;C_H*W?YBC^R M;C_H*W?YBM2BCV%/^F_\PY$9?]DW'_05N_S%']D3?]!6]_[['^%:E%'L*?;\ M7_F'(C+_ +(E_P"@I>_]]C_"C^R)?^@I>_\ ?8_PK4HH^KT^WXO_ ##DB9?] MD2_]!2]_[['^%']D2_\ 04O?^^Q_A6I11]7I]OQ?^80]=4OOPDQ_2 MC^QG_P"@IJ'_ ']_^M6I11]7I]OQ?^8BT@7"EL&0JWS'' QSSR,5JZ7_ ,@FT_ZX MK_*H]6TZ74[801ZG>6"DG>UIY>YU(P5)=&Q]5P?>M:?P1]%^2*CLCEK#XD6F MH:S86D<5K'#>>2(Q+>!;H^; LRNL&WYH_F"EMWW@W'&:TM1\536/BF#1TT^. M5) I)^T%9W!#$M'%L(=%VC<=XP3TZ9M+X8@6[LW%]>"SL546=@#&(8"J;%88 M3>Q )X9F&3G' Q"_A""74XKV;4]0D(>"::(^4%N)8@ DC$1A@> 2$*KQ]W!( M-C*&@?$"RUN:QMBUA%[-S=^;',9ICN0_:6W(ZF0E<_*8TQM*X"A?N\5OT %%%% !1110 4444 %%% M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 9UWJ-Q#J L[:R^T M.8O-/[T)@9QW%,^W:K_T!O\ R:6C_F:O^W+_ -GJ.[\4:38ZJ--N)ITN,QJ6 M%K*T2&0[4#2A=BECP,L.<5S14YN3YFM6NGEY$)-WU)/MVJ_] ;_R:6C[=JO_ M $!O_)I:BN/%6CVT$,IN)I?/EEBBCM[66:5VB8K)B-%+;588+8QR.>1FPNNZ M:^D0:JETK64[1I'*%8Y9W"*",9!W, 01P7F,94_>QTSTYH]E+^=_A_D M'*^Y/]NU7_H#?^32T?;M5_Z W_DTM2RZUI\&MV^CRW(2_N8FFAA*GYU7K@XQ MGVSGKZ52A\7:/<7=M;6\EW/)<1QRH8;">1520D(SLJ%4!*M]XC&"3Q1[*7\[ M_#_(.5]RQ]NU7_H#?^32T?;M5_Z W_DTM.?7]-2PM[WSW:"X=HX2D+NSL Q( M"@%B<(W;G''45FIXZT*2&68'4@D<@B;=I-T"9"VW8 8\LV3]T9-'LI?SO\/\ M@Y7W-#[=JO\ T!O_ ":6C[=JO_0&_P#)I:8WBC1DTN#47O-EK//]F1GB=6$N MXJ492-RD$-G(&W!SC!I;_P 2:5IM^ME*=(EMYIVGFMXX8#<2?:[:6W*QY(W$2*IQD'ZTQO%VBQZ5=:G M/<36UM:LJS?:;26%TW8QF-U#X.>N,=?0U,J#DG%S=GZ?Y"<&U9LG^W:K_P! M;_R:6C[=JO\ T!O_ ":6K0U&T-[-:>>HFA@6XD!! 6-BP5L].J-W[5!I.N6& MMQ-+8O,RJ%/[VWDA+*WW64.H+*<'##(.#@\57LI?SO\ #_(?*^XS[=JO_0&_ M\FEH^W:K_P! ;_R:6H3XKT;[3;P"XE>2X/R;+:5E WF,,S!<(I8$!F(#8X)% M6X]:T^6&VE2XRES<-;0G8WS2+NRO3C[CRE_._P_R#E?._#S:5_:K7-U#8$Q;;FXL+B%'$A^0J70!@?49 M ')P*N7WB73=.DFCF-Y(\#!91;6,]QL)4,,^6C8&#UZ4>RE_._P_R#E??2;G5([LFSMK47;(.;B46,YBCV+N8>;LV9 [ Y[=:/92_G?X?Y!RON3 M?;M5_P"@-_Y-+1]NU7_H#?\ DTM1CQ5HAL;>]%\OV:XLY+Z.38V/(39O<\?+ MM\Q,@X(R>.#BQJVMV.BI;M>FXS<2>5$EO;2SN[;2V L:L>BL>G:CV4OYW^'^ M0G:B;06EQYOVNV^U181AF/*C)R/E.6 PV#P>/E M.#V4OYW^'^0^*=)T_1SJT\MP;%6D5 MY8;2:4)L+!RP1254%6^8@#CK56;QOH=OCSVU"+]UYS^9I=TOE1Y(WR9C_=K\ MKB0?9OM9>160+'G:2<@8.>-IYSQBCV4OYW^'^ M0$*TD-S;2V\B MJV<-LD56VG!&<8R#Z5(FLZ?):V]RMQF&XF\B)MC?,^2N,8XY4\GCBCV4OYW^ M'^0&WFECA3S[>2)][R"- 490PRS <@=<].:/9 M2_G?X?Y!RON1?;M5_P"@-_Y-+4<]UJLUO)%_9&-Z%<_:5XR*EO?$.EZ<9Q0H#C<4C0L%SQD@#-37WB+ M3-/L;*\EFEE@O6"6QM;>2X:8E&<;5C5B1M5FSC&!3]E+^=_A_D/E?(6]C/+A&. 7V(=G.0=V,8. M<8I$\8Z')/=Q?:9E-J)S(\EI,B'R6*R['*!9"I!R%)/!H]E+^=_A_D'*^Y9^ MW:K_ - ;_P FEH^W:K_T!O\ R:6K0U&T-W%:B;]]+ ;A%*GF,$ MG&!RR^_- M9I\7Z(=(M=4CN9I[2[F,$!M[665Y'&[*A$4MQL;MVH]E+^=_A_D'*^Y8^W:K M_P! ;_R:6C[=JO\ T!O_ ":6K.FZG9ZO9+=V,WFPDE2=I5E8'#*RD JP(((( M!!ZU;H]E+^=_A_D'*^YE_;M5_P"@-_Y-+1]NU7_H#?\ DTM:E%'LI?SO\/\ M(.5]RAI^H2W<]S!/:_9Y(-N5\P/G<">PJ_678_\ (>U;_MC_ .@FM2G1;<-7 M?5_F$6[:A1116I04444 %%%% !1110 4444 %%%% !1110 4444 9?\ S-7_ M &Y?^SUYWXOOM-M_&E]'-?0P7A-DT,LFLPPPP-&V_=- TH+8!5AF-CTP1P1Z M)_S-7_;E_P"SUJ5C1^UZO]"8]?4\FT[Q5H^@W<.H#4](OMQO8I(;?5K02QB2 MZ>5'&^55*E2,_-D';P><33^(M"C\$R1+KNARW\NI+J+V<.J6^5!O%G9 S.%+ M!<@G(!8'UKU.BMBCR+5?$6A^(+^ZNGU?3K.&Y72T,;ZU;)*HANYGE.Z*8[2$ M96!5L\\<@@6+K7_"ECXNM+F'6!>V<5I%%'+;^)8P5=978^=YERK2KAAPV\8R M,=J]5HH \T\0:YX;U/6_MMMXIT%);:T5[2)4%PHD WK_"_?'I7M-% 'E.G>*=' M$FC:5/J^C0P:9>R7$E\=7M3%*F)0@11)OW'S%R&50,-R<#=)=:YH=QIP,A"C &-+1?'=EI5Q/+>7^CW=QJ2V\DLT.LVB MI#*L2Q.)-TF0F4#@H'.&/&1@^J44 >-V6N:"NC:K8+JEK#>/++.DUUXA@>UF M(N?,1403MY988Y\M>^?>_>^*M%UNU\479U;2;*2]TC^S[6UN-6M#)(X$QW$I M*R*"90!EL\'.!C/JM% 'EWB#7=!O[J6:V\1Z _EVEHT:OJL"K+)#,]/\ $]Q91)K&@Z3:0-)-(=3O[:X\QMFQ4,<-P.")'(._JG(Z M9]2HH \BT7QC8:5?HM_J&EZANTZ'3FN(]6LQ&QBEF D<--N"LCHW 8\D8R,5 MI^%/&&AVAO8V\0:?I^EB*);*SOM8MIY(7 ;?M=)'_=_)]&AT;PY]@U73[;58-/M;=[R/6+9(TV\21SQNX+H.2"%8_,<;3R;%A=^ M%[632+P^)]/^U1:M/<3QOXA#Q)$QGPPB,IC'WT^Z,\GWKURB@#Q70=6\.#PA MI6C75];0R0-9B\%_X@MYXI @Q)Y8^T/M7K\H"\$8'& T>(;2QBOM-FU?3=0T M^>[CADFM]8L_-GLXX@ "))5Y; CE44 >?0Z]X0T_5]"6R\3:*;&QM;B)G?5(68%C&1G+Y).UCF MD\.:[X/TG5-=N6\2:'&+F[S;G^TX3^YVA\##<#S9)S@]V/;%>A44 >2?\);H M]QX#\0^'CJ&FQ7,MM?K;ROJUGY<[2M(4"D3%AG>/O!0*T]4\=:)9^*+B\LM0 MTG4(KC3X[='75K1(TD5Y#^\WRAMOSC)56.,\$\5Z110!RT=JEC\-K"TCNH[N M."QMHEN(FW)*%" .I[@XR#[UU-9?B+_D W/_ '_ -"%:E8Q_C2]%^I*^)A6 M7_S-7_;E_P"SUJ5E_P#,U?\ ;E_[/16^SZK]0ET]34HHHK8H**** .(^(]Y8 M6MOHAO[@(B7YF:)-2CLIG00R*3&[RQ]&D3.&'!KC8=1TLZ9"I\0:"'@B1X8) MM7MR<1WHGC@=@QRWEJJEN03G+-R3[310!Y]IOC?P]J'B1]7N]7TG38HK3[+' M%<:K:M)*6<,S$1R,H4;5 ^;.2W XSD:?XNT9K'3M-FU#3;8[97;,6Z,#@J*]8HH \<>]\,6O@FV@3Q!;7%[]IMY;FVB\2(&"I*&;RBTX M2,XS]PK6SJOB;POJ_@RUL(M=LK=OMEHSP7.NPFX2..ZC9V,JS,<[%9@0Y;IC MGBO2J* /(GU3P[I&O'4]/U[3;Z"VNXYTAFUZ.::53!)$^QYI3RI<'#,HQNP: M5_%^DKK<'B+[9IK,]\7:PBU>R\Z.,6[1*S$S!"Q8YP'.%V]\@>N44 >2-XMT MF]%_IAO]*MXKW4X[S[9/JUF8XXP8G(PLS.7&P@#;C.#G'-0QWVAR^4Y\3:#; MW-M'#_LL1WKV&B@#QC3?$MEH^FI*FM6"W-YI\$, MHT[5K!I[26)Y&VDS/Y;H1)C(R1@\6EPDVH)I^M MV]M-N^RRHS*XFC _>.N0K#@GJ.*]4HH \7TW7=#T^]TJ>\U*&=(+7RHUL?$- MM$8 )W:-)L7""4K&4#'YPQ#'G.2/J&F);7N[Q3I%VMRVKK%:OJEHJVK322M% M(I##(=3@ABQ!D&-H#"O:** /'M0O/#]JQ71_%.GLUUIC6,LUUXA%P(#))$&8 M"28D;4WMA,9V@=<4T^(K+2=1AIZG!U;_MC_Z":U*R['_D/:M_VQ_]!-:E8T/A?J_S9,-O MO"BBBMB@HHHH **** "BBB@ HHHH **** "BBB@ HHHH R_^9J_[M2 MLO\ YFK_ +OJ%%%%;%!1110 4444 %%-=BJ,P&X@$@# MO7EMO>75GHFD7UA.L5Y-H44QF:,-^\EGB,C%>Y+.Q/3J>E 'JE%><7&O7MCJ MS<$FQ-XFU'^V98TU?9?K=S0R:)Y<3>3;K M$[+-]WS.<(V\ML.[;C)% 'HM%>5:UXEUG1M-T20Z^[7=Q:I>2_:GMX(YRQ3, M4:"!FDQD_*&4@$9^MXO$Q:8ZR\-Q+?W,,0L(MLC1Y;R'$8J45Y1JVN7EY9);:AXAM1/Y=D\%M9&.6+4 THWR!M@=P,9RFU M5(R01Q71>+-0O;'6&^P31V\[V]JBS>0CLN^\CC/)&2-K'C..<\'F@#M:*XR2 MYU9O"7B2V%[=7=W8S20)!CFL9[?PQ M6=FKZFHEGTM49$_T.[QP08_,QD'(+8*[@0%H ],HKS"VUK6+FY9([Y(;N:'3 MK:2\2UB\QLW-W$S\KC)" @'*J2<+@D&KKOB_6=*LHD&L[+FVFNU\RYD@A6\6 M*?8J[/)8R2;<9"&/@YR,C !ZS16#X?;;JOB.W3_41:@"@'16>")W _X$Q;ZL M:WJ "BBB@ HHHH **** ,OQ%_P @&Y_X#_Z$*U*R_$7_ " ;G_@/_H0K4K&/ M\:7HOU)7Q,*R_P#F:O\ MR_]GK4K+_YFK_MR_P#9Z*WV?5?J$NGJ:E%%%;%! M1110 45B>,9WMO!VKRH[1D6K@NO5 1@L/H"3^%)IM,TN\;3DN]8BM MGDAB1BL2ZXL(WL_$7VR:XAM6O"((?^);<27,49B" MA05RKRC;)N8>7USG(!ZI17G4VO:C9>)I].'B*2XN[;4;6V@TZ2. /=PO'"97 M.$!RH:23*X QSP0!GVWBO6+FQ22S\0?:KB>UBDO8_(B/]E7#W$*"':%!&0\P MVR;F_=9SUH ]5HKS>ZUW4[;QY;:#'KLY1IELY$GEMO/?=;F3STB6W!V@X&\M MMW@KL-8T/B;6+;P[H,,/BFTC=[,R3WNJWT4(^T+M!@=S X)7/*';(?[W!H ] MAHKS4ZK/J'C+28;O5PUW!K,B-I**A6",6\P23.W?\P(;+'!W\ 8J]<76HR^+ M+O3;*_\ [/6XU812S6]O$9"@L4DZLI!;( W,&XXZ 8 .\HKS_5TD\3_#S18M M0ES->7-M'+-&NT[]V-X Z'(W<=#6//J]YJ6J:3X@O(+B.337N+,10I\_GI9S MM1Z9XDOK^:SFN]074OL.HRM%-9317+$'3YG*JZ M11HS YXV=>"34^C^-M3@TRZU2\U2+4;"PNH_M#6\L=SNCEBP%\R.&,$K(4Z+ MQE@2>, 'JM%>5ZUKFJ64&JZ?JFLV]Y>KI#O]BMQ;2I%(L 9S<1%-X!8_*^$]&N[P$74]C!)-GKO9 6_4FM6@ HHHH R['_D/:M_VQ_]!-:E M9=C_ ,A[5O\ MC_Z":U*QH?"_5_FR8;?>%%%%;%!1110 4444 %%%% !1110 M 4444 %%%% !1110!E_\S5_VY?\ L]:E9=W:7_\ :HO;(VW^H\HB8M_>SV_" MC_B??]0W_P ?KFA-PV_NO[O^"'-Y,U** MR_\ B??]0W_Q^C_B??\ 4-_\?H]M_=?W?\$.;R9J5!9V<%A;"WMD*0JS,%W$ MXW,6.,]LDX'0#@8 JE_Q/O\ J&_^/T?\3[_J&_\ C]'MO[K^[_@AS>3-2BLO M_B??]0W_ ,?H_P")]_U#?_'Z/;?W7]W_ 0YO)ET65N-0:^$?^DM$(2^3]P$ MD#'3J34]9?\ Q/O^H;_X_1_Q/O\ J&_^/T>V_NO[O^"'-Y,U**R_^)]_U#?_ M !^C_B??]0W_ ,?H]M_=?W?\$.;R9J45E_\ $^_ZAO\ X_1_Q/O^H;_X_1[; M^Z_N_P""'-Y,U**R_P#B??\ 4-_\?H_XGW_4-_\ 'Z/;?W7]W_!#F\F:E%9? M_$^_ZAO_ (_1_P 3[_J&_P#C]'MO[K^[_@AS>3+MK9V]F)1;Q[/-E::0Y)+. MQY))_P @ <"IZR_^)]_U#?_ !^C_B??]0W_ ,?H]M_=?W?\$.;R9J45E_\ M$^_ZAO\ X_1_Q/O^H;_X_1[;^Z_N_P""'-Y,U**R_P#B??\ 4-_\?H_XGW_4 M-_\ 'Z/;?W7]W_!#F\F:E%9?_$^_ZAO_ (_1_P 3[_J&_P#C]'MO[K^[_@AS M>3#Q%_R ;G_@/_H0K4K$O;36KZT>VE.GA'QDJ7SP<_TK;I4VY5)2LTK+?YB6 MLFPK'FGAM_$X>:5(U-E@%V &=_O6Q4,UG;7#AYK>&1@, N@)Q^-55A*27+NF MF.2;V(_[3L/^?VV_[^K_ (T?VG8?\_MM_P!_5_QH_LRP_P"?*V_[]+_A1_9E MA_SY6W_?I?\ "E^^\OQ#WO(/[3L/^?VV_P"_J_XT?VG8?\_MM_W]7_&C^S+# M_GRMO^_2_P"%']F6'_/E;?\ ?I?\*/WWE^(>]Y$=Q=Z7=6TMO/=6LD,J%)$: M5<,I&"#SZ4L5]IT,*1)>P;$4*NZ<,<#CDDY/U-/_ +,L/^?*V_[]+_A1_9EA M_P ^5M_WZ7_"C]]Y?B'O>0?VG8?\_MM_W]7_ !H_M.P_Y_;;_OZO^-']F6'_ M #Y6W_?I?\*/[,L/^?*V_P"_2_X4?OO+\0][R*]O+I%K<74\-S;++=R"69O/ M!W,$5 >3Q\JJ./2K']IV'_/[;?\ ?U?\:/[,L/\ GRMO^_2_X4?V98?\^5M_ MWZ7_ H_?>7XA[WD']IV'_/[;?\ ?U?\:/[3L/\ G]MO^_J_XT?V98?\^5M_ MWZ7_ JMJ&GV2:;=.EG;JRPN01$H(.#[4I.M%-Z?B)N25]"S_:=A_P _MM_W M]7_&C^T[#_G]MO\ OZO^-5M/T^R?3;5WL[=F:%"28E))P/:K/]F6'_/E;?\ M?I?\*(NM))Z?B"7XC][R#^T[#_ )_;;_OZO^-5[V72-1MQ M!=75O)$)$DV^?M!*,&7.#R,@<'@]#D58_LRP_P"?*V_[]+_A1_9EA_SY6W_? MI?\ "C]]Y?B'O>0?VG8?\_MM_P!_5_QJ&[N=*O;.>TN+NW:&>-HY%$X4E6&" M,@Y'!ZBIO[,L/^?*V_[]+_A1_9EA_P ^5M_WZ7_"C]]Y?B'O>0B:AIT:*B7E MJJJ,!1*H 'YTO]IV'_/[;?\ ?U?\:/[,L/\ GRMO^_2_X4?V98?\^5M_WZ7_ M H_?>7XA[WD']IV'_/[;?\ ?U?\:/[3L/\ G]MO^_J_XT?V98?\^5M_WZ7_ M H_LRP_Y\K;_OTO^%'[[R_$/>\BGILL]:U10VT%O MN\B".+=UV(%S^52U5*#A&SWU_%W"*LM0HHHK0H**** "BBB@ HHHH **** " MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ** M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH MH **** "BBB@ JKJ?_(*O/\ K@__ *":M55U/_D%7G_7!_\ T$U%3X)>C_)B MELPTS_D%6?\ UP3_ -!%6JJZ9_R"K/\ ZX)_Z"*M44_@CZ+\D$=DSM-,>\@16;S)&3KN;HH)., '&,Y.[:M :YXD&L_\(ZT^D_VF<2B M\%I)Y(BV9QY7FYW;AC.\<'..U;MQX8TN[U674KB.YEGEB:&1'O)C"T97:5,6 M_P O!';;UYZ\U!_PAFA_9!;^3=\2^:)OM\_GAMNS_7;_ #,;>,;L8[58SEXO MB'J6(9;BQ$<=W9Q26ZI9S2 2.L)W;UR)4W2.NU!NRBC.9%%>@V=U#?64%W;R M"6">-98Y%& RL,@C/J#5";PYI,]J;9K7;$8HH5$4CQF-(SN0(5(*;2 05P<@ M>E:%K;0V=I#:VZ;((46.- <[5 P!S["@"6BBB@ HHHH **** "BBB@ HHHH M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB MB@ JG?:E'8R0QM#/*\V[:L*[CQC/&?>KE9=]_P A[2?^VW_H(K*M)QC[N]U^ M+)DVEH']M?\ 4,U+_OQ_]>C^VO\ J&:E_P!^/_KUJ50U76+/1;>*:]:;;+(( MHU@MY)W=R"C^VO^H9J7_? MC_Z],C\4:+):&[^WHD MC=,\JM&$C#;26W ;2"""#@@CI4FF>(-.U>>6"U>X M2XB57>"ZM9;>0*20&V2*K%201D#&01VHY*G\_P"""TNXG]M?]0S4O^_'_P!> MC^VO^H9J7_?C_P"O4JZUI[VD-TMQF&:X^S1ML;F3>4VXQG[P(STK.'C313:R MW(:_,$;K'O\ [,N<2,S; $_=_O#NX^7-')4_G_!!:7I;36;*]D:.)YEE6!;AHYK>2)UC8LJDJZ@CE&X M//'3D5FQ^-M$FNK6VB;4))+N)9H"FEW++)&0IWAA'C:/,3)S@;AG%')4_G_! M!:71]Q7:L M8&]FR#P!GCTI.G4:LY_@A.,GU&V>JM;V4$+Z;J):.-4)$'&0,>M3?VU_U#-2 M_P"_'_UZK+XPT=YH(8VOI99EW".+3KAV0;BI\P!"8_F!'SXZ5<;7M-6Q^V^> MQ@^TM:;EB7-' [3Z93RFD4%F19=NQG !RH8D;6R.#A\E3^?\$.TNX[ M^VO^H9J7_?C_ .O1_;7_ %#-2_[\?_7I+?Q'I-U:FY@O \(NQ9[@C?ZXL%"X MQW)&#T((.<VV\AC4 M[=X5I NP-MYVDYQCCD51MO'/AZZM)[I+N:.&&T:^8W%G-"7@49,B!T!D4#'* MYZCU&3DJ?S_@@M+N7O[:_P"H9J7_ 'X_^O1_;7_4,U+_ +\?_7J6SUK3[]K5 M;6Y$IN[;[5#A3AXLJ-W3C[R\'GGI5&+QAHDUU2VV4( M[(%J_-$SV^XU*XKXC7NGVMGI'VZY5%6^$QB34H[*9 MT6-U)C=Y(^A=^&+;P=#$GB"VN+TWD4UQ;1>)$#;%GWGRMTX2,[>?E*U['10!YQJ'BKPOJ M7A*RM(M:TZ)EOK.1[:^UBWEE6..ZC=R[^:X;Y%9OO$D<=>*YB;4-(MGO+=M< MTV\L;>XLUM#::[!%/+;Q^8HKTBB@#Q.VU&SL]&BM%\5Z/<3W6EBQ$LN MJ6H_LW?(HD V.N]=AW#DMF+&[D5P6P;S( M7AD2-9)VPR_*_P S '>P!SQ7L%% 'E%WXRT"[\46>L7%U'Y?V98UCM/$5M$8 MF$K']\%N$5QC!VC>.HYI8O$^C*8]&.L:,((]:?4?[1_M:U\DQM9O M^8)C;C()SBO5J* /,+OQ!H$MIJ:)XCT,M-K]G>1C^U(/FACEMF=OO]A&_'7C M@'=4M5EL9U2PN[>V(:!D0C$MPER32)]KEEUJS:"6 #E9(UF;][QA60$XVY?&5'J5% 'F.H>+-"_X2 MOS],UO3;82NOVNZ&LVQMKF(1XP\9DW"4$!0RKT"Y;'RCGYM>T_5_!=OI;ZAI M%E/I^@SV8%QK%F6N9WM_*"Q[)6 3())N^'M,\6Q+0DG:G"L"3GGW"B@#QG4+CPW:I%)IWB.QNF_LEX9$G\ M1),?-\V!@B>=,0N0C],#@9/2NR\+:]I_B/Q3J&I6UW8K(]E% EFE[!/<;8W< MM(XB=U"YE ')[YQG%=I10!EWW_(>TG_MM_Z"*U*R[[_D/:3_ -MO_016I6-+ MXI^OZ(F.["BBBMB@HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *** M* "BBB@ HHHH **** "LN^_Y#VD_]MO_ $$5J5EWW_(>TG_MM_Z"*QK_ KU M7YHF>WW&I1116Q04444 %%4]6GEM='OKB 9FBMY'0 9^8*2/UKSU7GTZ[$.D M79M3+IFB6ZSA%D8(\]RK-A@06().2.O)S0!Z=17G2>(+J/4+?3M6\4MIMO'+ M=QB_=+>-KIXYE5$9G0Q@[6.0J@MU& #5*[\6ZK'9ZA(EI45YMKVNZKH?B?2M+37I)'::TCE2[DMXS=":X*,8XE@W M/M7.2'0* I.XYW9QU_5=-T>&V7Q0#(VI7L-U>:C>00&V*2-Y<1 M"9_^$Y\D(W''^D$=N #U2BO(M&\2WVN7:0W.H+>0)=Z= M<1@SQ2R0-)))F.0QQ1JK@*N4PQ4_Q'-3:+XTU:X74+QM4$]G916U_-$TL,LL M,+2.)8Y?+A01NJ#<4^8@J 6P: /5Z*\U?Q#J O;%-0UA&&H6DDT6F0FW,J[_ M #77SHF0N8UC"+N0CE3N!!)$%AXHOCXHT335O8UMIE@MYK"22%=X:T\PR1PK M#O$><#?YFW<&7;TH ]1HK#\'.S>%;)225C#Q1L23NC1V5#D]TG_MM_P"@BM2LN^_Y#VD_]MO_ $$5J5C2^*?K^B)CNPHHHK8H**** M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ K M&U>YBM-6TR>=]D:^;EL$XRH':MFBLZL'.-D[;?@[BDKHR_\ A(M*_P"?K_R& MW^%'_"1:5_S]?^0V_P *U**GEK?S+[O^"*TNYE_\)%I7_/U_Y#;_ H_X2+2 MO^?K_P AM_A6I11RUOYE]W_!"TNYE_\ "1:5_P _7_D-O\*@LM6T+3[*&SM9 M_+MX$$<:;7.U1P!DC.!6W11RUOYE]W_!"TNYE_\ "1:5_P _7_D-O\*/^$BT MK_GZ_P#(;?X5J44JZ#%?SWR38N9XTBD?:_S*A8J,8P,; MV_.K'_"1:5_S]?\ D-O\*U**.6M_,ON_X(6EW,O_ (2+2O\ GZ_\AM_A1_PD M6E?\_7_D-O\ "M2BCEK?S+[O^"%I=S+_ .$BTK_GZ_\ (;?X4?\ "1:5_P _ M7_D-O\*U**.6M_,ON_X(6EW,O_A(M*_Y^O\ R&W^%'_"1:5_S]?^0V_PK4HH MY:W\R^[_ ((6EW,O_A(M*_Y^O_(;?X57OM5T+4K&>RNYS);SH8Y4"R+N4\$9 M !Y%;E%'+6_F7W?\$+2[F4/$.D@ "ZP!T C;_"AO$.DLI4W9P1CA'!_E6K11 MRUOYE]W_ 0M+N8MGJ^A6%E!9VLPBMX(UCC18WPJ@8 Z>E3?\)%I7_/U_P"0 MV_PK4HHY:W\R^[_@A:7 EX-31.1 3 ex31-1.htm

 

Exhibit 31.1

 

Certification of the Company’s Principal Executive Officer and Principal Financial Officer

Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002

and Securities and Exchange Commission Release 34-46427

 

I, Chong Khooi You, certify that:

 

1. I have reviewed this report on Form 10-Q of BioPlus Life Corp.;
   
2. Based on my knowledge, this annual report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this annual report;
   
3. Based on my knowledge, the financial statements, and other financial information included in this annual report, fairly present in all material respects the financial condition, results of operations and cash flows of the small business issuer as of, and for, the periods present in this annual report;
   
4. I am the registrant’s sole certifying officer(s) and I am responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

 

  a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
     
  b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
     
  c) Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
     
  d) Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

 

5. As the registrant’s sole certifying officer, I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

 

  a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and
     
  b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

 

Date: January 7, 2021  
    
  /s/ Chong Khooi You
 

Chong Khooi You

President and CEO

(Principal Executive Officer, Principal Financial
Officer, and Principal Accounting Officer)

 

   

 

 

 EX-32.1 4 ex32-1.htm

 

Exhibit 32.1

 

Certification of Principal Executive Officer and Principal Financial Officer

Pursuant to 18 U.S.C. Section 1350, as adopted pursuant to

Section 906 of the Sarbanes-Oxley Act of 2002

 

In connection with the Quarterly Report of BioPlus Life Corp. (the “Company”) on Form 10-Q for the period ended September 30, 2020 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, Chong Khooi You, certify pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that to the best of my knowledge and belief:

 

1. The Report fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

 

2. The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

 

Date: January 7, 2021

 

 

/s/ Chong Khooi You

 

Chong Khooi You

 

President and CEO

(Principal Executive Officer, Principal Financial
Officer, and Principal Accounting Officer)

 

   

 

 EX-101.INS 5 biopl-20200930.xml XBRL INSTANCE FILE 0001746214 2020-01-01 2020-09-30 0001746214 2020-09-30 0001746214 2019-12-31 0001746214 us-gaap:CommonStockMember 2019-01-01 2019-12-31 0001746214 us-gaap:CommonStockMember 2018-12-31 0001746214 us-gaap:CommonStockMember 2019-12-31 0001746214 us-gaap:AdditionalPaidInCapitalMember 2019-01-01 2019-12-31 0001746214 us-gaap:AdditionalPaidInCapitalMember 2018-12-31 0001746214 us-gaap:AdditionalPaidInCapitalMember 2019-12-31 0001746214 us-gaap:RetainedEarningsMember 2019-01-01 2019-12-31 0001746214 us-gaap:RetainedEarningsMember 2018-12-31 0001746214 us-gaap:RetainedEarningsMember 2019-12-31 0001746214 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2019-01-01 2019-12-31 0001746214 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2018-12-31 0001746214 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2019-12-31 0001746214 country:CN 2020-01-01 2020-09-30 0001746214 biopl:BioplusLifeInternationalHoldingsLimitedMember country:HK 2017-04-13 0001746214 biopl:BioLifeNeutraceuticalsSdnBhdMember 2017-04-13 0001746214 biopl:MotorVehicleMember 2019-12-31 0001746214 us-gaap:LandBuildingsAndImprovementsMember 2019-12-31 0001746214 biopl:ComputerHardwareMember 2019-12-31 0001746214 biopl:FurnitureAndFittingsMember 2019-12-31 0001746214 biopl:HandphoneMember 2019-12-31 0001746214 biopl:LandscapeMember 2019-12-31 0001746214 biopl:MachineryMember 2019-12-31 0001746214 us-gaap:OfficeEquipmentMember 2019-12-31 0001746214 us-gaap:BuildingImprovementsMember 2019-12-31 0001746214 biopl:SignboardMember 2019-12-31 0001746214 biopl:ToolsAndEquipmentMember 2019-12-31 0001746214 biopl:MotorVehicleMember biopl:FinanceLeasesAgreementMember 2019-01-01 2019-12-31 0001746214 biopl:FacilitiesAgreementMember us-gaap:BankOverdraftsMember 2019-09-30 0001746214 biopl:FacilitiesAgreementMember biopl:TermLoanMember 2016-10-09 2016-10-10 0001746214 biopl:ThirdPartyMember 2019-12-31 0001746214 country:MY 2019-12-31 0001746214 biopl:ThirdPartyMember country:MY 2019-12-31 0001746214 biopl:ThirdPartyMember country:HK 2019-12-31 0001746214 us-gaap:BankOverdraftsMember 2019-12-31 0001746214 biopl:TermLoanMember 2019-12-31 0001746214 country:CN 2019-12-31 0001746214 2020-10-12 0001746214 2019-01-01 2019-09-30 0001746214 2019-09-30 0001746214 2018-12-31 0001746214 biopl:BioplusLifeCorpLabuanMember 2020-01-01 2020-09-30 0001746214 biopl:BioplusLifeCorpLabuanMember 2020-09-30 0001746214 biopl:BioplusLifeInternationalHoldingsLtdMember 2020-01-01 2020-09-30 0001746214 biopl:BioplusLifeInternationalHoldingsLtdMember 2020-09-30 0001746214 biopl:BioplusLifeInternationalHoldingsLimitedMember biopl:HonkKongDollarMember 2020-09-30 0001746214 biopl:BioLifeHoldingsBerhadMember 2020-01-01 2020-09-30 0001746214 biopl:BioLifeHoldingsBerhadMember 2020-09-30 0001746214 biopl:BioLifeHoldingsBerhadMember biopl:MalaysianRinggitMember 2020-09-30 0001746214 biopl:BioLifeNeutraceuticalsSdnBhdMember 2020-01-01 2020-09-30 0001746214 biopl:BioLifeNeutraceuticalsSdnBhdMember 2020-09-30 0001746214 biopl:BioLifeNeutraceuticalsSdnBhdMember biopl:MalaysianRinggitMember 2020-09-30 0001746214 biopl:ComputerHardwareMember 2020-01-01 2020-09-30 0001746214 biopl:FurnitureAndFittingsMember 2020-01-01 2020-09-30 0001746214 biopl:HandphoneMember 2020-01-01 2020-09-30 0001746214 biopl:LandscapeMember 2020-01-01 2020-09-30 0001746214 us-gaap:LandBuildingsAndImprovementsMember 2020-01-01 2020-09-30 0001746214 biopl:MachineryMember 2020-01-01 2020-09-30 0001746214 biopl:MotorVehicleMember 2020-01-01 2020-09-30 0001746214 us-gaap:OfficeEquipmentMember 2020-01-01 2020-09-30 0001746214 us-gaap:BuildingImprovementsMember 2020-01-01 2020-09-30 0001746214 biopl:SignboardMember 2020-01-01 2020-09-30 0001746214 biopl:ToolsAndEquipmentMember 2020-01-01 2020-09-30 0001746214 biopl:PeriodEndMalaysianRinggitMember 2020-09-30 0001746214 biopl:PeriodEndMalaysianRinggitMember 2019-09-30 0001746214 biopl:PeriodAverageMalaysianRinggitMember 2020-09-30 0001746214 biopl:PeriodAverageMalaysianRinggitMember 2019-09-30 0001746214 biopl:PeriodEndRedminbiMember 2020-09-30 0001746214 biopl:PeriodEndRedminbiMember 2019-09-30 0001746214 biopl:PeriodAverageRedminbiMember 2020-09-30 0001746214 biopl:PeriodAverageRedminbiMember 2019-09-30 0001746214 biopl:MotorVehicleMember 2020-09-30 0001746214 us-gaap:LandBuildingsAndImprovementsMember 2020-09-30 0001746214 biopl:ComputerHardwareMember 2020-09-30 0001746214 biopl:FurnitureAndFittingsMember 2020-09-30 0001746214 biopl:HandphoneMember 2020-09-30 0001746214 biopl:LandscapeMember 2020-09-30 0001746214 biopl:MachineryMember 2020-09-30 0001746214 us-gaap:OfficeEquipmentMember 2020-09-30 0001746214 us-gaap:BuildingImprovementsMember 2020-09-30 0001746214 biopl:SignboardMember 2020-09-30 0001746214 biopl:ToolsAndEquipmentMember 2020-09-30 0001746214 biopl:MotorVehicleMember biopl:FinanceLeasesAgreementMember srt:MinimumMember 2020-01-01 2020-09-30 0001746214 biopl:MotorVehicleMember biopl:FinanceLeasesAgreementMember srt:MaximumMember 2020-01-01 2020-09-30 0001746214 biopl:FacilitiesAgreementMember us-gaap:BankOverdraftsMember 2020-09-30 0001746214 biopl:FacilitiesAgreementMember us-gaap:BankOverdraftsMember 2020-01-01 2020-09-30 0001746214 biopl:FacilitiesAgreementMember biopl:TermLoanMember 2020-09-30 0001746214 biopl:FacilitiesAgreementMember biopl:TermLoanMember 2020-01-01 2020-09-30 0001746214 us-gaap:BankOverdraftsMember 2020-09-30 0001746214 biopl:TermLoanMember 2020-09-30 0001746214 biopl:ThirdPartyMember 2020-09-30 0001746214 biopl:ThirdPartyMember country:MY 2020-09-30 0001746214 country:CN 2020-09-30 0001746214 country:MY 2020-09-30 0001746214 biopl:ThirdPartyMember country:HK 2020-09-30 0001746214 country:US 2020-09-30 0001746214 country:US 2020-01-01 2020-09-30 0001746214 country:MY 2020-01-01 2020-09-30 0001746214 country:HK 2020-01-01 2020-09-30 0001746214 country:MY 2019-01-01 2019-09-30 0001746214 country:HK 2019-01-01 2019-09-30 0001746214 country:CN 2019-01-01 2019-09-30 0001746214 us-gaap:CommonStockMember 2020-09-30 0001746214 2019-01-01 2019-12-31 0001746214 biopl:MotorVehicleMember biopl:FinanceLeasesAgreementMember 2020-09-30 0001746214 biopl:MotorVehicleMember biopl:FinanceLeasesAgreementMember 2019-12-31 0001746214 2020-07-01 2020-09-30 0001746214 2019-07-01 2019-09-30 0001746214 biopl:BioLifeNeutraceuticalsShenzhenPtyLtdLabuanMember 2020-01-01 2020-09-30 0001746214 biopl:BioLifeNeutraceuticalsShenzhenPtyLtdLabuanMember 2020-09-30 0001746214 biopl:BioLifeNeutraceuticalsShenzhenPtyLtdLabuanMember biopl:ChinaRenminbiMember 2020-09-30 0001746214 biopl:KitchenUtensilsMember 2020-01-01 2020-09-30 0001746214 biopl:KitchenUtensilsMember 2020-09-30 0001746214 biopl:KitchenUtensilsMember 2019-12-31 0001746214 biopl:FacilitiesAgreementMember us-gaap:BankOverdraftsMember biopl:MalaysianRinggitMember 2020-09-30 0001746214 biopl:FacilitiesAgreementMember biopl:TermLoanMember biopl:MalaysianRinggitMember 2020-09-30 0001746214 biopl:FacilitiesAgreementMember biopl:TermLoanMember biopl:MalaysianRinggitMember 2016-10-09 2016-10-10 0001746214 us-gaap:RevenueFromContractWithCustomerMember us-gaap:CustomerConcentrationRiskMember biopl:CustomerAMember 2020-01-01 2020-09-30 0001746214 us-gaap:RevenueFromContractWithCustomerMember us-gaap:CustomerConcentrationRiskMember biopl:CustomerAMember 2020-07-01 2020-09-30 0001746214 us-gaap:RevenueFromContractWithCustomerMember us-gaap:CustomerConcentrationRiskMember biopl:CustomerAMember 2019-07-01 2019-09-30 0001746214 us-gaap:RevenueFromContractWithCustomerMember us-gaap:CustomerConcentrationRiskMember biopl:CustomerBMember 2020-07-01 2020-09-30 0001746214 us-gaap:RevenueFromContractWithCustomerMember us-gaap:CustomerConcentrationRiskMember biopl:CustomerBMember 2019-07-01 2019-09-30 0001746214 us-gaap:RevenueFromContractWithCustomerMember us-gaap:CustomerConcentrationRiskMember 2020-07-01 2020-09-30 0001746214 us-gaap:RevenueFromContractWithCustomerMember us-gaap:CustomerConcentrationRiskMember 2019-07-01 2019-09-30 0001746214 us-gaap:RevenueFromContractWithCustomerMember us-gaap:CustomerConcentrationRiskMember biopl:CustomerAMember 2019-01-01 2019-09-30 0001746214 us-gaap:RevenueFromContractWithCustomerMember us-gaap:CustomerConcentrationRiskMember biopl:CustomerBMember 2020-01-01 2020-09-30 0001746214 us-gaap:RevenueFromContractWithCustomerMember us-gaap:CustomerConcentrationRiskMember biopl:CustomerBMember 2019-01-01 2019-09-30 0001746214 us-gaap:RevenueFromContractWithCustomerMember us-gaap:CustomerConcentrationRiskMember 2020-01-01 2020-09-30 0001746214 us-gaap:RevenueFromContractWithCustomerMember us-gaap:CustomerConcentrationRiskMember 2019-01-01 2019-09-30 0001746214 us-gaap:CostOfGoodsTotalMember us-gaap:SupplierConcentrationRiskMember biopl:CustomerAMember 2020-07-01 2020-09-30 0001746214 us-gaap:CostOfGoodsTotalMember us-gaap:SupplierConcentrationRiskMember biopl:CustomerAMember 2019-07-01 2019-09-30 0001746214 us-gaap:CostOfGoodsTotalMember us-gaap:SupplierConcentrationRiskMember biopl:CustomerBMember 2020-07-01 2020-09-30 0001746214 us-gaap:CostOfGoodsTotalMember us-gaap:SupplierConcentrationRiskMember biopl:CustomerBMember 2019-07-01 2019-09-30 0001746214 us-gaap:CostOfGoodsTotalMember us-gaap:SupplierConcentrationRiskMember 2019-07-01 2019-09-30 0001746214 us-gaap:CostOfGoodsTotalMember us-gaap:SupplierConcentrationRiskMember 2020-07-01 2020-09-30 0001746214 us-gaap:CostOfGoodsTotalMember us-gaap:SupplierConcentrationRiskMember biopl:CustomerAMember 2020-01-01 2020-09-30 0001746214 us-gaap:CostOfGoodsTotalMember us-gaap:SupplierConcentrationRiskMember biopl:CustomerAMember 2019-01-01 2019-09-30 0001746214 us-gaap:CostOfGoodsTotalMember us-gaap:SupplierConcentrationRiskMember biopl:CustomerBMember 2019-01-01 2019-09-30 0001746214 us-gaap:CostOfGoodsTotalMember us-gaap:SupplierConcentrationRiskMember biopl:CustomerCMember 2020-07-01 2020-09-30 0001746214 us-gaap:CostOfGoodsTotalMember us-gaap:SupplierConcentrationRiskMember biopl:CustomerCMember 2019-07-01 2019-09-30 0001746214 us-gaap:CostOfGoodsTotalMember us-gaap:SupplierConcentrationRiskMember biopl:CustomerBMember 2020-01-01 2020-09-30 0001746214 us-gaap:CostOfGoodsTotalMember us-gaap:SupplierConcentrationRiskMember 2020-01-01 2020-09-30 0001746214 us-gaap:CostOfGoodsTotalMember us-gaap:SupplierConcentrationRiskMember 2019-01-01 2019-09-30 0001746214 biopl:BioplusLifeCorpLabuanMember 2017-04-13 0001746214 biopl:BioLifeHoldingsBerhadMember country:MY 2017-04-13 0001746214 us-gaap:CommonStockMember 2020-01-01 2020-03-31 0001746214 us-gaap:CommonStockMember 2020-04-01 2020-06-30 0001746214 us-gaap:CommonStockMember 2020-07-01 2020-09-30 0001746214 us-gaap:CommonStockMember 2020-03-31 0001746214 us-gaap:CommonStockMember 2020-06-30 0001746214 us-gaap:AdditionalPaidInCapitalMember 2020-01-01 2020-03-31 0001746214 us-gaap:AdditionalPaidInCapitalMember 2020-04-01 2020-06-30 0001746214 us-gaap:AdditionalPaidInCapitalMember 2020-07-01 2020-09-30 0001746214 us-gaap:AdditionalPaidInCapitalMember 2020-03-31 0001746214 us-gaap:AdditionalPaidInCapitalMember 2020-06-30 0001746214 us-gaap:AdditionalPaidInCapitalMember 2020-09-30 0001746214 us-gaap:RetainedEarningsMember 2020-01-01 2020-03-31 0001746214 us-gaap:RetainedEarningsMember 2020-04-01 2020-06-30 0001746214 us-gaap:RetainedEarningsMember 2020-07-01 2020-09-30 0001746214 us-gaap:RetainedEarningsMember 2020-03-31 0001746214 us-gaap:RetainedEarningsMember 2020-06-30 0001746214 us-gaap:RetainedEarningsMember 2020-09-30 0001746214 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2020-01-01 2020-03-31 0001746214 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2020-04-01 2020-06-30 0001746214 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2020-07-01 2020-09-30 0001746214 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2020-03-31 0001746214 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2020-06-30 0001746214 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2020-09-30 0001746214 2020-01-01 2020-03-31 0001746214 2020-04-01 2020-06-30 0001746214 2020-03-31 0001746214 2020-06-30 0001746214 us-gaap:RevenueFromContractWithCustomerMember us-gaap:CustomerConcentrationRiskMember biopl:CustomerCMember 2020-07-01 2020-09-30 0001746214 us-gaap:RevenueFromContractWithCustomerMember us-gaap:CustomerConcentrationRiskMember biopl:CustomerCMember 2019-07-01 2019-09-30 0001746214 biopl:BioplusLifeInternationalHoldingsLtdMember biopl:ChinaRenminbiMember 2020-08-03 2020-08-05 iso4217:USD xbrli:shares iso4217:USD xbrli:shares xbrli:pure iso4217:MYR iso4217:CNY 10-Q false 2020-09-30 --12-31 BIOPLUS LIFE CORP. 0001746214 Non-accelerated Filer true true Q3 false false 2020 2044538 1736242 35931 35931 1998870 1998870 -123358 -216550 -114711 -82009 1796732 36291 36291 36291 1998870 1998870 1998870 -208331 -37855 99379 -169079 -150148 -90002 1657751 1847158 0.0001 0.0001 362905561 359305561 100 1 107992 5456207 500000 362905561 359305561 315930 -93192 7366 -93192 137234 40252 8219 170476 137234 8219 170476 -7993 32702 -17100 32702 60146 -15699 -87070 18931 60146 -87070 18931 No No 362905561 334162 210740 553917 308688 55446 7675 30282 19771 1370507 989709 3592689 3206956 210968 48298 31632 33343 39129 195027 510723 494045 3604 3604 4569 8489 872798 782806 82739 92133 550660 553144 41954 42631 675353 687908 1548151 1470714 36291 35931 1998870 1998870 99379 -216550 -90002 -82009 3592689 3206956 5821 2222182 2217247 2449661 1201326 989461 446437 1422514 614299 588637 210313 1027147 587027 400824 236124 0.00 0.00 0.00 0.00 362905561 358787945 362905561 358787945 298425 6267 119729 40252 359305561 359305561 362905561 362905561 362905561 3600000 360 360 360 307937 -9734 197380 24553 721176 559247 281687 188020 332840 -56060 -47378 -34845 380218 -23157 22477 -187355 161677 -212063 10708 69699 -74029 12290 253739 -204680 57768 -141160 442187 115135 9738 24912 93429 82857 -133810 -33692 133810 33692 173842 -154824 -19287 -6522 -25548 -71594 9015 18108 7155 28574 9738 24912 360 261989 69220 100730 255554 261989 100730 -72173 334162 100730 357526 303954 39174 133060 2222182 2217247 730914 584160 281687 196157 9738 24913 8137 -2063 2725 72173 17505 1099 17505 17505 -1942 23092 315928 7366 <table cellspacing="0" cellpadding="0" style="width: 100%"> <tr style="vertical-align: top"> <td style="font: 12pt Times New Roman, Times, Serif; width: 48px"><font style="font-size: 10pt"><b>16.</b></font></td> <td style="font: 12pt Times New Roman, Times, Serif"><font style="font-size: 10pt"><b>SIGNIFICANT EVENTS</b></font></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">During the fiscal year, the World Health Organization (WHO) declared the Coronavirus (COVID-19) outbreak to be a pandemic, which has caused severe global social and economic disruptions and uncertainties, including markets where the Company operates.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company considers this outbreak as non-adjusting-events. The consequences brought about by Covid-19 continue to evolve and whilst the Company actively monitoring and managing its operations to respond to these changes, the Company does not consider it practicable to provide any quantitative estimate on the potential impact it may have on the Company.</p> <table cellspacing="0" cellpadding="0" style="width: 100%; border-collapse: collapse"> <tr style="vertical-align: top"> <td style="font: 12pt Times New Roman, Times, Serif; width: 48px"><font style="font-size: 10pt"><b>15.</b></font></td> <td style="font: 12pt Times New Roman, Times, Serif"><font style="font-size: 10pt"><b>SUBSEQUENT EVENTS</b></font></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">In accordance with ASC Topic 855, &#8220;Subsequent Events&#8221;, which establishes general standards of accounting for and disclosure of events that occur after the balance sheet date but before financial statements are issued, the Company has evaluated all events or transactions that occurred after September 30, 2020 up through the date November 18, 2020 was the Company presented these audited consolidated financial statements.</p> <table cellspacing="0" cellpadding="0" style="width: 100%; border-collapse: collapse"> <tr style="vertical-align: top"> <td style="font: 12pt Times New Roman, Times, Serif; width: 48px"><font style="font-size: 10pt"><b>14.</b></font></td> <td style="font: 12pt Times New Roman, Times, Serif"><font style="font-size: 10pt"><b>FOREIGN CURRENCY EXCHANGE RATE</b></font></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company cannot guarantee that the current exchange rate will remain stable, therefore there is a possibility that the Company could post the same amount of income for two comparable periods and because of the fluctuating exchange rate post higher or lower income depending on exchange rate converted into US$ at the end of the financial period. The exchange rate could fluctuate depending on changes in political and economic environments without notice.</p> <table cellspacing="0" cellpadding="0" style="width: 100%"> <tr style="vertical-align: top"> <td style="font: 12pt Times New Roman, Times, Serif; width: 48px"><font style="font-size: 10pt"><b>13.</b></font></td> <td style="font: 12pt Times New Roman, Times, Serif; text-align: justify"><font style="font-size: 10pt"><b>OTHER INCOME</b></font></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p> <table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="padding-bottom: 1.5pt">&#160;</td> <td colspan="6" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt">Nine months ended</font></td> <td style="padding-bottom: 1.5pt">&#160;</td></tr> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="padding-bottom: 1.5pt">&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt">2020</font></td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="padding-bottom: 1.5pt">&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt">2019</font></td> <td style="padding-bottom: 1.5pt">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="width: 62%"><font style="font-size: 10pt">Other income</font></td> <td style="width: 1%">&#160;</td> <td style="width: 1%"><font style="font-size: 10pt">$</font></td> <td style="width: 16%; text-align: right"><font style="font-size: 10pt">192</font></td> <td style="width: 1%">&#160;</td> <td style="width: 1%">&#160;</td> <td style="width: 1%"><font style="font-size: 10pt">$</font></td> <td style="width: 16%; text-align: right"><font style="font-size: 10pt">77</font></td> <td style="width: 1%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="padding-bottom: 1.5pt"><font style="font-size: 10pt">Realized gain on foreign exchange</font></td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="border-bottom: black 1.5pt solid">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">1,999</font></td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="border-bottom: black 1.5pt solid">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">3,323</font></td> <td style="padding-bottom: 1.5pt">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="padding-bottom: 2.5pt">&#160;</td> <td style="padding-bottom: 2.5pt">&#160;</td> <td style="border-bottom: black 2.25pt double"><font style="font-size: 10pt">$</font></td> <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 10pt">2,191</font></td> <td style="padding-bottom: 2.5pt">&#160;</td> <td style="padding-bottom: 2.5pt">&#160;</td> <td style="border-bottom: black 2.25pt double"><font style="font-size: 10pt">$</font></td> <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 10pt">3,400</font></td> <td style="padding-bottom: 2.5pt">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right">&#160;</td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right">&#160;</td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="padding-bottom: 2.5pt"><font style="font-size: 10pt">Gain on disposal of subsidiary</font></td> <td style="padding-bottom: 2.5pt">&#160;</td> <td style="border-bottom: black 2.25pt double"><font style="font-size: 10pt">$</font></td> <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 10pt">17,505</font></td> <td style="padding-bottom: 2.5pt">&#160;</td> <td style="padding-bottom: 2.5pt">&#160;</td> <td style="border-bottom: black 2.25pt double"><font style="font-size: 10pt">$</font></td> <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 10pt">1,099</font></td> <td style="padding-bottom: 2.5pt">&#160;</td></tr> </table> <table cellspacing="0" cellpadding="0" style="width: 100%"> <tr style="vertical-align: top"> <td style="font: 12pt Times New Roman, Times, Serif; width: 48px"><font style="font-size: 10pt"><b>12.</b></font></td> <td style="font: 12pt Times New Roman, Times, Serif; text-align: justify"><font style="font-size: 10pt"><b>CONCENTRATION OF RISK</b></font></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><b>&#160;</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">(a) Major Customers</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">For the three months ended September 30, 2020 and 2019, the customers who accounted for 10% or more of the Company&#8217;s revenues and its accounts receivable at period-end are presented as follows:</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p> <table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="padding-bottom: 1.5pt">&#160;</td> <td colspan="6" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt">Revenues</font></td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="padding-bottom: 1.5pt">&#160;</td> <td colspan="6" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt">Percentage of revenues</font></td> <td style="padding-bottom: 1.5pt">&#160;</td></tr> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="padding-bottom: 1.5pt">&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt">2020</font></td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="padding-bottom: 1.5pt">&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt">2019</font></td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="padding-bottom: 1.5pt">&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt">2020</font></td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="padding-bottom: 1.5pt">&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt">2019</font></td> <td style="padding-bottom: 1.5pt">&#160;</td></tr> <tr style="vertical-align: bottom"> <td>&#160;</td> <td>&#160;</td> <td colspan="2">&#160;</td> <td>&#160;</td> <td>&#160;</td> <td colspan="2">&#160;</td> <td>&#160;</td> <td>&#160;</td> <td colspan="2">&#160;</td> <td>&#160;</td> <td>&#160;</td> <td colspan="2">&#160;</td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="width: 44%"><font style="font-size: 10pt">Customer A</font></td> <td style="width: 1%">&#160;</td> <td style="width: 1%"><font style="font-size: 10pt">$</font></td> <td style="width: 11%; text-align: right"><font style="font-size: 10pt">-</font></td> <td style="width: 1%">&#160;</td> <td style="width: 1%">&#160;</td> <td style="width: 1%"><font style="font-size: 10pt">$</font></td> <td style="width: 11%; text-align: right"><font style="font-size: 10pt">55,257</font></td> <td style="width: 1%">&#160;</td> <td style="width: 1%">&#160;</td> <td style="width: 1%">&#160;</td> <td style="width: 11%; text-align: right"><font style="font-size: 10pt">-</font></td> <td style="width: 1%">&#160;</td> <td style="width: 1%">&#160;</td> <td style="width: 1%">&#160;</td> <td style="width: 11%; text-align: right"><font style="font-size: 10pt">12</font></td> <td style="width: 1%"><font style="font-size: 10pt">%</font></td></tr> <tr style="vertical-align: bottom; background-color: white"> <td><font style="font-size: 10pt">Customer B</font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">152,423</font></td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">53,979</font></td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">15</font></td> <td><font style="font-size: 10pt">%</font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">12</font></td> <td><font style="font-size: 10pt">%</font></td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="padding-bottom: 1.5pt"><font style="font-size: 10pt">Customer C</font></td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="border-bottom: black 1.5pt solid">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">369,623</font></td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="border-bottom: black 1.5pt solid">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">-</font></td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">37</font></td> <td style="padding-bottom: 1.5pt"><font style="font-size: 10pt">%</font></td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">-</font></td> <td style="padding-bottom: 1.5pt">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right">&#160;</td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right">&#160;</td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right">&#160;</td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right">&#160;</td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="padding-bottom: 2.5pt">&#160;</td> <td style="padding-bottom: 2.5pt">&#160;</td> <td style="border-bottom: black 2.25pt double"><font style="font-size: 10pt">$</font></td> <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 10pt">522,046</font></td> <td style="padding-bottom: 2.5pt">&#160;</td> <td style="padding-bottom: 2.5pt">&#160;</td> <td style="border-bottom: black 2.25pt double"><font style="font-size: 10pt">$</font></td> <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 10pt">109,236</font></td> <td style="padding-bottom: 2.5pt">&#160;</td> <td style="padding-bottom: 2.5pt">&#160;</td> <td style="padding-bottom: 2.5pt">&#160;</td> <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 10pt">52</font></td> <td style="padding-bottom: 2.5pt"><font style="font-size: 10pt">%</font></td> <td style="padding-bottom: 2.5pt">&#160;</td> <td style="padding-bottom: 2.5pt">&#160;</td> <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 10pt">24</font></td> <td style="padding-bottom: 2.5pt"><font style="font-size: 10pt">%</font></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">For the nine months ended September 30, 2020 and 2019, the customers who accounted for 10% or more of the Company&#8217;s revenues and its accounts receivable at period-end are presented as follows:</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p> <table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1.5pt; text-align: center">&#160;</td> <td style="padding-bottom: 1.5pt; text-align: center">&#160;</td> <td colspan="6" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt">Revenues</font></td> <td style="padding-bottom: 1.5pt; text-align: center">&#160;</td> <td style="padding-bottom: 1.5pt; text-align: center">&#160;</td> <td colspan="6" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt">Percentage of revenues</font></td> <td style="padding-bottom: 1.5pt; text-align: center">&#160;</td></tr> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1.5pt; text-align: center">&#160;</td> <td style="padding-bottom: 1.5pt; text-align: center">&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt">2020</font></td> <td style="padding-bottom: 1.5pt; text-align: center">&#160;</td> <td style="padding-bottom: 1.5pt; text-align: center">&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt">2019</font></td> <td style="padding-bottom: 1.5pt; text-align: center">&#160;</td> <td style="padding-bottom: 1.5pt; text-align: center">&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt">2020</font></td> <td style="padding-bottom: 1.5pt; text-align: center">&#160;</td> <td style="padding-bottom: 1.5pt; text-align: center">&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt">2019</font></td> <td style="padding-bottom: 1.5pt; text-align: center">&#160;</td></tr> <tr style="vertical-align: bottom"> <td>&#160;</td> <td>&#160;</td> <td colspan="2">&#160;</td> <td>&#160;</td> <td>&#160;</td> <td colspan="2">&#160;</td> <td>&#160;</td> <td>&#160;</td> <td colspan="2">&#160;</td> <td>&#160;</td> <td>&#160;</td> <td colspan="2">&#160;</td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="width: 44%"><font style="font-size: 10pt">Customer A</font></td> <td style="width: 1%">&#160;</td> <td style="width: 1%"><font style="font-size: 10pt">$</font></td> <td style="width: 11%; text-align: right"><font style="font-size: 10pt">138,771</font></td> <td style="width: 1%">&#160;</td> <td style="width: 1%">&#160;</td> <td style="width: 1%"><font style="font-size: 10pt">$</font></td> <td style="width: 11%; text-align: right"><font style="font-size: 10pt">153,195</font></td> <td style="width: 1%">&#160;</td> <td style="width: 1%">&#160;</td> <td style="width: 1%">&#160;</td> <td style="width: 11%; text-align: right"><font style="font-size: 10pt">5</font></td> <td style="width: 1%"><font style="font-size: 10pt">%</font></td> <td style="width: 1%">&#160;</td> <td style="width: 1%">&#160;</td> <td style="width: 11%; text-align: right"><font style="font-size: 10pt">12</font></td> <td style="width: 1%"><font style="font-size: 10pt">%</font></td></tr> <tr style="vertical-align: bottom; background-color: white"> <td><font style="font-size: 10pt">Customer B</font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">964,146</font></td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">49,515</font></td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">39</font></td> <td><font style="font-size: 10pt">%</font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">4</font></td> <td><font style="font-size: 10pt">%</font></td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="border-bottom: black 1.5pt solid">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: right">&#160;</td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="border-bottom: black 1.5pt solid">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: right">&#160;</td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: right">&#160;</td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: right">&#160;</td> <td style="padding-bottom: 1.5pt">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="padding-bottom: 2.5pt">&#160;</td> <td style="padding-bottom: 2.5pt">&#160;</td> <td style="border-bottom: black 2.25pt double"><font style="font-size: 10pt">$</font></td> <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 10pt">1,102,917</font></td> <td style="padding-bottom: 2.5pt">&#160;</td> <td style="padding-bottom: 2.5pt">&#160;</td> <td style="border-bottom: black 2.25pt double"><font style="font-size: 10pt">$</font></td> <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 10pt">202,710</font></td> <td style="padding-bottom: 2.5pt">&#160;</td> <td style="padding-bottom: 2.5pt">&#160;</td> <td style="padding-bottom: 2.5pt">&#160;</td> <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 10pt">44</font></td> <td style="padding-bottom: 2.5pt"><font style="font-size: 10pt">%</font></td> <td style="padding-bottom: 2.5pt">&#160;</td> <td style="padding-bottom: 2.5pt">&#160;</td> <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 10pt">16</font></td> <td style="padding-bottom: 2.5pt"><font style="font-size: 10pt">%</font></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">(b) Major Suppliers</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">For the three months ended September 30, 2020 and 2019, there was no supplier who accounted for 10% or more of the Company&#8217;s purchases nor with significant outstanding payables.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p> <table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="padding-bottom: 1.5pt">&#160;</td> <td colspan="6" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt">Revenues</font></td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="padding-bottom: 1.5pt">&#160;</td> <td colspan="6" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt">Percentage of revenues</font></td> <td style="padding-bottom: 1.5pt">&#160;</td></tr> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="padding-bottom: 1.5pt">&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt">2020</font></td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="padding-bottom: 1.5pt">&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt">2019</font></td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="padding-bottom: 1.5pt">&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt">2020</font></td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="padding-bottom: 1.5pt">&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt">2019</font></td> <td style="padding-bottom: 1.5pt">&#160;</td></tr> <tr style="vertical-align: bottom"> <td>&#160;</td> <td>&#160;</td> <td colspan="2">&#160;</td> <td>&#160;</td> <td>&#160;</td> <td colspan="2">&#160;</td> <td>&#160;</td> <td>&#160;</td> <td colspan="2">&#160;</td> <td>&#160;</td> <td>&#160;</td> <td colspan="2">&#160;</td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="width: 44%"><font style="font-size: 10pt">Supplier A</font></td> <td style="width: 1%">&#160;</td> <td style="width: 1%"><font style="font-size: 10pt">$</font></td> <td style="width: 11%; text-align: right"><font style="font-size: 10pt">352,297</font></td> <td style="width: 1%">&#160;</td> <td style="width: 1%">&#160;</td> <td style="width: 1%"><font style="font-size: 10pt">$</font></td> <td style="width: 11%; text-align: right"><font style="font-size: 10pt">93,455</font></td> <td style="width: 1%">&#160;</td> <td style="width: 1%">&#160;</td> <td style="width: 1%">&#160;</td> <td style="width: 11%; text-align: right"><font style="font-size: 10pt">64</font></td> <td style="width: 1%"><font style="font-size: 10pt">%</font></td> <td style="width: 1%">&#160;</td> <td style="width: 1%">&#160;</td> <td style="width: 11%; text-align: right"><font style="font-size: 10pt">88</font></td> <td style="width: 1%"><font style="font-size: 10pt">%</font></td></tr> <tr style="vertical-align: bottom; background-color: white"> <td><font style="font-size: 10pt">Supplier B</font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">99,328</font></td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">-</font></td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">18</font></td> <td><font style="font-size: 10pt">%</font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">-</font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="padding-bottom: 1.5pt"><font style="font-size: 10pt">Supplier C</font></td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="border-bottom: black 1.5pt solid">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">65,418</font></td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="border-bottom: black 1.5pt solid">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">-</font></td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">12</font></td> <td style="padding-bottom: 1.5pt"><font style="font-size: 10pt">%</font></td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">-</font></td> <td style="padding-bottom: 1.5pt">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right">&#160;</td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right">&#160;</td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right">&#160;</td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right">&#160;</td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="padding-bottom: 2.5pt">&#160;</td> <td style="padding-bottom: 2.5pt">&#160;</td> <td style="border-bottom: black 2.25pt double"><font style="font-size: 10pt">$</font></td> <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 10pt">517,043</font></td> <td style="padding-bottom: 2.5pt">&#160;</td> <td style="padding-bottom: 2.5pt">&#160;</td> <td style="border-bottom: black 2.25pt double"><font style="font-size: 10pt">$</font></td> <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 10pt">93,455</font></td> <td style="padding-bottom: 2.5pt">&#160;</td> <td style="padding-bottom: 2.5pt">&#160;</td> <td style="padding-bottom: 2.5pt">&#160;</td> <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 10pt">94</font></td> <td style="padding-bottom: 2.5pt"><font style="font-size: 10pt">%</font></td> <td style="padding-bottom: 2.5pt">&#160;</td> <td style="padding-bottom: 2.5pt">&#160;</td> <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 10pt">88</font></td> <td style="padding-bottom: 2.5pt"><font style="font-size: 10pt">%</font></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">For the nine months ended September 30, 2020 and 2019, there was no supplier who accounted for 10% or more of the Company&#8217;s purchases nor with significant outstanding payables.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p> <table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="padding-bottom: 1.5pt">&#160;</td> <td colspan="6" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt">Revenues</font></td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="padding-bottom: 1.5pt">&#160;</td> <td colspan="6" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt">Percentage of revenues</font></td> <td style="padding-bottom: 1.5pt">&#160;</td></tr> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="padding-bottom: 1.5pt">&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt">2020</font></td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="padding-bottom: 1.5pt">&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt">2019</font></td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="padding-bottom: 1.5pt">&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt">2020</font></td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="padding-bottom: 1.5pt">&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt">2019</font></td> <td style="padding-bottom: 1.5pt">&#160;</td></tr> <tr style="vertical-align: bottom"> <td>&#160;</td> <td>&#160;</td> <td colspan="2">&#160;</td> <td>&#160;</td> <td>&#160;</td> <td colspan="2">&#160;</td> <td>&#160;</td> <td>&#160;</td> <td colspan="2">&#160;</td> <td>&#160;</td> <td>&#160;</td> <td colspan="2">&#160;</td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="width: 44%"><font style="font-size: 10pt">Supplier A</font></td> <td style="width: 1%">&#160;</td> <td style="width: 1%"><font style="font-size: 10pt">$</font></td> <td style="width: 11%; text-align: right"><font style="font-size: 10pt">633,555</font></td> <td style="width: 1%">&#160;</td> <td style="width: 1%">&#160;</td> <td style="width: 1%"><font style="font-size: 10pt">$</font></td> <td style="width: 11%; text-align: right"><font style="font-size: 10pt">267,081</font></td> <td style="width: 1%">&#160;</td> <td style="width: 1%">&#160;</td> <td style="width: 1%">&#160;</td> <td style="width: 11%; text-align: right"><font style="font-size: 10pt">58</font></td> <td style="width: 1%"><font style="font-size: 10pt">%</font></td> <td style="width: 1%">&#160;</td> <td style="width: 1%">&#160;</td> <td style="width: 11%; text-align: right"><font style="font-size: 10pt">88</font></td> <td style="width: 1%"><font style="font-size: 10pt">%</font></td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="padding-bottom: 1.5pt"><font style="font-size: 10pt">Supplier B</font></td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="border-bottom: black 1.5pt solid">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">250,203</font></td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="border-bottom: black 1.5pt solid">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">16,308</font></td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">23</font></td> <td style="padding-bottom: 1.5pt"><font style="font-size: 10pt">%</font></td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">5</font></td> <td style="padding-bottom: 1.5pt"><font style="font-size: 10pt">%</font></td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right">&#160;</td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right">&#160;</td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right">&#160;</td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right">&#160;</td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="padding-bottom: 2.5pt">&#160;</td> <td style="padding-bottom: 2.5pt">&#160;</td> <td style="border-bottom: black 2.25pt double"><font style="font-size: 10pt">$</font></td> <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 10pt">883,758</font></td> <td style="padding-bottom: 2.5pt">&#160;</td> <td style="padding-bottom: 2.5pt">&#160;</td> <td style="border-bottom: black 2.25pt double"><font style="font-size: 10pt">$</font></td> <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 10pt">283,389</font></td> <td style="padding-bottom: 2.5pt">&#160;</td> <td style="padding-bottom: 2.5pt">&#160;</td> <td style="padding-bottom: 2.5pt">&#160;</td> <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 10pt">81</font></td> <td style="padding-bottom: 2.5pt"><font style="font-size: 10pt">%</font></td> <td style="padding-bottom: 2.5pt">&#160;</td> <td style="padding-bottom: 2.5pt">&#160;</td> <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 10pt">93</font></td> <td style="padding-bottom: 2.5pt"><font style="font-size: 10pt">%</font></td></tr> </table> <table cellspacing="0" cellpadding="0" style="width: 100%"> <tr style="vertical-align: top"> <td style="font: 12pt Times New Roman, Times, Serif; width: 48px"><font style="font-size: 10pt"><b>11.</b></font></td> <td style="font: 12pt Times New Roman, Times, Serif; text-align: justify"><font style="font-size: 10pt"><b>STOCKHOLDERS&#8217; EQUITY</b></font></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">During the year, the Company has issued the following common stock:</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td>&#160;</td> <td style="padding-bottom: 1.5pt">&#160;</td> <td colspan="6" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt">As of</font></td> <td style="padding-bottom: 1.5pt">&#160;</td></tr> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="padding-bottom: 1.5pt">&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt">September 30, 2020</font></td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="padding-bottom: 1.5pt">&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt">December 31, 2019</font></td> <td style="padding-bottom: 1.5pt">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td><font style="font-size: 10pt">Issued and fully paid:</font></td> <td>&#160;</td> <td><font style="font-size: 10pt">$</font></td> <td style="text-align: right">&#160;</td> <td>&#160;</td> <td>&#160;</td> <td><font style="font-size: 10pt">$</font></td> <td style="text-align: right">&#160;</td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right">&#160;</td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right">&#160;</td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="width: 62%"><font style="font-size: 10pt">At the beginning of the period</font></td> <td style="width: 1%">&#160;</td> <td style="width: 1%">&#160;</td> <td style="width: 16%; text-align: right"><font style="font-size: 10pt">2,034,801</font></td> <td style="width: 1%">&#160;</td> <td style="width: 1%">&#160;</td> <td style="width: 1%">&#160;</td> <td style="width: 16%; text-align: right"><font style="font-size: 10pt">2,034,801</font></td> <td style="width: 1%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="padding-bottom: 1.5pt"><font style="font-size: 10pt">Issued during the period</font></td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="border-bottom: black 1.5pt solid">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">360</font></td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="border-bottom: black 1.5pt solid">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">-</font></td> <td style="padding-bottom: 1.5pt">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right">&#160;</td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right">&#160;</td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="padding-bottom: 1.5pt"><font style="font-size: 10pt">At the end of the period</font></td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="border-bottom: black 1.5pt solid"><font style="font-size: 10pt">$</font></td> <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">2,035,161</font></td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="border-bottom: black 1.5pt solid"><font style="font-size: 10pt">$</font></td> <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">2,034,801</font></td> <td style="padding-bottom: 1.5pt">&#160;</td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">As of September 30, 2020, and December 31, 2019, Bioplus Life Corp has an issued and outstanding common share of 362,905,561 and 359,305,561 respectively.</p> <table cellspacing="0" cellpadding="0" style="width: 100%; border-collapse: collapse"> <tr style="vertical-align: top"> <td style="font: 12pt Times New Roman, Times, Serif; width: 48px"><font style="font-size: 10pt"><b>9.</b></font></td> <td style="font: 12pt Times New Roman, Times, Serif"><font style="font-size: 10pt"><b>OTHER PAYABLES AND ACCRUED LIABILITIES</b></font></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&#160;</p> <table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="padding-bottom: 1.5pt">&#160;</td> <td colspan="6" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt">As of</font></td> <td style="padding-bottom: 1.5pt">&#160;</td></tr> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="padding-bottom: 1.5pt">&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt">September 30, 2020</font></td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="padding-bottom: 1.5pt">&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt">December 31, 2019</font></td> <td style="padding-bottom: 1.5pt">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td><font style="font-size: 10pt">Other payables generated from:</font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">$ </font></td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">$ </font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="width: 62%; padding-left: 10pt"><font style="font-size: 10pt">Local</font></td> <td style="width: 1%">&#160;</td> <td style="width: 1%">&#160;</td> <td style="width: 16%; text-align: right"><font style="font-size: 10pt">5,262</font></td> <td style="width: 1%">&#160;</td> <td style="width: 1%">&#160;</td> <td style="width: 1%">&#160;</td> <td style="width: 16%; text-align: right"><font style="font-size: 10pt">41,645</font></td> <td style="width: 1%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="padding-left: 10pt"><font style="font-size: 10pt">Foreign, representing:</font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right">&#160;</td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right">&#160;</td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="padding-left: 20pt"><font style="font-size: 10pt">Malaysia</font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">-</font></td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">-</font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="padding-left: 30pt"><font style="font-size: 10pt">Common outstanding from non-trade payable</font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">36,562</font></td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">37,110</font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="padding-left: 30pt"><font style="font-size: 10pt">Common outstanding from third parties</font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">827</font></td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">1,004</font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="padding-left: 20pt"><font style="font-size: 10pt">China</font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">-</font></td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">-</font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="padding-bottom: 1.5pt; padding-left: 30pt"><font style="font-size: 10pt">Common outstanding from third parties</font></td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="border-bottom: black 1.5pt solid">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">147</font></td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="border-bottom: black 1.5pt solid">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">861</font></td> <td style="padding-bottom: 1.5pt">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td>&#160;</td> <td>&#160;</td> <td><font style="font-size: 10pt">$</font></td> <td style="text-align: right"><font style="font-size: 10pt">42,798</font></td> <td>&#160;</td> <td>&#160;</td> <td><font style="font-size: 10pt">$</font></td> <td style="text-align: right"><font style="font-size: 10pt">80,620</font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right">&#160;</td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right">&#160;</td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td><font style="font-size: 10pt">Accrued other expenses</font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right">&#160;</td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right">&#160;</td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="padding-left: 10pt"><font style="font-size: 10pt">Local</font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right">&#160;</td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right">&#160;</td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="padding-left: 10pt"><font style="font-size: 10pt">Foreign, representing:</font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right">&#160;</td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right">&#160;</td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="padding-left: 20pt"><font style="font-size: 10pt">Malaysia</font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right">&#160;</td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right">&#160;</td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="padding-left: 30pt"><font style="font-size: 10pt">Payroll</font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">23,640</font></td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">18,550</font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="padding-left: 30pt"><font style="font-size: 10pt">Payroll deduction</font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">8,961</font></td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">7,873</font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="padding-left: 30pt"><font style="font-size: 10pt">Professional Fee</font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">1,619</font></td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">11,499</font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="padding-left: 30pt"><font style="font-size: 10pt">Commission</font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">37,255</font></td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">43,563</font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="padding-bottom: 1.5pt; padding-left: 30pt"><font style="font-size: 10pt">Expenses</font></td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="border-bottom: black 1.5pt solid">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">787</font></td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="border-bottom: black 1.5pt solid">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">1,157</font></td> <td style="padding-bottom: 1.5pt">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td>&#160;</td> <td>&#160;</td> <td><font style="font-size: 10pt">$</font></td> <td style="text-align: right"><font style="font-size: 10pt">72,262</font></td> <td>&#160;</td> <td>&#160;</td> <td><font style="font-size: 10pt">$</font></td> <td style="text-align: right"><font style="font-size: 10pt">82,642</font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="padding-left: 20pt"><font style="font-size: 10pt">Hong Kong</font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">-</font></td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">-</font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right">&#160;</td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right">&#160;</td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td><font style="font-size: 10pt">Deposit received from customers</font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">285,663</font></td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">226,783</font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right">&#160;</td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right">&#160;</td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="padding-bottom: 1.5pt"><font style="font-size: 10pt">Share subscription receipts in advance</font></td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="border-bottom: black 1.5pt solid">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">110,000</font></td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="border-bottom: black 1.5pt solid">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">104,000</font></td> <td style="padding-bottom: 1.5pt">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="padding-bottom: 2.5pt">&#160;</td> <td style="padding-bottom: 2.5pt">&#160;</td> <td style="border-bottom: black 2.25pt double"><font style="font-size: 10pt">$</font></td> <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 10pt">510,723</font></td> <td style="padding-bottom: 2.5pt">&#160;</td> <td style="padding-bottom: 2.5pt">&#160;</td> <td style="border-bottom: black 2.25pt double"><font style="font-size: 10pt">$</font></td> <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 10pt">494,045</font></td> <td style="padding-bottom: 2.5pt">&#160;</td></tr> </table> <table cellspacing="0" cellpadding="0" style="width: 100%; border-collapse: collapse"> <tr style="vertical-align: top"> <td style="font: 12pt Times New Roman, Times, Serif; width: 48px"><font style="font-size: 10pt"><b>8.</b></font></td> <td style="font: 12pt Times New Roman, Times, Serif"><font style="font-size: 10pt"><b>BANK BORROWINGS</b></font></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 27pt; text-indent: -27pt">&#160;</p> <table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="padding-bottom: 1.5pt">&#160;</td> <td colspan="6" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt">As of</font></td> <td style="padding-bottom: 1.5pt">&#160;</td></tr> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="padding-bottom: 1.5pt">&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt">September 30, 2020</font></td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="padding-bottom: 1.5pt">&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt">December 31, 2019</font></td> <td style="padding-bottom: 1.5pt">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td><font style="font-size: 10pt"><b>Secured: -</b></font></td> <td>&#160;</td> <td colspan="2"><font style="font-size: 10pt">$</font></td> <td>&#160;</td> <td>&#160;</td> <td colspan="2"><font style="font-size: 10pt">$</font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="width: 62%"><font style="font-size: 10pt">Bank overdraft</font></td> <td style="width: 1%">&#160;</td> <td style="width: 1%">&#160;</td> <td style="width: 16%; text-align: right"><font style="font-size: 10pt">72,173</font></td> <td style="width: 1%">&#160;</td> <td style="width: 1%">&#160;</td> <td style="width: 1%">&#160;</td> <td style="width: 16%; text-align: right"><font style="font-size: 10pt">141,520</font></td> <td style="width: 1%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="padding-bottom: 1.5pt"><font style="font-size: 10pt">Term loan</font></td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="border-bottom: black 1.5pt solid">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">589,789</font></td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="border-bottom: black 1.5pt solid">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">606,651</font></td> <td style="padding-bottom: 1.5pt">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="padding-bottom: 2.5pt">&#160;</td> <td style="padding-bottom: 2.5pt">&#160;</td> <td style="border-bottom: black 2.25pt double">&#160;</td> <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 10pt">661,962</font></td> <td style="padding-bottom: 2.5pt">&#160;</td> <td style="padding-bottom: 2.5pt">&#160;</td> <td style="border-bottom: black 2.25pt double">&#160;</td> <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 10pt">748,171</font></td> <td style="padding-bottom: 2.5pt">&#160;</td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p> <table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="padding-bottom: 1.5pt">&#160;</td> <td colspan="6" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt">As of</font></td> <td style="padding-bottom: 1.5pt">&#160;</td></tr> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="padding-bottom: 1.5pt">&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt">September 30, 2020</font></td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="padding-bottom: 1.5pt">&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt">December 31, 2019</font></td> <td style="padding-bottom: 1.5pt">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td><font style="font-size: 10pt"><b>Analyzed as:</b></font></td> <td>&#160;</td> <td colspan="2"><font style="font-size: 10pt">$</font></td> <td>&#160;</td> <td>&#160;</td> <td colspan="2"><font style="font-size: 10pt">$</font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="width: 62%"><font style="font-size: 10pt">Current portion</font></td> <td style="width: 1%">&#160;</td> <td style="width: 1%">&#160;</td> <td style="width: 16%; text-align: right"><font style="font-size: 10pt">111,302</font></td> <td style="width: 1%">&#160;</td> <td style="width: 1%">&#160;</td> <td style="width: 1%">&#160;</td> <td style="width: 16%; text-align: right"><font style="font-size: 10pt">195,027</font></td> <td style="width: 1%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="padding-bottom: 1.5pt"><font style="font-size: 10pt">Non-current portion</font></td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="border-bottom: black 1.5pt solid">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">550,660</font></td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="border-bottom: black 1.5pt solid">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">553,144</font></td> <td style="padding-bottom: 1.5pt">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="padding-bottom: 2.5pt">&#160;</td> <td style="padding-bottom: 2.5pt">&#160;</td> <td style="border-bottom: black 2.25pt double"><font style="font-size: 10pt">$</font></td> <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 10pt">661,962</font></td> <td style="padding-bottom: 2.5pt">&#160;</td> <td style="padding-bottom: 2.5pt">&#160;</td> <td style="border-bottom: black 2.25pt double"><font style="font-size: 10pt">$</font></td> <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 10pt">748,171</font></td> <td style="padding-bottom: 2.5pt">&#160;</td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The bank overdraft of the Company is secured by way of the following:</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%"> <tr style="vertical-align: top"> <td style="width: 24px">&#160;</td> <td style="width: 24px"><font style="font-size: 10pt">a.</font></td> <td style="text-align: justify"><font style="font-size: 10pt">A Facilities Agreement for US$377,277 (MYR579,171);</font></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p> <table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%"> <tr style="vertical-align: top"> <td style="width: 24px">&#160;</td> <td style="width: 24px"><font style="font-size: 10pt">b.</font></td> <td style="text-align: justify"><font style="font-size: 10pt">Master Facility Agreement.</font></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p> <table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%"> <tr style="vertical-align: top"> <td style="width: 24px">&#160;</td> <td style="width: 24px"><font style="font-size: 10pt">c.</font></td> <td style="text-align: justify"><font style="font-size: 10pt">Joint and Several Guarantee to be executed by the subsidiary directors of Bio Life Neutraceuticals Sdn Bhd. </font></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">Interested charged on the bank overdraft is 4% (2019: 4%) above the bank base lending rate per annum.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">The term loan of the Company is secured by way of the following:</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p> <table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%"> <tr style="vertical-align: top"> <td style="width: 24px">&#160;</td> <td style="width: 24px"><font style="font-size: 10pt">a.</font></td> <td><font style="font-size: 10pt">A Facilities Agreement for US$1,705,086 (MYR2,842,719);</font></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p> <table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%"> <tr style="vertical-align: top"> <td style="width: 24px">&#160;</td> <td style="width: 24px"><font style="font-size: 10pt">b.</font></td> <td><font style="font-size: 10pt">Master Facility Agreement.</font></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p> <table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%"> <tr style="vertical-align: top"> <td style="width: 24px">&#160;</td> <td style="width: 24px"><font style="font-size: 10pt">c.</font></td> <td><font style="font-size: 10pt">Joint and Several Guarantee to be executed by the subsidiary directors of Bio Life Neutraceuticals Sdn Bhd. </font></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The term loan is payable by 240 monthly installments of US$4,492 (MYR18,248) each including interest, commencing from Oct 10, 2016 and subject to interest at 4% per annum flat.</p> <table cellspacing="0" cellpadding="0" style="width: 100%; border-collapse: collapse"> <tr style="vertical-align: top"> <td style="font: 12pt Times New Roman, Times, Serif; width: 48px"><font style="font-size: 10pt"><b>7.</b></font></td> <td style="font: 12pt Times New Roman, Times, Serif"><font style="font-size: 10pt"><b>OBLIGATION UNDER FINANCE LEASE</b></font></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 27pt; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company purchased motor vehicles under finance lease agreements with the effective interest rate of 2.48% - 4.31% per annum (2019: 5.22% per annum), with principal and interest payable monthly. The obligation under the finance leases are as follows:</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 27pt; text-align: justify">&#160;</p> <table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td style="text-align: justify">&#160;</td> <td style="padding-bottom: 1.5pt">&#160;</td> <td colspan="6" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt">As of</font></td> <td style="padding-bottom: 1.5pt">&#160;</td></tr> <tr style="vertical-align: bottom"> <td style="text-align: justify">&#160;</td> <td style="padding-bottom: 1.5pt">&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">September 30, 2020</font></td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="padding-bottom: 1.5pt">&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt">December 31, 2019</font></td> <td style="padding-bottom: 1.5pt">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="text-align: justify"><font style="font-size: 10pt"><b>Present value of hire purchase liabilities:</b></font></td> <td>&#160;</td> <td><font style="font-size: 10pt">$</font></td> <td style="text-align: right">&#160;</td> <td>&#160;</td> <td>&#160;</td> <td><font style="font-size: 10pt">$</font></td> <td style="text-align: right">&#160;</td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="width: 62%; text-align: justify"><font style="font-size: 10pt">Not later than one year</font></td> <td style="width: 1%">&#160;</td> <td style="width: 1%">&#160;</td> <td style="width: 16%; text-align: right"><font style="font-size: 10pt">31,632</font></td> <td style="width: 1%">&#160;</td> <td style="width: 1%">&#160;</td> <td style="width: 1%">&#160;</td> <td style="width: 16%; text-align: right"><font style="font-size: 10pt">33,343</font></td> <td style="width: 1%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="text-align: justify"><font style="font-size: 10pt">Later than one year but not later than two years</font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">32,097</font></td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">32,496</font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="padding-bottom: 1.5pt; text-align: justify"><font style="font-size: 10pt">Later than two years but not later than five years</font></td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="border-bottom: black 1.5pt solid">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">50,642</font></td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="border-bottom: black 1.5pt solid">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">59,637</font></td> <td style="padding-bottom: 1.5pt">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="padding-bottom: 2.5pt; text-align: justify">&#160;</td> <td style="padding-bottom: 2.5pt">&#160;</td> <td style="border-bottom: black 2.25pt double">&#160;</td> <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 10pt">114,371</font></td> <td style="padding-bottom: 2.5pt">&#160;</td> <td style="padding-bottom: 2.5pt">&#160;</td> <td style="border-bottom: black 2.25pt double">&#160;</td> <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 10pt">125,476</font></td> <td style="padding-bottom: 2.5pt">&#160;</td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p> <table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td style="text-align: justify">&#160;</td> <td style="padding-bottom: 1.5pt">&#160;</td> <td colspan="6" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt">As Of</font></td> <td style="padding-bottom: 1.5pt">&#160;</td></tr> <tr style="vertical-align: bottom"> <td>&#160;</td> <td style="padding-bottom: 1.5pt">&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt">September 30, 2020</font></td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="padding-bottom: 1.5pt">&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt">December 31, 2019</font></td> <td style="padding-bottom: 1.5pt">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="text-align: justify"><font style="font-size: 10pt"><b>Analyzed as:</b></font></td> <td>&#160;</td> <td><font style="font-size: 10pt">$</font></td> <td style="text-align: right">&#160;</td> <td>&#160;</td> <td>&#160;</td> <td><font style="font-size: 10pt">$</font></td> <td style="text-align: right">&#160;</td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="width: 62%; text-align: justify"><font style="font-size: 10pt">Current portion</font></td> <td style="width: 1%">&#160;</td> <td style="width: 1%">&#160;</td> <td style="width: 16%; text-align: right"><font style="font-size: 10pt">31,632</font></td> <td style="width: 1%">&#160;</td> <td style="width: 1%">&#160;</td> <td style="width: 1%">&#160;</td> <td style="width: 16%; text-align: right"><font style="font-size: 10pt">33,343</font></td> <td style="width: 1%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="padding-bottom: 1.5pt; text-align: justify"><font style="font-size: 10pt">Non-current portion</font></td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="border-bottom: black 1.5pt solid">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">82,739</font></td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="border-bottom: black 1.5pt solid">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">92,133</font></td> <td style="padding-bottom: 1.5pt">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="padding-bottom: 2.5pt; text-align: justify">&#160;</td> <td style="padding-bottom: 2.5pt">&#160;</td> <td style="border-bottom: black 2.25pt double">&#160;</td> <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 10pt">114,371</font></td> <td style="padding-bottom: 2.5pt">&#160;</td> <td style="padding-bottom: 2.5pt">&#160;</td> <td style="border-bottom: black 2.25pt double">&#160;</td> <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 10pt">125,476</font></td> <td style="padding-bottom: 2.5pt">&#160;</td></tr> </table> <table cellspacing="0" cellpadding="0" style="width: 100%; border-collapse: collapse"> <tr style="vertical-align: top"> <td style="font: 12pt Times New Roman, Times, Serif; width: 48px"><font style="font-size: 10pt"><b>6.</b></font></td> <td style="font: 12pt Times New Roman, Times, Serif"><font style="font-size: 10pt"><b>PROPERTY, PLANT AND EQUIPMENT, NET</b></font></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Property, plant and equipment consisted of the following:</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td>&#160;</td> <td style="padding-bottom: 1.5pt">&#160;</td> <td colspan="6" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt">As of</font></td> <td style="padding-bottom: 1.5pt">&#160;</td></tr> <tr style="vertical-align: bottom"> <td>&#160;</td> <td style="padding-bottom: 1.5pt">&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt">September 30, 2020</font></td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="padding-bottom: 1.5pt">&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt">December 31, 2019</font></td> <td style="padding-bottom: 1.5pt">&#160;</td></tr> <tr style="vertical-align: bottom"> <td>&#160;</td> <td>&#160;</td> <td colspan="2">&#160;</td> <td>&#160;</td> <td>&#160;</td> <td colspan="2">&#160;</td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="width: 62%"><font style="font-size: 10pt">Computer hardware</font></td> <td style="width: 1%">&#160;</td> <td style="width: 1%"><font style="font-size: 10pt">$</font></td> <td style="width: 16%; text-align: right"><font style="font-size: 10pt">40,430</font></td> <td style="width: 1%">&#160;</td> <td style="width: 1%">&#160;</td> <td style="width: 1%"><font style="font-size: 10pt">$</font></td> <td style="width: 16%; text-align: right"><font style="font-size: 10pt">32,814</font></td> <td style="width: 1%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td><font style="font-size: 10pt">Furniture &#38; fittings</font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">112,198</font></td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">106,945</font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td><font style="font-size: 10pt">Handphone</font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">3,724</font></td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">3,514</font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td><font style="font-size: 10pt">Landscape</font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">3,691</font></td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">3,475</font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td><font style="font-size: 10pt">Leasehold land and building</font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">1,875,962</font></td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">1,872,476</font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td><font style="font-size: 10pt">Machinery</font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">175,677</font></td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">119,413</font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td><font style="font-size: 10pt">Motor vehicle</font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">243,630</font></td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">243,630</font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td><font style="font-size: 10pt">Office equipment</font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">59,123</font></td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">52,725</font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td><font style="font-size: 10pt">Renovation</font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">142,099</font></td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">92,646</font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td><font style="font-size: 10pt">Signboard</font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">5,470</font></td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">4,648</font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td><font style="font-size: 10pt">Tools and equipment</font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">6,930</font></td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">4,348</font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="padding-bottom: 1.5pt"><font style="font-size: 10pt">Kitchen utensils</font></td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="border-bottom: black 1.5pt solid">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">1,740</font></td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="border-bottom: black 1.5pt solid">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">-</font></td> <td style="padding-bottom: 1.5pt">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td>&#160;</td> <td>&#160;</td> <td><font style="font-size: 10pt">$</font></td> <td style="text-align: right"><font style="font-size: 10pt">2,670,674</font></td> <td>&#160;</td> <td>&#160;</td> <td><font style="font-size: 10pt">$</font></td> <td style="text-align: right"><font style="font-size: 10pt">2,536,634</font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td><font style="font-size: 10pt">(Less): Accumulated depreciation</font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">(412,814</font></td> <td><font style="font-size: 10pt">)</font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">(315,762</font></td> <td><font style="font-size: 10pt">)</font></td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="padding-bottom: 1.5pt"><font style="font-size: 10pt">Add/(Less): Foreign translation difference</font></td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="border-bottom: black 1.5pt solid">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">(35,678</font></td> <td style="padding-bottom: 1.5pt"><font style="font-size: 10pt">)</font></td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="border-bottom: black 1.5pt solid">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">(3,625</font></td> <td style="padding-bottom: 1.5pt"><font style="font-size: 10pt">)</font></td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="padding-bottom: 2.5pt"><font style="font-size: 10pt">Property, plant and equipment, net</font></td> <td style="padding-bottom: 2.5pt">&#160;</td> <td style="border-bottom: black 2.25pt double"><font style="font-size: 10pt">$</font></td> <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 10pt">2,222,182</font></td> <td style="padding-bottom: 2.5pt">&#160;</td> <td style="padding-bottom: 2.5pt">&#160;</td> <td style="border-bottom: black 2.25pt double"><font style="font-size: 10pt">$</font></td> <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 10pt">2,217,247</font></td> <td style="padding-bottom: 2.5pt">&#160;</td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Depreciation expense for the period ended September 30, 2020 and September 30, 2019 were $93, 429 and $82,857, respectively.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">As of September 30, 2020, and December 31, 2019 the Company acquired motor vehicles under finance leases with carrying value of $101,385 and $129,925 respectively.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The leasehold land and building with carrying amount of $1,786,756 and $1,797,002 as of September 30, 2020 and December 31, 2019, respectively have been charged to licensed bank to secure banking facilities granted to the Company.</p> <table cellspacing="0" cellpadding="0" style="width: 100%; border-collapse: collapse"> <tr style="vertical-align: top"> <td style="font: 12pt Times New Roman, Times, Serif; width: 48px"><font style="font-size: 10pt"><b>5.</b></font></td> <td style="font: 12pt Times New Roman, Times, Serif"><font style="font-size: 10pt"><b>OTHER RECEIVABLES, DEPOSITS AND PREPAYMENTS</b></font></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p> <table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="padding-bottom: 1.5pt">&#160;</td> <td colspan="6" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt">As of</font></td> <td style="padding-bottom: 1.5pt">&#160;</td></tr> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="padding-bottom: 1.5pt">&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt">September 30, 2020</font></td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="padding-bottom: 1.5pt">&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt">December 31, 2019</font></td> <td style="padding-bottom: 1.5pt">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="width: 62%"><font style="font-size: 10pt">Other receivables</font></td> <td style="width: 1%">&#160;</td> <td style="width: 1%"><font style="font-size: 10pt">$</font></td> <td style="width: 16%; text-align: right"><font style="font-size: 10pt">12,970</font></td> <td style="width: 1%">&#160;</td> <td style="width: 1%">&#160;</td> <td style="width: 1%"><font style="font-size: 10pt">$</font></td> <td style="width: 16%; text-align: right"><font style="font-size: 10pt">9,981</font></td> <td style="width: 1%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td><font style="font-size: 10pt">Deposits</font></td> <td>&#160;</td> <td><font style="font-size: 10pt">5.1</font></td> <td style="text-align: right"><font style="font-size: 10pt">19,394</font></td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">63,308</font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="padding-bottom: 1.5pt"><font style="font-size: 10pt">Prepayments</font></td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="border-bottom: black 1.5pt solid"><font style="font-size: 10pt">5.2</font></td> <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">6,810</font></td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="border-bottom: black 1.5pt solid">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">59,771</font></td> <td style="padding-bottom: 1.5pt">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="padding-bottom: 2.5pt">&#160;</td> <td style="padding-bottom: 2.5pt">&#160;</td> <td style="border-bottom: black 2.25pt double"><font style="font-size: 10pt">$</font></td> <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 10pt">39,174</font></td> <td style="padding-bottom: 2.5pt">&#160;</td> <td style="padding-bottom: 2.5pt">&#160;</td> <td style="border-bottom: black 2.25pt double"><font style="font-size: 10pt">$</font></td> <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 10pt">133,060</font></td> <td style="padding-bottom: 2.5pt">&#160;</td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">5.1 The deposits of $ 19,394 (2019: $ 63,308) representing deposits paid for rental of hostels and various utilities.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 13.5pt; text-indent: -13.5pt">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">5.2 The prepayments of $ 6,810 (2019: $ 59,771) representing advanced payments made to suppliers for purchase of manufacturing materials.</p> <table cellspacing="0" cellpadding="0" style="width: 100%; border-collapse: collapse"> <tr style="vertical-align: top"> <td style="font: 12pt Times New Roman, Times, Serif; width: 48px"><font style="font-size: 10pt"><b>4.</b></font></td> <td style="font: 12pt Times New Roman, Times, Serif"><font style="font-size: 10pt"><b>INVENTORIES</b></font></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p> <table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="padding-bottom: 1.5pt">&#160;</td> <td colspan="6" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt">As of</font></td> <td style="padding-bottom: 1.5pt">&#160;</td></tr> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="padding-bottom: 1.5pt">&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt">September 30, 2020</font></td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="padding-bottom: 1.5pt">&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt">December 31, 2019</font></td> <td style="padding-bottom: 1.5pt">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="width: 62%"><font style="font-size: 10pt">Raw material</font></td> <td style="width: 1%">&#160;</td> <td style="width: 1%"><font style="font-size: 10pt">$</font></td> <td style="width: 16%; text-align: right"><font style="font-size: 10pt">302,918</font></td> <td style="width: 1%">&#160;</td> <td style="width: 1%">&#160;</td> <td style="width: 1%"><font style="font-size: 10pt">$</font></td> <td style="width: 16%; text-align: right"><font style="font-size: 10pt">245,877</font></td> <td style="width: 1%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td><font style="font-size: 10pt">Packing Material</font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">27,294</font></td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">23,858</font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="padding-bottom: 1.5pt"><font style="font-size: 10pt">Finished goods</font></td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="border-bottom: black 1.5pt solid">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">27,314</font></td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="border-bottom: black 1.5pt solid">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">34,219</font></td> <td style="padding-bottom: 1.5pt">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="padding-bottom: 2.5pt"><font style="font-size: 10pt">Total inventories</font></td> <td style="padding-bottom: 2.5pt">&#160;</td> <td style="border-bottom: black 2.25pt double"><font style="font-size: 10pt">$</font></td> <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 10pt">357,526</font></td> <td style="padding-bottom: 2.5pt">&#160;</td> <td style="padding-bottom: 2.5pt">&#160;</td> <td style="border-bottom: black 2.25pt double"><font style="font-size: 10pt">$</font></td> <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 10pt">303,954</font></td> <td style="padding-bottom: 2.5pt">&#160;</td></tr> </table> <table cellspacing="0" cellpadding="0" style="width: 100%; border-collapse: collapse"> <tr style="vertical-align: top"> <td style="font: 12pt Times New Roman, Times, Serif; width: 48px"><font style="font-size: 10pt"><b>3.</b></font></td> <td style="font: 12pt Times New Roman, Times, Serif"><font style="font-size: 10pt"><b>AMOUNT DUE FROM RELATED PARTIES </b></font></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The amounts are unsecured, bear no interest and are payable on demand.</p> <table cellspacing="0" cellpadding="0" style="width: 100%; border-collapse: collapse"> <tr style="vertical-align: top"> <td style="font: 12pt Times New Roman, Times, Serif; width: 48px"><font style="font-size: 10pt">&#9679;</font></td> <td style="font: 12pt Times New Roman, Times, Serif"><font style="font-size: 10pt">Basis of presentation</font></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">These accompanying financial statements have been prepared in accordance with generally accepted accounting principles in the United States of America (&#8220;US GAAP&#8221;).</p> <table cellspacing="0" cellpadding="0" style="width: 100%"> <tr style="vertical-align: top"> <td style="font: 12pt Times New Roman, Times, Serif; width: 48px"><font style="font-size: 10pt">&#9679;</font></td> <td style="font: 12pt Times New Roman, Times, Serif; text-align: justify"><font style="font-size: 10pt">Basis of consolidation</font></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">In this Quarterly Report, &#8220;the Company,&#8221; &#8220;us&#8221; or &#8220;we&#8221; refer to the consolidated entity, including its subsidiaries and affiliates. The terms refer only to the publicly held holding company, The Bioplus Life Corporation, excluding its subsidiaries and affiliates. Furthermore, in which the Company has a variable interest have been consolidated where the Company is the primary beneficiary. All intercompany transactions and balances have been eliminated in consolidation.</p> <table cellspacing="0" cellpadding="0" style="width: 100%; border-collapse: collapse"> <tr style="vertical-align: top"> <td style="font: 12pt Times New Roman, Times, Serif; width: 48px"><font style="font-size: 10pt">&#9679;</font></td> <td style="font: 12pt Times New Roman, Times, Serif"><font style="font-size: 10pt">Use of estimates</font></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">In preparing these financial statements, management makes estimates and assumptions that affect the reported amounts of assets and liabilities in the balance sheets and revenues and expenses during the periods reported. Actual results may differ from these estimates.</p> <table cellspacing="0" cellpadding="0" style="width: 100%; border-collapse: collapse"> <tr style="vertical-align: top"> <td style="font: 12pt Times New Roman, Times, Serif; width: 48px"><font style="font-size: 10pt">&#9679;</font></td> <td style="font: 12pt Times New Roman, Times, Serif"><font style="font-size: 10pt">Cash and cash equivalents</font></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Cash and cash equivalents represent cash on hand, demand deposits placed with banks or other financial institutions and all highly liquid investments with an original maturity of three months or less as of the purchase date of such investments.</p> <table cellspacing="0" cellpadding="0" style="width: 100%; border-collapse: collapse"> <tr style="vertical-align: top"> <td style="font: 12pt Times New Roman, Times, Serif; width: 48px"><font style="font-size: 10pt">&#9679;</font></td> <td style="font: 12pt Times New Roman, Times, Serif"><font style="font-size: 10pt">Property, plant and equipment</font></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Property and plant and equipment are stated at cost less accumulated depreciation and accumulated impairment losses, if any. Depreciation is calculated on the straight-line basis to write off the cost over the following expected useful lives of the assets concerned. The principal annual rates used are as follows:</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td style="border-bottom: black 1.5pt solid"><font style="font-size: 10pt">Categories</font></td> <td style="padding-bottom: 1.5pt">&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt">Principal Annual Rates/Expected Useful Life</font></td> <td style="padding-bottom: 1.5pt">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="width: 76%"><font style="font-size: 10pt">Computer hardware</font></td> <td style="width: 1%">&#160;</td> <td style="width: 1%">&#160;</td> <td style="width: 21%; text-align: right"><font style="font-size: 10pt">20</font></td> <td style="width: 1%"><font style="font-size: 10pt">%</font></td></tr> <tr style="vertical-align: bottom; background-color: white"> <td><font style="font-size: 10pt">Furniture &#38; fittings</font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">10</font></td> <td><font style="font-size: 10pt">%</font></td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td><font style="font-size: 10pt">Handphone</font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">20</font></td> <td><font style="font-size: 10pt">%</font></td></tr> <tr style="vertical-align: bottom; background-color: white"> <td><font style="font-size: 10pt">Landscape</font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">20</font></td> <td><font style="font-size: 10pt">%</font></td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td><font style="font-size: 10pt">Leasehold land and building</font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">99 years</font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td><font style="font-size: 10pt">Machinery</font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">10</font></td> <td><font style="font-size: 10pt">%</font></td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td><font style="font-size: 10pt">Motor vehicle</font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">20</font></td> <td><font style="font-size: 10pt">%</font></td></tr> <tr style="vertical-align: bottom; background-color: white"> <td><font style="font-size: 10pt">Office equipment</font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">10</font></td> <td><font style="font-size: 10pt">%</font></td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td><font style="font-size: 10pt">Renovation</font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">20</font></td> <td><font style="font-size: 10pt">%</font></td></tr> <tr style="vertical-align: bottom; background-color: white"> <td><font style="font-size: 10pt">Signboard</font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">10</font></td> <td><font style="font-size: 10pt">%</font></td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td><font style="font-size: 10pt">Tools and equipment</font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">10</font></td> <td><font style="font-size: 10pt">%</font></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Kitchen utensils &#9; 10%</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Fully depreciated plant and equipment are retained in the financial statements until they are no longer in use.</p> <table cellspacing="0" cellpadding="0" style="width: 100%; border-collapse: collapse"> <tr style="vertical-align: top"> <td style="font: 12pt Times New Roman, Times, Serif; width: 48px"><font style="font-size: 10pt">&#9679;</font></td> <td style="font: 12pt Times New Roman, Times, Serif"><font style="font-size: 10pt">Inventories</font></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Inventories consisting of products available for sell, are stated at the lower of cost or market value. Cost of inventory is determined using the first-in, first-out (FIFO) method. Inventory reserve is recorded to write down the cost of inventory to the estimated market value due to slow-moving merchandise and damaged goods, which is dependent upon factors such as historical and forecasted consumer demand, and promotional environment. The Company takes ownership, risks and rewards of the products purchased. Write downs are recorded in cost of revenues in the Consolidated Statements of Operations and Comprehensive Income.</p> <table cellspacing="0" cellpadding="0" style="width: 100%; border-collapse: collapse"> <tr style="vertical-align: top"> <td style="font: 12pt Times New Roman, Times, Serif; width: 48px"><font style="font-size: 10pt">&#9679;</font></td> <td style="font: 12pt Times New Roman, Times, Serif"><font style="font-size: 10pt">Revenue recognition </font></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Revenues are recognized when control of the promised goods or services are transferred to a customer, in an amount that reflects the consideration that the Company expects to receive in exchange for those goods or services. The Company applies the following five steps in order to determine the appropriate amount of revenue to be recognized as it fulfills its obligations under each of its agreements:</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr> <td style="width: 24px; text-align: justify">&#160;</td> <td style="vertical-align: top; width: 24px; text-align: justify"><font style="font-size: 10pt">&#9679;</font></td> <td style="vertical-align: top; text-align: justify"><font style="font-size: 10pt">identify the contract with a customer;</font></td></tr> <tr> <td style="text-align: justify">&#160;</td> <td style="vertical-align: top; text-align: justify"><font style="font-size: 10pt">&#9679;</font></td> <td style="vertical-align: top; text-align: justify"><font style="font-size: 10pt">identify the performance obligations in the contract;</font></td></tr> <tr> <td style="text-align: justify">&#160;</td> <td style="vertical-align: top; text-align: justify"><font style="font-size: 10pt">&#9679;</font></td> <td style="vertical-align: top; text-align: justify"><font style="font-size: 10pt">determine the transaction price;</font></td></tr> <tr> <td style="text-align: justify">&#160;</td> <td style="vertical-align: top; text-align: justify"><font style="font-size: 10pt">&#9679;</font></td> <td style="vertical-align: top; text-align: justify"><font style="font-size: 10pt">allocate the transaction price to performance obligations in the contract; and</font></td></tr> <tr> <td style="text-align: justify">&#160;</td> <td style="vertical-align: top; text-align: justify"><font style="font-size: 10pt">&#9679;</font></td> <td style="vertical-align: top; text-align: justify"><font style="font-size: 10pt">recognize revenue as the performance obligation is satisfied.</font></td></tr> </table> <table cellspacing="0" cellpadding="0" style="width: 100%; border-collapse: collapse"> <tr style="vertical-align: top"> <td style="font: 12pt Times New Roman, Times, Serif; width: 48px"><font style="font-size: 10pt">&#9679;</font></td> <td style="font: 12pt Times New Roman, Times, Serif"><font style="font-size: 10pt">Cost of revenues</font></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Cost of revenue includes the purchase cost of retail goods for re-sale to customers and packing materials (such as boxes). It excludes purchasing and receiving costs, inspection costs, warehousing costs, internal transfer costs and other costs of distribution network in cost of revenues.</p> <table cellspacing="0" cellpadding="0" style="width: 100%; border-collapse: collapse"> <tr style="vertical-align: top"> <td style="font: 12pt Times New Roman, Times, Serif; width: 48px"><font style="font-size: 10pt">&#9679;</font></td> <td style="font: 12pt Times New Roman, Times, Serif"><font style="font-size: 10pt">Shipping and handling fees</font></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 27pt; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Shipping and handling fees, if billed to customers, are included in revenue. Shipping and handling fees associated with inbound and outbound freight are expensed as incurred and included in selling and distribution expenses.</p> <table cellspacing="0" cellpadding="0" style="width: 100%; border-collapse: collapse"> <tr style="vertical-align: top"> <td style="font: 12pt Times New Roman, Times, Serif; width: 48px"><font style="font-size: 10pt">&#9679;</font></td> <td style="font: 12pt Times New Roman, Times, Serif"><font style="font-size: 10pt">Comprehensive income</font></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">ASC Topic 220, &#8220;<i>Comprehensive Income</i>&#8221; establishes standards for reporting and display of comprehensive income, its components and accumulated balances. Comprehensive income as defined includes all changes in equity during a period from non-owner sources. Accumulated other comprehensive income, as presented in the accompanying statements of stockholders&#8217; equity consists of changes in unrealized gains and losses on foreign currency translation and cumulative net change in the fair value of available-for-sale investments held at the balance sheet date. This comprehensive income is not included in the computation of income tax expense or benefit.</p> <table cellspacing="0" cellpadding="0" style="width: 100%; border-collapse: collapse"> <tr style="vertical-align: top"> <td style="font: 12pt Times New Roman, Times, Serif; width: 48px"><font style="font-size: 10pt">&#9679;</font></td> <td style="font: 12pt Times New Roman, Times, Serif"><font style="font-size: 10pt">Income tax expense</font></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Income taxes are determined in accordance with the provisions of ASC Topic 740, &#8220;<i>Income Taxes</i>&#8221; (&#8220;ASC Topic 740&#8221;). Under this method, deferred tax assets and liabilities are recognized for the future tax consequences attributable to differences between the financial statement carrying amounts of existing assets and liabilities and their respective tax basis. Deferred tax assets and liabilities are measured using enacted income tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. Any effect on deferred tax assets and liabilities of a change in tax rates is recognized in income in the period that includes the enactment date.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">ASC 740 prescribes a comprehensive model for how companies should recognize, measure, present, and disclosed in their financial statements uncertain tax positions taken or expected to be taken on a tax return. Under ASC 740, tax positions must initially be recognized in the financial statements when it is more likely than not the position will be sustained upon examination by the tax authorities. Such tax positions must initially and subsequently be measured as the largest amount of tax benefit that has a greater than 50% likelihood of being realized upon ultimate settlement with the tax authority assuming full knowledge of the position and relevant facts.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company conducts major businesses in Malaysia and is subject to tax in their own jurisdictions. As a result of its business activities, the Company will file separate tax returns that are subject to examination by the foreign tax authorities.</p> <table cellspacing="0" cellpadding="0" style="width: 100%; border-collapse: collapse"> <tr style="vertical-align: top"> <td style="font: 12pt Times New Roman, Times, Serif; width: 48px"><font style="font-size: 10pt">&#9679;</font></td> <td style="font: 12pt Times New Roman, Times, Serif"><font style="font-size: 10pt">Related parties</font></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 27pt; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Parties, which can be a corporation or individual, are considered to be related if the Company has the ability, directly or indirectly, to control the other party or exercise significant influence over the other party in making financial and operating decisions. Companies are also considered to be related if they are subject to common control or common significant influence.</p> <table cellspacing="0" cellpadding="0" style="width: 100%; border-collapse: collapse"> <tr style="vertical-align: top"> <td style="font: 12pt Times New Roman, Times, Serif; width: 48px"><font style="font-size: 10pt">&#9679;</font></td> <td style="font: 12pt Times New Roman, Times, Serif"><font style="font-size: 10pt">Recent accounting pronouncements</font></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">Management has considered all recent accounting pronouncements issued since the last audit of our financial statements. The Company&#8217;s management believes that these recent pronouncements will not have a material effect on the Company&#8217;s financial statements.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The principal annual rates used are as follows:</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td style="border-bottom: black 1.5pt solid"><font style="font-size: 10pt">Categories</font></td> <td style="padding-bottom: 1.5pt">&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt">Principal Annual Rates/Expected Useful Life</font></td> <td style="padding-bottom: 1.5pt">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="width: 76%"><font style="font-size: 10pt">Computer hardware</font></td> <td style="width: 1%">&#160;</td> <td style="width: 1%">&#160;</td> <td style="width: 21%; text-align: right"><font style="font-size: 10pt">20</font></td> <td style="width: 1%"><font style="font-size: 10pt">%</font></td></tr> <tr style="vertical-align: bottom; background-color: white"> <td><font style="font-size: 10pt">Furniture &#38; fittings</font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">10</font></td> <td><font style="font-size: 10pt">%</font></td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td><font style="font-size: 10pt">Handphone</font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">20</font></td> <td><font style="font-size: 10pt">%</font></td></tr> <tr style="vertical-align: bottom; background-color: white"> <td><font style="font-size: 10pt">Landscape</font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">20</font></td> <td><font style="font-size: 10pt">%</font></td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td><font style="font-size: 10pt">Leasehold land and building</font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">99 years</font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td><font style="font-size: 10pt">Machinery</font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">10</font></td> <td><font style="font-size: 10pt">%</font></td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td><font style="font-size: 10pt">Motor vehicle</font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">20</font></td> <td><font style="font-size: 10pt">%</font></td></tr> <tr style="vertical-align: bottom; background-color: white"> <td><font style="font-size: 10pt">Office equipment</font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">10</font></td> <td><font style="font-size: 10pt">%</font></td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td><font style="font-size: 10pt">Renovation</font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">20</font></td> <td><font style="font-size: 10pt">%</font></td></tr> <tr style="vertical-align: bottom; background-color: white"> <td><font style="font-size: 10pt">Signboard</font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">10</font></td> <td><font style="font-size: 10pt">%</font></td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td><font style="font-size: 10pt">Tools and equipment</font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">10</font></td> <td><font style="font-size: 10pt">%</font></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Kitchen utensils &#9; 10%</p> <table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="padding-bottom: 1.5pt">&#160;</td> <td colspan="6" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt">As of</font></td> <td style="padding-bottom: 1.5pt">&#160;</td></tr> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="padding-bottom: 1.5pt">&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt">September 30, 2020</font></td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="padding-bottom: 1.5pt">&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt">December 31, 2019</font></td> <td style="padding-bottom: 1.5pt">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="width: 62%"><font style="font-size: 10pt">Raw material</font></td> <td style="width: 1%">&#160;</td> <td style="width: 1%"><font style="font-size: 10pt">$</font></td> <td style="width: 16%; text-align: right"><font style="font-size: 10pt">302,918</font></td> <td style="width: 1%">&#160;</td> <td style="width: 1%">&#160;</td> <td style="width: 1%"><font style="font-size: 10pt">$</font></td> <td style="width: 16%; text-align: right"><font style="font-size: 10pt">245,877</font></td> <td style="width: 1%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td><font style="font-size: 10pt">Packing Material</font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">27,294</font></td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">23,858</font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="padding-bottom: 1.5pt"><font style="font-size: 10pt">Finished goods</font></td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="border-bottom: black 1.5pt solid">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">27,314</font></td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="border-bottom: black 1.5pt solid">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">34,219</font></td> <td style="padding-bottom: 1.5pt">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="padding-bottom: 2.5pt"><font style="font-size: 10pt">Total inventories</font></td> <td style="padding-bottom: 2.5pt">&#160;</td> <td style="border-bottom: black 2.25pt double"><font style="font-size: 10pt">$</font></td> <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 10pt">357,526</font></td> <td style="padding-bottom: 2.5pt">&#160;</td> <td style="padding-bottom: 2.5pt">&#160;</td> <td style="border-bottom: black 2.25pt double"><font style="font-size: 10pt">$</font></td> <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 10pt">303,954</font></td> <td style="padding-bottom: 2.5pt">&#160;</td></tr> </table> <table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="padding-bottom: 1.5pt">&#160;</td> <td colspan="6" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt">As of</font></td> <td style="padding-bottom: 1.5pt">&#160;</td></tr> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="padding-bottom: 1.5pt">&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt">September 30, 2020</font></td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="padding-bottom: 1.5pt">&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt">December 31, 2019</font></td> <td style="padding-bottom: 1.5pt">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="width: 62%"><font style="font-size: 10pt">Other receivables</font></td> <td style="width: 1%">&#160;</td> <td style="width: 1%"><font style="font-size: 10pt">$</font></td> <td style="width: 16%; text-align: right"><font style="font-size: 10pt">12,970</font></td> <td style="width: 1%">&#160;</td> <td style="width: 1%">&#160;</td> <td style="width: 1%"><font style="font-size: 10pt">$</font></td> <td style="width: 16%; text-align: right"><font style="font-size: 10pt">9,981</font></td> <td style="width: 1%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td><font style="font-size: 10pt">Deposits</font></td> <td>&#160;</td> <td><font style="font-size: 10pt">5.1</font></td> <td style="text-align: right"><font style="font-size: 10pt">19,394</font></td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">63,308</font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="padding-bottom: 1.5pt"><font style="font-size: 10pt">Prepayments</font></td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="border-bottom: black 1.5pt solid"><font style="font-size: 10pt">5.2</font></td> <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">6,810</font></td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="border-bottom: black 1.5pt solid">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">59,771</font></td> <td style="padding-bottom: 1.5pt">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="padding-bottom: 2.5pt">&#160;</td> <td style="padding-bottom: 2.5pt">&#160;</td> <td style="border-bottom: black 2.25pt double"><font style="font-size: 10pt">$</font></td> <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 10pt">39,174</font></td> <td style="padding-bottom: 2.5pt">&#160;</td> <td style="padding-bottom: 2.5pt">&#160;</td> <td style="border-bottom: black 2.25pt double"><font style="font-size: 10pt">$</font></td> <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 10pt">133,060</font></td> <td style="padding-bottom: 2.5pt">&#160;</td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">5.1 The deposits of $ 19,394 (2019: $ 63,308) representing deposits paid for rental of hostels and various utilities.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 13.5pt; text-indent: -13.5pt">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">5.2 The prepayments of $ 6,810 (2019: $ 59,771) representing advanced payments made to suppliers for purchase of manufacturing materials.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Property, plant and equipment consisted of the following:</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td>&#160;</td> <td style="padding-bottom: 1.5pt">&#160;</td> <td colspan="6" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt">As of</font></td> <td style="padding-bottom: 1.5pt">&#160;</td></tr> <tr style="vertical-align: bottom"> <td>&#160;</td> <td style="padding-bottom: 1.5pt">&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt">September 30, 2020</font></td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="padding-bottom: 1.5pt">&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt">December 31, 2019</font></td> <td style="padding-bottom: 1.5pt">&#160;</td></tr> <tr style="vertical-align: bottom"> <td>&#160;</td> <td>&#160;</td> <td colspan="2">&#160;</td> <td>&#160;</td> <td>&#160;</td> <td colspan="2">&#160;</td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="width: 62%"><font style="font-size: 10pt">Computer hardware</font></td> <td style="width: 1%">&#160;</td> <td style="width: 1%"><font style="font-size: 10pt">$</font></td> <td style="width: 16%; text-align: right"><font style="font-size: 10pt">40,430</font></td> <td style="width: 1%">&#160;</td> <td style="width: 1%">&#160;</td> <td style="width: 1%"><font style="font-size: 10pt">$</font></td> <td style="width: 16%; text-align: right"><font style="font-size: 10pt">32,814</font></td> <td style="width: 1%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td><font style="font-size: 10pt">Furniture &#38; fittings</font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">112,198</font></td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">106,945</font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td><font style="font-size: 10pt">Handphone</font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">3,724</font></td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">3,514</font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td><font style="font-size: 10pt">Landscape</font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">3,691</font></td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">3,475</font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td><font style="font-size: 10pt">Leasehold land and building</font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">1,875,962</font></td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">1,872,476</font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td><font style="font-size: 10pt">Machinery</font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">175,677</font></td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">119,413</font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td><font style="font-size: 10pt">Motor vehicle</font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">243,630</font></td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">243,630</font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td><font style="font-size: 10pt">Office equipment</font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">59,123</font></td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">52,725</font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td><font style="font-size: 10pt">Renovation</font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">142,099</font></td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">92,646</font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td><font style="font-size: 10pt">Signboard</font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">5,470</font></td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">4,648</font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td><font style="font-size: 10pt">Tools and equipment</font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">6,930</font></td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">4,348</font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="padding-bottom: 1.5pt"><font style="font-size: 10pt">Kitchen utensils</font></td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="border-bottom: black 1.5pt solid">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">1,740</font></td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="border-bottom: black 1.5pt solid">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">-</font></td> <td style="padding-bottom: 1.5pt">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td>&#160;</td> <td>&#160;</td> <td><font style="font-size: 10pt">$</font></td> <td style="text-align: right"><font style="font-size: 10pt">2,670,674</font></td> <td>&#160;</td> <td>&#160;</td> <td><font style="font-size: 10pt">$</font></td> <td style="text-align: right"><font style="font-size: 10pt">2,536,634</font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td><font style="font-size: 10pt">(Less): Accumulated depreciation</font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">(412,814</font></td> <td><font style="font-size: 10pt">)</font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">(315,762</font></td> <td><font style="font-size: 10pt">)</font></td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="padding-bottom: 1.5pt"><font style="font-size: 10pt">Add/(Less): Foreign translation difference</font></td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="border-bottom: black 1.5pt solid">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">(35,678</font></td> <td style="padding-bottom: 1.5pt"><font style="font-size: 10pt">)</font></td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="border-bottom: black 1.5pt solid">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">(3,625</font></td> <td style="padding-bottom: 1.5pt"><font style="font-size: 10pt">)</font></td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="padding-bottom: 2.5pt"><font style="font-size: 10pt">Property, plant and equipment, net</font></td> <td style="padding-bottom: 2.5pt">&#160;</td> <td style="border-bottom: black 2.25pt double"><font style="font-size: 10pt">$</font></td> <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 10pt">2,222,182</font></td> <td style="padding-bottom: 2.5pt">&#160;</td> <td style="padding-bottom: 2.5pt">&#160;</td> <td style="border-bottom: black 2.25pt double"><font style="font-size: 10pt">$</font></td> <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 10pt">2,217,247</font></td> <td style="padding-bottom: 2.5pt">&#160;</td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The obligation under the finance leases are as follows:</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 27pt; text-align: justify">&#160;</p> <table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td style="text-align: justify">&#160;</td> <td style="padding-bottom: 1.5pt">&#160;</td> <td colspan="6" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt">As of</font></td> <td style="padding-bottom: 1.5pt">&#160;</td></tr> <tr style="vertical-align: bottom"> <td style="text-align: justify">&#160;</td> <td style="padding-bottom: 1.5pt">&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">September 30, 2020</font></td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="padding-bottom: 1.5pt">&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt">December 31, 2019</font></td> <td style="padding-bottom: 1.5pt">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="text-align: justify"><font style="font-size: 10pt"><b>Present value of hire purchase liabilities:</b></font></td> <td>&#160;</td> <td><font style="font-size: 10pt">$</font></td> <td style="text-align: right">&#160;</td> <td>&#160;</td> <td>&#160;</td> <td><font style="font-size: 10pt">$</font></td> <td style="text-align: right">&#160;</td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="width: 62%; text-align: justify"><font style="font-size: 10pt">Not later than one year</font></td> <td style="width: 1%">&#160;</td> <td style="width: 1%">&#160;</td> <td style="width: 16%; text-align: right"><font style="font-size: 10pt">31,632</font></td> <td style="width: 1%">&#160;</td> <td style="width: 1%">&#160;</td> <td style="width: 1%">&#160;</td> <td style="width: 16%; text-align: right"><font style="font-size: 10pt">33,343</font></td> <td style="width: 1%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="text-align: justify"><font style="font-size: 10pt">Later than one year but not later than two years</font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">32,097</font></td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">32,496</font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="padding-bottom: 1.5pt; text-align: justify"><font style="font-size: 10pt">Later than two years but not later than five years</font></td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="border-bottom: black 1.5pt solid">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">50,642</font></td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="border-bottom: black 1.5pt solid">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">59,637</font></td> <td style="padding-bottom: 1.5pt">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="padding-bottom: 2.5pt; text-align: justify">&#160;</td> <td style="padding-bottom: 2.5pt">&#160;</td> <td style="border-bottom: black 2.25pt double">&#160;</td> <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 10pt">114,371</font></td> <td style="padding-bottom: 2.5pt">&#160;</td> <td style="padding-bottom: 2.5pt">&#160;</td> <td style="border-bottom: black 2.25pt double">&#160;</td> <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 10pt">125,476</font></td> <td style="padding-bottom: 2.5pt">&#160;</td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p> <table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td style="text-align: justify">&#160;</td> <td style="padding-bottom: 1.5pt">&#160;</td> <td colspan="6" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt">As Of</font></td> <td style="padding-bottom: 1.5pt">&#160;</td></tr> <tr style="vertical-align: bottom"> <td>&#160;</td> <td style="padding-bottom: 1.5pt">&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt">September 30, 2020</font></td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="padding-bottom: 1.5pt">&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt">December 31, 2019</font></td> <td style="padding-bottom: 1.5pt">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="text-align: justify"><font style="font-size: 10pt"><b>Analyzed as:</b></font></td> <td>&#160;</td> <td><font style="font-size: 10pt">$</font></td> <td style="text-align: right">&#160;</td> <td>&#160;</td> <td>&#160;</td> <td><font style="font-size: 10pt">$</font></td> <td style="text-align: right">&#160;</td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="width: 62%; text-align: justify"><font style="font-size: 10pt">Current portion</font></td> <td style="width: 1%">&#160;</td> <td style="width: 1%">&#160;</td> <td style="width: 16%; text-align: right"><font style="font-size: 10pt">31,632</font></td> <td style="width: 1%">&#160;</td> <td style="width: 1%">&#160;</td> <td style="width: 1%">&#160;</td> <td style="width: 16%; text-align: right"><font style="font-size: 10pt">33,343</font></td> <td style="width: 1%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="padding-bottom: 1.5pt; text-align: justify"><font style="font-size: 10pt">Non-current portion</font></td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="border-bottom: black 1.5pt solid">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">82,739</font></td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="border-bottom: black 1.5pt solid">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">92,133</font></td> <td style="padding-bottom: 1.5pt">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="padding-bottom: 2.5pt; text-align: justify">&#160;</td> <td style="padding-bottom: 2.5pt">&#160;</td> <td style="border-bottom: black 2.25pt double">&#160;</td> <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 10pt">114,371</font></td> <td style="padding-bottom: 2.5pt">&#160;</td> <td style="padding-bottom: 2.5pt">&#160;</td> <td style="border-bottom: black 2.25pt double">&#160;</td> <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 10pt">125,476</font></td> <td style="padding-bottom: 2.5pt">&#160;</td></tr> </table> <table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="padding-bottom: 1.5pt">&#160;</td> <td colspan="6" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt">As of</font></td> <td style="padding-bottom: 1.5pt">&#160;</td></tr> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="padding-bottom: 1.5pt">&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt">September 30, 2020</font></td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="padding-bottom: 1.5pt">&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt">December 31, 2019</font></td> <td style="padding-bottom: 1.5pt">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td><font style="font-size: 10pt"><b>Secured: -</b></font></td> <td>&#160;</td> <td colspan="2"><font style="font-size: 10pt">$</font></td> <td>&#160;</td> <td>&#160;</td> <td colspan="2"><font style="font-size: 10pt">$</font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="width: 62%"><font style="font-size: 10pt">Bank overdraft</font></td> <td style="width: 1%">&#160;</td> <td style="width: 1%">&#160;</td> <td style="width: 16%; text-align: right"><font style="font-size: 10pt">72,173</font></td> <td style="width: 1%">&#160;</td> <td style="width: 1%">&#160;</td> <td style="width: 1%">&#160;</td> <td style="width: 16%; text-align: right"><font style="font-size: 10pt">141,520</font></td> <td style="width: 1%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="padding-bottom: 1.5pt"><font style="font-size: 10pt">Term loan</font></td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="border-bottom: black 1.5pt solid">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">589,789</font></td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="border-bottom: black 1.5pt solid">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">606,651</font></td> <td style="padding-bottom: 1.5pt">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="padding-bottom: 2.5pt">&#160;</td> <td style="padding-bottom: 2.5pt">&#160;</td> <td style="border-bottom: black 2.25pt double">&#160;</td> <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 10pt">661,962</font></td> <td style="padding-bottom: 2.5pt">&#160;</td> <td style="padding-bottom: 2.5pt">&#160;</td> <td style="border-bottom: black 2.25pt double">&#160;</td> <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 10pt">748,171</font></td> <td style="padding-bottom: 2.5pt">&#160;</td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p> <table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="padding-bottom: 1.5pt">&#160;</td> <td colspan="6" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt">As of</font></td> <td style="padding-bottom: 1.5pt">&#160;</td></tr> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="padding-bottom: 1.5pt">&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt">September 30, 2020</font></td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="padding-bottom: 1.5pt">&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt">December 31, 2019</font></td> <td style="padding-bottom: 1.5pt">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td><font style="font-size: 10pt"><b>Analyzed as:</b></font></td> <td>&#160;</td> <td colspan="2"><font style="font-size: 10pt">$</font></td> <td>&#160;</td> <td>&#160;</td> <td colspan="2"><font style="font-size: 10pt">$</font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="width: 62%"><font style="font-size: 10pt">Current portion</font></td> <td style="width: 1%">&#160;</td> <td style="width: 1%">&#160;</td> <td style="width: 16%; text-align: right"><font style="font-size: 10pt">111,302</font></td> <td style="width: 1%">&#160;</td> <td style="width: 1%">&#160;</td> <td style="width: 1%">&#160;</td> <td style="width: 16%; text-align: right"><font style="font-size: 10pt">195,027</font></td> <td style="width: 1%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="padding-bottom: 1.5pt"><font style="font-size: 10pt">Non-current portion</font></td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="border-bottom: black 1.5pt solid">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">550,660</font></td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="border-bottom: black 1.5pt solid">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">553,144</font></td> <td style="padding-bottom: 1.5pt">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="padding-bottom: 2.5pt">&#160;</td> <td style="padding-bottom: 2.5pt">&#160;</td> <td style="border-bottom: black 2.25pt double"><font style="font-size: 10pt">$</font></td> <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 10pt">661,962</font></td> <td style="padding-bottom: 2.5pt">&#160;</td> <td style="padding-bottom: 2.5pt">&#160;</td> <td style="border-bottom: black 2.25pt double"><font style="font-size: 10pt">$</font></td> <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 10pt">748,171</font></td> <td style="padding-bottom: 2.5pt">&#160;</td></tr> </table> <table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="padding-bottom: 1.5pt">&#160;</td> <td colspan="6" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt">As of</font></td> <td style="padding-bottom: 1.5pt">&#160;</td></tr> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="padding-bottom: 1.5pt">&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt">September 30, 2020</font></td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="padding-bottom: 1.5pt">&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt">December 31, 2019</font></td> <td style="padding-bottom: 1.5pt">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td><font style="font-size: 10pt">Other payables generated from:</font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">$ </font></td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">$ </font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="width: 62%; padding-left: 10pt"><font style="font-size: 10pt">Local</font></td> <td style="width: 1%">&#160;</td> <td style="width: 1%">&#160;</td> <td style="width: 16%; text-align: right"><font style="font-size: 10pt">5,262</font></td> <td style="width: 1%">&#160;</td> <td style="width: 1%">&#160;</td> <td style="width: 1%">&#160;</td> <td style="width: 16%; text-align: right"><font style="font-size: 10pt">41,645</font></td> <td style="width: 1%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="padding-left: 10pt"><font style="font-size: 10pt">Foreign, representing:</font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right">&#160;</td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right">&#160;</td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="padding-left: 20pt"><font style="font-size: 10pt">Malaysia</font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">-</font></td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">-</font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="padding-left: 30pt"><font style="font-size: 10pt">Common outstanding from non-trade payable</font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">36,562</font></td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">37,110</font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="padding-left: 30pt"><font style="font-size: 10pt">Common outstanding from third parties</font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">827</font></td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">1,004</font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="padding-left: 20pt"><font style="font-size: 10pt">China</font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">-</font></td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">-</font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="padding-bottom: 1.5pt; padding-left: 30pt"><font style="font-size: 10pt">Common outstanding from third parties</font></td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="border-bottom: black 1.5pt solid">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">147</font></td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="border-bottom: black 1.5pt solid">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">861</font></td> <td style="padding-bottom: 1.5pt">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td>&#160;</td> <td>&#160;</td> <td><font style="font-size: 10pt">$</font></td> <td style="text-align: right"><font style="font-size: 10pt">42,798</font></td> <td>&#160;</td> <td>&#160;</td> <td><font style="font-size: 10pt">$</font></td> <td style="text-align: right"><font style="font-size: 10pt">80,620</font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right">&#160;</td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right">&#160;</td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td><font style="font-size: 10pt">Accrued other expenses</font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right">&#160;</td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right">&#160;</td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="padding-left: 10pt"><font style="font-size: 10pt">Local</font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right">&#160;</td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right">&#160;</td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="padding-left: 10pt"><font style="font-size: 10pt">Foreign, representing:</font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right">&#160;</td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right">&#160;</td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="padding-left: 20pt"><font style="font-size: 10pt">Malaysia</font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right">&#160;</td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right">&#160;</td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="padding-left: 30pt"><font style="font-size: 10pt">Payroll</font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">23,640</font></td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">18,550</font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="padding-left: 30pt"><font style="font-size: 10pt">Payroll deduction</font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">8,961</font></td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">7,873</font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="padding-left: 30pt"><font style="font-size: 10pt">Professional Fee</font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">1,619</font></td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">11,499</font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="padding-left: 30pt"><font style="font-size: 10pt">Commission</font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">37,255</font></td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">43,563</font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="padding-bottom: 1.5pt; padding-left: 30pt"><font style="font-size: 10pt">Expenses</font></td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="border-bottom: black 1.5pt solid">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">787</font></td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="border-bottom: black 1.5pt solid">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">1,157</font></td> <td style="padding-bottom: 1.5pt">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td>&#160;</td> <td>&#160;</td> <td><font style="font-size: 10pt">$</font></td> <td style="text-align: right"><font style="font-size: 10pt">72,262</font></td> <td>&#160;</td> <td>&#160;</td> <td><font style="font-size: 10pt">$</font></td> <td style="text-align: right"><font style="font-size: 10pt">82,642</font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="padding-left: 20pt"><font style="font-size: 10pt">Hong Kong</font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">-</font></td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">-</font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right">&#160;</td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right">&#160;</td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td><font style="font-size: 10pt">Deposit received from customers</font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">285,663</font></td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">226,783</font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right">&#160;</td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right">&#160;</td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="padding-bottom: 1.5pt"><font style="font-size: 10pt">Share subscription receipts in advance</font></td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="border-bottom: black 1.5pt solid">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">110,000</font></td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="border-bottom: black 1.5pt solid">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">104,000</font></td> <td style="padding-bottom: 1.5pt">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="padding-bottom: 2.5pt">&#160;</td> <td style="padding-bottom: 2.5pt">&#160;</td> <td style="border-bottom: black 2.25pt double"><font style="font-size: 10pt">$</font></td> <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 10pt">510,723</font></td> <td style="padding-bottom: 2.5pt">&#160;</td> <td style="padding-bottom: 2.5pt">&#160;</td> <td style="border-bottom: black 2.25pt double"><font style="font-size: 10pt">$</font></td> <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 10pt">494,045</font></td> <td style="padding-bottom: 2.5pt">&#160;</td></tr> </table> <table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td>&#160;</td> <td style="padding-bottom: 1.5pt">&#160;</td> <td colspan="6" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt">As of</font></td> <td style="padding-bottom: 1.5pt">&#160;</td></tr> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="padding-bottom: 1.5pt">&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt">September 30, 2020</font></td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="padding-bottom: 1.5pt">&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt">December 31, 2019</font></td> <td style="padding-bottom: 1.5pt">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td><font style="font-size: 10pt">Issued and fully paid:</font></td> <td>&#160;</td> <td><font style="font-size: 10pt">$</font></td> <td style="text-align: right">&#160;</td> <td>&#160;</td> <td>&#160;</td> <td><font style="font-size: 10pt">$</font></td> <td style="text-align: right">&#160;</td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right">&#160;</td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right">&#160;</td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="width: 62%"><font style="font-size: 10pt">At the beginning of the period</font></td> <td style="width: 1%">&#160;</td> <td style="width: 1%">&#160;</td> <td style="width: 16%; text-align: right"><font style="font-size: 10pt">2,034,801</font></td> <td style="width: 1%">&#160;</td> <td style="width: 1%">&#160;</td> <td style="width: 1%">&#160;</td> <td style="width: 16%; text-align: right"><font style="font-size: 10pt">2,034,801</font></td> <td style="width: 1%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="padding-bottom: 1.5pt"><font style="font-size: 10pt">Issued during the period</font></td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="border-bottom: black 1.5pt solid">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">360</font></td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="border-bottom: black 1.5pt solid">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">-</font></td> <td style="padding-bottom: 1.5pt">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right">&#160;</td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right">&#160;</td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="padding-bottom: 1.5pt"><font style="font-size: 10pt">At the end of the period</font></td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="border-bottom: black 1.5pt solid"><font style="font-size: 10pt">$</font></td> <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">2,035,161</font></td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="border-bottom: black 1.5pt solid"><font style="font-size: 10pt">$</font></td> <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">2,034,801</font></td> <td style="padding-bottom: 1.5pt">&#160;</td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">(a) Major Customers</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">For the three months ended September 30, 2020 and 2019, the customers who accounted for 10% or more of the Company&#8217;s revenues and its accounts receivable at period-end are presented as follows:</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p> <table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="padding-bottom: 1.5pt">&#160;</td> <td colspan="6" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt">Revenues</font></td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="padding-bottom: 1.5pt">&#160;</td> <td colspan="6" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt">Percentage of revenues</font></td> <td style="padding-bottom: 1.5pt">&#160;</td></tr> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="padding-bottom: 1.5pt">&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt">2020</font></td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="padding-bottom: 1.5pt">&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt">2019</font></td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="padding-bottom: 1.5pt">&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt">2020</font></td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="padding-bottom: 1.5pt">&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt">2019</font></td> <td style="padding-bottom: 1.5pt">&#160;</td></tr> <tr style="vertical-align: bottom"> <td>&#160;</td> <td>&#160;</td> <td colspan="2">&#160;</td> <td>&#160;</td> <td>&#160;</td> <td colspan="2">&#160;</td> <td>&#160;</td> <td>&#160;</td> <td colspan="2">&#160;</td> <td>&#160;</td> <td>&#160;</td> <td colspan="2">&#160;</td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="width: 44%"><font style="font-size: 10pt">Customer A</font></td> <td style="width: 1%">&#160;</td> <td style="width: 1%"><font style="font-size: 10pt">$</font></td> <td style="width: 11%; text-align: right"><font style="font-size: 10pt">-</font></td> <td style="width: 1%">&#160;</td> <td style="width: 1%">&#160;</td> <td style="width: 1%"><font style="font-size: 10pt">$</font></td> <td style="width: 11%; text-align: right"><font style="font-size: 10pt">55,257</font></td> <td style="width: 1%">&#160;</td> <td style="width: 1%">&#160;</td> <td style="width: 1%">&#160;</td> <td style="width: 11%; text-align: right"><font style="font-size: 10pt">-</font></td> <td style="width: 1%">&#160;</td> <td style="width: 1%">&#160;</td> <td style="width: 1%">&#160;</td> <td style="width: 11%; text-align: right"><font style="font-size: 10pt">12</font></td> <td style="width: 1%"><font style="font-size: 10pt">%</font></td></tr> <tr style="vertical-align: bottom; background-color: white"> <td><font style="font-size: 10pt">Customer B</font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">152,423</font></td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">53,979</font></td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">15</font></td> <td><font style="font-size: 10pt">%</font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">12</font></td> <td><font style="font-size: 10pt">%</font></td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="padding-bottom: 1.5pt"><font style="font-size: 10pt">Customer C</font></td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="border-bottom: black 1.5pt solid">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">369,623</font></td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="border-bottom: black 1.5pt solid">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">-</font></td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">37</font></td> <td style="padding-bottom: 1.5pt"><font style="font-size: 10pt">%</font></td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">-</font></td> <td style="padding-bottom: 1.5pt">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right">&#160;</td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right">&#160;</td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right">&#160;</td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right">&#160;</td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="padding-bottom: 2.5pt">&#160;</td> <td style="padding-bottom: 2.5pt">&#160;</td> <td style="border-bottom: black 2.25pt double"><font style="font-size: 10pt">$</font></td> <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 10pt">522,046</font></td> <td style="padding-bottom: 2.5pt">&#160;</td> <td style="padding-bottom: 2.5pt">&#160;</td> <td style="border-bottom: black 2.25pt double"><font style="font-size: 10pt">$</font></td> <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 10pt">109,236</font></td> <td style="padding-bottom: 2.5pt">&#160;</td> <td style="padding-bottom: 2.5pt">&#160;</td> <td style="padding-bottom: 2.5pt">&#160;</td> <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 10pt">52</font></td> <td style="padding-bottom: 2.5pt"><font style="font-size: 10pt">%</font></td> <td style="padding-bottom: 2.5pt">&#160;</td> <td style="padding-bottom: 2.5pt">&#160;</td> <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 10pt">24</font></td> <td style="padding-bottom: 2.5pt"><font style="font-size: 10pt">%</font></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">For the nine months ended September 30, 2020 and 2019, the customers who accounted for 10% or more of the Company&#8217;s revenues and its accounts receivable at period-end are presented as follows:</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p> <table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1.5pt; text-align: center">&#160;</td> <td style="padding-bottom: 1.5pt; text-align: center">&#160;</td> <td colspan="6" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt">Revenues</font></td> <td style="padding-bottom: 1.5pt; text-align: center">&#160;</td> <td style="padding-bottom: 1.5pt; text-align: center">&#160;</td> <td colspan="6" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt">Percentage of revenues</font></td> <td style="padding-bottom: 1.5pt; text-align: center">&#160;</td></tr> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1.5pt; text-align: center">&#160;</td> <td style="padding-bottom: 1.5pt; text-align: center">&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt">2020</font></td> <td style="padding-bottom: 1.5pt; text-align: center">&#160;</td> <td style="padding-bottom: 1.5pt; text-align: center">&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt">2019</font></td> <td style="padding-bottom: 1.5pt; text-align: center">&#160;</td> <td style="padding-bottom: 1.5pt; text-align: center">&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt">2020</font></td> <td style="padding-bottom: 1.5pt; text-align: center">&#160;</td> <td style="padding-bottom: 1.5pt; text-align: center">&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt">2019</font></td> <td style="padding-bottom: 1.5pt; text-align: center">&#160;</td></tr> <tr style="vertical-align: bottom"> <td>&#160;</td> <td>&#160;</td> <td colspan="2">&#160;</td> <td>&#160;</td> <td>&#160;</td> <td colspan="2">&#160;</td> <td>&#160;</td> <td>&#160;</td> <td colspan="2">&#160;</td> <td>&#160;</td> <td>&#160;</td> <td colspan="2">&#160;</td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="width: 44%"><font style="font-size: 10pt">Customer A</font></td> <td style="width: 1%">&#160;</td> <td style="width: 1%"><font style="font-size: 10pt">$</font></td> <td style="width: 11%; text-align: right"><font style="font-size: 10pt">138,771</font></td> <td style="width: 1%">&#160;</td> <td style="width: 1%">&#160;</td> <td style="width: 1%"><font style="font-size: 10pt">$</font></td> <td style="width: 11%; text-align: right"><font style="font-size: 10pt">153,195</font></td> <td style="width: 1%">&#160;</td> <td style="width: 1%">&#160;</td> <td style="width: 1%">&#160;</td> <td style="width: 11%; text-align: right"><font style="font-size: 10pt">5</font></td> <td style="width: 1%"><font style="font-size: 10pt">%</font></td> <td style="width: 1%">&#160;</td> <td style="width: 1%">&#160;</td> <td style="width: 11%; text-align: right"><font style="font-size: 10pt">12</font></td> <td style="width: 1%"><font style="font-size: 10pt">%</font></td></tr> <tr style="vertical-align: bottom; background-color: white"> <td><font style="font-size: 10pt">Customer B</font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">964,146</font></td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">49,515</font></td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">39</font></td> <td><font style="font-size: 10pt">%</font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">4</font></td> <td><font style="font-size: 10pt">%</font></td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="border-bottom: black 1.5pt solid">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: right">&#160;</td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="border-bottom: black 1.5pt solid">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: right">&#160;</td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: right">&#160;</td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: right">&#160;</td> <td style="padding-bottom: 1.5pt">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="padding-bottom: 2.5pt">&#160;</td> <td style="padding-bottom: 2.5pt">&#160;</td> <td style="border-bottom: black 2.25pt double"><font style="font-size: 10pt">$</font></td> <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 10pt">1,102,917</font></td> <td style="padding-bottom: 2.5pt">&#160;</td> <td style="padding-bottom: 2.5pt">&#160;</td> <td style="border-bottom: black 2.25pt double"><font style="font-size: 10pt">$</font></td> <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 10pt">202,710</font></td> <td style="padding-bottom: 2.5pt">&#160;</td> <td style="padding-bottom: 2.5pt">&#160;</td> <td style="padding-bottom: 2.5pt">&#160;</td> <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 10pt">44</font></td> <td style="padding-bottom: 2.5pt"><font style="font-size: 10pt">%</font></td> <td style="padding-bottom: 2.5pt">&#160;</td> <td style="padding-bottom: 2.5pt">&#160;</td> <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 10pt">16</font></td> <td style="padding-bottom: 2.5pt"><font style="font-size: 10pt">%</font></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">(b) Major Suppliers</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">For the three months ended September 30, 2020 and 2019, there was no supplier who accounted for 10% or more of the Company&#8217;s purchases nor with significant outstanding payables.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p> <table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="padding-bottom: 1.5pt">&#160;</td> <td colspan="6" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt">Revenues</font></td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="padding-bottom: 1.5pt">&#160;</td> <td colspan="6" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt">Percentage of revenues</font></td> <td style="padding-bottom: 1.5pt">&#160;</td></tr> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="padding-bottom: 1.5pt">&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt">2020</font></td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="padding-bottom: 1.5pt">&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt">2019</font></td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="padding-bottom: 1.5pt">&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt">2020</font></td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="padding-bottom: 1.5pt">&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt">2019</font></td> <td style="padding-bottom: 1.5pt">&#160;</td></tr> <tr style="vertical-align: bottom"> <td>&#160;</td> <td>&#160;</td> <td colspan="2">&#160;</td> <td>&#160;</td> <td>&#160;</td> <td colspan="2">&#160;</td> <td>&#160;</td> <td>&#160;</td> <td colspan="2">&#160;</td> <td>&#160;</td> <td>&#160;</td> <td colspan="2">&#160;</td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="width: 44%"><font style="font-size: 10pt">Supplier A</font></td> <td style="width: 1%">&#160;</td> <td style="width: 1%"><font style="font-size: 10pt">$</font></td> <td style="width: 11%; text-align: right"><font style="font-size: 10pt">352,297</font></td> <td style="width: 1%">&#160;</td> <td style="width: 1%">&#160;</td> <td style="width: 1%"><font style="font-size: 10pt">$</font></td> <td style="width: 11%; text-align: right"><font style="font-size: 10pt">93,455</font></td> <td style="width: 1%">&#160;</td> <td style="width: 1%">&#160;</td> <td style="width: 1%">&#160;</td> <td style="width: 11%; text-align: right"><font style="font-size: 10pt">64</font></td> <td style="width: 1%"><font style="font-size: 10pt">%</font></td> <td style="width: 1%">&#160;</td> <td style="width: 1%">&#160;</td> <td style="width: 11%; text-align: right"><font style="font-size: 10pt">88</font></td> <td style="width: 1%"><font style="font-size: 10pt">%</font></td></tr> <tr style="vertical-align: bottom; background-color: white"> <td><font style="font-size: 10pt">Supplier B</font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">99,328</font></td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">-</font></td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">18</font></td> <td><font style="font-size: 10pt">%</font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">-</font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="padding-bottom: 1.5pt"><font style="font-size: 10pt">Supplier C</font></td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="border-bottom: black 1.5pt solid">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">65,418</font></td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="border-bottom: black 1.5pt solid">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">-</font></td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">12</font></td> <td style="padding-bottom: 1.5pt"><font style="font-size: 10pt">%</font></td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">-</font></td> <td style="padding-bottom: 1.5pt">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right">&#160;</td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right">&#160;</td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right">&#160;</td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right">&#160;</td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="padding-bottom: 2.5pt">&#160;</td> <td style="padding-bottom: 2.5pt">&#160;</td> <td style="border-bottom: black 2.25pt double"><font style="font-size: 10pt">$</font></td> <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 10pt">517,043</font></td> <td style="padding-bottom: 2.5pt">&#160;</td> <td style="padding-bottom: 2.5pt">&#160;</td> <td style="border-bottom: black 2.25pt double"><font style="font-size: 10pt">$</font></td> <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 10pt">93,455</font></td> <td style="padding-bottom: 2.5pt">&#160;</td> <td style="padding-bottom: 2.5pt">&#160;</td> <td style="padding-bottom: 2.5pt">&#160;</td> <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 10pt">94</font></td> <td style="padding-bottom: 2.5pt"><font style="font-size: 10pt">%</font></td> <td style="padding-bottom: 2.5pt">&#160;</td> <td style="padding-bottom: 2.5pt">&#160;</td> <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 10pt">88</font></td> <td style="padding-bottom: 2.5pt"><font style="font-size: 10pt">%</font></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">For the nine months ended September 30, 2020 and 2019, there was no supplier who accounted for 10% or more of the Company&#8217;s purchases nor with significant outstanding payables.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p> <table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="padding-bottom: 1.5pt">&#160;</td> <td colspan="6" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt">Revenues</font></td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="padding-bottom: 1.5pt">&#160;</td> <td colspan="6" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt">Percentage of revenues</font></td> <td style="padding-bottom: 1.5pt">&#160;</td></tr> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="padding-bottom: 1.5pt">&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt">2020</font></td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="padding-bottom: 1.5pt">&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt">2019</font></td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="padding-bottom: 1.5pt">&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt">2020</font></td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="padding-bottom: 1.5pt">&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt">2019</font></td> <td style="padding-bottom: 1.5pt">&#160;</td></tr> <tr style="vertical-align: bottom"> <td>&#160;</td> <td>&#160;</td> <td colspan="2">&#160;</td> <td>&#160;</td> <td>&#160;</td> <td colspan="2">&#160;</td> <td>&#160;</td> <td>&#160;</td> <td colspan="2">&#160;</td> <td>&#160;</td> <td>&#160;</td> <td colspan="2">&#160;</td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="width: 44%"><font style="font-size: 10pt">Supplier A</font></td> <td style="width: 1%">&#160;</td> <td style="width: 1%"><font style="font-size: 10pt">$</font></td> <td style="width: 11%; text-align: right"><font style="font-size: 10pt">633,555</font></td> <td style="width: 1%">&#160;</td> <td style="width: 1%">&#160;</td> <td style="width: 1%"><font style="font-size: 10pt">$</font></td> <td style="width: 11%; text-align: right"><font style="font-size: 10pt">267,081</font></td> <td style="width: 1%">&#160;</td> <td style="width: 1%">&#160;</td> <td style="width: 1%">&#160;</td> <td style="width: 11%; text-align: right"><font style="font-size: 10pt">58</font></td> <td style="width: 1%"><font style="font-size: 10pt">%</font></td> <td style="width: 1%">&#160;</td> <td style="width: 1%">&#160;</td> <td style="width: 11%; text-align: right"><font style="font-size: 10pt">88</font></td> <td style="width: 1%"><font style="font-size: 10pt">%</font></td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="padding-bottom: 1.5pt"><font style="font-size: 10pt">Supplier B</font></td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="border-bottom: black 1.5pt solid">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">250,203</font></td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="border-bottom: black 1.5pt solid">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">16,308</font></td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">23</font></td> <td style="padding-bottom: 1.5pt"><font style="font-size: 10pt">%</font></td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">5</font></td> <td style="padding-bottom: 1.5pt"><font style="font-size: 10pt">%</font></td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right">&#160;</td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right">&#160;</td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right">&#160;</td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right">&#160;</td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="padding-bottom: 2.5pt">&#160;</td> <td style="padding-bottom: 2.5pt">&#160;</td> <td style="border-bottom: black 2.25pt double"><font style="font-size: 10pt">$</font></td> <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 10pt">883,758</font></td> <td style="padding-bottom: 2.5pt">&#160;</td> <td style="padding-bottom: 2.5pt">&#160;</td> <td style="border-bottom: black 2.25pt double"><font style="font-size: 10pt">$</font></td> <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 10pt">283,389</font></td> <td style="padding-bottom: 2.5pt">&#160;</td> <td style="padding-bottom: 2.5pt">&#160;</td> <td style="padding-bottom: 2.5pt">&#160;</td> <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 10pt">81</font></td> <td style="padding-bottom: 2.5pt"><font style="font-size: 10pt">%</font></td> <td style="padding-bottom: 2.5pt">&#160;</td> <td style="padding-bottom: 2.5pt">&#160;</td> <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 10pt">93</font></td> <td style="padding-bottom: 2.5pt"><font style="font-size: 10pt">%</font></td></tr> </table> <table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="padding-bottom: 1.5pt">&#160;</td> <td colspan="6" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt">Nine months ended</font></td> <td style="padding-bottom: 1.5pt">&#160;</td></tr> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="padding-bottom: 1.5pt">&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt">2020</font></td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="padding-bottom: 1.5pt">&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt">2019</font></td> <td style="padding-bottom: 1.5pt">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="width: 62%"><font style="font-size: 10pt">Other income</font></td> <td style="width: 1%">&#160;</td> <td style="width: 1%"><font style="font-size: 10pt">$</font></td> <td style="width: 16%; text-align: right"><font style="font-size: 10pt">192</font></td> <td style="width: 1%">&#160;</td> <td style="width: 1%">&#160;</td> <td style="width: 1%"><font style="font-size: 10pt">$</font></td> <td style="width: 16%; text-align: right"><font style="font-size: 10pt">77</font></td> <td style="width: 1%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="padding-bottom: 1.5pt"><font style="font-size: 10pt">Realized gain on foreign exchange</font></td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="border-bottom: black 1.5pt solid">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">1,999</font></td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="border-bottom: black 1.5pt solid">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">3,323</font></td> <td style="padding-bottom: 1.5pt">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="padding-bottom: 2.5pt">&#160;</td> <td style="padding-bottom: 2.5pt">&#160;</td> <td style="border-bottom: black 2.25pt double"><font style="font-size: 10pt">$</font></td> <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 10pt">2,191</font></td> <td style="padding-bottom: 2.5pt">&#160;</td> <td style="padding-bottom: 2.5pt">&#160;</td> <td style="border-bottom: black 2.25pt double"><font style="font-size: 10pt">$</font></td> <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 10pt">3,400</font></td> <td style="padding-bottom: 2.5pt">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right">&#160;</td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right">&#160;</td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="padding-bottom: 2.5pt"><font style="font-size: 10pt">Gain on disposal of subsidiary</font></td> <td style="padding-bottom: 2.5pt">&#160;</td> <td style="border-bottom: black 2.25pt double"><font style="font-size: 10pt">$</font></td> <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 10pt">17,505</font></td> <td style="padding-bottom: 2.5pt">&#160;</td> <td style="padding-bottom: 2.5pt">&#160;</td> <td style="border-bottom: black 2.25pt double"><font style="font-size: 10pt">$</font></td> <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 10pt">1,099</font></td> <td style="padding-bottom: 2.5pt">&#160;</td></tr> </table> 1.00 1.00 1.00 0.998 Malaysia, Labuan Hong Kong Malaysia Malaysia, Selangor Shenzhen 2017-05-19 2017-06-20 2016-05-19 2009-08-27 2017-10-27 1 1 1 1 1 Investment Holding Investment Holding Investment Holding Trading of Consumer Products Trading of Healthy Supplement and Cosmetics 1 0.20 0.10 0.20 0.20 0.10 0.20 0.10 0.20 0.10 0.10 0.10 P99Y 4.1585 4.1349 4.2038 4.1870 0.1473 0.1454 0.1446 0.1471 302918 245877 27294 23858 27314 34219 12970 9981 19394 63308 6810 59771 6810 59771 2670674 2536634 243630 1872476 32814 106945 3514 3475 119413 52725 92646 4648 4348 243630 1875962 40430 112198 3724 3691 175677 59123 142099 5470 6930 101385 129925 1740 412814 315762 35678 3625 5.22 2.48 4.31 31632 33343 32097 32496 50642 59637 114371 125476 377277 1705086 579171 2842719 Master Facility Agreement. Joint and Several Guarantee to be executed by the subsidiary directors of Bio Life Neutraceuticals Sdn Bhd. Master Facility Agreement. Joint and Several Guarantee to be executed by the subsidiary directors of Bio Life Neutraceuticals Sdn Bhd. 0.04 0.04 0.04 The term loan is payable by 240 monthly installments 4492 18248 661962 748171 141520 606651 72173 589789 41645 5262 37110 36562 42798 80620 1004 861 827 147 18550 23640 7873 8961 11499 1619 43563 37255 1157 787 82642 72262 226783 285663 110000 104000 461206 Begin to expire in 2039 4896 0.25 0.24 0.165 -58232 -36326 -1054 392990 -17775 47020 -1859 -1469 315929 7366 2035161 2034801 2034801 138771 55257 152423 53979 522046 109236 153195 964146 49515 1102917 202710 352297 93455 99328 93455 517043 633555 267081 16308 65418 250203 883758 283389 369623 0.05 0.12 0.15 0.12 0.52 0.24 0.12 0.39 0.04 0.44 0.16 0.64 0.88 0.18 0.88 0.94 0.58 0.88 0.05 0.12 0.23 0.81 0.93 0.37 2191 3400 1999 3323 17505 1099 Tax positions must initially and subsequently be measured as the largest amount of tax benefit that has a greater than 50% likelihood of being realized upon ultimate settlement with the tax authority assuming full knowledge of the position and relevant facts. 192 77 2192 3400 592 285 <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><b>NOTE 1- ORGANIZATION AND BUSINESS BACKGROUND</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Bioplus Life Corp., a Nevada corporation (&#8220;the Company&#8221;) was incorporated under the laws of the State of Nevada on April 13, 2017. For purposes of financial statements presentation, Bioplus Life Corp. and its subsidiaries are herein referred to as &#8220;the Company&#8221; or &#8220;We&#8221;.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">We have historically conducted our business through Bio Life Neutraceuticals Sdn Bhd, a private limited liability company, incorporated in Malaysia. Bioplus Life Corp. (US), incorporated in United State of Nevada, is an investment holding company with 100% equity interest in Bioplus Life Corp. (Labuan), a company incorporated in Labuan, which subsequent hold 100% equity interest in Bioplus Life International Holdings Limited, a company incorporated in Hong Kong, which subsequent hold 99.8% equity interest in Bio Life Holdings Berhad, a company incorporated in Malaysia, which subsequent hold 100% equity interest in Bio Life Neutraceuticals Sdn Bhd. On December 31, 2017, Bioplus Life Corp was organized to be holding company parent to, and succeed to the operations of, Bioplus Life Corp. (Labuan), Bioplus Life International Holdings Ltd, Bio Life Holdings Berhad and Bio Life Neutraceuticals Sdn Bhd. This transaction was accounted for as a transaction among entities under common control and the assets, liabilities, revenues, and expenses, and as if the transfer occurred at the beginning of the period. Prior periods have been retrospectively adjusted to furnish comparative information.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company, through its subsidiaries, supplies high quality health products. Details of the Company&#8217;s subsidiaries:</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td style="border-bottom: black 1.5pt solid; width: 6%; text-align: center"><font style="font-size: 10pt">No</font></td> <td style="width: 1%; text-align: center">&#160;</td> <td style="border-bottom: black 1.5pt solid; width: 28%; text-align: center"><font style="font-size: 10pt">Company Name</font></td> <td style="width: 1%; text-align: center">&#160;</td> <td style="border-bottom: black 1.5pt solid; width: 16%; text-align: center"><font style="font-size: 10pt">Place/Date of Incorporation</font></td> <td style="width: 1%; text-align: center">&#160;</td> <td style="border-bottom: black 1.5pt solid; width: 23%; text-align: center"><font style="font-size: 10pt">Particulars of Issued Capital</font></td> <td style="width: 1%; text-align: center">&#160;</td> <td style="border-bottom: black 1.5pt solid; width: 23%; text-align: center"><font style="font-size: 10pt">Principal Activities</font></td></tr> <tr style="vertical-align: top"> <td style="text-align: center"><font style="font-size: 10pt">1</font></td> <td>&#160;</td> <td><font style="font-size: 10pt">Bioplus Life Corp. (Labuan)</font></td> <td>&#160;</td> <td> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">Malaysia, Labuan</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">May 19, 2017</p></td> <td>&#160;</td> <td style="text-align: center"><font style="font-size: 10pt">100 shares of <br /> ordinary shares of US$1 each</font></td> <td>&#160;</td> <td style="text-align: center"><font style="font-size: 10pt">Investment Holding</font></td></tr> <tr style="vertical-align: top"> <td style="text-align: center">&#160;</td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: center">&#160;</td> <td>&#160;</td> <td style="text-align: center">&#160;</td> <td>&#160;</td> <td style="text-align: center">&#160;</td></tr> <tr style="vertical-align: top"> <td style="text-align: center"><font style="font-size: 10pt">2</font></td> <td>&#160;</td> <td><font style="font-size: 10pt">Bioplus Life International Holdings Ltd. (A)</font></td> <td>&#160;</td> <td> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">Hong Kong</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">June 20, 2017</p></td> <td>&#160;</td> <td style="text-align: center"><font style="font-size: 10pt">1 shares of ordinary shares <br /> of HK$1 each</font></td> <td>&#160;</td> <td style="text-align: center"><font style="font-size: 10pt">Investment Holding</font></td></tr> <tr style="vertical-align: top"> <td style="text-align: center">&#160;</td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: center">&#160;</td> <td>&#160;</td> <td style="text-align: center">&#160;</td> <td>&#160;</td> <td style="text-align: center">&#160;</td></tr> <tr style="vertical-align: top"> <td style="text-align: center"><font style="font-size: 10pt">3</font></td> <td>&#160;</td> <td><font style="font-size: 10pt">Bio Life Holdings Berhad</font></td> <td>&#160;</td> <td> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">Malaysia</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">May 19, 2016</p></td> <td>&#160;</td> <td style="text-align: center"><font style="font-size: 10pt">107,992 shares of ordinary shares of RM1 each</font></td> <td>&#160;</td> <td style="text-align: center"><font style="font-size: 10pt">Investment Holding</font></td></tr> <tr style="vertical-align: top"> <td style="text-align: center">&#160;</td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: center">&#160;</td> <td>&#160;</td> <td style="text-align: center">&#160;</td> <td>&#160;</td> <td style="text-align: center">&#160;</td></tr> <tr style="vertical-align: top"> <td> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">4</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p></td> <td>&#160;</td> <td><font style="font-size: 10pt">Bio Life Neutraceuticals Sdn Bhd</font></td> <td>&#160;</td> <td> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">Malaysia, Selangor</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">August 27, 2009</p></td> <td>&#160;</td> <td style="text-align: center"><font style="font-size: 10pt">5,456,207 shares of ordinary shares of RM1 each</font></td> <td>&#160;</td> <td style="text-align: center"><font style="font-size: 10pt">Trading of Consumer Products</font></td></tr> <tr style="vertical-align: top"> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td></tr> <tr style="vertical-align: top"> <td style="text-align: center"><font style="font-size: 10pt">5</font></td> <td>&#160;</td> <td><font style="font-size: 10pt">Bio Life Neutraceuticals (Shenzhen) Pty Ltd. (B)</font></td> <td>&#160;</td> <td> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">Shenzhen</p> <p style="font: 10pt/106% Times New Roman, Times, Serif; margin: 0 0 8pt; text-align: center">October 27, 2017</p></td> <td>&#160;</td> <td style="text-align: center"><font style="font-size: 10pt">500,000 shares of ordinary shares of RMB1 each</font></td> <td>&#160;</td> <td style="text-align: center"><font style="font-size: 10pt">Trading of Healthy Supplement and Cosmetics</font></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">(A) Bioplus Life International Holdings Ltd. was officially disposed off by the Group on August 5, 2020 at a consideration of RMB 5,000. The transfer results in gain on disposal of subsidiary of USD 17,505 as disclosed in Note 13 in Consolidated Statements of Operations and Comprehensive Income/(Loss).</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">(B) Bio Life Neutraceuticals (Shenzhen) Pty Ltd. was being officially de-registered in Shenzhen on September 4, 2020.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company, through its subsidiaries, supplies high quality health products. Details of the Company&#8217;s subsidiaries:</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td style="border-bottom: black 1.5pt solid; width: 6%; text-align: center"><font style="font-size: 10pt">No</font></td> <td style="width: 1%; text-align: center">&#160;</td> <td style="border-bottom: black 1.5pt solid; width: 28%; text-align: center"><font style="font-size: 10pt">Company Name</font></td> <td style="width: 1%; text-align: center">&#160;</td> <td style="border-bottom: black 1.5pt solid; width: 16%; text-align: center"><font style="font-size: 10pt">Place/Date of Incorporation</font></td> <td style="width: 1%; text-align: center">&#160;</td> <td style="border-bottom: black 1.5pt solid; width: 23%; text-align: center"><font style="font-size: 10pt">Particulars of Issued Capital</font></td> <td style="width: 1%; text-align: center">&#160;</td> <td style="border-bottom: black 1.5pt solid; width: 23%; text-align: center"><font style="font-size: 10pt">Principal Activities</font></td></tr> <tr style="vertical-align: top"> <td style="text-align: center"><font style="font-size: 10pt">1</font></td> <td>&#160;</td> <td><font style="font-size: 10pt">Bioplus Life Corp. (Labuan)</font></td> <td>&#160;</td> <td> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">Malaysia, Labuan</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">May 19, 2017</p></td> <td>&#160;</td> <td style="text-align: center"><font style="font-size: 10pt">100 shares of <br /> ordinary shares of US$1 each</font></td> <td>&#160;</td> <td style="text-align: center"><font style="font-size: 10pt">Investment Holding</font></td></tr> <tr style="vertical-align: top"> <td style="text-align: center">&#160;</td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: center">&#160;</td> <td>&#160;</td> <td style="text-align: center">&#160;</td> <td>&#160;</td> <td style="text-align: center">&#160;</td></tr> <tr style="vertical-align: top"> <td style="text-align: center"><font style="font-size: 10pt">2</font></td> <td>&#160;</td> <td><font style="font-size: 10pt">Bioplus Life International Holdings Ltd. (A)</font></td> <td>&#160;</td> <td> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">Hong Kong</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">June 20, 2017</p></td> <td>&#160;</td> <td style="text-align: center"><font style="font-size: 10pt">1 shares of ordinary shares <br /> of HK$1 each</font></td> <td>&#160;</td> <td style="text-align: center"><font style="font-size: 10pt">Investment Holding</font></td></tr> <tr style="vertical-align: top"> <td style="text-align: center">&#160;</td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: center">&#160;</td> <td>&#160;</td> <td style="text-align: center">&#160;</td> <td>&#160;</td> <td style="text-align: center">&#160;</td></tr> <tr style="vertical-align: top"> <td style="text-align: center"><font style="font-size: 10pt">3</font></td> <td>&#160;</td> <td><font style="font-size: 10pt">Bio Life Holdings Berhad</font></td> <td>&#160;</td> <td> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">Malaysia</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">May 19, 2016</p></td> <td>&#160;</td> <td style="text-align: center"><font style="font-size: 10pt">107,992 shares of ordinary shares of RM1 each</font></td> <td>&#160;</td> <td style="text-align: center"><font style="font-size: 10pt">Investment Holding</font></td></tr> <tr style="vertical-align: top"> <td style="text-align: center">&#160;</td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: center">&#160;</td> <td>&#160;</td> <td style="text-align: center">&#160;</td> <td>&#160;</td> <td style="text-align: center">&#160;</td></tr> <tr style="vertical-align: top"> <td> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">4</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p></td> <td>&#160;</td> <td><font style="font-size: 10pt">Bio Life Neutraceuticals Sdn Bhd</font></td> <td>&#160;</td> <td> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">Malaysia, Selangor</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">August 27, 2009</p></td> <td>&#160;</td> <td style="text-align: center"><font style="font-size: 10pt">5,456,207 shares of ordinary shares of RM1 each</font></td> <td>&#160;</td> <td style="text-align: center"><font style="font-size: 10pt">Trading of Consumer Products</font></td></tr> <tr style="vertical-align: top"> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td></tr> <tr style="vertical-align: top"> <td style="text-align: center"><font style="font-size: 10pt">5</font></td> <td>&#160;</td> <td><font style="font-size: 10pt">Bio Life Neutraceuticals (Shenzhen) Pty Ltd. (B)</font></td> <td>&#160;</td> <td> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">Shenzhen</p> <p style="font: 10pt/106% Times New Roman, Times, Serif; margin: 0 0 8pt; text-align: center">October 27, 2017</p></td> <td>&#160;</td> <td style="text-align: center"><font style="font-size: 10pt">500,000 shares of ordinary shares of RMB1 each</font></td> <td>&#160;</td> <td style="text-align: center"><font style="font-size: 10pt">Trading of Healthy Supplement and Cosmetics</font></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">(A) Bioplus Life International Holdings Ltd. was officially disposed off by the Group on August 5, 2020 at a consideration of RMB 5,000. The transfer results in gain on disposal of subsidiary of USD 17,505 as disclosed in Note 13 in Consolidated Statements of Operations and Comprehensive Income/(Loss).</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">(B) Bio Life Neutraceuticals (Shenzhen) Pty Ltd. was being officially de-registered in Shenzhen on September 4, 2020.</p> <table cellspacing="0" cellpadding="0" style="width: 100%; border-collapse: collapse"> <tr style="vertical-align: top"> <td style="font: 12pt Times New Roman, Times, Serif; width: 48px"><font style="font-size: 10pt">&#9679;</font></td> <td style="font: 12pt Times New Roman, Times, Serif"><font style="font-size: 10pt">Fair value of financial instruments</font></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The carrying value of the Company&#8217;s financial instruments: cash and cash equivalents, trade receivable, deposits and other receivables, amount due to related parties and other payables approximate at their fair values because of the short-term nature of these financial instruments.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company also follows the guidance of the ASC Topic 820-10, &#8220;<i>Fair Value Measurements and Disclosures</i>&#8221; (&#8220;ASC 820-10&#8221;), with respect to financial assets and liabilities that are measured at fair value. ASC 820-10 establishes a three-tier fair value hierarchy that prioritizes the inputs used in measuring fair value as follows:</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: top"> <td style="width: 38px; text-align: justify"><font style="font-size: 10pt">&#9679;</font></td> <td style="text-align: justify"><font style="font-size: 10pt"><i>Level 1</i>: Observable inputs such as quoted prices in active markets; </font></td></tr> <tr style="vertical-align: top"> <td style="text-align: justify"><font style="font-size: 10pt">&#9679;</font></td> <td style="text-align: justify"><font style="font-size: 10pt"><i>Level 2</i>: Inputs, other than the quoted prices in active markets, that are observable either directly or indirectly; and </font></td></tr> <tr style="vertical-align: top"> <td style="text-align: justify"><font style="font-size: 10pt">&#9679;</font></td> <td style="text-align: justify"><font style="font-size: 10pt"><i>Level 3</i>: Unobservable inputs in which there is little or no market data, which require the reporting entity to develop its own assumptions </font></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">As of September 30, 2020, and December 31, 2019, the Company did not have any nonfinancial assets and liabilities that are recognized or disclosed at fair value in the financial statements, at least annually, on a recurring basis, nor did the Company have any assets or liabilities measured at fair value on a non-recurring basis.</p> <table cellspacing="0" cellpadding="0" style="width: 100%; border-collapse: collapse"> <tr style="vertical-align: top"> <td style="font: 12pt Times New Roman, Times, Serif; width: 48px"><font style="font-size: 10pt">&#9679;</font></td> <td style="font: 12pt Times New Roman, Times, Serif"><font style="font-size: 10pt">Foreign currencies translation</font></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Transactions denominated in currencies other than the functional currency are translated into the functional currency at the exchange rates prevailing at the dates of the transaction. Monetary assets and liabilities denominated in currencies other than the functional currency are translated into the functional currency using the applicable exchange rates at the balance sheet dates. The resulting exchange differences are recorded in the statement of operations.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The functional currency of the Company is the United States Dollars (&#8220;US$&#8221;) and the accompanying financial statements have been expressed in US$. In addition, the Company maintains its books and record in a local currency, Malaysian Ringgit (&#8220;MYR&#8221; or &#8220;RM&#8221;), which is functional currency as being the primary currency of the economic environment in which the entity operates.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">In general, for consolidation purposes, assets and liabilities of its subsidiaries whose functional currency is not US$ are translated into US$, in accordance with ASC Topic 830-30, &#8220;<i>Translation of Financial Statement&#8221;</i>, using the exchange rate on the balance sheet date. Revenues and expenses are translated at average rates prevailing during the period. The gains and losses resulting from translation of financial statements of foreign subsidiary are recorded as a separate component of accumulated other comprehensive income.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Translation of amounts from the local currency of the Company into US$1 has been made at the following exchange rates for the respective period:</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td style="text-align: justify">&#160;</td> <td style="padding-bottom: 1.5pt">&#160;</td> <td colspan="6" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt">As of and for the nine months ended September&#160;30,</font></td> <td style="padding-bottom: 1.5pt">&#160;</td></tr> <tr style="vertical-align: bottom"> <td style="text-align: justify">&#160;</td> <td style="padding-bottom: 1.5pt">&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt">2020</font></td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="padding-bottom: 1.5pt">&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt">2019</font></td> <td style="padding-bottom: 1.5pt">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="width: 62%"><font style="font-size: 10pt">Period-end MYR: US$1 exchange rate</font></td> <td style="width: 1%">&#160;</td> <td style="width: 1%">&#160;</td> <td style="width: 16%; text-align: right"><font style="font-size: 10pt">4.1585</font></td> <td style="width: 1%">&#160;</td> <td style="width: 1%">&#160;</td> <td style="width: 1%">&#160;</td> <td style="width: 16%; text-align: right"><font style="font-size: 10pt">4.1349</font></td> <td style="width: 1%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td><font style="font-size: 10pt">Period average MYR: US$1 exchange rate</font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">4.2038</font></td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">4.1870</font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td><font style="font-size: 10pt">Period-end US$1: RMB exchange rate</font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">0.1473</font></td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">0.1454</font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td><font style="font-size: 10pt">Period average US$1: RMB exchange rate</font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">0.1446</font></td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">0.1471</font></td> <td>&#160;</td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 38.5pt; text-align: justify; background-color: white"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Translation of amounts from the local currency of the Company into US$1 has been made at the following exchange rates for the respective period:</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td style="text-align: justify">&#160;</td> <td style="padding-bottom: 1.5pt">&#160;</td> <td colspan="6" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt">As of and for the nine months ended September&#160;30,</font></td> <td style="padding-bottom: 1.5pt">&#160;</td></tr> <tr style="vertical-align: bottom"> <td style="text-align: justify">&#160;</td> <td style="padding-bottom: 1.5pt">&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt">2020</font></td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="padding-bottom: 1.5pt">&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt">2019</font></td> <td style="padding-bottom: 1.5pt">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="width: 62%"><font style="font-size: 10pt">Period-end MYR: US$1 exchange rate</font></td> <td style="width: 1%">&#160;</td> <td style="width: 1%">&#160;</td> <td style="width: 16%; text-align: right"><font style="font-size: 10pt">4.1585</font></td> <td style="width: 1%">&#160;</td> <td style="width: 1%">&#160;</td> <td style="width: 1%">&#160;</td> <td style="width: 16%; text-align: right"><font style="font-size: 10pt">4.1349</font></td> <td style="width: 1%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td><font style="font-size: 10pt">Period average MYR: US$1 exchange rate</font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">4.2038</font></td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">4.1870</font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td><font style="font-size: 10pt">Period-end US$1: RMB exchange rate</font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">0.1473</font></td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">0.1454</font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td><font style="font-size: 10pt">Period average US$1: RMB exchange rate</font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">0.1446</font></td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">0.1471</font></td> <td>&#160;</td></tr> </table> <table cellspacing="0" cellpadding="0" style="width: 100%; border-collapse: collapse"> <tr style="vertical-align: top"> <td style="font: 12pt Times New Roman, Times, Serif; width: 48px"><font style="font-size: 10pt"><b>2. </b></font></td> <td style="font: 12pt Times New Roman, Times, Serif"><font style="font-size: 10pt"><b>SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES</b></font></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <table cellspacing="0" cellpadding="0" style="width: 100%; border-collapse: collapse"> <tr style="vertical-align: top"> <td style="font: 12pt Times New Roman, Times, Serif; width: 48px"><font style="font-size: 10pt">&#9679;</font></td> <td style="font: 12pt Times New Roman, Times, Serif"><font style="font-size: 10pt">Basis of presentation</font></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">These accompanying financial statements have been prepared in accordance with generally accepted accounting principles in the United States of America (&#8220;US GAAP&#8221;).</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <table cellspacing="0" cellpadding="0" style="width: 100%"> <tr style="vertical-align: top"> <td style="font: 12pt Times New Roman, Times, Serif; width: 48px"><font style="font-size: 10pt">&#9679;</font></td> <td style="font: 12pt Times New Roman, Times, Serif; text-align: justify"><font style="font-size: 10pt">Basis of consolidation</font></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">In this Quarterly Report, &#8220;the Company,&#8221; &#8220;us&#8221; or &#8220;we&#8221; refer to the consolidated entity, including its subsidiaries and affiliates. The terms refer only to the publicly held holding company, The Bioplus Life Corporation, excluding its subsidiaries and affiliates. Furthermore, in which the Company has a variable interest have been consolidated where the Company is the primary beneficiary. All intercompany transactions and balances have been eliminated in consolidation.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <table cellspacing="0" cellpadding="0" style="width: 100%; border-collapse: collapse"> <tr style="vertical-align: top"> <td style="font: 12pt Times New Roman, Times, Serif; width: 48px"><font style="font-size: 10pt">&#9679;</font></td> <td style="font: 12pt Times New Roman, Times, Serif"><font style="font-size: 10pt">Use of estimates</font></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">In preparing these financial statements, management makes estimates and assumptions that affect the reported amounts of assets and liabilities in the balance sheets and revenues and expenses during the periods reported. Actual results may differ from these estimates.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <table cellspacing="0" cellpadding="0" style="width: 100%; border-collapse: collapse"> <tr style="vertical-align: top"> <td style="font: 12pt Times New Roman, Times, Serif; width: 48px"><font style="font-size: 10pt">&#9679;</font></td> <td style="font: 12pt Times New Roman, Times, Serif"><font style="font-size: 10pt">Cash and cash equivalents</font></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Cash and cash equivalents represent cash on hand, demand deposits placed with banks or other financial institutions and all highly liquid investments with an original maturity of three months or less as of the purchase date of such investments.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <table cellspacing="0" cellpadding="0" style="width: 100%; border-collapse: collapse"> <tr style="vertical-align: top"> <td style="font: 12pt Times New Roman, Times, Serif; width: 48px"><font style="font-size: 10pt">&#9679;</font></td> <td style="font: 12pt Times New Roman, Times, Serif"><font style="font-size: 10pt">Property, plant and equipment</font></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Property and plant and equipment are stated at cost less accumulated depreciation and accumulated impairment losses, if any. Depreciation is calculated on the straight-line basis to write off the cost over the following expected useful lives of the assets concerned. The principal annual rates used are as follows:</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td style="border-bottom: black 1.5pt solid"><font style="font-size: 10pt">Categories</font></td> <td style="padding-bottom: 1.5pt">&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt">Principal Annual Rates/Expected Useful Life</font></td> <td style="padding-bottom: 1.5pt">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="width: 76%"><font style="font-size: 10pt">Computer hardware</font></td> <td style="width: 1%">&#160;</td> <td style="width: 1%">&#160;</td> <td style="width: 21%; text-align: right"><font style="font-size: 10pt">20</font></td> <td style="width: 1%"><font style="font-size: 10pt">%</font></td></tr> <tr style="vertical-align: bottom; background-color: white"> <td><font style="font-size: 10pt">Furniture &#38; fittings</font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">10</font></td> <td><font style="font-size: 10pt">%</font></td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td><font style="font-size: 10pt">Handphone</font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">20</font></td> <td><font style="font-size: 10pt">%</font></td></tr> <tr style="vertical-align: bottom; background-color: white"> <td><font style="font-size: 10pt">Landscape</font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">20</font></td> <td><font style="font-size: 10pt">%</font></td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td><font style="font-size: 10pt">Leasehold land and building</font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">99 years</font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td><font style="font-size: 10pt">Machinery</font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">10</font></td> <td><font style="font-size: 10pt">%</font></td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td><font style="font-size: 10pt">Motor vehicle</font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">20</font></td> <td><font style="font-size: 10pt">%</font></td></tr> <tr style="vertical-align: bottom; background-color: white"> <td><font style="font-size: 10pt">Office equipment</font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">10</font></td> <td><font style="font-size: 10pt">%</font></td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td><font style="font-size: 10pt">Renovation</font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">20</font></td> <td><font style="font-size: 10pt">%</font></td></tr> <tr style="vertical-align: bottom; background-color: white"> <td><font style="font-size: 10pt">Signboard</font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">10</font></td> <td><font style="font-size: 10pt">%</font></td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td><font style="font-size: 10pt">Tools and equipment</font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">10</font></td> <td><font style="font-size: 10pt">%</font></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Kitchen utensils &#9; 10%</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Fully depreciated plant and equipment are retained in the financial statements until they are no longer in use.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: top"> <td style="width: 48px"><font style="font-size: 10pt">&#9679;</font></td> <td><font style="font-size: 10pt">Inventories</font></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Inventories consisting of products available for sell, are stated at the lower of cost or market value. Cost of inventory is determined using the first-in, first-out (FIFO) method. Inventory reserve is recorded to write down the cost of inventory to the estimated market value due to slow-moving merchandise and damaged goods, which is dependent upon factors such as historical and forecasted consumer demand, and promotional environment. The Company takes ownership, risks and rewards of the products purchased. Write downs are recorded in cost of revenues in the Consolidated Statements of Operations and Comprehensive Income.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;&#160;</p> <table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: top"> <td style="width: 48px"><font style="font-size: 10pt">&#9679;</font></td> <td><font style="font-size: 10pt">Revenue recognition </font></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Revenues are recognized when control of the promised goods or services are transferred to a customer, in an amount that reflects the consideration that the Company expects to receive in exchange for those goods or services. The Company applies the following five steps in order to determine the appropriate amount of revenue to be recognized as it fulfills its obligations under each of its agreements:</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr> <td style="width: 24px; text-align: justify">&#160;</td> <td style="vertical-align: top; width: 24px; text-align: justify"><font style="font-size: 10pt">&#9679;</font></td> <td style="vertical-align: top; text-align: justify"><font style="font-size: 10pt">identify the contract with a customer;</font></td></tr> <tr> <td style="text-align: justify">&#160;</td> <td style="vertical-align: top; text-align: justify"><font style="font-size: 10pt">&#9679;</font></td> <td style="vertical-align: top; text-align: justify"><font style="font-size: 10pt">identify the performance obligations in the contract;</font></td></tr> <tr> <td style="text-align: justify">&#160;</td> <td style="vertical-align: top; text-align: justify"><font style="font-size: 10pt">&#9679;</font></td> <td style="vertical-align: top; text-align: justify"><font style="font-size: 10pt">determine the transaction price;</font></td></tr> <tr> <td style="text-align: justify">&#160;</td> <td style="vertical-align: top; text-align: justify"><font style="font-size: 10pt">&#9679;</font></td> <td style="vertical-align: top; text-align: justify"><font style="font-size: 10pt">allocate the transaction price to performance obligations in the contract; and</font></td></tr> <tr> <td style="text-align: justify">&#160;</td> <td style="vertical-align: top; text-align: justify"><font style="font-size: 10pt">&#9679;</font></td> <td style="vertical-align: top; text-align: justify"><font style="font-size: 10pt">recognize revenue as the performance obligation is satisfied.</font></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: top"> <td style="width: 48px"><font style="font-size: 10pt">&#9679;</font></td> <td><font style="font-size: 10pt">Cost of revenues</font></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Cost of revenue includes the purchase cost of retail goods for re-sale to customers and packing materials (such as boxes). It excludes purchasing and receiving costs, inspection costs, warehousing costs, internal transfer costs and other costs of distribution network in cost of revenues.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: top"> <td style="width: 48px"><font style="font-size: 10pt">&#9679;</font></td> <td><font style="font-size: 10pt">Shipping and handling fees</font></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 27pt; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Shipping and handling fees, if billed to customers, are included in revenue. Shipping and handling fees associated with inbound and outbound freight are expensed as incurred and included in selling and distribution expenses.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 27pt; text-align: justify">&#160;</p> <table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: top"> <td style="width: 48px"><font style="font-size: 10pt">&#9679;</font></td> <td><font style="font-size: 10pt">Comprehensive income</font></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">ASC Topic 220, &#8220;<i>Comprehensive Income</i>&#8221; establishes standards for reporting and display of comprehensive income, its components and accumulated balances. Comprehensive income as defined includes all changes in equity during a period from non-owner sources. Accumulated other comprehensive income, as presented in the accompanying statements of stockholders&#8217; equity consists of changes in unrealized gains and losses on foreign currency translation and cumulative net change in the fair value of available-for-sale investments held at the balance sheet date. This comprehensive income is not included in the computation of income tax expense or benefit.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: top"> <td style="width: 48px"><font style="font-size: 10pt">&#9679;</font></td> <td><font style="font-size: 10pt">Income tax expense</font></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Income taxes are determined in accordance with the provisions of ASC Topic 740, &#8220;<i>Income Taxes</i>&#8221; (&#8220;ASC Topic 740&#8221;). Under this method, deferred tax assets and liabilities are recognized for the future tax consequences attributable to differences between the financial statement carrying amounts of existing assets and liabilities and their respective tax basis. Deferred tax assets and liabilities are measured using enacted income tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. Any effect on deferred tax assets and liabilities of a change in tax rates is recognized in income in the period that includes the enactment date.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">ASC 740 prescribes a comprehensive model for how companies should recognize, measure, present, and disclosed in their financial statements uncertain tax positions taken or expected to be taken on a tax return. Under ASC 740, tax positions must initially be recognized in the financial statements when it is more likely than not the position will be sustained upon examination by the tax authorities. Such tax positions must initially and subsequently be measured as the largest amount of tax benefit that has a greater than 50% likelihood of being realized upon ultimate settlement with the tax authority assuming full knowledge of the position and relevant facts.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company conducts major businesses in Malaysia and is subject to tax in their own jurisdictions. As a result of its business activities, the Company will file separate tax returns that are subject to examination by the foreign tax authorities.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: top"> <td style="width: 48px"><font style="font-size: 10pt">&#9679;</font></td> <td><font style="font-size: 10pt">Foreign currencies translation</font></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Transactions denominated in currencies other than the functional currency are translated into the functional currency at the exchange rates prevailing at the dates of the transaction. Monetary assets and liabilities denominated in currencies other than the functional currency are translated into the functional currency using the applicable exchange rates at the balance sheet dates. The resulting exchange differences are recorded in the statement of operations.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The functional currency of the Company is the United States Dollars (&#8220;US$&#8221;) and the accompanying financial statements have been expressed in US$. In addition, the Company maintains its books and record in a local currency, Malaysian Ringgit (&#8220;MYR&#8221; or &#8220;RM&#8221;), which is functional currency as being the primary currency of the economic environment in which the entity operates.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">In general, for consolidation purposes, assets and liabilities of its subsidiaries whose functional currency is not US$ are translated into US$, in accordance with ASC Topic 830-30, &#8220;<i>Translation of Financial Statement&#8221;</i>, using the exchange rate on the balance sheet date. Revenues and expenses are translated at average rates prevailing during the period. The gains and losses resulting from translation of financial statements of foreign subsidiary are recorded as a separate component of accumulated other comprehensive income.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Translation of amounts from the local currency of the Company into US$1 has been made at the following exchange rates for the respective period:</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td style="text-align: justify">&#160;</td> <td style="padding-bottom: 1.5pt">&#160;</td> <td colspan="6" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt">As of and for the nine months ended September&#160;30,</font></td> <td style="padding-bottom: 1.5pt">&#160;</td></tr> <tr style="vertical-align: bottom"> <td style="text-align: justify">&#160;</td> <td style="padding-bottom: 1.5pt">&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt">2020</font></td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="padding-bottom: 1.5pt">&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt">2019</font></td> <td style="padding-bottom: 1.5pt">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="width: 62%"><font style="font-size: 10pt">Period-end MYR: US$1 exchange rate</font></td> <td style="width: 1%">&#160;</td> <td style="width: 1%">&#160;</td> <td style="width: 16%; text-align: right"><font style="font-size: 10pt">4.1585</font></td> <td style="width: 1%">&#160;</td> <td style="width: 1%">&#160;</td> <td style="width: 1%">&#160;</td> <td style="width: 16%; text-align: right"><font style="font-size: 10pt">4.1349</font></td> <td style="width: 1%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td><font style="font-size: 10pt">Period average MYR: US$1 exchange rate</font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">4.2038</font></td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">4.1870</font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td><font style="font-size: 10pt">Period-end US$1: RMB exchange rate</font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">0.1473</font></td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">0.1454</font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td><font style="font-size: 10pt">Period average US$1: RMB exchange rate</font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">0.1446</font></td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">0.1471</font></td> <td>&#160;</td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 38.5pt; text-align: justify; background-color: white">&#160;</p> <table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: top"> <td style="width: 48px"><font style="font-size: 10pt">&#9679;</font></td> <td><font style="font-size: 10pt">Related parties</font></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 27pt; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Parties, which can be a corporation or individual, are considered to be related if the Company has the ability, directly or indirectly, to control the other party or exercise significant influence over the other party in making financial and operating decisions. Companies are also considered to be related if they are subject to common control or common significant influence.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: top"> <td style="width: 48px"><font style="font-size: 10pt">&#9679;</font></td> <td><font style="font-size: 10pt">Fair value of financial instruments</font></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The carrying value of the Company&#8217;s financial instruments: cash and cash equivalents, trade receivable, deposits and other receivables, amount due to related parties and other payables approximate at their fair values because of the short-term nature of these financial instruments.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company also follows the guidance of the ASC Topic 820-10, &#8220;<i>Fair Value Measurements and Disclosures</i>&#8221; (&#8220;ASC 820-10&#8221;), with respect to financial assets and liabilities that are measured at fair value. ASC 820-10 establishes a three-tier fair value hierarchy that prioritizes the inputs used in measuring fair value as follows:</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: top"> <td style="width: 38px; text-align: justify"><font style="font-size: 10pt">&#9679;</font></td> <td style="text-align: justify"><font style="font-size: 10pt"><i>Level 1</i>: Observable inputs such as quoted prices in active markets; </font></td></tr> <tr style="vertical-align: top"> <td style="text-align: justify"><font style="font-size: 10pt">&#9679;</font></td> <td style="text-align: justify"><font style="font-size: 10pt"><i>Level 2</i>: Inputs, other than the quoted prices in active markets, that are observable either directly or indirectly; and </font></td></tr> <tr style="vertical-align: top"> <td style="text-align: justify"><font style="font-size: 10pt">&#9679;</font></td> <td style="text-align: justify"><font style="font-size: 10pt"><i>Level 3</i>: Unobservable inputs in which there is little or no market data, which require the reporting entity to develop its own assumptions </font></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">As of September 30, 2020, and December 31, 2019, the Company did not have any nonfinancial assets and liabilities that are recognized or disclosed at fair value in the financial statements, at least annually, on a recurring basis, nor did the Company have any assets or liabilities measured at fair value on a non-recurring basis.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: top"> <td style="width: 48px"><font style="font-size: 10pt">&#9679;</font></td> <td><font style="font-size: 10pt">Recent accounting pronouncements</font></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">Management has considered all recent accounting pronouncements issued since the last audit of our financial statements. The Company&#8217;s management believes that these recent pronouncements will not have a material effect on the Company&#8217;s financial statements.</p> <table cellspacing="0" cellpadding="0" style="width: 100%; border-collapse: collapse"> <tr style="vertical-align: top"> <td style="font: 12pt Times New Roman, Times, Serif; width: 48px"><font style="font-size: 10pt"><b>10.</b></font></td> <td style="font: 12pt Times New Roman, Times, Serif"><font style="font-size: 10pt"><b>INCOME TAXES</b></font></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1.5pt; text-align: center">&#160;</td> <td style="padding-bottom: 1.5pt">&#160;</td> <td colspan="6" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt">Nine months ended</font></td> <td style="padding-bottom: 1.5pt">&#160;</td></tr> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="padding-bottom: 1.5pt">&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt">2020</font></td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="padding-bottom: 1.5pt">&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt">2019</font></td> <td style="padding-bottom: 1.5pt">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td><font style="font-size: 10pt">Tax jurisdictions from:</font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right">&#160;</td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right">&#160;</td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="width: 62%; padding-left: 10pt"><font style="font-size: 10pt">Local</font></td> <td style="width: 1%">&#160;</td> <td style="width: 1%"><font style="font-size: 10pt">$</font></td> <td style="width: 16%; text-align: right"><font style="font-size: 10pt">(58,232</font></td> <td style="width: 1%"><font style="font-size: 10pt">)</font></td> <td style="width: 1%">&#160;</td> <td style="width: 1%"><font style="font-size: 10pt">$</font></td> <td style="width: 16%; text-align: right"><font style="font-size: 10pt">(36,326</font></td> <td style="width: 1%"><font style="font-size: 10pt">)</font></td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="padding-left: 10pt"><font style="font-size: 10pt">Foreign, representing:</font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right">&#160;</td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right">&#160;</td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="padding-left: 20pt"><font style="font-size: 10pt">Malaysia</font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">392,990</font></td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">47,020</font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="padding-left: 20pt"><font style="font-size: 10pt">Hong Kong</font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">(17,775</font></td> <td><font style="font-size: 10pt">)</font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">(1,859</font></td> <td><font style="font-size: 10pt">)</font></td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="padding-bottom: 1.5pt; padding-left: 20pt"><font style="font-size: 10pt">China</font></td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="border-bottom: black 1.5pt solid">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">(1,054</font></td> <td style="padding-bottom: 1.5pt"><font style="font-size: 10pt">)</font></td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="border-bottom: black 1.5pt solid">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">(1,469</font></td> <td style="padding-bottom: 1.5pt"><font style="font-size: 10pt">)</font></td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="padding-bottom: 1.5pt"><font style="font-size: 10pt">Profit/(Loss) before income tax</font></td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="border-bottom: black 1.5pt solid"><font style="font-size: 10pt">$</font></td> <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">315,929</font></td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="border-bottom: black 1.5pt solid"><font style="font-size: 10pt">$</font></td> <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">7,366</font></td> <td style="padding-bottom: 1.5pt">&#160;</td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The provision for income taxes consisted of the following:</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td>&#160;</td> <td style="padding-bottom: 1.5pt">&#160;</td> <td colspan="6" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt">Nine months ended</font></td> <td style="padding-bottom: 1.5pt">&#160;</td></tr> <tr style="vertical-align: bottom"> <td>&#160;</td> <td style="padding-bottom: 1.5pt">&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt">2020</font></td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="padding-bottom: 1.5pt">&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt">2019</font></td> <td style="padding-bottom: 1.5pt">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="width: 62%"><font style="font-size: 10pt">Tax expense - Current</font></td> <td style="width: 1%">&#160;</td> <td style="width: 1%">&#160;</td> <td style="width: 16%; text-align: right">&#160;</td> <td style="width: 1%">&#160;</td> <td style="width: 1%">&#160;</td> <td style="width: 1%">&#160;</td> <td style="width: 16%; text-align: right">&#160;</td> <td style="width: 1%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="padding-left: 10pt"><font style="font-size: 10pt">Local</font></td> <td>&#160;</td> <td><font style="font-size: 10pt">$</font></td> <td style="text-align: right"><font style="font-size: 10pt">-</font></td> <td>&#160;</td> <td>&#160;</td> <td><font style="font-size: 10pt">$</font></td> <td style="text-align: right"><font style="font-size: 10pt">-</font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="padding-left: 10pt"><font style="font-size: 10pt">Foreign, representing:</font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right">&#160;</td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right">&#160;</td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="padding-left: 20pt"><font style="font-size: 10pt">Malaysia</font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">-</font></td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">-</font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="padding-left: 20pt"><font style="font-size: 10pt">Hong Kong</font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">-</font></td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">-</font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right">&#160;</td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right">&#160;</td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td><font style="font-size: 10pt">Tax expense &#8211; Prior year</font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right">&#160;</td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right">&#160;</td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="padding-left: 10pt"><font style="font-size: 10pt">Foreign, representing:</font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right">&#160;</td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right">&#160;</td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="padding-left: 20pt"><font style="font-size: 10pt">Malaysia</font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">-</font></td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">-</font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right">&#160;</td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right">&#160;</td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td><font style="font-size: 10pt">Deferred</font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right">&#160;</td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right">&#160;</td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="padding-left: 10pt"><font style="font-size: 10pt">Local</font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">-</font></td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">-</font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="padding-left: 10pt"><font style="font-size: 10pt">Foreign, representing:</font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right">&#160;</td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right">&#160;</td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="padding-left: 20pt"><font style="font-size: 10pt">Malaysia</font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">-</font></td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">-</font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="padding-bottom: 1.5pt; padding-left: 20pt"><font style="font-size: 10pt">Hong Kong</font></td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="border-bottom: black 1.5pt solid">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">-</font></td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="border-bottom: black 1.5pt solid">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">-</font></td> <td style="padding-bottom: 1.5pt">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="padding-bottom: 2.5pt">&#160;</td> <td style="padding-bottom: 2.5pt">&#160;</td> <td style="border-bottom: black 2.25pt double"><font style="font-size: 10pt">$</font></td> <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 10pt">-</font></td> <td style="padding-bottom: 2.5pt">&#160;</td> <td style="padding-bottom: 2.5pt">&#160;</td> <td style="border-bottom: black 2.25pt double"><font style="font-size: 10pt">$</font></td> <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 10pt">-</font></td> <td style="padding-bottom: 2.5pt">&#160;</td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The effective tax rate in the periods presented is the result of the mix of income earned in various tax jurisdictions that apply a broad range of income tax rates. The Company has subsidiaries that operate in various countries: United States, Hong Kong and Malaysia that are subject to taxes in the jurisdictions in which they operate, as follows:</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><i>United States of America</i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company is registered in the State of Nevada and is subject to the tax laws of the United States of America. As of September 30, 2020, the operations in the United States of America incurred $461,206 of cumulative net operating losses which can be carried forward to offset future taxable income. The net operating loss carry forwards begin to expire in 2039, if unutilized. The Company has provided for a full valuation allowance of $4,896 against the deferred tax assets on the expected future tax benefits from the net operating loss carry forwards as the management believes it is more likely than not that these assets will not be realized in the future.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><i>&#160;</i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><i>Malaysia</i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Bio Life Holdings Berhad (&#8220;BLHB&#8221;) and Bio Life Neutraceuticals Sdn Bhd (&#8220;BLNSB&#8221;) are subject to the Malaysia Corporate Tax Laws at a tax rate of 24% on the assessable income for its tax year.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><i>Hong Kong</i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Bioplus Life International Holdings Ltd is subject to Hong Kong Profits Tax, which is charged at the statutory income tax rate of 16.5% on its assessable income.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><i>&#160;</i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><i>China</i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><i>&#160;</i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Bio Life Neutraceuticals (Shenzhen) Pty Ltd. is registered in the Shen Zhen and is subject to the China Corporate Tax, which is charged at the statutory income tax rate of 25% on its assessable income.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"></p> <table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1.5pt; text-align: center">&#160;</td> <td style="padding-bottom: 1.5pt">&#160;</td> <td colspan="6" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt">Nine months ended</font></td> <td style="padding-bottom: 1.5pt">&#160;</td></tr> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="padding-bottom: 1.5pt">&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt">2020</font></td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="padding-bottom: 1.5pt">&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt">2019</font></td> <td style="padding-bottom: 1.5pt">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td><font style="font-size: 10pt">Tax jurisdictions from:</font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right">&#160;</td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right">&#160;</td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="width: 62%; padding-left: 10pt"><font style="font-size: 10pt">Local</font></td> <td style="width: 1%">&#160;</td> <td style="width: 1%"><font style="font-size: 10pt">$</font></td> <td style="width: 16%; text-align: right"><font style="font-size: 10pt">(58,232</font></td> <td style="width: 1%"><font style="font-size: 10pt">)</font></td> <td style="width: 1%">&#160;</td> <td style="width: 1%"><font style="font-size: 10pt">$</font></td> <td style="width: 16%; text-align: right"><font style="font-size: 10pt">(36,326</font></td> <td style="width: 1%"><font style="font-size: 10pt">)</font></td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="padding-left: 10pt"><font style="font-size: 10pt">Foreign, representing:</font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right">&#160;</td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right">&#160;</td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="padding-left: 20pt"><font style="font-size: 10pt">Malaysia</font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">392,990</font></td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">47,020</font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="padding-left: 20pt"><font style="font-size: 10pt">Hong Kong</font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">(17,775</font></td> <td><font style="font-size: 10pt">)</font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">(1,859</font></td> <td><font style="font-size: 10pt">)</font></td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="padding-bottom: 1.5pt; padding-left: 20pt"><font style="font-size: 10pt">China</font></td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="border-bottom: black 1.5pt solid">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">(1,054</font></td> <td style="padding-bottom: 1.5pt"><font style="font-size: 10pt">)</font></td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="border-bottom: black 1.5pt solid">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">(1,469</font></td> <td style="padding-bottom: 1.5pt"><font style="font-size: 10pt">)</font></td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="padding-bottom: 1.5pt"><font style="font-size: 10pt">Profit/(Loss) before income tax</font></td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="border-bottom: black 1.5pt solid"><font style="font-size: 10pt">$</font></td> <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">315,929</font></td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="border-bottom: black 1.5pt solid"><font style="font-size: 10pt">$</font></td> <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">7,366</font></td> <td style="padding-bottom: 1.5pt">&#160;</td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The provision for income taxes consisted of the following:</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td>&#160;</td> <td style="padding-bottom: 1.5pt">&#160;</td> <td colspan="6" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt">Nine months ended</font></td> <td style="padding-bottom: 1.5pt">&#160;</td></tr> <tr style="vertical-align: bottom"> <td>&#160;</td> <td style="padding-bottom: 1.5pt">&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt">2020</font></td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="padding-bottom: 1.5pt">&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt">2019</font></td> <td style="padding-bottom: 1.5pt">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="width: 62%"><font style="font-size: 10pt">Tax expense - Current</font></td> <td style="width: 1%">&#160;</td> <td style="width: 1%">&#160;</td> <td style="width: 16%; text-align: right">&#160;</td> <td style="width: 1%">&#160;</td> <td style="width: 1%">&#160;</td> <td style="width: 1%">&#160;</td> <td style="width: 16%; text-align: right">&#160;</td> <td style="width: 1%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="padding-left: 10pt"><font style="font-size: 10pt">Local</font></td> <td>&#160;</td> <td><font style="font-size: 10pt">$</font></td> <td style="text-align: right"><font style="font-size: 10pt">-</font></td> <td>&#160;</td> <td>&#160;</td> <td><font style="font-size: 10pt">$</font></td> <td style="text-align: right"><font style="font-size: 10pt">-</font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="padding-left: 10pt"><font style="font-size: 10pt">Foreign, representing:</font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right">&#160;</td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right">&#160;</td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="padding-left: 20pt"><font style="font-size: 10pt">Malaysia</font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">-</font></td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">-</font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="padding-left: 20pt"><font style="font-size: 10pt">Hong Kong</font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">-</font></td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">-</font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right">&#160;</td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right">&#160;</td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td><font style="font-size: 10pt">Tax expense &#8211; Prior year</font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right">&#160;</td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right">&#160;</td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="padding-left: 10pt"><font style="font-size: 10pt">Foreign, representing:</font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right">&#160;</td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right">&#160;</td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="padding-left: 20pt"><font style="font-size: 10pt">Malaysia</font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">-</font></td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">-</font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right">&#160;</td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right">&#160;</td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td><font style="font-size: 10pt">Deferred</font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right">&#160;</td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right">&#160;</td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="padding-left: 10pt"><font style="font-size: 10pt">Local</font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">-</font></td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">-</font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="padding-left: 10pt"><font style="font-size: 10pt">Foreign, representing:</font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right">&#160;</td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right">&#160;</td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="padding-left: 20pt"><font style="font-size: 10pt">Malaysia</font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">-</font></td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">-</font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="padding-bottom: 1.5pt; padding-left: 20pt"><font style="font-size: 10pt">Hong Kong</font></td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="border-bottom: black 1.5pt solid">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">-</font></td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="border-bottom: black 1.5pt solid">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">-</font></td> <td style="padding-bottom: 1.5pt">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="padding-bottom: 2.5pt">&#160;</td> <td style="padding-bottom: 2.5pt">&#160;</td> <td style="border-bottom: black 2.25pt double"><font style="font-size: 10pt">$</font></td> <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 10pt">-</font></td> <td style="padding-bottom: 2.5pt">&#160;</td> <td style="padding-bottom: 2.5pt">&#160;</td> <td style="border-bottom: black 2.25pt double"><font style="font-size: 10pt">$</font></td> <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 10pt">-</font></td> <td style="padding-bottom: 2.5pt">&#160;</td></tr> </table> 5000 The deposits of $ 19,394 (2019: $ 63,308) representing deposits paid for rental of hostels and various utilities. The prepayments of $ 6,810 (2019: $ 59,771) representing advanced payments made to suppliers for purchase of manufacturing materials. Bioplus Life International Holdings Ltd. was officially disposed off by the Group on August 5, 2020 at a consideration of RMB 5,000. The transfer results in gain on disposal of subsidiary of USD 17,505 as disclosed in Note 13 in Consolidated Statements of Operations and Comprehensive Income/(Loss). Bio Life Neutraceuticals (Shenzhen) Pty Ltd. was being officially de-registered in Shenzhen on September 4, 2020. EX-101.SCH 6 biopl-20200930.xsd XBRL SCHEMA FILE 00000001 - Document - Document and Entity Information link:presentationLink link:calculationLink link:definitionLink 00000002 - Statement - Consolidated Balance Sheets link:presentationLink link:calculationLink link:definitionLink 00000003 - Statement - Consolidated Balance Sheets (Parenthetical) link:presentationLink link:calculationLink link:definitionLink 00000004 - Statement - Consolidated Statements of Operations and Comprehensive Income/ (Loss) (Unaudited) link:presentationLink link:calculationLink link:definitionLink 00000005 - Statement - Consolidated Statement of Changes in Stockholders' Equity link:presentationLink link:calculationLink link:definitionLink 00000006 - Statement - Consolidated Statements of Cash Flows (Unaudited) link:presentationLink link:calculationLink link:definitionLink 00000007 - Disclosure - Organization and Business Background link:presentationLink link:calculationLink link:definitionLink 00000008 - Disclosure - Summary of Significant Accounting Policies link:presentationLink link:calculationLink link:definitionLink 00000009 - Disclosure - Amount Due from Related Parties link:presentationLink link:calculationLink link:definitionLink 00000010 - Disclosure - Inventories link:presentationLink link:calculationLink link:definitionLink 00000011 - Disclosure - Other Receivables, Deposits and Prepayments link:presentationLink link:calculationLink link:definitionLink 00000012 - Disclosure - Property, Plant and Equipment, Net link:presentationLink link:calculationLink link:definitionLink 00000013 - Disclosure - Obligation Under Finance Lease link:presentationLink link:calculationLink link:definitionLink 00000014 - Disclosure - Bank Borrowings link:presentationLink link:calculationLink link:definitionLink 00000015 - Disclosure - Other Payables and Accrued Liabilities link:presentationLink link:calculationLink link:definitionLink 00000016 - Disclosure - Income Taxes link:presentationLink link:calculationLink link:definitionLink 00000017 - Disclosure - Stockholders' Equity link:presentationLink link:calculationLink link:definitionLink 00000018 - Disclosure - Concentration of Risk link:presentationLink link:calculationLink link:definitionLink 00000019 - Disclosure - Other Income link:presentationLink link:calculationLink link:definitionLink 00000020 - Disclosure - Foreign Currency Exchange Rate link:presentationLink link:calculationLink link:definitionLink 00000021 - Disclosure - Subsequent Events link:presentationLink link:calculationLink link:definitionLink 00000022 - Disclosure - Significant Events link:presentationLink link:calculationLink link:definitionLink 00000023 - Disclosure - Summary of Significant Accounting Policies (Policies) link:presentationLink link:calculationLink link:definitionLink 00000024 - Disclosure - Organization and Business Background (Tables) link:presentationLink link:calculationLink link:definitionLink 00000025 - Disclosure - Summary of Significant Accounting Policies (Tables) link:presentationLink link:calculationLink link:definitionLink 00000026 - Disclosure - Inventories (Tables) link:presentationLink link:calculationLink link:definitionLink 00000027 - Disclosure - Other Receivables, Deposits and Prepayments (Tables) link:presentationLink link:calculationLink link:definitionLink 00000028 - Disclosure - Property, Plant and Equipment, Net (Tables) link:presentationLink link:calculationLink link:definitionLink 00000029 - Disclosure - Obligation Under Finance Lease (Tables) link:presentationLink link:calculationLink link:definitionLink 00000030 - Disclosure - Bank Borrowings (Tables) link:presentationLink link:calculationLink link:definitionLink 00000031 - Disclosure - Other Payables and Accrued Liabilities (Tables) link:presentationLink link:calculationLink link:definitionLink 00000032 - Disclosure - Income Taxes (Tables) link:presentationLink link:calculationLink link:definitionLink 00000033 - Disclosure - Stockholders' Equity (Tables) link:presentationLink link:calculationLink link:definitionLink 00000034 - Disclosure - Concentration of Risk (Tables) link:presentationLink link:calculationLink link:definitionLink 00000035 - Disclosure - Other Income (Tables) link:presentationLink link:calculationLink link:definitionLink 00000036 - Disclosure - Organization and Business Background (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000037 - Disclosure - Organization and Business Background - Schedule of Subsidiaries Details (Details) link:presentationLink link:calculationLink link:definitionLink 00000038 - Disclosure - Organization and Business Background - Schedule of Subsidiaries Details (Details) (Parenthetical) link:presentationLink link:calculationLink link:definitionLink 00000039 - Disclosure - Summary of Significant Accounting Policies (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000040 - Disclosure - Summary of Significant Accounting Policies - Schedule of Property Plant and Equipment, Principal Annual Rates/Expected Useful Life (Details) link:presentationLink link:calculationLink link:definitionLink 00000041 - Disclosure - Summary of Significant Accounting Policies - Schedule of Exchange Rates (Details) link:presentationLink link:calculationLink link:definitionLink 00000042 - Disclosure - Inventories - Schedule of Inventories (Details) link:presentationLink link:calculationLink link:definitionLink 00000043 - Disclosure - Other Receivables, Deposits and Prepayments - Summary of Other Receivables, Deposits and Prepayments (Details) link:presentationLink link:calculationLink link:definitionLink 00000044 - Disclosure - Other Receivables, Deposits and Prepayments - Summary of Other Receivables, Deposits and Prepayments (Details) (Parenthetical) link:presentationLink link:calculationLink link:definitionLink 00000045 - Disclosure - Property, Plant and Equipment, Net (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000046 - Disclosure - Property, Plant and Equipment, Net - Schedule of Property, Plant and Equipment (Details) link:presentationLink link:calculationLink link:definitionLink 00000047 - Disclosure - Obligation Under Finance Lease (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000048 - Disclosure - Obligation Under Finance Lease - Schedule of Obligation Under Finance Lease (Details) link:presentationLink link:calculationLink link:definitionLink 00000049 - Disclosure - Bank Borrowings (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000050 - Disclosure - Bank Borrowings - Schedule of Bank Borrowings (Details) link:presentationLink link:calculationLink link:definitionLink 00000051 - Disclosure - Other Payables and Accrued Liabilities - Schedule of Other Payables and Accrued Liabilities (Details) link:presentationLink link:calculationLink link:definitionLink 00000052 - Disclosure - Income Taxes (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000053 - Disclosure - Income Taxes - Schedule of Profit or Loss Before Income Tax (Details) link:presentationLink link:calculationLink link:definitionLink 00000054 - Disclosure - Income Taxes - Schedule of Provision for Income Tax (Details) link:presentationLink link:calculationLink link:definitionLink 00000055 - Disclosure - Stockholders' Equity (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000056 - Disclosure - Stockholders' Equity - Schedule of Stockholders' Equity (Details) link:presentationLink link:calculationLink link:definitionLink 00000057 - Disclosure - Concentration of Risk - Schedules of Concentration of Risk by Major Customer and Major Suppliers (Details) link:presentationLink link:calculationLink link:definitionLink 00000058 - Disclosure - Other Income - Schedule of Other Income (Details) link:presentationLink link:calculationLink link:definitionLink EX-101.CAL 7 biopl-20200930_cal.xml XBRL CALCULATION FILE EX-101.DEF 8 biopl-20200930_def.xml XBRL DEFINITION FILE EX-101.LAB 9 biopl-20200930_lab.xml XBRL LABEL FILE Equity Components [Axis] Common Stock [Member] Additional Paid Up Share Capital [Member] Accumulated Profit /(Loss) [Member] Accumulated Other Comprehensive Loss [Member] Geographical [Axis] China [Member] Investment, Name [Axis] Bioplus Life International Holdings Limited [Member] Hong Kong [Member] Bio Life Neutraceuticals Sdn Bhd [Member] Property, Plant and Equipment, Type [Axis] Motor Vehicle [Member] Leasehold Land and Building [Member] Computer Hardware [Member] Furniture & Fittings [Member] Handphone [Member] Landscape [Member] Machinery [Member] Office Equipment [Member] Renovation [Member] Signboard [Member] Tools and Equipment [Member] Collaborative Arrangement and Arrangement Other than Collaborative [Axis] Finance Leases Agreement [Member] Facilities Agreement [Member] Short-term Debt, Type [Axis] Bank Overdraft [Member] Term Loan [Member] Related Party [Axis] Third Party [Member] Malaysia [Member] Bioplus Life Corp. (Labuan) [Member] Bioplus Life International Holdings Ltd. [Member] Award Type [Axis] HK [Member] Bio Life Holdings Berhad [Member] RM [Member] Period-End MYR [Member] Period Average MYR [Member] Period-End RMB [Member] Period Average RMB [Member] Statistical Measurement [Axis] Minimum [Member] Maximum [Member] United States of America [Member] Bio Life Neutraceuticals (Shenzhen) Pty Ltd. (Labuan) [Member] RMB [Member] Kitchen Utensils [Member] Concentration Risk Benchmark [Axis] Revenues and Its Accounts Receivable [Member] Concentration Risk Type [Axis] Major Customers [Member] Customer [Axis] Customer A [Member] Customer B [Member] Outstanding Payables [Member] Major Suppliers [Member] Customer C [Member] Consolidated Entities [Axis] Common stock [Member] Additional paid up share capital [Member] Accumulated profit/(loss) Accumulated other comprehensive loss Cover [Abstract] Entity Registrant Name Entity Central Index Key Document Type Document Period End Date Amendment Flag Current Fiscal Year End Date Entity Current Reporting Status Entity Interactive Data Current Entity Filer Category Entity Small Business Flag Entity Emerging Growth Company Entity Ex Transition Period Entity Shell Company Entity Common Stock, Shares Outstanding Document Fiscal Period Focus Document Fiscal Year Focus Statement of Financial Position [Abstract] ASSETS Current assets: Cash and bank balances Account receivables Income tax receivables Amount due from related parties Amount due from directors Inventories Other receivables, deposits and prepayments Total current assets Non-current assets: Property, plant and equipment, net Total non-current assets TOTAL ASSETS LIABILITIES AND STOCKHOLDERS' EQUITY Current liabilities: Account payables Obligation under finance lease Bank borrowings Other payables and accrued liabilities Provision for taxation Bank overdraft Amount due to directors Total current liabilities Non-current liabilities: Obligation under finance lease Bank borrowings Deferred taxation Total non-current liabilities TOTAL LIABILITIES Stockholders' equity: Common stock, par value $0.0001: 362,905,561 and 359,305,561 shares issued and outstanding as of September 30, 2020 and December 31 2019, respectively. Additional paid up share capital Accumulated profit/(loss) Other comprehensive loss Total stockholders' equity TOTAL LIABILITIES AND STOCKHOLDERS EQUITY Common stock, par value Common stock, shares issued Common stock, shares outstanding Income Statement [Abstract] Revenues, net Cost of revenues Gross profit Other income Operating expenses: General and operating expenses Finance cost Total expenses Profit from operations Gain on disposal of subsidiary Income tax expense NET PROFIT Other comprehensive income/(loss): - Foreign currency translation gain/(loss) TOTAL COMPREHENSIVE INCOME/(LOSS) Earnings per share Weighted average number of common shares outstanding -Basic and diluted Statement [Table] Statement [Line Items] Balance Balance, shares Common stock issued Common stock issued, shares Net profit (loss) Foreign currency translation gain Balance Balance, shares Statement of Cash Flows [Abstract] Cash flows from operating activities: Net profit Adjustments to reconcile net profit/(loss) to net cash used in operating activities: Depreciation of property, plant and equipment Interest expenses Bad debt written off Operating profit before working capital changes Changes in operating assets and liabilities: Inventories Account receivables Other receivables, deposits and prepayments Amount due from related parties Amount due from directors Account payable Other payables and accrued liabilities Cash generated from/ (used in) operating activities Tax refunded Tax paid Net cash generated from/(used in) operating activities Cash flows from investing activities: Purchase of property, plant and equipment Net cash used in investing activities Cash flows from financing activities: Proceed from issued shares Interest expenses Repayment of term loan borrowing Repayment of hire purchase borrowing Net cash used in financing activities Foreign currency translation adjustment NET CHANGE IN CASH AND CASH EQUIVALENTS CASH AND CASH EQUIVALENTS, BEGINNING OF FINANCIAL PERIOD CASH AND CASH EQUIVALENTS, END OF FINANCIAL PERIOD CASH AND CASH EQUIVALENTS INFORMATION Cash and bank balance Bank overdraft Cash and cash equivalents, end of financial period Organization, Consolidation and Presentation of Financial Statements [Abstract] Organization and Business Background Accounting Policies [Abstract] Summary of Significant Accounting Policies Related Party Transactions [Abstract] Amount Due from Related Parties Inventory Disclosure [Abstract] Inventories Other Receivables Deposits And Prepayments Other Receivables, Deposits and Prepayments Property, Plant and Equipment [Abstract] Property, Plant and Equipment, Net Leases [Abstract] Obligation Under Finance Lease Debt Disclosure [Abstract] Bank Borrowings Payables and Accruals [Abstract] Other Payables and Accrued Liabilities Income Tax Disclosure [Abstract] Income Taxes Equity [Abstract] Stockholders' Equity Risks and Uncertainties [Abstract] Concentration of Risk Other Income and Expenses [Abstract] Other Income Foreign Currency [Abstract] Foreign Currency Exchange Rate Subsequent Events [Abstract] Subsequent Events Significant Events Significant Events Basis of Presentation Basis of Consolidation Use of Estimates Cash and Cash Equivalents Property, Plant and Equipment Inventories Revenue Recognition Cost of Revenues Shipping and Handling Fees Comprehensive Income Income Tax Expense Foreign Currencies Translation Related Parties Fair Value of Financial Instruments Recent Accounting Pronouncements Schedule of Subsidiaries Details Schedule of Property Plant and Equipment, Principal Annual Rates/Expected Useful Life Schedule of Exchange Rates Schedule of Inventories Summary of Other Receivables, Deposits and Prepayments Schedule of Property, Plant and Equipment Schedule of Obligation Under Finance Lease Schedule of Bank Borrowings Schedule of Other Payables and Accrued Liabilities Schedule of Profit or Loss Before Income Tax Schedule of Provision for Income Tax Schedule of Stockholders' Equity Schedules of Concentration of Risk by Major Customer and Major Suppliers Schedule of Other Income Equity interest, percentage Place of incorporation Date of incorporation Ordinary shares, issued Ordinary shares, per share Principal activities Consideration from disposal of subsidiary Currency translation conversion Income tax likelihood, description Long-Lived Tangible Asset [Axis] Principal annual rates Expected useful life Exchange rates Raw material Packing Material Finished goods Total inventories Other Receivables Deposits And Prepayments - Summary Of Other Receivables Deposits And Prepayments Other receivables Deposits Prepayments Other receivables, deposits and prepayments Other Receivables Deposits And Prepayments - Summary Of Other Receivables Deposits And Prepayments Details Prepayments Depreciation expense Property, plant and equipment (Less): Accumulated depreciation Add/(Less): Foreign translation difference Property, plant and equipment, net Effective interest rate Present value of hire purchase liabilities: Not later than one year Present value of hire purchase liabilities: Later than one year but not later than two years Present value of hire purchase liabilities: Later than two years but not later than five years Present value of hire purchase liabilities Current portion Non-current portion Lease liability Secured facility Secured facility, description Secured facility, interest rate Secured facility, term Secured facility, payment Bank Borrowings Current portion Non-current portion Other payables generated from Local Other payables from non-trade payable Common outstanding from third parties Accrued other expenses Accrued expenses - Balance bring forward Accrued expenses - payroll Accrued expenses - payroll deduction Accrued expenses - professional fee Accrued expenses - Commission Accrued expenses - expense Accrued expenses Deposits received from customers Share subscription receipts in advance Cumulative net operating loss Net operating loss carryforward expiration Valuation allowance Income tax rate, percentage Tax jurisdictions from: Local Tax jurisdictions from: Foreign, representing Profit/(Loss) before income tax Tax expense - Current Local Tax expense - Current Foreign, representing Tax expense - Prior year Foreign, representing Deferred Local Deferred Foreign, representing Provision for income taxes At the beginning of the period Issued during the period At the end of the period Revenues Percentage of revenues Other income Realized gain on foreign exchange Other income Gain on disposal of subsidiary Bank overdraft. Bio Life Holdings Berhad [Member] Bio Life Neutraceuticals Sdn Bhd [Member] Bio Life Solution Sdn. Bhd. [Member] Bioplus Life Corp. (Labuan) [Member] Bioplus Life International Holdings Limited [Member] Bioplus Life International Holdings Ltd. [Member] Cash and bank balance. Cash and cash equivalents. Computer Hardware [Member] D and L Wellness Sdn. Bhd. [Member] Facilities Agreement [Member] Finance cost. Finance Leases Agreement [Member] Foreign currency translation adjustment. Furniture &amp; Fittings [Member] GO3U Trading Sdn. Bhd. [Member] Greenpro Asia Strategic SPC [Member] Greenpro Venture Capital Limited [Member] Handphone [Member] HK [Member] Increase decrease in other receivables, deposits and prepayments. Increase decrease in tax paid. Lab Tests [Member] Landscape [Member] Machinery [Member] RM [Member] Motor Vehicle [Member] Mr. Chong Khooi You [Member] Operating profit before working capital changes. Ordinary Shares [Member] Other payables and accrued liabilities [Text Block] Other receivables, deposits and prepayments, current. Other receivables, deposits and prepayments [Text Block] Packaging Charges [Member] Payment of interest expenses. Provision for taxation, current Purchases [Member] Related parties [Policy Text Block] Related Party A [Member] Related Party B [Member] Schedule of property plant and equipment, principal annual rates/expected useful life [Table Text Block] Shipping and handling fees [Policy Text Block] Signboard [Member] Summary of other receivables, deposits and prepayments [Table Text Block] Term Loan [Member] Third Party [Member] Tools and Equipment [Member] United States of America [Member] Year-End MYR [Member] Year-End RMB [Member] Yearly Average MYR [Member] Yearly Average RMB [Member] Amount due from directors. Cash generated from used in operating activities. Bioplus Life Corp. (ShenZhen) [Member] Place of incorporation. Date of incorporation. Principal activities. Currency translation conversion. Principal annual rates. Period-End MYR [Member] Period Average MYR [Member] Period-End RMB [Member] Period Average RMB [Member] Prepayments, current. Prepayments. Foreign translation difference related to property, plant and equipment, net. Effective interest rate on finance lease. Present value of hire purchase liabilities: Not later than one year. Present value of hire purchase liabilities:Later than one year but not later than two years. Present value of hire purchase liabilities: Later than two years but not later than five years. Secured facility. Secured facility, description. Other payables generated from Local. Other payables from non-trade payable Common outstanding from third parties. Accrued expenses - Balance bring forward. Accrued expenses - payroll deductions Accrued expenses - expenses. Share subscription receipts in advance. Net operating loss carryforward expiration. Amount of prior foreign income tax expense (benefit) pertaining to income (loss) from continuing operations. Malaysia Labuan [Member] Bio Life Neutraceuticals (Shenzhen) Pty Ltd. (Labuan) [Member] China Renminbi [Member] Basis of consolidation policy [Policy Text Block] Kitchen Utensils [Member] Inventory, packing material, net of reserves. Customer A [Member] Customer B [Member] Customer C [Member] Significant event [Text Block] Amount due from related parties [Text Block] Amount of increase (decrease) in related party receivables classified as other, due within one year or operating cycle, if longer. Bad debt written off. Increase (decrease) in tax refunded. Other income excluding realized gain on foreign exchange. Other income before operating expenses. Assets, Current Assets, Noncurrent Assets Liabilities, Current Loans Payable to Bank, Noncurrent Liabilities, Noncurrent Liabilities Stockholders' Equity Attributable to Parent Liabilities and Equity Cost of Revenue Gross Profit General and Administrative Expense FinanceCost Operating Expenses Operating Income (Loss) Comprehensive Income (Loss), Net of Tax, Attributable to Parent Shares, Outstanding OperatingProfitBeforeWorkingCapitalChanges Increase (Decrease) in Inventories Increase (Decrease) in Accounts Receivable IncreaseDecreaseInOtherReceivablesDepositsAndPrepayments Increase (Decrease) in Due from Related Parties, Current IncreaseDecreaseInDueFromOtherRelatedPartyCurrent Increase (Decrease) in Accounts Payable CashGeneratedFromUsedInOperatingActivities IncreaseDecreaseInTaxRefunded Net Cash Provided by (Used in) Operating Activities Payments to Acquire Property, Plant, and Equipment Net Cash Provided by (Used in) Investing Activities PaymentOfInterestExpenses Repayments of Debt Repayments of Short-term Debt Net Cash Provided by (Used in) Financing Activities ForeignCurrencyTranslationAdjustment Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations BankOverdraft CashAndCashEquivalents Inventory Disclosure [Text Block] SignificantEventTextBlock Inventory, Policy [Policy Text Block] Prepayments [Default Label] Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment ForeignTranslationDifferencePropertyPlantAndEquipment Loans Payable to Bank Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest OtherIncomeExcludingRealizedGainOnForeignExchange Other Income [Default Label] Gain (Loss) on Disposition of Stock in Subsidiary EX-101.PRE 10 biopl-20200930_pre.xml XBRL PRESENTATION FILE XML 11 R1.htm IDEA: XBRL DOCUMENT v3.20.4
Document and Entity Information - shares
 9 Months Ended
Sep. 30, 2020
Oct. 12, 2020
Cover [Abstract]    
Entity Registrant Name BIOPLUS LIFE CORP.  
Entity Central Index Key 0001746214  
Document Type 10-Q  
Document Period End Date Sep. 30, 2020  
Amendment Flag false  
Current Fiscal Year End Date --12-31  
Entity Current Reporting Status No  
Entity Interactive Data Current No  
Entity Filer Category Non-accelerated Filer  
Entity Small Business Flag true  
Entity Emerging Growth Company true  
Entity Ex Transition Period false  
Entity Shell Company false  
Entity Common Stock, Shares Outstanding   362,905,561
Document Fiscal Period Focus Q3  
Document Fiscal Year Focus 2020  
XML 12 R2.htm IDEA: XBRL DOCUMENT v3.20.4
Consolidated Balance Sheets - USD ($)
Sep. 30, 2020
Dec. 31, 2019
Current assets:    
Cash and bank balances $ 334,162 $ 210,740
Account receivables 553,917 308,688
Income tax receivables 55,446 7,675
Amount due from related parties 30,282 19,771
Amount due from directors 5,821
Inventories 357,526 303,954
Other receivables, deposits and prepayments 39,174 133,060
Total current assets 1,370,507 989,709
Non-current assets:    
Property, plant and equipment, net 2,222,182 2,217,247
Total non-current assets 2,222,182 2,217,247
TOTAL ASSETS 3,592,689 3,206,956
Current liabilities:    
Account payables 210,968 48,298
Obligation under finance lease 31,632 33,343
Bank borrowings 39,129 195,027
Other payables and accrued liabilities 510,723 494,045
Provision for taxation 3,604 3,604
Bank overdraft 72,173  
Amount due to directors 4,569 8,489
Total current liabilities 872,798 782,806
Non-current liabilities:    
Obligation under finance lease 82,739 92,133
Bank borrowings 550,660 553,144
Deferred taxation 41,954 42,631
Total non-current liabilities 675,353 687,908
TOTAL LIABILITIES 1,548,151 1,470,714
Stockholders' equity:    
Common stock, par value $0.0001: 362,905,561 and 359,305,561 shares issued and outstanding as of September 30, 2020 and December 31 2019, respectively. 36,291 35,931
Additional paid up share capital 1,998,870 1,998,870
Accumulated profit/(loss) 99,379 (216,550)
Other comprehensive loss (90,002) (82,009)
Total stockholders' equity 2,044,538 1,736,242
TOTAL LIABILITIES AND STOCKHOLDERS EQUITY $ 3,592,689 $ 3,206,956
XML 13 R3.htm IDEA: XBRL DOCUMENT v3.20.4
Consolidated Balance Sheets (Parenthetical) - $ / shares
Sep. 30, 2020
Dec. 31, 2019
Statement of Financial Position [Abstract]    
Common stock, par value $ 0.0001 $ 0.0001
Common stock, shares issued 362,905,561 359,305,561
Common stock, shares outstanding 362,905,561 359,305,561
XML 14 R4.htm IDEA: XBRL DOCUMENT v3.20.4
Consolidated Statements of Operations and Comprehensive Income/ (Loss) (Unaudited) - USD ($)
 3 Months Ended 9 Months Ended
Sep. 30, 2020
Sep. 30, 2019
Sep. 30, 2020
Sep. 30, 2019
Income Statement [Abstract]        
Revenues, net $ 989,461 $ 446,437 $ 2,449,661 $ 1,201,326
Cost of revenues (588,637) (210,313) (1,422,514) (614,299)
Gross profit 400,824 236,124 1,027,147 587,027
Other income 592 285 2,192 3,400
Operating expenses:        
General and operating expenses (281,687) (188,020) (721,176) (559,247)
Finance cost (8,137) (9,738) (24,913)
Total expenses (281,687) (196,157) (730,914) (584,160)
Profit from operations 119,729 40,252 298,425 6,267
Gain on disposal of subsidiary 17,505 17,505 1,099
Income tax expense
NET PROFIT 137,234 40,252 315,930 7,366
Other comprehensive income/(loss):        
- Foreign currency translation gain/(loss) 60,146 (15,699) (7,993) (17,100)
TOTAL COMPREHENSIVE INCOME/(LOSS) $ 197,380 $ 24,553 $ 307,937 $ (9,734)
Earnings per share $ 0.00 $ 0.00 $ 0.00 $ 0.00
Weighted average number of common shares outstanding -Basic and diluted 362,905,561 358,787,945 362,905,561 358,787,945
XML 15 R5.htm IDEA: XBRL DOCUMENT v3.20.4
Consolidated Statement of Changes in Stockholders' Equity - USD ($)
Common Stock [Member]
Additional Paid Up Share Capital [Member]
Accumulated Profit /(Loss) [Member]
Accumulated Other Comprehensive Loss [Member]
Total
Balance at Dec. 31, 2018 $ 35,931 $ 1,998,870 $ (123,358) $ (114,711) $ 1,796,732
Balance, shares at Dec. 31, 2018 359,305,561        
Common stock issued        
Net profit (loss) (93,192) (93,192)
Foreign currency translation gain 32,702 32,702
Balance at Dec. 31, 2019 $ 35,931 1,998,870 (216,550) (82,009) 1,736,242
Balance, shares at Dec. 31, 2019 359,305,561        
Common stock issued $ 360 360
Common stock issued, shares 3,600,000        
Net profit (loss) 8,219 8,219
Foreign currency translation gain (87,070) (87,070)
Balance at Mar. 31, 2020 $ 36,291 1,998,870 (208,331) (169,079) 1,657,751
Balance, shares at Mar. 31, 2020 362,905,561        
Balance at Dec. 31, 2019 $ 35,931 1,998,870 (216,550) (82,009) 1,736,242
Balance, shares at Dec. 31, 2019 359,305,561        
Common stock issued         360
Net profit (loss)         315,930
Foreign currency translation gain         (7,993)
Balance at Sep. 30, 2020 $ 36,291 1,998,870 99,379 (90,002) 2,044,538
Balance, shares at Sep. 30, 2020 362,905,561        
Balance at Mar. 31, 2020 $ 36,291 1,998,870 (208,331) (169,079) 1,657,751
Balance, shares at Mar. 31, 2020 362,905,561        
Net profit (loss) 170,476 170,476
Foreign currency translation gain 18,931 18,931
Balance at Jun. 30, 2020 $ 36,291 1,998,870 (37,855) (150,148) 1,847,158
Balance, shares at Jun. 30, 2020 362,905,561        
Net profit (loss) 137,234 137,234
Foreign currency translation gain 60,146 60,146
Balance at Sep. 30, 2020 $ 36,291 $ 1,998,870 $ 99,379 $ (90,002) $ 2,044,538
Balance, shares at Sep. 30, 2020 362,905,561        
XML 16 R6.htm IDEA: XBRL DOCUMENT v3.20.4
Consolidated Statements of Cash Flows (Unaudited) - USD ($)
 9 Months Ended
Sep. 30, 2020
Sep. 30, 2019
Cash flows from operating activities:    
Net profit $ 315,928 $ 7,366
Adjustments to reconcile net profit/(loss) to net cash used in operating activities:    
Depreciation of property, plant and equipment 93,429 82,857
Interest expenses 9,738 24,912
Bad debt written off 23,092
Operating profit before working capital changes 442,187 115,135
Changes in operating assets and liabilities:    
Inventories (57,768) 141,160
Account receivables (253,739) 204,680
Other receivables, deposits and prepayments 74,029 (12,290)
Amount due from related parties (10,708) (69,699)
Amount due from directors 2,063 (2,725)
Account payable 161,677 (212,063)
Other payables and accrued liabilities 22,477 (187,355)
Cash generated from/ (used in) operating activities 380,218 (23,157)
Tax refunded 1,942
Tax paid (47,378) (34,845)
Net cash generated from/(used in) operating activities 332,840 (56,060)
Cash flows from investing activities:    
Purchase of property, plant and equipment (133,810) (33,692)
Net cash used in investing activities (133,810) (33,692)
Cash flows from financing activities:    
Proceed from issued shares 360
Interest expenses (9,738) (24,912)
Repayment of term loan borrowing (7,155) (28,574)
Repayment of hire purchase borrowing (9,015) (18,108)
Net cash used in financing activities (25,548) (71,594)
Foreign currency translation adjustment 19,287 6,522
NET CHANGE IN CASH AND CASH EQUIVALENTS 173,842 (154,824)
CASH AND CASH EQUIVALENTS, BEGINNING OF FINANCIAL PERIOD 69,220 255,554
CASH AND CASH EQUIVALENTS, END OF FINANCIAL PERIOD 261,989 100,730
CASH AND CASH EQUIVALENTS INFORMATION    
Cash and bank balance 334,162 100,730
Bank overdraft (72,173)
Cash and cash equivalents, end of financial period $ 261,989 $ 100,730
XML 17 R7.htm IDEA: XBRL DOCUMENT v3.20.4
Organization and Business Background
 9 Months Ended
Sep. 30, 2020
Organization, Consolidation and Presentation of Financial Statements [Abstract]  
Organization and Business Background

NOTE 1- ORGANIZATION AND BUSINESS BACKGROUND

 

Bioplus Life Corp., a Nevada corporation (“the Company”) was incorporated under the laws of the State of Nevada on April 13, 2017. For purposes of financial statements presentation, Bioplus Life Corp. and its subsidiaries are herein referred to as “the Company” or “We”.

 

We have historically conducted our business through Bio Life Neutraceuticals Sdn Bhd, a private limited liability company, incorporated in Malaysia. Bioplus Life Corp. (US), incorporated in United State of Nevada, is an investment holding company with 100% equity interest in Bioplus Life Corp. (Labuan), a company incorporated in Labuan, which subsequent hold 100% equity interest in Bioplus Life International Holdings Limited, a company incorporated in Hong Kong, which subsequent hold 99.8% equity interest in Bio Life Holdings Berhad, a company incorporated in Malaysia, which subsequent hold 100% equity interest in Bio Life Neutraceuticals Sdn Bhd. On December 31, 2017, Bioplus Life Corp was organized to be holding company parent to, and succeed to the operations of, Bioplus Life Corp. (Labuan), Bioplus Life International Holdings Ltd, Bio Life Holdings Berhad and Bio Life Neutraceuticals Sdn Bhd. This transaction was accounted for as a transaction among entities under common control and the assets, liabilities, revenues, and expenses, and as if the transfer occurred at the beginning of the period. Prior periods have been retrospectively adjusted to furnish comparative information.

 

The Company, through its subsidiaries, supplies high quality health products. Details of the Company’s subsidiaries:

 

No   Company Name   Place/Date of Incorporation   Particulars of Issued Capital   Principal Activities
1   Bioplus Life Corp. (Labuan)  

Malaysia, Labuan

May 19, 2017

   100 shares of
ordinary shares of US$1 each		   Investment Holding
                 
2   Bioplus Life International Holdings Ltd. (A)  

Hong Kong

June 20, 2017

   1 shares of ordinary shares
of HK$1 each		   Investment Holding
                 
3   Bio Life Holdings Berhad  

Malaysia

May 19, 2016

   107,992 shares of ordinary shares of RM1 each   Investment Holding
                 

4

 

   Bio Life Neutraceuticals Sdn Bhd  

Malaysia, Selangor

August 27, 2009

   5,456,207 shares of ordinary shares of RM1 each   Trading of Consumer Products
                 
5   Bio Life Neutraceuticals (Shenzhen) Pty Ltd. (B)  

Shenzhen

October 27, 2017

   500,000 shares of ordinary shares of RMB1 each   Trading of Healthy Supplement and Cosmetics

 

(A) Bioplus Life International Holdings Ltd. was officially disposed off by the Group on August 5, 2020 at a consideration of RMB 5,000. The transfer results in gain on disposal of subsidiary of USD 17,505 as disclosed in Note 13 in Consolidated Statements of Operations and Comprehensive Income/(Loss).

 

(B) Bio Life Neutraceuticals (Shenzhen) Pty Ltd. was being officially de-registered in Shenzhen on September 4, 2020.
XML 18 R8.htm IDEA: XBRL DOCUMENT v3.20.4
Summary of Significant Accounting Policies
 9 Months Ended
Sep. 30, 2020
Accounting Policies [Abstract]  
Summary of Significant Accounting Policies
2. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

 

● Basis of presentation

 

These accompanying financial statements have been prepared in accordance with generally accepted accounting principles in the United States of America (“US GAAP”).

 

● Basis of consolidation

 

In this Quarterly Report, “the Company,” “us” or “we” refer to the consolidated entity, including its subsidiaries and affiliates. The terms refer only to the publicly held holding company, The Bioplus Life Corporation, excluding its subsidiaries and affiliates. Furthermore, in which the Company has a variable interest have been consolidated where the Company is the primary beneficiary. All intercompany transactions and balances have been eliminated in consolidation.

 

● Use of estimates

 

In preparing these financial statements, management makes estimates and assumptions that affect the reported amounts of assets and liabilities in the balance sheets and revenues and expenses during the periods reported. Actual results may differ from these estimates.

 

● Cash and cash equivalents

 

Cash and cash equivalents represent cash on hand, demand deposits placed with banks or other financial institutions and all highly liquid investments with an original maturity of three months or less as of the purchase date of such investments.

 

● Property, plant and equipment

 

Property and plant and equipment are stated at cost less accumulated depreciation and accumulated impairment losses, if any. Depreciation is calculated on the straight-line basis to write off the cost over the following expected useful lives of the assets concerned. The principal annual rates used are as follows:

 

Categories   Principal Annual Rates/Expected Useful Life  
Computer hardware     20 %
Furniture & fittings     10 %
Handphone     20 %
Landscape     20 %
Leasehold land and building     99 years  
Machinery     10 %
Motor vehicle     20 %
Office equipment     10 %
Renovation     20 %
Signboard     10 %
Tools and equipment     10 %

Kitchen utensils 10%

 

Fully depreciated plant and equipment are retained in the financial statements until they are no longer in use.

 

● Inventories

 

Inventories consisting of products available for sell, are stated at the lower of cost or market value. Cost of inventory is determined using the first-in, first-out (FIFO) method. Inventory reserve is recorded to write down the cost of inventory to the estimated market value due to slow-moving merchandise and damaged goods, which is dependent upon factors such as historical and forecasted consumer demand, and promotional environment. The Company takes ownership, risks and rewards of the products purchased. Write downs are recorded in cost of revenues in the Consolidated Statements of Operations and Comprehensive Income.

  

● Revenue recognition

 

Revenues are recognized when control of the promised goods or services are transferred to a customer, in an amount that reflects the consideration that the Company expects to receive in exchange for those goods or services. The Company applies the following five steps in order to determine the appropriate amount of revenue to be recognized as it fulfills its obligations under each of its agreements:

 

  ● identify the contract with a customer;
  ● identify the performance obligations in the contract;
  ● determine the transaction price;
  ● allocate the transaction price to performance obligations in the contract; and
  ● recognize revenue as the performance obligation is satisfied.

 

● Cost of revenues

 

Cost of revenue includes the purchase cost of retail goods for re-sale to customers and packing materials (such as boxes). It excludes purchasing and receiving costs, inspection costs, warehousing costs, internal transfer costs and other costs of distribution network in cost of revenues.

 

● Shipping and handling fees

 

Shipping and handling fees, if billed to customers, are included in revenue. Shipping and handling fees associated with inbound and outbound freight are expensed as incurred and included in selling and distribution expenses.

 

● Comprehensive income

 

ASC Topic 220, “Comprehensive Income” establishes standards for reporting and display of comprehensive income, its components and accumulated balances. Comprehensive income as defined includes all changes in equity during a period from non-owner sources. Accumulated other comprehensive income, as presented in the accompanying statements of stockholders’ equity consists of changes in unrealized gains and losses on foreign currency translation and cumulative net change in the fair value of available-for-sale investments held at the balance sheet date. This comprehensive income is not included in the computation of income tax expense or benefit.

 

● Income tax expense

 

Income taxes are determined in accordance with the provisions of ASC Topic 740, “Income Taxes” (“ASC Topic 740”). Under this method, deferred tax assets and liabilities are recognized for the future tax consequences attributable to differences between the financial statement carrying amounts of existing assets and liabilities and their respective tax basis. Deferred tax assets and liabilities are measured using enacted income tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. Any effect on deferred tax assets and liabilities of a change in tax rates is recognized in income in the period that includes the enactment date.

 

ASC 740 prescribes a comprehensive model for how companies should recognize, measure, present, and disclosed in their financial statements uncertain tax positions taken or expected to be taken on a tax return. Under ASC 740, tax positions must initially be recognized in the financial statements when it is more likely than not the position will be sustained upon examination by the tax authorities. Such tax positions must initially and subsequently be measured as the largest amount of tax benefit that has a greater than 50% likelihood of being realized upon ultimate settlement with the tax authority assuming full knowledge of the position and relevant facts.

 

The Company conducts major businesses in Malaysia and is subject to tax in their own jurisdictions. As a result of its business activities, the Company will file separate tax returns that are subject to examination by the foreign tax authorities.

 

● Foreign currencies translation

 

Transactions denominated in currencies other than the functional currency are translated into the functional currency at the exchange rates prevailing at the dates of the transaction. Monetary assets and liabilities denominated in currencies other than the functional currency are translated into the functional currency using the applicable exchange rates at the balance sheet dates. The resulting exchange differences are recorded in the statement of operations.

 

The functional currency of the Company is the United States Dollars (“US$”) and the accompanying financial statements have been expressed in US$. In addition, the Company maintains its books and record in a local currency, Malaysian Ringgit (“MYR” or “RM”), which is functional currency as being the primary currency of the economic environment in which the entity operates.

 

In general, for consolidation purposes, assets and liabilities of its subsidiaries whose functional currency is not US$ are translated into US$, in accordance with ASC Topic 830-30, “Translation of Financial Statement”, using the exchange rate on the balance sheet date. Revenues and expenses are translated at average rates prevailing during the period. The gains and losses resulting from translation of financial statements of foreign subsidiary are recorded as a separate component of accumulated other comprehensive income.

 

Translation of amounts from the local currency of the Company into US$1 has been made at the following exchange rates for the respective period:

 

    As of and for the nine months ended September 30,  
    2020     2019  
Period-end MYR: US$1 exchange rate     4.1585       4.1349  
Period average MYR: US$1 exchange rate     4.2038       4.1870  
Period-end US$1: RMB exchange rate     0.1473       0.1454  
Period average US$1: RMB exchange rate     0.1446       0.1471  

 

● Related parties

 

Parties, which can be a corporation or individual, are considered to be related if the Company has the ability, directly or indirectly, to control the other party or exercise significant influence over the other party in making financial and operating decisions. Companies are also considered to be related if they are subject to common control or common significant influence.

 

● Fair value of financial instruments

 

The carrying value of the Company’s financial instruments: cash and cash equivalents, trade receivable, deposits and other receivables, amount due to related parties and other payables approximate at their fair values because of the short-term nature of these financial instruments.

 

The Company also follows the guidance of the ASC Topic 820-10, “Fair Value Measurements and Disclosures” (“ASC 820-10”), with respect to financial assets and liabilities that are measured at fair value. ASC 820-10 establishes a three-tier fair value hierarchy that prioritizes the inputs used in measuring fair value as follows:

 

● Level 1: Observable inputs such as quoted prices in active markets;
● Level 2: Inputs, other than the quoted prices in active markets, that are observable either directly or indirectly; and
● Level 3: Unobservable inputs in which there is little or no market data, which require the reporting entity to develop its own assumptions

 

As of September 30, 2020, and December 31, 2019, the Company did not have any nonfinancial assets and liabilities that are recognized or disclosed at fair value in the financial statements, at least annually, on a recurring basis, nor did the Company have any assets or liabilities measured at fair value on a non-recurring basis.

 

● Recent accounting pronouncements

 

Management has considered all recent accounting pronouncements issued since the last audit of our financial statements. The Company’s management believes that these recent pronouncements will not have a material effect on the Company’s financial statements.
XML 19 R9.htm IDEA: XBRL DOCUMENT v3.20.4
Amount Due from Related Parties
 9 Months Ended
Sep. 30, 2020
Related Party Transactions [Abstract]  
Amount Due from Related Parties
3. AMOUNT DUE FROM RELATED PARTIES

 

The amounts are unsecured, bear no interest and are payable on demand.
XML 20 R10.htm IDEA: XBRL DOCUMENT v3.20.4
Inventories
 9 Months Ended
Sep. 30, 2020
Inventory Disclosure [Abstract]  
Inventories
4. INVENTORIES

 

    As of  
    September 30, 2020     December 31, 2019  
Raw material   $ 302,918     $ 245,877  
Packing Material     27,294       23,858  
Finished goods     27,314       34,219  
Total inventories   $ 357,526     $ 303,954  
XML 21 R11.htm IDEA: XBRL DOCUMENT v3.20.4
Other Receivables, Deposits and Prepayments
 9 Months Ended
Sep. 30, 2020
Other Receivables Deposits And Prepayments  
Other Receivables, Deposits and Prepayments
5. OTHER RECEIVABLES, DEPOSITS AND PREPAYMENTS

 

    As of  
    September 30, 2020     December 31, 2019  
Other receivables   $ 12,970     $ 9,981  
Deposits   5.1 19,394       63,308  
Prepayments   5.2 6,810       59,771  
    $ 39,174     $ 133,060  

 

5.1 The deposits of $ 19,394 (2019: $ 63,308) representing deposits paid for rental of hostels and various utilities.

 

5.2 The prepayments of $ 6,810 (2019: $ 59,771) representing advanced payments made to suppliers for purchase of manufacturing materials.
XML 22 R12.htm IDEA: XBRL DOCUMENT v3.20.4
Property, Plant and Equipment, Net
 9 Months Ended
Sep. 30, 2020
Property, Plant and Equipment [Abstract]  
Property, Plant and Equipment, Net
6. PROPERTY, PLANT AND EQUIPMENT, NET

 

Property, plant and equipment consisted of the following:

 

    As of  
    September 30, 2020     December 31, 2019  
             
Computer hardware   $ 40,430     $ 32,814  
Furniture & fittings     112,198       106,945  
Handphone     3,724       3,514  
Landscape     3,691       3,475  
Leasehold land and building     1,875,962       1,872,476  
Machinery     175,677       119,413  
Motor vehicle     243,630       243,630  
Office equipment     59,123       52,725  
Renovation     142,099       92,646  
Signboard     5,470       4,648  
Tools and equipment     6,930       4,348  
Kitchen utensils     1,740       -  
    $ 2,670,674     $ 2,536,634  
(Less): Accumulated depreciation     (412,814 )     (315,762 )
Add/(Less): Foreign translation difference     (35,678 )     (3,625 )
Property, plant and equipment, net   $ 2,222,182     $ 2,217,247  

 

Depreciation expense for the period ended September 30, 2020 and September 30, 2019 were $93, 429 and $82,857, respectively.

 

As of September 30, 2020, and December 31, 2019 the Company acquired motor vehicles under finance leases with carrying value of $101,385 and $129,925 respectively.

 

The leasehold land and building with carrying amount of $1,786,756 and $1,797,002 as of September 30, 2020 and December 31, 2019, respectively have been charged to licensed bank to secure banking facilities granted to the Company.
XML 23 R13.htm IDEA: XBRL DOCUMENT v3.20.4
Obligation Under Finance Lease
 9 Months Ended
Sep. 30, 2020
Leases [Abstract]  
Obligation Under Finance Lease
7. OBLIGATION UNDER FINANCE LEASE

 

The Company purchased motor vehicles under finance lease agreements with the effective interest rate of 2.48% - 4.31% per annum (2019: 5.22% per annum), with principal and interest payable monthly. The obligation under the finance leases are as follows:

 

    As of  
    September 30, 2020     December 31, 2019  
Present value of hire purchase liabilities:   $       $    
Not later than one year     31,632       33,343  
Later than one year but not later than two years     32,097       32,496  
Later than two years but not later than five years     50,642       59,637  
      114,371       125,476  

 

    As Of  
    September 30, 2020     December 31, 2019  
Analyzed as:   $       $    
Current portion     31,632       33,343  
Non-current portion     82,739       92,133  
      114,371       125,476  
XML 24 R14.htm IDEA: XBRL DOCUMENT v3.20.4
Bank Borrowings
 9 Months Ended
Sep. 30, 2020
Debt Disclosure [Abstract]  
Bank Borrowings
8. BANK BORROWINGS

 

    As of  
    September 30, 2020     December 31, 2019  
Secured: -   $     $  
Bank overdraft     72,173       141,520  
Term loan     589,789       606,651  
      661,962       748,171  

 

    As of  
    September 30, 2020     December 31, 2019  
Analyzed as:   $     $  
Current portion     111,302       195,027  
Non-current portion     550,660       553,144  
    $ 661,962     $ 748,171  

 

The bank overdraft of the Company is secured by way of the following:

 

  a. A Facilities Agreement for US$377,277 (MYR579,171);

 

  b. Master Facility Agreement.

 

  c. Joint and Several Guarantee to be executed by the subsidiary directors of Bio Life Neutraceuticals Sdn Bhd.

 

Interested charged on the bank overdraft is 4% (2019: 4%) above the bank base lending rate per annum.

 

The term loan of the Company is secured by way of the following:

 

  a. A Facilities Agreement for US$1,705,086 (MYR2,842,719);

 

  b. Master Facility Agreement.

 

  c. Joint and Several Guarantee to be executed by the subsidiary directors of Bio Life Neutraceuticals Sdn Bhd.

 

The term loan is payable by 240 monthly installments of US$4,492 (MYR18,248) each including interest, commencing from Oct 10, 2016 and subject to interest at 4% per annum flat.
XML 25 R15.htm IDEA: XBRL DOCUMENT v3.20.4
Other Payables and Accrued Liabilities
 9 Months Ended
Sep. 30, 2020
Payables and Accruals [Abstract]  
Other Payables and Accrued Liabilities
9. OTHER PAYABLES AND ACCRUED LIABILITIES

 

    As of  
    September 30, 2020     December 31, 2019  
Other payables generated from:     $       $  
Local     5,262       41,645  
Foreign, representing:                
Malaysia     -       -  
Common outstanding from non-trade payable     36,562       37,110  
Common outstanding from third parties     827       1,004  
China     -       -  
Common outstanding from third parties     147       861  
    $ 42,798     $ 80,620  
                 
Accrued other expenses                
Local                
Foreign, representing:                
Malaysia                
Payroll     23,640       18,550  
Payroll deduction     8,961       7,873  
Professional Fee     1,619       11,499  
Commission     37,255       43,563  
Expenses     787       1,157  
    $ 72,262     $ 82,642  
Hong Kong     -       -  
                 
Deposit received from customers     285,663       226,783  
                 
Share subscription receipts in advance     110,000       104,000  
    $ 510,723     $ 494,045  
XML 26 R16.htm IDEA: XBRL DOCUMENT v3.20.4
Income Taxes
 9 Months Ended
Sep. 30, 2020
Income Tax Disclosure [Abstract]  
Income Taxes
10. INCOME TAXES

 

    Nine months ended  
    2020     2019  
Tax jurisdictions from:                
Local   $ (58,232 )   $ (36,326 )
Foreign, representing:                
Malaysia     392,990       47,020  
Hong Kong     (17,775 )     (1,859 )
China     (1,054 )     (1,469 )
Profit/(Loss) before income tax   $ 315,929     $ 7,366  

 

The provision for income taxes consisted of the following:

 

    Nine months ended  
    2020     2019  
Tax expense - Current                
Local   $ -     $ -  
Foreign, representing:                
Malaysia     -       -  
Hong Kong     -       -  
                 
Tax expense – Prior year                
Foreign, representing:                
Malaysia     -       -  
                 
Deferred                
Local     -       -  
Foreign, representing:                
Malaysia     -       -  
Hong Kong     -       -  
    $ -     $ -  

 

The effective tax rate in the periods presented is the result of the mix of income earned in various tax jurisdictions that apply a broad range of income tax rates. The Company has subsidiaries that operate in various countries: United States, Hong Kong and Malaysia that are subject to taxes in the jurisdictions in which they operate, as follows:

 

United States of America

 

The Company is registered in the State of Nevada and is subject to the tax laws of the United States of America. As of September 30, 2020, the operations in the United States of America incurred $461,206 of cumulative net operating losses which can be carried forward to offset future taxable income. The net operating loss carry forwards begin to expire in 2039, if unutilized. The Company has provided for a full valuation allowance of $4,896 against the deferred tax assets on the expected future tax benefits from the net operating loss carry forwards as the management believes it is more likely than not that these assets will not be realized in the future.

 

Malaysia

 

Bio Life Holdings Berhad (“BLHB”) and Bio Life Neutraceuticals Sdn Bhd (“BLNSB”) are subject to the Malaysia Corporate Tax Laws at a tax rate of 24% on the assessable income for its tax year.

 

Hong Kong

 

Bioplus Life International Holdings Ltd is subject to Hong Kong Profits Tax, which is charged at the statutory income tax rate of 16.5% on its assessable income.

 

China

 

Bio Life Neutraceuticals (Shenzhen) Pty Ltd. is registered in the Shen Zhen and is subject to the China Corporate Tax, which is charged at the statutory income tax rate of 25% on its assessable income.
XML 27 R17.htm IDEA: XBRL DOCUMENT v3.20.4
Stockholders' Equity
 9 Months Ended
Sep. 30, 2020
Equity [Abstract]  
Stockholders' Equity
11. STOCKHOLDERS’ EQUITY

 

During the year, the Company has issued the following common stock:

 

    As of  
    September 30, 2020     December 31, 2019  
Issued and fully paid:   $       $    
                 
At the beginning of the period     2,034,801       2,034,801  
Issued during the period     360       -  
                 
At the end of the period   $ 2,035,161     $ 2,034,801  

 

As of September 30, 2020, and December 31, 2019, Bioplus Life Corp has an issued and outstanding common share of 362,905,561 and 359,305,561 respectively.
XML 28 R18.htm IDEA: XBRL DOCUMENT v3.20.4
Concentration of Risk
 9 Months Ended
Sep. 30, 2020
Risks and Uncertainties [Abstract]  
Concentration of Risk
12. CONCENTRATION OF RISK

 

(a) Major Customers

 

For the three months ended September 30, 2020 and 2019, the customers who accounted for 10% or more of the Company’s revenues and its accounts receivable at period-end are presented as follows:

 

    Revenues     Percentage of revenues  
    2020     2019     2020     2019  
                         
Customer A   $ -     $ 55,257       -       12 %
Customer B     152,423       53,979       15 %     12 %
Customer C     369,623       -       37 %     -  
                                 
    $ 522,046     $ 109,236       52 %     24 %

 

For the nine months ended September 30, 2020 and 2019, the customers who accounted for 10% or more of the Company’s revenues and its accounts receivable at period-end are presented as follows:

 

    Revenues     Percentage of revenues  
    2020     2019     2020     2019  
                         
Customer A   $ 138,771     $ 153,195       5 %     12 %
Customer B     964,146       49,515       39 %     4 %
                                 
    $ 1,102,917     $ 202,710       44 %     16 %

 

(b) Major Suppliers

 

For the three months ended September 30, 2020 and 2019, there was no supplier who accounted for 10% or more of the Company’s purchases nor with significant outstanding payables.

 

    Revenues     Percentage of revenues  
    2020     2019     2020     2019  
                         
Supplier A   $ 352,297     $ 93,455       64 %     88 %
Supplier B     99,328       -       18 %     -  
Supplier C     65,418       -       12 %     -  
                                 
    $ 517,043     $ 93,455       94 %     88 %

 

For the nine months ended September 30, 2020 and 2019, there was no supplier who accounted for 10% or more of the Company’s purchases nor with significant outstanding payables.

 

    Revenues     Percentage of revenues  
    2020     2019     2020     2019  
                         
Supplier A   $ 633,555     $ 267,081       58 %     88 %
Supplier B     250,203       16,308       23 %     5 %
                                 
    $ 883,758     $ 283,389       81 %     93 %
XML 29 R19.htm IDEA: XBRL DOCUMENT v3.20.4
Other Income
 9 Months Ended
Sep. 30, 2020
Other Income and Expenses [Abstract]  
Other Income
13. OTHER INCOME

 

    Nine months ended  
    2020     2019  
Other income   $ 192     $ 77  
Realized gain on foreign exchange     1,999       3,323  
    $ 2,191     $ 3,400  
                 
Gain on disposal of subsidiary   $ 17,505     $ 1,099  
XML 30 R20.htm IDEA: XBRL DOCUMENT v3.20.4
Foreign Currency Exchange Rate
 9 Months Ended
Sep. 30, 2020
Foreign Currency [Abstract]  
Foreign Currency Exchange Rate
14. FOREIGN CURRENCY EXCHANGE RATE

 

The Company cannot guarantee that the current exchange rate will remain stable, therefore there is a possibility that the Company could post the same amount of income for two comparable periods and because of the fluctuating exchange rate post higher or lower income depending on exchange rate converted into US$ at the end of the financial period. The exchange rate could fluctuate depending on changes in political and economic environments without notice.
XML 31 R21.htm IDEA: XBRL DOCUMENT v3.20.4
Subsequent Events
 9 Months Ended
Sep. 30, 2020
Subsequent Events [Abstract]  
Subsequent Events
15. SUBSEQUENT EVENTS

 

In accordance with ASC Topic 855, “Subsequent Events”, which establishes general standards of accounting for and disclosure of events that occur after the balance sheet date but before financial statements are issued, the Company has evaluated all events or transactions that occurred after September 30, 2020 up through the date November 18, 2020 was the Company presented these audited consolidated financial statements.
XML 32 R22.htm IDEA: XBRL DOCUMENT v3.20.4
Significant Events
 9 Months Ended
Sep. 30, 2020
Significant Events  
Significant Events
16. SIGNIFICANT EVENTS

 

During the fiscal year, the World Health Organization (WHO) declared the Coronavirus (COVID-19) outbreak to be a pandemic, which has caused severe global social and economic disruptions and uncertainties, including markets where the Company operates.

 

The Company considers this outbreak as non-adjusting-events. The consequences brought about by Covid-19 continue to evolve and whilst the Company actively monitoring and managing its operations to respond to these changes, the Company does not consider it practicable to provide any quantitative estimate on the potential impact it may have on the Company.
XML 33 R23.htm IDEA: XBRL DOCUMENT v3.20.4
Summary of Significant Accounting Policies (Policies)
 9 Months Ended
Sep. 30, 2020
Accounting Policies [Abstract]  
Basis of Presentation
● Basis of presentation

 

These accompanying financial statements have been prepared in accordance with generally accepted accounting principles in the United States of America (“US GAAP”).
Basis of Consolidation
● Basis of consolidation

 

In this Quarterly Report, “the Company,” “us” or “we” refer to the consolidated entity, including its subsidiaries and affiliates. The terms refer only to the publicly held holding company, The Bioplus Life Corporation, excluding its subsidiaries and affiliates. Furthermore, in which the Company has a variable interest have been consolidated where the Company is the primary beneficiary. All intercompany transactions and balances have been eliminated in consolidation.
Use of Estimates
● Use of estimates

 

In preparing these financial statements, management makes estimates and assumptions that affect the reported amounts of assets and liabilities in the balance sheets and revenues and expenses during the periods reported. Actual results may differ from these estimates.
Cash and Cash Equivalents
● Cash and cash equivalents

 

Cash and cash equivalents represent cash on hand, demand deposits placed with banks or other financial institutions and all highly liquid investments with an original maturity of three months or less as of the purchase date of such investments.
Property, Plant and Equipment
● Property, plant and equipment

 

Property and plant and equipment are stated at cost less accumulated depreciation and accumulated impairment losses, if any. Depreciation is calculated on the straight-line basis to write off the cost over the following expected useful lives of the assets concerned. The principal annual rates used are as follows:

 

Categories   Principal Annual Rates/Expected Useful Life  
Computer hardware     20 %
Furniture & fittings     10 %
Handphone     20 %
Landscape     20 %
Leasehold land and building     99 years  
Machinery     10 %
Motor vehicle     20 %
Office equipment     10 %
Renovation     20 %
Signboard     10 %
Tools and equipment     10 %

Kitchen utensils 10%

 

Fully depreciated plant and equipment are retained in the financial statements until they are no longer in use.
Inventories
● Inventories

 

Inventories consisting of products available for sell, are stated at the lower of cost or market value. Cost of inventory is determined using the first-in, first-out (FIFO) method. Inventory reserve is recorded to write down the cost of inventory to the estimated market value due to slow-moving merchandise and damaged goods, which is dependent upon factors such as historical and forecasted consumer demand, and promotional environment. The Company takes ownership, risks and rewards of the products purchased. Write downs are recorded in cost of revenues in the Consolidated Statements of Operations and Comprehensive Income.
Revenue Recognition
● Revenue recognition

 

Revenues are recognized when control of the promised goods or services are transferred to a customer, in an amount that reflects the consideration that the Company expects to receive in exchange for those goods or services. The Company applies the following five steps in order to determine the appropriate amount of revenue to be recognized as it fulfills its obligations under each of its agreements:

 

  ● identify the contract with a customer;
  ● identify the performance obligations in the contract;
  ● determine the transaction price;
  ● allocate the transaction price to performance obligations in the contract; and
  ● recognize revenue as the performance obligation is satisfied.
Cost of Revenues
● Cost of revenues

 

Cost of revenue includes the purchase cost of retail goods for re-sale to customers and packing materials (such as boxes). It excludes purchasing and receiving costs, inspection costs, warehousing costs, internal transfer costs and other costs of distribution network in cost of revenues.
Shipping and Handling Fees
● Shipping and handling fees

 

Shipping and handling fees, if billed to customers, are included in revenue. Shipping and handling fees associated with inbound and outbound freight are expensed as incurred and included in selling and distribution expenses.
Comprehensive Income
● Comprehensive income

 

ASC Topic 220, “Comprehensive Income” establishes standards for reporting and display of comprehensive income, its components and accumulated balances. Comprehensive income as defined includes all changes in equity during a period from non-owner sources. Accumulated other comprehensive income, as presented in the accompanying statements of stockholders’ equity consists of changes in unrealized gains and losses on foreign currency translation and cumulative net change in the fair value of available-for-sale investments held at the balance sheet date. This comprehensive income is not included in the computation of income tax expense or benefit.
Income Tax Expense
● Income tax expense

 

Income taxes are determined in accordance with the provisions of ASC Topic 740, “Income Taxes” (“ASC Topic 740”). Under this method, deferred tax assets and liabilities are recognized for the future tax consequences attributable to differences between the financial statement carrying amounts of existing assets and liabilities and their respective tax basis. Deferred tax assets and liabilities are measured using enacted income tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. Any effect on deferred tax assets and liabilities of a change in tax rates is recognized in income in the period that includes the enactment date.

 

ASC 740 prescribes a comprehensive model for how companies should recognize, measure, present, and disclosed in their financial statements uncertain tax positions taken or expected to be taken on a tax return. Under ASC 740, tax positions must initially be recognized in the financial statements when it is more likely than not the position will be sustained upon examination by the tax authorities. Such tax positions must initially and subsequently be measured as the largest amount of tax benefit that has a greater than 50% likelihood of being realized upon ultimate settlement with the tax authority assuming full knowledge of the position and relevant facts.

 

The Company conducts major businesses in Malaysia and is subject to tax in their own jurisdictions. As a result of its business activities, the Company will file separate tax returns that are subject to examination by the foreign tax authorities.
Foreign Currencies Translation
● Foreign currencies translation

 

Transactions denominated in currencies other than the functional currency are translated into the functional currency at the exchange rates prevailing at the dates of the transaction. Monetary assets and liabilities denominated in currencies other than the functional currency are translated into the functional currency using the applicable exchange rates at the balance sheet dates. The resulting exchange differences are recorded in the statement of operations.

 

The functional currency of the Company is the United States Dollars (“US$”) and the accompanying financial statements have been expressed in US$. In addition, the Company maintains its books and record in a local currency, Malaysian Ringgit (“MYR” or “RM”), which is functional currency as being the primary currency of the economic environment in which the entity operates.

 

In general, for consolidation purposes, assets and liabilities of its subsidiaries whose functional currency is not US$ are translated into US$, in accordance with ASC Topic 830-30, “Translation of Financial Statement”, using the exchange rate on the balance sheet date. Revenues and expenses are translated at average rates prevailing during the period. The gains and losses resulting from translation of financial statements of foreign subsidiary are recorded as a separate component of accumulated other comprehensive income.

 

Translation of amounts from the local currency of the Company into US$1 has been made at the following exchange rates for the respective period:

 

    As of and for the nine months ended September 30,  
    2020     2019  
Period-end MYR: US$1 exchange rate     4.1585       4.1349  
Period average MYR: US$1 exchange rate     4.2038       4.1870  
Period-end US$1: RMB exchange rate     0.1473       0.1454  
Period average US$1: RMB exchange rate     0.1446       0.1471  
Related Parties
● Related parties

 

Parties, which can be a corporation or individual, are considered to be related if the Company has the ability, directly or indirectly, to control the other party or exercise significant influence over the other party in making financial and operating decisions. Companies are also considered to be related if they are subject to common control or common significant influence.
Fair Value of Financial Instruments
● Fair value of financial instruments

 

The carrying value of the Company’s financial instruments: cash and cash equivalents, trade receivable, deposits and other receivables, amount due to related parties and other payables approximate at their fair values because of the short-term nature of these financial instruments.

 

The Company also follows the guidance of the ASC Topic 820-10, “Fair Value Measurements and Disclosures” (“ASC 820-10”), with respect to financial assets and liabilities that are measured at fair value. ASC 820-10 establishes a three-tier fair value hierarchy that prioritizes the inputs used in measuring fair value as follows:

 

● Level 1: Observable inputs such as quoted prices in active markets;
● Level 2: Inputs, other than the quoted prices in active markets, that are observable either directly or indirectly; and
● Level 3: Unobservable inputs in which there is little or no market data, which require the reporting entity to develop its own assumptions

 

As of September 30, 2020, and December 31, 2019, the Company did not have any nonfinancial assets and liabilities that are recognized or disclosed at fair value in the financial statements, at least annually, on a recurring basis, nor did the Company have any assets or liabilities measured at fair value on a non-recurring basis.
Recent Accounting Pronouncements
● Recent accounting pronouncements

 

Management has considered all recent accounting pronouncements issued since the last audit of our financial statements. The Company’s management believes that these recent pronouncements will not have a material effect on the Company’s financial statements.
XML 34 R24.htm IDEA: XBRL DOCUMENT v3.20.4
Organization and Business Background (Tables)
 9 Months Ended
Sep. 30, 2020
Organization, Consolidation and Presentation of Financial Statements [Abstract]  
Schedule of Subsidiaries Details

The Company, through its subsidiaries, supplies high quality health products. Details of the Company’s subsidiaries:

 

No   Company Name   Place/Date of Incorporation   Particulars of Issued Capital   Principal Activities
1   Bioplus Life Corp. (Labuan)  

Malaysia, Labuan

May 19, 2017

   100 shares of
ordinary shares of US$1 each		   Investment Holding
                 
2   Bioplus Life International Holdings Ltd. (A)  

Hong Kong

June 20, 2017

   1 shares of ordinary shares
of HK$1 each		   Investment Holding
                 
3   Bio Life Holdings Berhad  

Malaysia

May 19, 2016

   107,992 shares of ordinary shares of RM1 each   Investment Holding
                 

4

 

   Bio Life Neutraceuticals Sdn Bhd  

Malaysia, Selangor

August 27, 2009

   5,456,207 shares of ordinary shares of RM1 each   Trading of Consumer Products
                 
5   Bio Life Neutraceuticals (Shenzhen) Pty Ltd. (B)  

Shenzhen

October 27, 2017

   500,000 shares of ordinary shares of RMB1 each   Trading of Healthy Supplement and Cosmetics

 

(A) Bioplus Life International Holdings Ltd. was officially disposed off by the Group on August 5, 2020 at a consideration of RMB 5,000. The transfer results in gain on disposal of subsidiary of USD 17,505 as disclosed in Note 13 in Consolidated Statements of Operations and Comprehensive Income/(Loss).

 

(B) Bio Life Neutraceuticals (Shenzhen) Pty Ltd. was being officially de-registered in Shenzhen on September 4, 2020.
XML 35 R25.htm IDEA: XBRL DOCUMENT v3.20.4
Summary of Significant Accounting Policies (Tables)
 9 Months Ended
Sep. 30, 2020
Accounting Policies [Abstract]  
Schedule of Property Plant and Equipment, Principal Annual Rates/Expected Useful Life

The principal annual rates used are as follows:

 

Categories   Principal Annual Rates/Expected Useful Life  
Computer hardware     20 %
Furniture & fittings     10 %
Handphone     20 %
Landscape     20 %
Leasehold land and building     99 years  
Machinery     10 %
Motor vehicle     20 %
Office equipment     10 %
Renovation     20 %
Signboard     10 %
Tools and equipment     10 %

Kitchen utensils 10%
Schedule of Exchange Rates

Translation of amounts from the local currency of the Company into US$1 has been made at the following exchange rates for the respective period:

 

    As of and for the nine months ended September 30,  
    2020     2019  
Period-end MYR: US$1 exchange rate     4.1585       4.1349  
Period average MYR: US$1 exchange rate     4.2038       4.1870  
Period-end US$1: RMB exchange rate     0.1473       0.1454  
Period average US$1: RMB exchange rate     0.1446       0.1471  
XML 36 R26.htm IDEA: XBRL DOCUMENT v3.20.4
Inventories (Tables)
 9 Months Ended
Sep. 30, 2020
Inventory Disclosure [Abstract]  
Schedule of Inventories
    As of  
    September 30, 2020     December 31, 2019  
Raw material   $ 302,918     $ 245,877  
Packing Material     27,294       23,858  
Finished goods     27,314       34,219  
Total inventories   $ 357,526     $ 303,954  
XML 37 R27.htm IDEA: XBRL DOCUMENT v3.20.4
Other Receivables, Deposits and Prepayments (Tables)
 9 Months Ended
Sep. 30, 2020
Other Receivables Deposits And Prepayments  
Summary of Other Receivables, Deposits and Prepayments
    As of  
    September 30, 2020     December 31, 2019  
Other receivables   $ 12,970     $ 9,981  
Deposits   5.1 19,394       63,308  
Prepayments   5.2 6,810       59,771  
    $ 39,174     $ 133,060  

 

5.1 The deposits of $ 19,394 (2019: $ 63,308) representing deposits paid for rental of hostels and various utilities.

 

5.2 The prepayments of $ 6,810 (2019: $ 59,771) representing advanced payments made to suppliers for purchase of manufacturing materials.
XML 38 R28.htm IDEA: XBRL DOCUMENT v3.20.4
Property, Plant and Equipment, Net (Tables)
 9 Months Ended
Sep. 30, 2020
Property, Plant and Equipment [Abstract]  
Schedule of Property, Plant and Equipment

Property, plant and equipment consisted of the following:

 

    As of  
    September 30, 2020     December 31, 2019  
             
Computer hardware   $ 40,430     $ 32,814  
Furniture & fittings     112,198       106,945  
Handphone     3,724       3,514  
Landscape     3,691       3,475  
Leasehold land and building     1,875,962       1,872,476  
Machinery     175,677       119,413  
Motor vehicle     243,630       243,630  
Office equipment     59,123       52,725  
Renovation     142,099       92,646  
Signboard     5,470       4,648  
Tools and equipment     6,930       4,348  
Kitchen utensils     1,740       -  
    $ 2,670,674     $ 2,536,634  
(Less): Accumulated depreciation     (412,814 )     (315,762 )
Add/(Less): Foreign translation difference     (35,678 )     (3,625 )
Property, plant and equipment, net   $ 2,222,182     $ 2,217,247  
XML 39 R29.htm IDEA: XBRL DOCUMENT v3.20.4
Obligation Under Finance Lease (Tables)
 9 Months Ended
Sep. 30, 2020
Leases [Abstract]  
Schedule of Obligation Under Finance Lease

The obligation under the finance leases are as follows:

 

    As of  
    September 30, 2020     December 31, 2019  
Present value of hire purchase liabilities:   $       $    
Not later than one year     31,632       33,343  
Later than one year but not later than two years     32,097       32,496  
Later than two years but not later than five years     50,642       59,637  
      114,371       125,476  

 

    As Of  
    September 30, 2020     December 31, 2019  
Analyzed as:   $       $    
Current portion     31,632       33,343  
Non-current portion     82,739       92,133  
      114,371       125,476  
XML 40 R30.htm IDEA: XBRL DOCUMENT v3.20.4
Bank Borrowings (Tables)
 9 Months Ended
Sep. 30, 2020
Debt Disclosure [Abstract]  
Schedule of Bank Borrowings
    As of  
    September 30, 2020     December 31, 2019  
Secured: -   $     $  
Bank overdraft     72,173       141,520  
Term loan     589,789       606,651  
      661,962       748,171  

 

    As of  
    September 30, 2020     December 31, 2019  
Analyzed as:   $     $  
Current portion     111,302       195,027  
Non-current portion     550,660       553,144  
    $ 661,962     $ 748,171  
XML 41 R31.htm IDEA: XBRL DOCUMENT v3.20.4
Other Payables and Accrued Liabilities (Tables)
 9 Months Ended
Sep. 30, 2020
Payables and Accruals [Abstract]  
Schedule of Other Payables and Accrued Liabilities
    As of  
    September 30, 2020     December 31, 2019  
Other payables generated from:     $       $  
Local     5,262       41,645  
Foreign, representing:                
Malaysia     -       -  
Common outstanding from non-trade payable     36,562       37,110  
Common outstanding from third parties     827       1,004  
China     -       -  
Common outstanding from third parties     147       861  
    $ 42,798     $ 80,620  
                 
Accrued other expenses                
Local                
Foreign, representing:                
Malaysia                
Payroll     23,640       18,550  
Payroll deduction     8,961       7,873  
Professional Fee     1,619       11,499  
Commission     37,255       43,563  
Expenses     787       1,157  
    $ 72,262     $ 82,642  
Hong Kong     -       -  
                 
Deposit received from customers     285,663       226,783  
                 
Share subscription receipts in advance     110,000       104,000  
    $ 510,723     $ 494,045  
XML 42 R32.htm IDEA: XBRL DOCUMENT v3.20.4
Income Taxes (Tables)
 9 Months Ended
Sep. 30, 2020
Income Tax Disclosure [Abstract]  
Schedule of Profit or Loss Before Income Tax
    Nine months ended  
    2020     2019  
Tax jurisdictions from:                
Local   $ (58,232 )   $ (36,326 )
Foreign, representing:                
Malaysia     392,990       47,020  
Hong Kong     (17,775 )     (1,859 )
China     (1,054 )     (1,469 )
Profit/(Loss) before income tax   $ 315,929     $ 7,366  
Schedule of Provision for Income Tax

The provision for income taxes consisted of the following:

 

    Nine months ended  
    2020     2019  
Tax expense - Current                
Local   $ -     $ -  
Foreign, representing:                
Malaysia     -       -  
Hong Kong     -       -  
                 
Tax expense – Prior year                
Foreign, representing:                
Malaysia     -       -  
                 
Deferred                
Local     -       -  
Foreign, representing:                
Malaysia     -       -  
Hong Kong     -       -  
    $ -     $ -  
XML 43 R33.htm IDEA: XBRL DOCUMENT v3.20.4
Stockholders' Equity (Tables)
 9 Months Ended
Sep. 30, 2020
Equity [Abstract]  
Schedule of Stockholders' Equity
    As of  
    September 30, 2020     December 31, 2019  
Issued and fully paid:   $       $    
                 
At the beginning of the period     2,034,801       2,034,801  
Issued during the period     360       -  
                 
At the end of the period   $ 2,035,161     $ 2,034,801  
XML 44 R34.htm IDEA: XBRL DOCUMENT v3.20.4
Concentration of Risk (Tables)
 9 Months Ended
Sep. 30, 2020
Risks and Uncertainties [Abstract]  
Schedules of Concentration of Risk by Major Customer and Major Suppliers

(a) Major Customers

 

For the three months ended September 30, 2020 and 2019, the customers who accounted for 10% or more of the Company’s revenues and its accounts receivable at period-end are presented as follows:

 

    Revenues     Percentage of revenues  
    2020     2019     2020     2019  
                         
Customer A   $ -     $ 55,257       -       12 %
Customer B     152,423       53,979       15 %     12 %
Customer C     369,623       -       37 %     -  
                                 
    $ 522,046     $ 109,236       52 %     24 %

 

For the nine months ended September 30, 2020 and 2019, the customers who accounted for 10% or more of the Company’s revenues and its accounts receivable at period-end are presented as follows:

 

    Revenues     Percentage of revenues  
    2020     2019     2020     2019  
                         
Customer A   $ 138,771     $ 153,195       5 %     12 %
Customer B     964,146       49,515       39 %     4 %
                                 
    $ 1,102,917     $ 202,710       44 %     16 %

 

(b) Major Suppliers

 

For the three months ended September 30, 2020 and 2019, there was no supplier who accounted for 10% or more of the Company’s purchases nor with significant outstanding payables.

 

    Revenues     Percentage of revenues  
    2020     2019     2020     2019  
                         
Supplier A   $ 352,297     $ 93,455       64 %     88 %
Supplier B     99,328       -       18 %     -  
Supplier C     65,418       -       12 %     -  
                                 
    $ 517,043     $ 93,455       94 %     88 %

 

For the nine months ended September 30, 2020 and 2019, there was no supplier who accounted for 10% or more of the Company’s purchases nor with significant outstanding payables.

 

    Revenues     Percentage of revenues  
    2020     2019     2020     2019  
                         
Supplier A   $ 633,555     $ 267,081       58 %     88 %
Supplier B     250,203       16,308       23 %     5 %
                                 
    $ 883,758     $ 283,389       81 %     93 %
XML 45 R35.htm IDEA: XBRL DOCUMENT v3.20.4
Other Income (Tables)
 9 Months Ended
Sep. 30, 2020
Other Income and Expenses [Abstract]  
Schedule of Other Income
    Nine months ended  
    2020     2019  
Other income   $ 192     $ 77  
Realized gain on foreign exchange     1,999       3,323  
    $ 2,191     $ 3,400  
                 
Gain on disposal of subsidiary   $ 17,505     $ 1,099  
XML 46 R36.htm IDEA: XBRL DOCUMENT v3.20.4
Organization and Business Background (Details Narrative)
Apr. 13, 2017
Bio Life Neutraceuticals Sdn Bhd [Member]  
Equity interest, percentage 100.00%
Hong Kong [Member] | Bioplus Life International Holdings Limited [Member]  
Equity interest, percentage 100.00%
Bioplus Life Corp. (Labuan) [Member]  
Equity interest, percentage 100.00%
Bio Life Holdings Berhad [Member] | Malaysia [Member]  
Equity interest, percentage 99.80%
XML 47 R37.htm IDEA: XBRL DOCUMENT v3.20.4
Organization and Business Background - Schedule of Subsidiaries Details (Details) - $ / shares
 9 Months Ended
Sep. 30, 2020
Dec. 31, 2019
Ordinary shares, issued 362,905,561 359,305,561
Bioplus Life Corp. (Labuan) [Member]    
Place of incorporation Malaysia, Labuan  
Date of incorporation May 19, 2017  
Ordinary shares, issued 100  
Ordinary shares, per share $ 1  
Principal activities Investment Holding  
Bioplus Life International Holdings Ltd. [Member]    
Place of incorporation [1] Hong Kong  
Date of incorporation [1] Jun. 20, 2017  
Ordinary shares, issued [1] 1  
Principal activities [1] Investment Holding  
Bioplus Life International Holdings Limited [Member] | HK [Member]    
Ordinary shares, per share [1] $ 1  
Bio Life Holdings Berhad [Member]    
Place of incorporation Malaysia  
Date of incorporation May 19, 2016  
Ordinary shares, issued 107,992  
Principal activities Investment Holding  
Bio Life Holdings Berhad [Member] | RM [Member]    
Ordinary shares, per share $ 1  
Bio Life Neutraceuticals Sdn Bhd [Member]    
Place of incorporation Malaysia, Selangor  
Date of incorporation Aug. 27, 2009  
Ordinary shares, issued 5,456,207  
Principal activities Trading of Consumer Products  
Bio Life Neutraceuticals Sdn Bhd [Member] | RM [Member]    
Ordinary shares, per share $ 1  
Bio Life Neutraceuticals (Shenzhen) Pty Ltd. (Labuan) [Member]    
Place of incorporation [2] Shenzhen  
Date of incorporation [2] Oct. 27, 2017  
Ordinary shares, issued [2] 500,000  
Principal activities [2] Trading of Healthy Supplement and Cosmetics  
Bio Life Neutraceuticals (Shenzhen) Pty Ltd. (Labuan) [Member] | RMB [Member]    
Ordinary shares, per share [2] $ 1  
[1] Bioplus Life International Holdings Ltd. was officially disposed off by the Group on August 5, 2020 at a consideration of RMB 5,000. The transfer results in gain on disposal of subsidiary of USD 17,505 as disclosed in Note 13 in Consolidated Statements of Operations and Comprehensive Income/(Loss).
[2] Bio Life Neutraceuticals (Shenzhen) Pty Ltd. was being officially de-registered in Shenzhen on September 4, 2020.
XML 48 R38.htm IDEA: XBRL DOCUMENT v3.20.4
Organization and Business Background - Schedule of Subsidiaries Details (Details) (Parenthetical)
 3 Months Ended 9 Months Ended
Aug. 05, 2020
CNY (¥)
Sep. 30, 2020
USD ($)
Sep. 30, 2019
USD ($)
Sep. 30, 2020
USD ($)
Sep. 30, 2019
USD ($)
Gain on disposal of subsidiary   $ 17,505 $ 17,505 $ 1,099
Bioplus Life International Holdings Ltd. [Member]          
Gain on disposal of subsidiary       $ 17,505  
Bioplus Life International Holdings Ltd. [Member] | RMB [Member]          
Consideration from disposal of subsidiary | ¥ ¥ 5,000        
XML 49 R39.htm IDEA: XBRL DOCUMENT v3.20.4
Summary of Significant Accounting Policies (Details Narrative)
 9 Months Ended
Sep. 30, 2020
USD ($)
Accounting Policies [Abstract]  
Currency translation conversion $ 1
Income tax likelihood, description Tax positions must initially and subsequently be measured as the largest amount of tax benefit that has a greater than 50% likelihood of being realized upon ultimate settlement with the tax authority assuming full knowledge of the position and relevant facts.
XML 50 R40.htm IDEA: XBRL DOCUMENT v3.20.4
Summary of Significant Accounting Policies - Schedule of Property Plant and Equipment, Principal Annual Rates/Expected Useful Life (Details)
 9 Months Ended
Sep. 30, 2020
Computer Hardware [Member]  
Principal annual rates 20.00%
Furniture & Fittings [Member]  
Principal annual rates 10.00%
Handphone [Member]  
Principal annual rates 20.00%
Landscape [Member]  
Principal annual rates 20.00%
Leasehold Land and Building [Member]  
Expected useful life 99 years
Machinery [Member]  
Principal annual rates 10.00%
Motor Vehicle [Member]  
Principal annual rates 20.00%
Office Equipment [Member]  
Principal annual rates 10.00%
Renovation [Member]  
Principal annual rates 20.00%
Signboard [Member]  
Principal annual rates 10.00%
Tools and Equipment [Member]  
Principal annual rates 10.00%
Kitchen Utensils [Member]  
Principal annual rates 10.00%
XML 51 R41.htm IDEA: XBRL DOCUMENT v3.20.4
Summary of Significant Accounting Policies - Schedule of Exchange Rates (Details)
Sep. 30, 2020
Sep. 30, 2019
Period-End MYR [Member]    
Exchange rates 4.1585 4.1349
Period Average MYR [Member]    
Exchange rates 4.2038 4.1870
Period-End RMB [Member]    
Exchange rates 0.1473 0.1454
Period Average RMB [Member]    
Exchange rates 0.1446 0.1471
XML 52 R42.htm IDEA: XBRL DOCUMENT v3.20.4
Inventories - Schedule of Inventories (Details) - USD ($)
Sep. 30, 2020
Dec. 31, 2019
Inventory Disclosure [Abstract]    
Raw material $ 302,918 $ 245,877
Packing Material 27,294 23,858
Finished goods 27,314 34,219
Total inventories $ 357,526 $ 303,954
XML 53 R43.htm IDEA: XBRL DOCUMENT v3.20.4
Other Receivables, Deposits and Prepayments - Summary of Other Receivables, Deposits and Prepayments (Details) - USD ($)
Sep. 30, 2020
Dec. 31, 2019
Other Receivables Deposits And Prepayments    
Other receivables $ 12,970 $ 9,981
Deposits [1] 19,394 63,308
Prepayments [2] 6,810 59,771
Other receivables, deposits and prepayments $ 39,174 $ 133,060
[1] The deposits of $ 19,394 (2019: $ 63,308) representing deposits paid for rental of hostels and various utilities.
[2] The prepayments of $ 6,810 (2019: $ 59,771) representing advanced payments made to suppliers for purchase of manufacturing materials.
XML 54 R44.htm IDEA: XBRL DOCUMENT v3.20.4
Other Receivables, Deposits and Prepayments - Summary of Other Receivables, Deposits and Prepayments (Details) (Parenthetical) - USD ($)
Sep. 30, 2020
Dec. 31, 2019
Other Receivables Deposits And Prepayments    
Deposits [1] $ 19,394 $ 63,308
Prepayments $ 6,810 $ 59,771
[1] The deposits of $ 19,394 (2019: $ 63,308) representing deposits paid for rental of hostels and various utilities.
XML 55 R45.htm IDEA: XBRL DOCUMENT v3.20.4
Property, Plant and Equipment, Net (Details Narrative) - USD ($)
 9 Months Ended
Sep. 30, 2020
Sep. 30, 2019
Dec. 31, 2019
Depreciation expense $ 93,429 $ 82,857  
Property, plant and equipment 2,670,674   $ 2,536,634
Motor Vehicle [Member]      
Property, plant and equipment 243,630   243,630
Motor Vehicle [Member] | Finance Leases Agreement [Member]      
Property, plant and equipment 101,385   129,925
Leasehold Land and Building [Member]      
Property, plant and equipment $ 1,875,962   $ 1,872,476
XML 56 R46.htm IDEA: XBRL DOCUMENT v3.20.4
Property, Plant and Equipment, Net - Schedule of Property, Plant and Equipment (Details) - USD ($)
Sep. 30, 2020
Dec. 31, 2019
Property, plant and equipment $ 2,670,674 $ 2,536,634
(Less): Accumulated depreciation (412,814) (315,762)
Add/(Less): Foreign translation difference (35,678) (3,625)
Property, plant and equipment, net 2,222,182 2,217,247
Computer Hardware [Member]    
Property, plant and equipment 40,430 32,814
Furniture & Fittings [Member]    
Property, plant and equipment 112,198 106,945
Handphone [Member]    
Property, plant and equipment 3,724 3,514
Landscape [Member]    
Property, plant and equipment 3,691 3,475
Leasehold Land and Building [Member]    
Property, plant and equipment 1,875,962 1,872,476
Machinery [Member]    
Property, plant and equipment 175,677 119,413
Motor Vehicle [Member]    
Property, plant and equipment 243,630 243,630
Office Equipment [Member]    
Property, plant and equipment 59,123 52,725
Renovation [Member]    
Property, plant and equipment 142,099 92,646
Signboard [Member]    
Property, plant and equipment 5,470 4,648
Tools and Equipment [Member]    
Property, plant and equipment 6,930 4,348
Kitchen Utensils [Member]    
Property, plant and equipment $ 1,740
XML 57 R47.htm IDEA: XBRL DOCUMENT v3.20.4
Obligation Under Finance Lease (Details Narrative) - Motor Vehicle [Member] - Finance Leases Agreement [Member]
 9 Months Ended 12 Months Ended
Sep. 30, 2020
Dec. 31, 2019
Effective interest rate   522.00%
Minimum [Member]    
Effective interest rate 248.00%  
Maximum [Member]    
Effective interest rate 431.00%  
XML 58 R48.htm IDEA: XBRL DOCUMENT v3.20.4
Obligation Under Finance Lease - Schedule of Obligation Under Finance Lease (Details) - USD ($)
Sep. 30, 2020
Dec. 31, 2019
Leases [Abstract]    
Present value of hire purchase liabilities: Not later than one year $ 31,632 $ 33,343
Present value of hire purchase liabilities: Later than one year but not later than two years 32,097 32,496
Present value of hire purchase liabilities: Later than two years but not later than five years 50,642 59,637
Present value of hire purchase liabilities 114,371 125,476
Current portion 31,632 33,343
Non-current portion 82,739 92,133
Lease liability $ 114,371 $ 125,476
XML 59 R49.htm IDEA: XBRL DOCUMENT v3.20.4
Bank Borrowings (Details Narrative) - Facilities Agreement [Member]
 9 Months Ended
Oct. 10, 2016
USD ($)
Oct. 10, 2016
MYR (RM)
Sep. 30, 2020
USD ($)
Sep. 30, 2020
MYR (RM)
Sep. 30, 2019
Bank Overdraft [Member]          
Secured facility | $     $ 377,277    
Secured facility, description     Master Facility Agreement. Joint and Several Guarantee to be executed by the subsidiary directors of Bio Life Neutraceuticals Sdn Bhd.    
Secured facility, interest rate     4.00% 4.00% 4.00%
Bank Overdraft [Member] | RM [Member]          
Secured facility | RM       RM 579,171  
Term Loan [Member]          
Secured facility | $     $ 1,705,086    
Secured facility, description     Master Facility Agreement. Joint and Several Guarantee to be executed by the subsidiary directors of Bio Life Neutraceuticals Sdn Bhd.    
Secured facility, interest rate     4.00% 4.00%  
Secured facility, term The term loan is payable by 240 monthly installments The term loan is payable by 240 monthly installments      
Secured facility, payment | $ $ 4,492        
Term Loan [Member] | RM [Member]          
Secured facility | RM       RM 2,842,719  
Secured facility, payment | RM   RM 18,248      
XML 60 R50.htm IDEA: XBRL DOCUMENT v3.20.4
Bank Borrowings - Schedule of Bank Borrowings (Details) - USD ($)
Sep. 30, 2020
Dec. 31, 2019
Bank Borrowings $ 661,962 $ 748,171
Current portion 39,129 195,027
Non-current portion 550,660 553,144
Bank Overdraft [Member]    
Bank Borrowings 72,173 141,520
Term Loan [Member]    
Bank Borrowings $ 589,789 $ 606,651
XML 61 R51.htm IDEA: XBRL DOCUMENT v3.20.4
Other Payables and Accrued Liabilities - Schedule of Other Payables and Accrued Liabilities (Details) - USD ($)
Sep. 30, 2020
Dec. 31, 2019
Common outstanding from third parties $ 42,798 $ 80,620
Share subscription receipts in advance 110,000 104,000
Other payables and accrued liabilities 510,723 494,045
Malaysia [Member]    
Accrued expenses - Balance bring forward  
Accrued expenses - payroll 23,640 18,550
Accrued expenses - payroll deduction 8,961 7,873
Accrued expenses - professional fee 1,619 11,499
Accrued expenses - Commission 37,255 43,563
Accrued expenses - expense 787 1,157
Accrued expenses 72,262 82,642
China [Member]    
Common outstanding from third parties 147 861
Third Party [Member]    
Other payables generated from Local 5,262 41,645
Accrued other expenses
Third Party [Member] | Malaysia [Member]    
Other payables from non-trade payable 36,562 37,110
Common outstanding from third parties 827 1,004
Third Party [Member] | Hong Kong [Member]    
Deposits received from customers $ 285,663 $ 226,783
XML 62 R52.htm IDEA: XBRL DOCUMENT v3.20.4
Income Taxes (Details Narrative)
 9 Months Ended
Sep. 30, 2020
USD ($)
United States of America [Member]  
Cumulative net operating loss $ 461,206
Net operating loss carryforward expiration Begin to expire in 2039
Valuation allowance $ 4,896
Malaysia [Member]  
Income tax rate, percentage 24.00%
Hong Kong [Member]  
Income tax rate, percentage 16.50%
China [Member]  
Income tax rate, percentage 25.00%
XML 63 R53.htm IDEA: XBRL DOCUMENT v3.20.4
Income Taxes - Schedule of Profit or Loss Before Income Tax (Details) - USD ($)
 9 Months Ended
Sep. 30, 2020
Sep. 30, 2019
Tax jurisdictions from: Local $ (58,232) $ (36,326)
Profit/(Loss) before income tax 315,929 7,366
Malaysia [Member]    
Tax jurisdictions from: Foreign, representing 392,990 47,020
Hong Kong [Member]    
Tax jurisdictions from: Foreign, representing (17,775) (1,859)
China [Member]    
Tax jurisdictions from: Foreign, representing $ (1,054) $ (1,469)
XML 64 R54.htm IDEA: XBRL DOCUMENT v3.20.4
Income Taxes - Schedule of Provision for Income Tax (Details) - USD ($)
 3 Months Ended 9 Months Ended
Sep. 30, 2020
Sep. 30, 2019
Sep. 30, 2020
Sep. 30, 2019
Tax expense - Current Local    
Deferred Local    
Provision for income taxes
Malaysia [Member]        
Tax expense - Current Foreign, representing    
Tax expense - Prior year Foreign, representing    
Deferred Foreign, representing    
Hong Kong [Member]        
Tax expense - Current Foreign, representing    
Deferred Foreign, representing    
XML 65 R55.htm IDEA: XBRL DOCUMENT v3.20.4
Stockholders' Equity (Details Narrative) - shares
Sep. 30, 2020
Dec. 31, 2019
Equity [Abstract]    
Common stock, shares issued 362,905,561 359,305,561
Common stock, shares outstanding 362,905,561 359,305,561
XML 66 R56.htm IDEA: XBRL DOCUMENT v3.20.4
Stockholders' Equity - Schedule of Stockholders' Equity (Details) - USD ($)
 3 Months Ended 9 Months Ended 12 Months Ended
Mar. 31, 2020
Sep. 30, 2020
Dec. 31, 2019
Equity [Abstract]      
At the beginning of the period $ 2,034,801 $ 2,034,801 $ 2,034,801
Issued during the period $ 360 360
At the end of the period   $ 2,035,161 $ 2,034,801
XML 67 R57.htm IDEA: XBRL DOCUMENT v3.20.4
Concentration of Risk - Schedules of Concentration of Risk by Major Customer and Major Suppliers (Details) - USD ($)
 3 Months Ended 9 Months Ended
Sep. 30, 2020
Sep. 30, 2019
Sep. 30, 2020
Sep. 30, 2019
Revenues and Its Accounts Receivable [Member] | Major Customers [Member]        
Revenues $ 522,046 $ 109,236 $ 1,102,917 $ 202,710
Percentage of revenues 52.00% 24.00% 44.00% 16.00%
Revenues and Its Accounts Receivable [Member] | Major Customers [Member] | Customer A [Member]        
Revenues $ 55,257 $ 138,771 $ 153,195
Percentage of revenues 12.00% 5.00% 12.00%
Revenues and Its Accounts Receivable [Member] | Major Customers [Member] | Customer B [Member]        
Revenues $ 152,423 $ 53,979 $ 964,146 $ 49,515
Percentage of revenues 15.00% 12.00% 39.00% 4.00%
Revenues and Its Accounts Receivable [Member] | Major Customers [Member] | Customer C [Member]        
Revenues $ 369,623    
Percentage of revenues 37.00%    
Outstanding Payables [Member] | Major Suppliers [Member]        
Revenues $ 517,043 $ 93,455 $ 883,758 $ 283,389
Percentage of revenues 94.00% 88.00% 81.00% 93.00%
Outstanding Payables [Member] | Major Suppliers [Member] | Customer A [Member]        
Revenues $ 352,297 $ 93,455 $ 633,555 $ 267,081
Percentage of revenues 64.00% 88.00% 58.00% 88.00%
Outstanding Payables [Member] | Major Suppliers [Member] | Customer B [Member]        
Revenues $ 99,328 $ 250,203 $ 16,308
Percentage of revenues 18.00% 23.00% 5.00%
Outstanding Payables [Member] | Major Suppliers [Member] | Customer C [Member]        
Revenues $ 65,418    
Percentage of revenues 12.00%    
XML 68 R58.htm IDEA: XBRL DOCUMENT v3.20.4
Other Income - Schedule of Other Income (Details) - USD ($)
 9 Months Ended
Sep. 30, 2020
Sep. 30, 2019
Other Income and Expenses [Abstract]    
Other income $ 192 $ 77
Realized gain on foreign exchange 1,999 3,323
Other income 2,191 3,400
Gain on disposal of subsidiary $ 17,505 $ 1,099
EXCEL 69 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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

-8?20$3;8T.P6BP^0"X99K>]9!:GJ)4AM=ZB>5CWJ#GO!K^_"W=?K)FB"+>>9L M48QZP[;ANW)!9Z]VSVO(>[GPS9X@%W<20$:]\P&<<*F=#\T1S?DE,.X4'-QN M5<%>Z2(H-Y5!_>5LM=5F59\&[J*/;J.)P^&S#>*%^S]AM,NESM349E6I3&CC MZ%11 QJ_UEO?$T:6:M0['"*DR<6E"1 D<6W:4\&Q]9W"I:_S]JX#X*(8N@L- M#>XZ;\#Y(">P;0N=P]5S,9:%-)D237 ] HP(P.AD@.+=3"+(F(",WQ!R7D/4 M/_#"+L7M5CD$F1"0R2D@:\;)6IH5@DP)R/1DD9Q(OT:0YP3D.2_DK5M)HY^: MAF9VCRNOC?(>!FBVP9%\3T"^YX6<5V4IW;Z.W%ROC(:?2>CN+UEF*UB,$.0' M O(#+^27LH81TTJ)I;.EN*L/@IZ?2?""PDO01P+R(R_DM=G! :"P#M!P0*W: M ^81&-;*0;0RI7<2+NW/Q%1MK=.9&R6]PI248X;,DAE+LQ%CZYQ] M@)2F,Q0IJPR9M=(.Q9G<-^.PZ6)88UP%L_A&RP7&I+PR9!;+M_I/]'1N4,266^$TJDE^D@9W>CBG-Q,R:P6G@T1A2IHFY M37,D'SP*23[JXG_6]3HQ/$I):29^DZKDW]X^!D?))6:6"ZUJ[,"8\DQ\RL=< M/Q*,27DF9O8,C9EB3,HS,;-GZ,2G$TW*,S&S9VA,',V$TDW"7L=0F.<8D])- MPJZ;ES3R#S&',^95H6KJI@5C4N))N!^ D1DE7I 22CT)=XE#8N(IE)#O69C= M0R>^G6A2%DJ8+41C=J))62CAMA"5GW<2RX2R4,)M(1*ST^F4A1)F"[TJ(Z8J M2%UX\54Z2.DP)F6AY(VKG>[:.<;O*BD+I2G"GIY2%TCKH]KG?XV61* M62AEME 'L]OCL%8M,29EH9390C3F#F-2%DJY'[0=+2:?.Q]CDN_[F2UT%/,E MJAB3LE#*;*'C5>\S)\:D+)1R6PB7O=VQ63=A3,I":6.A_N$_4KE:0D&5?X5+ M>-B?R2*;.5%_M*]ND[1^\[*LBF("^V[-C97YX2]7A[^+??X'4$L#!!0 ( M ."C)U(3)^RZ[P$ *4B : >&PO7W)E;',O=V]R:V)O;VLN>&UL+G)E M;'/-VKM.ZT 4A>%7B?P 3/8MP!&AHJ%%O( 5)A>1Q)8]"'A[HE"$95&KU;Y8=N]7;(Q_++ MX/3>#:_C-N?2S)[;89/+LDD?^\OI,9T/7Y;-\/@B3:H=I!"D]8,, M@JQ^D$.0UP\*"(KZ00L(6M0/NH:@Z_I!-Q!T4S_H%H)NZP?)'&6<$R1-L";0 M6I!K(?!:$&PA$%N0;"$P6Q!M(5!;D&TA<%L0;B&06Y!N(;!;$&\AT%M1;R70 M6U%O)=!;)R_;!'HKZJT$>BOJK01Z*^JM!'HKZJT$>BOJK01Z*^JM!'HKZJT$ M>AOJ;01Z&^IM!'H;ZFT$>MMDLX1 ;T.]C4!O0[V-0&]#O8U ;T.]C4!O0[V- M0&]#O8U ;T>]G4!O1[V=0&]'O9U ;T>]G4!OGVQV$^CMJ+<3Z.VHMQ/H[:BW M$^CMJ+<3Z.VHMQ/H':AW$.@=J'<0Z!VH=Q#H':AW$.@=J'<0Z!V3CY4$>@?J M'01Z!^H=!'H'ZAU_J?=8/O=YO/1\K_'Y?TEU.=V;+X\_+[]/HH2+,\X)_DJY M_P)02P,$% @ X*,G4F(CYQC8 0 2"( !, !;0V]N=&5N=%]4>7!E M&ULS=I=3X,P% ;@O[)P:T;7K_D1YXUZJU[X!RJ<#3*@3=O-^>\M3$TT M2EQFXGL#@;;G/;3)<\7EXXNC,-FU31<6616CNV L%!6U)N3649=&EM:W)J9' MOV+.%&NS(B9FLSDK;!>IB]/8U\BN+F]H:39-G-SNTNM0VVZ1>6I"-KG>3^RS M%IEQKJD+$],XVW;EEY3I6T*>5@YS0E6[<)(F9.S;A'[DYX"W=?=;\KXN:?)@ M?+PS;9K%=@T+\:6AD(^7^*9'NUS6!96VV+1I21Z<)U.&BBBV3;XO>C*>'-,. MT_[*C\X?RHP%IID/WKJ03LS3X7'O1]*OGKI4B'RLQS_Q(S&5/OK[J#_MDLI? M9J?M?;9^/9Q'8,/M^#W^?,8?]0_L0X#T(4'Z4"!]:) ^YB!]G(+T<0;2QSE( M'WR&T@B*J!R%5(YB*D=!E:.HRE%8Y2BN&UL M4$L! A0#% @ X*,G4EGLTZKO *P( !$ ( !KP M &1O8U!R;W!S+V-O&UL4$L! A0#% @ X*,G4IE&PO=V]R M:W-H965T&UL4$L! A0#% @ X*,G4DQ4.36&!@ J1D M !@ ("!!0P 'AL+W=O&PO=V]R:W-H965T&UL4$L! A0#% @ X*,G4IHTZ9K\!0 "R, !@ ("! M(AL 'AL+W=O @< #L< 8 " @50A !X;"]W;W)K&PO=V]R:W-H965T&UL4$L! A0#% @ MX*,G4@EEB\U^#@ X"0 !@ ("!&"\ 'AL+W=O&PO=V]R M:W-H965T&UL M4$L! A0#% @ X*,G4H,3_$!O! , D !D ("![D4 M 'AL+W=O&PO=V]R:W-H965T&UL4$L! A0#% @ MX*,G4CEH;E* P .0< !D ("!.%( 'AL+W=O&PO=V]R:W-H965T&UL4$L! A0#% @ X*,G4GO ?931 P M*0H !D ("!L%X 'AL+W=O&PO=V]R:W-H965T&UL4$L! A0#% @ X*,G4N?S,<;* @ !P8 !D M ("!:6@ 'AL+W=O&PO=V]R:W-H M965T&UL4$L! M A0#% @ X*,G4G373#U6! G D !D ("!L'X 'AL M+W=O&PO=V]R:W-H965T&UL4$L! A0#% @ X*,G M4C[&?[+& @ +08 !D ("!RXD 'AL+W=O&PO=V]R:W-H965T&UL4$L! A0#% @ X*,G4A7V,2.8 @ >04 M !D ("!FY, 'AL+W=O&PO=V]R:W-H965T M&0, $H' 9 " @0J: !X;"]W;W)K&UL4$L! A0#% @ X*,G4D-'51]B @ +04 !D M ("!6IT 'AL+W=O&PO=V]R:W-H965T M&UL4$L! A0# M% @ X*,G4E;&&B=Y @ )P< !D ("!GZ8 'AL+W=O M&PO=V]R:W-H965T&UL4$L! A0#% @ X*,G4EFA M=I72 @ #08 !D ("!L[( 'AL+W=O&PO=V]R:W-H965TY !X;"]W;W)K&UL4$L! A0#% @ X*,G4C&PO M=V]R:W-H965T&UL4$L! A0#% @ X*,G4D;V\CC^ @ (@D !D ("! M+\4 'AL+W=O&PO=V]R:W-H965T+MP:9 ( ,@& 9 M " @1W- !X;"]W;W)K&UL4$L! A0#% M @ X*,G4BW\'PWE @ )0D !D ("!N,\ 'AL+W=O&PO=V]R:W-H965T&PO=V]R:W-H965T]O[0( +$( 9 " @1_A !X;"]W;W)K&UL4$L! A0#% @ X*,G4J&+CZT< P +PX !D M ("!0^0 'AL+W=O&PO=V]R M:W-H965TKI !X;"]W;W)K&UL M4$L! A0#% @ X*,G4CG+^I[X! HAH !D ("!P^P M 'AL+W=O&PO=V]R:W-H965T7!E <&UL4$L%!@ !" $( !1( $ XML 70 Show.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} XML 71 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 72 FilingSummary.xml IDEA: XBRL DOCUMENT 3.20.4 html 177 288 1 true 49 0 false 6 false false R1.htm 00000001 - Document - Document and Entity Information Sheet http://bioplus.in/role/DocumentAndEntityInformation Document and Entity Information Cover 1 false false R2.htm 00000002 - Statement - Consolidated Balance Sheets Sheet http://bioplus.in/role/BalanceSheets Consolidated Balance Sheets Statements 2 false false R3.htm 00000003 - Statement - Consolidated Balance Sheets (Parenthetical) Sheet http://bioplus.in/role/BalanceSheetsParenthetical Consolidated Balance Sheets (Parenthetical) Statements 3 false false R4.htm 00000004 - Statement - Consolidated Statements of Operations and Comprehensive Income/ (Loss) (Unaudited) Sheet http://bioplus.in/role/StatementsOfOperationsAndComprehensiveIncomeLoss Consolidated Statements of Operations and Comprehensive Income/ (Loss) (Unaudited) Statements 4 false false R5.htm 00000005 - Statement - Consolidated Statement of Changes in Stockholders' Equity Sheet http://bioplus.in/role/StatementOfChangesInStockholdersEquity Consolidated Statement of Changes in Stockholders' Equity Statements 5 false false R6.htm 00000006 - Statement - Consolidated Statements of Cash Flows (Unaudited) Sheet http://bioplus.in/role/StatementsOfCashFlows Consolidated Statements of Cash Flows (Unaudited) Statements 6 false false R7.htm 00000007 - Disclosure - Organization and Business Background Sheet http://bioplus.in/role/OrganizationAndBusinessBackground Organization and Business Background Notes 7 false false R8.htm 00000008 - Disclosure - Summary of Significant Accounting Policies Sheet http://bioplus.in/role/SummaryOfSignificantAccountingPolicies Summary of Significant Accounting Policies Notes 8 false false R9.htm 00000009 - Disclosure - Amount Due from Related Parties Sheet http://bioplus.in/role/AmountDueFromRelatedParties Amount Due from Related Parties Notes 9 false false R10.htm 00000010 - Disclosure - Inventories Sheet http://bioplus.in/role/Inventories Inventories Notes 10 false false R11.htm 00000011 - Disclosure - Other Receivables, Deposits and Prepayments Sheet http://bioplus.in/role/OtherReceivablesDepositsAndPrepayments Other Receivables, Deposits and Prepayments Notes 11 false false R12.htm 00000012 - Disclosure - Property, Plant and Equipment, Net Sheet http://bioplus.in/role/PropertyPlantAndEquipmentNet Property, Plant and Equipment, Net Notes 12 false false R13.htm 00000013 - Disclosure - Obligation Under Finance Lease Sheet http://bioplus.in/role/ObligationUnderFinanceLease Obligation Under Finance Lease Notes 13 false false R14.htm 00000014 - Disclosure - Bank Borrowings Sheet http://bioplus.in/role/BankBorrowings Bank Borrowings Notes 14 false false R15.htm 00000015 - Disclosure - Other Payables and Accrued Liabilities Sheet http://bioplus.in/role/OtherPayablesAndAccruedLiabilities Other Payables and Accrued Liabilities Notes 15 false false R16.htm 00000016 - Disclosure - Income Taxes Sheet http://bioplus.in/role/IncomeTaxes Income Taxes Notes 16 false false R17.htm 00000017 - Disclosure - Stockholders' Equity Sheet http://bioplus.in/role/StockholdersEquity Stockholders' Equity Notes 17 false false R18.htm 00000018 - Disclosure - Concentration of Risk Sheet http://bioplus.in/role/ConcentrationOfRisk Concentration of Risk Notes 18 false false R19.htm 00000019 - Disclosure - Other Income Sheet http://bioplus.in/role/OtherIncome Other Income Notes 19 false false R20.htm 00000020 - Disclosure - Foreign Currency Exchange Rate Sheet http://bioplus.in/role/ForeignCurrencyExchangeRate Foreign Currency Exchange Rate Notes 20 false false R21.htm 00000021 - Disclosure - Subsequent Events Sheet http://bioplus.in/role/SubsequentEvents Subsequent Events Notes 21 false false R22.htm 00000022 - Disclosure - Significant Events Sheet http://bioplus.in/role/SignificantEvents Significant Events Notes 22 false false R23.htm 00000023 - Disclosure - Summary of Significant Accounting Policies (Policies) Sheet http://bioplus.in/role/SummaryOfSignificantAccountingPoliciesPolicies Summary of Significant Accounting Policies (Policies) Policies http://bioplus.in/role/SummaryOfSignificantAccountingPolicies 23 false false R24.htm 00000024 - Disclosure - Organization and Business Background (Tables) Sheet http://bioplus.in/role/OrganizationAndBusinessBackgroundTables Organization and Business Background (Tables) Tables http://bioplus.in/role/OrganizationAndBusinessBackground 24 false false R25.htm 00000025 - Disclosure - Summary of Significant Accounting Policies (Tables) Sheet http://bioplus.in/role/SummaryOfSignificantAccountingPoliciesTables Summary of Significant Accounting Policies (Tables) Tables http://bioplus.in/role/SummaryOfSignificantAccountingPolicies 25 false false R26.htm 00000026 - Disclosure - Inventories (Tables) Sheet http://bioplus.in/role/InventoriesTables Inventories (Tables) Tables http://bioplus.in/role/Inventories 26 false false R27.htm 00000027 - Disclosure - Other Receivables, Deposits and Prepayments (Tables) Sheet http://bioplus.in/role/OtherReceivablesDepositsAndPrepaymentsTables Other Receivables, Deposits and Prepayments (Tables) Tables http://bioplus.in/role/OtherReceivablesDepositsAndPrepayments 27 false false R28.htm 00000028 - Disclosure - Property, Plant and Equipment, Net (Tables) Sheet http://bioplus.in/role/PropertyPlantAndEquipmentNetTables Property, Plant and Equipment, Net (Tables) Tables http://bioplus.in/role/PropertyPlantAndEquipmentNet 28 false false R29.htm 00000029 - Disclosure - Obligation Under Finance Lease (Tables) Sheet http://bioplus.in/role/ObligationUnderFinanceLeaseTables Obligation Under Finance Lease (Tables) Tables http://bioplus.in/role/ObligationUnderFinanceLease 29 false false R30.htm 00000030 - Disclosure - Bank Borrowings (Tables) Sheet http://bioplus.in/role/BankBorrowingsTables Bank Borrowings (Tables) Tables http://bioplus.in/role/BankBorrowings 30 false false R31.htm 00000031 - Disclosure - Other Payables and Accrued Liabilities (Tables) Sheet http://bioplus.in/role/OtherPayablesAndAccruedLiabilitiesTables Other Payables and Accrued Liabilities (Tables) Tables http://bioplus.in/role/OtherPayablesAndAccruedLiabilities 31 false false R32.htm 00000032 - Disclosure - Income Taxes (Tables) Sheet http://bioplus.in/role/IncomeTaxesTables Income Taxes (Tables) Tables http://bioplus.in/role/IncomeTaxes 32 false false R33.htm 00000033 - Disclosure - Stockholders' Equity (Tables) Sheet http://bioplus.in/role/StockholdersEquityTables Stockholders' Equity (Tables) Tables http://bioplus.in/role/StockholdersEquity 33 false false R34.htm 00000034 - Disclosure - Concentration of Risk (Tables) Sheet http://bioplus.in/role/ConcentrationOfRiskTables Concentration of Risk (Tables) Tables http://bioplus.in/role/ConcentrationOfRisk 34 false false R35.htm 00000035 - Disclosure - Other Income (Tables) Sheet http://bioplus.in/role/OtherIncomeTables Other Income (Tables) Tables http://bioplus.in/role/OtherIncome 35 false false R36.htm 00000036 - Disclosure - Organization and Business Background (Details Narrative) Sheet http://bioplus.in/role/OrganizationAndBusinessBackgroundDetailsNarrative Organization and Business Background (Details Narrative) Details http://bioplus.in/role/OrganizationAndBusinessBackgroundTables 36 false false R37.htm 00000037 - Disclosure - Organization and Business Background - Schedule of Subsidiaries Details (Details) Sheet http://bioplus.in/role/OrganizationAndBusinessBackground-ScheduleOfSubsidiariesDetailsDetails Organization and Business Background - Schedule of Subsidiaries Details (Details) Details 37 false false R38.htm 00000038 - Disclosure - Organization and Business Background - Schedule of Subsidiaries Details (Details) (Parenthetical) Sheet http://bioplus.in/role/OrganizationAndBusinessBackground-ScheduleOfSubsidiariesDetailsDetailsParenthetical Organization and Business Background - Schedule of Subsidiaries Details (Details) (Parenthetical) Details 38 false false R39.htm 00000039 - Disclosure - Summary of Significant Accounting Policies (Details Narrative) Sheet http://bioplus.in/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative Summary of Significant Accounting Policies (Details Narrative) Details http://bioplus.in/role/SummaryOfSignificantAccountingPoliciesTables 39 false false R40.htm 00000040 - Disclosure - Summary of Significant Accounting Policies - Schedule of Property Plant and Equipment, Principal Annual Rates/Expected Useful Life (Details) Sheet http://bioplus.in/role/SummaryOfSignificantAccountingPolicies-ScheduleOfPropertyPlantAndEquipmentPrincipalAnnualRatesexpectedUsefulLifeDetails Summary of Significant Accounting Policies - Schedule of Property Plant and Equipment, Principal Annual Rates/Expected Useful Life (Details) Details 40 false false R41.htm 00000041 - Disclosure - Summary of Significant Accounting Policies - Schedule of Exchange Rates (Details) Sheet http://bioplus.in/role/SummaryOfSignificantAccountingPolicies-ScheduleOfExchangeRatesDetails Summary of Significant Accounting Policies - Schedule of Exchange Rates (Details) Details 41 false false R42.htm 00000042 - Disclosure - Inventories - Schedule of Inventories (Details) Sheet http://bioplus.in/role/Inventories-ScheduleOfInventoriesDetails Inventories - Schedule of Inventories (Details) Details 42 false false R43.htm 00000043 - Disclosure - Other Receivables, Deposits and Prepayments - Summary of Other Receivables, Deposits and Prepayments (Details) Sheet http://bioplus.in/role/OtherReceivablesDepositsAndPrepayments-SummaryOfOtherReceivablesDepositsAndPrepaymentsDetails Other Receivables, Deposits and Prepayments - Summary of Other Receivables, Deposits and Prepayments (Details) Details 43 false false R44.htm 00000044 - Disclosure - Other Receivables, Deposits and Prepayments - Summary of Other Receivables, Deposits and Prepayments (Details) (Parenthetical) Sheet http://bioplus.in/role/OtherReceivablesDepositsAndPrepayments-SummaryOfOtherReceivablesDepositsAndPrepaymentsDetailsParenthetical Other Receivables, Deposits and Prepayments - Summary of Other Receivables, Deposits and Prepayments (Details) (Parenthetical) Details 44 false false R45.htm 00000045 - Disclosure - Property, Plant and Equipment, Net (Details Narrative) Sheet http://bioplus.in/role/PropertyPlantAndEquipmentNetDetailsNarrative Property, Plant and Equipment, Net (Details Narrative) Details http://bioplus.in/role/PropertyPlantAndEquipmentNetTables 45 false false R46.htm 00000046 - Disclosure - Property, Plant and Equipment, Net - Schedule of Property, Plant and Equipment (Details) Sheet http://bioplus.in/role/PropertyPlantAndEquipmentNet-ScheduleOfPropertyPlantAndEquipmentDetails Property, Plant and Equipment, Net - Schedule of Property, Plant and Equipment (Details) Details 46 false false R47.htm 00000047 - Disclosure - Obligation Under Finance Lease (Details Narrative) Sheet http://bioplus.in/role/ObligationUnderFinanceLeaseDetailsNarrative Obligation Under Finance Lease (Details Narrative) Details http://bioplus.in/role/ObligationUnderFinanceLeaseTables 47 false false R48.htm 00000048 - Disclosure - Obligation Under Finance Lease - Schedule of Obligation Under Finance Lease (Details) Sheet http://bioplus.in/role/ObligationUnderFinanceLease-ScheduleOfObligationUnderFinanceLeaseDetails Obligation Under Finance Lease - Schedule of Obligation Under Finance Lease (Details) Details 48 false false R49.htm 00000049 - Disclosure - Bank Borrowings (Details Narrative) Sheet http://bioplus.in/role/BankBorrowingsDetailsNarrative Bank Borrowings (Details Narrative) Details http://bioplus.in/role/BankBorrowingsTables 49 false false R50.htm 00000050 - Disclosure - Bank Borrowings - Schedule of Bank Borrowings (Details) Sheet http://bioplus.in/role/BankBorrowings-ScheduleOfBankBorrowingsDetails Bank Borrowings - Schedule of Bank Borrowings (Details) Details 50 false false R51.htm 00000051 - Disclosure - Other Payables and Accrued Liabilities - Schedule of Other Payables and Accrued Liabilities (Details) Sheet http://bioplus.in/role/OtherPayablesAndAccruedLiabilities-ScheduleOfOtherPayablesAndAccruedLiabilitiesDetails Other Payables and Accrued Liabilities - Schedule of Other Payables and Accrued Liabilities (Details) Details 51 false false R52.htm 00000052 - Disclosure - Income Taxes (Details Narrative) Sheet http://bioplus.in/role/IncomeTaxesDetailsNarrative Income Taxes (Details Narrative) Details http://bioplus.in/role/IncomeTaxesTables 52 false false R53.htm 00000053 - Disclosure - Income Taxes - Schedule of Profit or Loss Before Income Tax (Details) Sheet http://bioplus.in/role/IncomeTaxes-ScheduleOfProfitOrLossBeforeIncomeTaxDetails Income Taxes - Schedule of Profit or Loss Before Income Tax (Details) Details 53 false false R54.htm 00000054 - Disclosure - Income Taxes - Schedule of Provision for Income Tax (Details) Sheet http://bioplus.in/role/IncomeTaxes-ScheduleOfProvisionForIncomeTaxDetails Income Taxes - Schedule of Provision for Income Tax (Details) Details 54 false false R55.htm 00000055 - Disclosure - Stockholders' Equity (Details Narrative) Sheet http://bioplus.in/role/StockholdersEquityDetailsNarrative Stockholders' Equity (Details Narrative) Details http://bioplus.in/role/StockholdersEquityTables 55 false false R56.htm 00000056 - Disclosure - Stockholders' Equity - Schedule of Stockholders' Equity (Details) Sheet http://bioplus.in/role/StockholdersEquity-ScheduleOfStockholdersEquityDetails Stockholders' Equity - Schedule of Stockholders' Equity (Details) Details 56 false false R57.htm 00000057 - Disclosure - Concentration of Risk - Schedules of Concentration of Risk by Major Customer and Major Suppliers (Details) Sheet http://bioplus.in/role/ConcentrationOfRisk-SchedulesOfConcentrationOfRiskByMajorCustomerAndMajorSuppliersDetails Concentration of Risk - Schedules of Concentration of Risk by Major Customer and Major Suppliers (Details) Details 57 false false R58.htm 00000058 - Disclosure - Other Income - Schedule of Other Income (Details) Sheet http://bioplus.in/role/OtherIncome-ScheduleOfOtherIncomeDetails Other Income - Schedule of Other Income (Details) Details 58 false false All Reports Book All Reports biopl-20200930.xml biopl-20200930.xsd biopl-20200930_cal.xml biopl-20200930_def.xml biopl-20200930_lab.xml biopl-20200930_pre.xml http://xbrl.sec.gov/country/2020-01-31 http://fasb.org/us-gaap/2020-01-31 http://xbrl.sec.gov/dei/2020-01-31 http://fasb.org/srt/2020-01-31 true true ZIP 74 0001493152-21-000499-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001493152-21-000499-xbrl.zip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end